data_1ayk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ayk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.492 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.498 ' C ' ' HG ' ' A' ' 163' ' ' SER . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.443 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 61' ' ' ILE . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.571 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 104' ' ' THR . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.543 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 10.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.584 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 18' ' ' ILE . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.584 ' H ' ' HG1' ' A' ' 15' ' ' THR . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 61' ' ' ILE . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.65 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.54 ' CG ' HD22 ' A' ' 106' ' ' ASN . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.633 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.633 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.435 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.458 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.627 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.627 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.503 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 153' ' ' ILE . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 159' ' ' ILE . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HH ' ' CG ' ' A' ' 31' ' ' ASP . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' CG ' ' HH ' ' A' ' 21' ' ' TYR . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.591 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 47' ' ' LEU . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 59' ' ' ILE . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 61' ' ' ILE . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 106' ' ' ASN . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' O ' ' OG ' ' A' ' 123' ' ' SER . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.426 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' OH ' ' OD1' ' A' ' 31' ' ' ASP . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' A' ' 21' ' ' TYR . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 47' ' ' LEU . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.417 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.592 HD22 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.592 ' NE ' HD22 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.458 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.458 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.409 ' OH ' ' OD1' ' A' ' 31' ' ' ASP . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' A' ' 21' ' ' TYR . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.418 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 61' ' ' ILE . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.653 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.653 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 122' ' ' HIS . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 159' ' ' ILE . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 18' ' ' ILE . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 59' ' ' ILE . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.653 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.532 ' CG ' HD22 ' A' ' 106' ' ' ASN . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.452 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 80.9 m-20 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.476 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 132' ' ' ILE . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.476 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 153' ' ' ILE . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 47' ' ' LEU . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 59' ' ' ILE . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.681 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.485 ' CG ' HD22 ' A' ' 106' ' ' ASN . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.474 ' NE ' ' O ' ' A' ' 141' ' ' THR . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.413 ' O ' ' CG2' ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.474 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.8 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 159' ' ' ILE . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' OG1' ' OE2' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' LEU . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 59' ' ' ILE . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.47 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.409 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.409 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 8' ' ' ARG . 52.4 mtt-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.72 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.72 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' H ' ' HG1' ' A' ' 15' ' ' THR . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.648 HD22 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NE ' HD22 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 129' ' ' SER . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 134' ' ' ALA . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 8' ' ' ARG . 41.6 mtt-85 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 121.468 0.652 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.74 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.74 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 44.6 m80 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 47' ' ' LEU . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 106' ' ' ASN . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 94.1 m-20 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.418 ' O ' ' OG ' ' A' ' 123' ' ' SER . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.427 ' C ' ' HG ' ' A' ' 139' ' ' SER . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 145' ' ' ASP . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 143' ' ' SER . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 47' ' ' LEU . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.49 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.1 m-80 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 159' ' ' ILE . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.545 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 18' ' ' ILE . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 24' ' ' ASP . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' THR . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 47' ' ' LEU . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.545 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.671 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.0 OUTLIER -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.554 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.554 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' NE2' ' A' ' 147' ' ' GLN . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.516 ' NE2' ' OD2' ' A' ' 145' ' ' ASP . 50.4 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.524 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.692 ' H ' ' HZ3' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.466 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.692 ' HZ3' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 59' ' ' ILE . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 102' ' ' ARG . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.663 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.597 ' CG ' HD22 ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.432 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.539 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.539 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 132' ' ' ILE . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.708 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.708 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 18' ' ' ILE . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD21 ' A' ' 111' ' ' ASN . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.3 m120 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.435 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.64 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 32.0 m170 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.556 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.433 ' O ' ' OG1' ' A' ' 45' ' ' THR . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.64 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.556 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.403 ' N ' ' HH ' ' A' ' 140' ' ' TYR . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.407 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.461 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.461 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.55 ' HG ' ' N ' ' A' ' 130' ' ' THR . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.55 ' N ' ' HG ' ' A' ' 129' ' ' SER . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.403 ' HH ' ' N ' ' A' ' 111' ' ' ASN . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.6 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 159' ' ' ILE . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.161 0.505 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.703 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.703 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.591 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.591 ' H ' ' HG1' ' A' ' 22' ' ' THR . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.413 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.582 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 109' ' ' GLU . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.625 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.6 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 159' ' ' ILE . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.478 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 45' ' ' THR . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 130' ' ' THR . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 129' ' ' SER . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 153' ' ' ILE . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 159' ' ' ILE . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 15.0 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.8 m170 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.525 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.43 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' H ' ' HG1' ' A' ' 15' ' ' THR . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 59' ' ' ILE . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.463 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.454 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.438 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 129' ' ' SER . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.459 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 159' ' ' ILE . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.535 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 18' ' ' ILE . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 47' ' ' LEU . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.535 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.3 m120 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.562 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.409 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.545 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.545 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 153' ' ' ILE . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.481 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.594 ' HG ' ' N ' ' A' ' 130' ' ' THR . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.594 ' N ' ' HG ' ' A' ' 129' ' ' SER . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 153' ' ' ILE . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 159' ' ' ILE . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.453 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.585 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' LEU . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.585 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 60' ' ' MET . 72.6 tp60 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 102' ' ' ARG . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.51 ' NE2' ' NE2' ' A' ' 128' ' ' HIS . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.51 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 50.3 m170 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 45' ' ' THR . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 124' ' ' LEU . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' A' ' 123' ' ' SER . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.456 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 159' ' ' ILE . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.496 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 18' ' ' ILE . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 47' ' ' LEU . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.484 ' C ' ' HG ' ' A' ' 163' ' ' SER . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.496 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' CB ' ' HZ1' ' A' ' 51' ' ' LYS . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 159' ' ' ILE . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.484 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 24.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.508 0.67 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 18' ' ' ILE . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.4 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.4 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 153' ' ' ILE . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.475 ' HG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' O ' ' NE2' ' A' ' 157' ' ' GLN . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.494 ' N ' HD21 ' A' ' 71' ' ' ASN . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.582 HD22 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.582 ' NE ' HD22 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.571 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HE ' HD21 ' A' ' 111' ' ' ASN . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.554 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 145' ' ' ASP . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' SER . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 3.2 mm-40 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 18' ' ' ILE . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.509 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.701 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 18' ' ' ILE . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.406 ' O ' ' OG1' ' A' ' 45' ' ' THR . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 61' ' ' ILE . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' NE2' ' NE2' ' A' ' 68' ' ' HIS . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.682 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.512 ' O ' ' C ' ' A' ' 109' ' ' GLU . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.44 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' OH ' ' OD1' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 18' ' ' ILE . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.43 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.41 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.475 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.475 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.41 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HG2' ' A' ' 8' ' ' ARG . 56.4 mtt-85 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.586 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 18' ' ' ILE . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.586 ' H ' ' HG1' ' A' ' 15' ' ' THR . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.535 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.525 HD22 ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' CG ' HD22 ' A' ' 106' ' ' ASN . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 123' ' ' SER . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 124' ' ' LEU . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' A' ' 123' ' ' SER . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 134' ' ' ALA . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.724 0.773 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.15 -49.93 75.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.134 . . . . 0.0 109.055 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.1 p -99.17 140.95 32.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.494 -0.754 . . . . 0.0 109.639 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.64 139.76 53.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.17 -146.51 50.43 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.29 149.14 72.07 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.265 . . . . 0.0 108.689 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -62.43 106.06 0.46 Allowed 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.089 1.193 . . . . 0.0 109.831 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -95.65 156.01 16.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.167 -0.958 . . . . 0.0 108.844 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.492 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.498 ' C ' ' HG ' ' A' ' 163' ' ' SER . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 61' ' ' ILE . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.571 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 104' ' ' THR . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.543 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.543 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 10.4 m -75.57 65.92 1.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.05 135.36 46.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.437 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -156.29 76.44 4.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.791 . . . . 0.0 109.716 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.72 105.99 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.138 1.225 . . . . 0.0 109.676 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.52 138.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 110.438 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.27 149.97 53.62 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.537 0.657 0 C-N-CA 120.925 1.083 . . . . 0.0 109.961 178.709 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.72 146.6 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.333 -0.854 . . . . 0.0 108.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.3 p -88.76 164.29 15.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -67.02 139.23 57.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.336 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.99 -165.27 37.85 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 8' ' ' ARG . 20.1 m-20 -77.91 133.13 66.12 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.181 -1.188 . . . . 0.0 108.763 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD2' HH11 ' A' ' 8' ' ' ARG . 4.8 Cg_endo -63.15 20.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 120.958 1.105 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.621 ' H ' ' C ' ' A' ' 6' ' ' ASN . 10.0 mpt_? -98.04 165.79 11.74 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -0.892 . . . . 0.0 108.894 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.584 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 18' ' ' ILE . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.584 ' H ' ' HG1' ' A' ' 15' ' ' THR . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 61' ' ' ILE . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.65 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.54 ' CG ' HD22 ' A' ' 106' ' ' ASN . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.633 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.633 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.435 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m -76.65 62.83 2.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 27.4 mt-30 -70.77 136.22 48.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 108.805 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 12.6 m120 -152.56 149.49 22.69 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 108.761 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.1 168.04 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.59 135.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.262 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -80.29 150.25 70.57 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.823 1.015 . . . . 0.0 109.693 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.749 0.785 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.9 mt -86.47 -72.25 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 109.506 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.3 p -93.03 152.48 19.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 109.614 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.99 140.5 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.839 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.93 -157.9 53.64 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -77.25 149.98 79.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.259 -1.142 . . . . 0.0 109.013 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.4 -178.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.075 1.184 . . . . 0.0 110.007 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -145.71 151.58 38.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.367 -0.833 . . . . 0.0 108.906 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.458 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.627 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.627 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.503 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 153' ' ' ILE . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 159' ' ' ILE . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m -73.81 73.98 1.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 93.1 mt-30 -74.71 135.86 41.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.818 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 164' ' ' GLN . 73.8 m-20 -152.76 68.03 6.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.283 -0.885 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.9 110.62 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.478 1.452 . . . . 0.0 110.147 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.07 144.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.2 150.08 73.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 108.476 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.322 -0.848 0 C-N-CA 120.878 1.052 . . . . 0.0 110.045 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.9 mm? -79.61 129.18 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.0 p -97.7 -174.27 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.658 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.6 tt0 -67.74 172.37 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.19 38.6 0.09 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 4' ' ' GLU . 27.7 m120 -157.68 66.3 3.57 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.309 -1.112 . . . . 0.0 108.948 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.78 130.98 33.23 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.535 1.49 . . . . 0.0 110.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 -88.55 171.6 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HH ' ' CG ' ' A' ' 31' ' ' ASP . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' CG ' ' HH ' ' A' ' 21' ' ' TYR . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.591 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 47' ' ' LEU . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 59' ' ' ILE . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 61' ' ' ILE . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 106' ' ' ASN . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' O ' ' OG ' ' A' ' 123' ' ' SER . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m -77.35 66.14 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.415 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 96.8 mm-40 -73.89 130.27 39.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.058 -1.027 . . . . 0.0 108.328 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 25.1 m120 -155.11 91.37 2.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.08 -1.013 . . . . 0.0 109.819 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.76 144.24 99.48 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 120.849 1.032 . . . . 0.0 109.543 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -81.32 149.17 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.648 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -78.95 149.42 73.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.205 -0.935 . . . . 0.0 108.87 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 C-N-CA 120.842 1.028 . . . . 0.0 109.865 179.791 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.318 0.58 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.28 -39.64 87.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.493 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.9 p -91.35 170.05 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -69.02 136.39 52.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 108.989 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.49 -163.61 53.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 19.6 m120 -78.43 147.94 72.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 108.816 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.63 145.85 93.81 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 121.323 1.348 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 62.7 mtm-85 -148.04 149.6 32.39 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.445 -0.785 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' OH ' ' OD1' ' A' ' 31' ' ' ASP . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' OH ' ' A' ' 21' ' ' TYR . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 47' ' ' LEU . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.417 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.592 HD22 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.592 ' NE ' HD22 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.458 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.458 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m -77.87 56.07 1.5 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.51 136.51 42.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.051 -1.03 . . . . 0.0 109.532 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 167' ' ' VAL . 74.6 m-80 -153.38 67.38 6.16 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.994 . . . . 0.0 110.432 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.39 41.52 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.248 1.298 . . . . 0.0 109.683 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 165' ' ' ASN . 5.1 t -85.87 144.89 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.956 . . . . 0.0 109.328 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -128.27 78.27 75.79 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.42 -0.8 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.073 1.182 . . . . 0.0 109.7 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.29 0.567 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.72 140.02 57.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.107 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 6.2 p -97.13 126.56 42.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.239 -0.913 . . . . 0.0 109.241 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -71.09 139.97 50.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 110.179 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.05 -26.9 6.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.334 -0.854 . . . . 0.0 111.007 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . 12.4 m120 -160.29 66.6 2.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.787 -1.42 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.83 110.94 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.322 1.348 . . . . 0.0 109.739 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -92.37 147.82 22.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 109.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.409 ' OH ' ' OD1' ' A' ' 31' ' ' ASP . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' OD1' ' OH ' ' A' ' 21' ' ' TYR . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.418 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 61' ' ' ILE . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.653 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.653 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 122' ' ' HIS . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 159' ' ' ILE . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -77.89 88.05 4.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.433 ' NE2' ' O ' ' A' ' 162' ' ' ARG . 24.7 mp0 -67.51 128.89 38.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 108.726 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.29 70.62 5.01 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.39 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.16 119.97 7.56 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.267 1.311 . . . . 0.0 109.868 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.03 131.74 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.377 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -80.06 150.05 70.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 120.794 0.996 . . . . 0.0 109.854 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.46 0.648 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.69 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.9 p -93.69 170.14 9.8 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.318 -1.489 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' A' ' 6' ' ' ASN . 80.0 tt0 -69.71 165.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.85 22.13 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 4' ' ' GLU . 66.4 m-80 -153.82 67.69 5.99 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.257 . . . . 0.0 108.409 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.74 94.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.465 1.444 . . . . 0.0 110.142 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -143.43 145.95 33.05 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 18' ' ' ILE . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 59' ' ' ILE . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.653 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.532 ' CG ' HD22 ' A' ' 106' ' ' ASN . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.452 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 80.9 m-20 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.476 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 132' ' ' ILE . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.476 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 153' ' ' ILE . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 165' ' ' ASN . 19.4 m -74.76 88.43 2.25 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -71.29 43.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.217 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 163' ' ' SER . 73.4 m-20 -153.36 104.95 2.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -53.73 106.6 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.572 0.848 . . . . 0.0 109.912 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.32 143.58 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 109.653 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -78.33 147.83 73.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.322 -0.834 0 C-N-CA 120.914 1.076 . . . . 0.0 109.789 179.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.38 146.58 51.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.127 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.6 p -91.15 151.53 20.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.72 139.71 53.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.572 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 6' ' ' ASN . . . 100.2 -101.32 2.32 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 83.0 m-20 -157.33 106.04 1.86 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 109.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.11 139.92 86.14 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.574 0.849 . . . . 0.0 110.164 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -90.68 172.38 8.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 47' ' ' LEU . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 59' ' ' ILE . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.681 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.485 ' CG ' HD22 ' A' ' 106' ' ' ASN . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.468 ' O ' ' OG1' ' A' ' 104' ' ' THR . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.474 ' NE ' ' O ' ' A' ' 141' ' ' THR . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' O ' ' CG2' ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.474 ' O ' ' NE ' ' A' ' 114' ' ' ARG . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.8 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 159' ' ' ILE . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m -75.06 53.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.24 136.27 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -152.03 147.87 20.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.947 -1.095 . . . . 0.0 109.449 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.74 108.64 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.218 1.279 . . . . 0.0 109.926 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.44 140.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 109.536 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.24 149.83 70.0 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 108.695 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.324 -0.732 0 C-N-CA 120.993 1.129 . . . . 0.0 110.172 179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.4 ' H1 ' ' H ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.4 ' H ' ' H1 ' ' A' ' 1' ' ' VAL . 91.5 mt -72.94 152.21 41.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -90.66 160.7 15.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.023 . . . . 0.0 109.786 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.43 136.0 55.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.39 -0.819 . . . . 0.0 109.345 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.89 -176.79 39.38 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 8' ' ' ARG . 9.3 m120 -82.81 124.04 77.48 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.218 -1.166 . . . . 0.0 109.332 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.84 75.73 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 108.803 -1.268 . . . . 0.0 108.803 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.505 ' N ' ' O ' ' A' ' 6' ' ' ASN . 97.9 mtt180 -146.14 152.32 39.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' OG1' ' OE2' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' LEU . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 59' ' ' ILE . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.409 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.409 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 165' ' ' ASN . 56.1 m -76.82 88.0 3.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -71.65 37.28 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.823 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 163' ' ' SER . 14.8 m120 -149.65 69.49 9.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.214 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -67.43 55.97 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.465 1.443 . . . . 0.0 109.691 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.35 146.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.905 -1.122 . . . . 0.0 108.768 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.36 149.66 69.3 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 108.987 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 120.835 1.024 . . . . 0.0 109.479 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -67.96 122.55 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 108.826 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.421 ' OG1' ' C ' ' A' ' 6' ' ' ASN . 31.9 p -100.01 124.9 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.392 -0.818 . . . . 0.0 109.376 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -78.05 103.16 7.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 6' ' ' ASN . . . 78.93 19.61 72.39 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.659 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 5' ' ' GLY . 28.4 m120 -156.68 63.17 3.09 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.664 -1.492 . . . . 0.0 110.271 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.44 129.02 27.95 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.444 1.429 . . . . 0.0 110.045 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 8' ' ' ARG . 52.4 mtt-85 -91.52 150.33 21.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.367 -0.833 . . . . 0.0 109.186 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.72 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.72 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' H ' ' HG1' ' A' ' 15' ' ' THR . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.648 HD22 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NE ' HD22 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 129' ' ' SER . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 134' ' ' ALA . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m -76.64 83.46 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -74.03 127.84 33.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -157.81 151.54 19.43 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.0 108.712 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.5 135.48 70.54 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 N-CA-C 109.387 -1.044 . . . . 0.0 109.387 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 79.9 t -89.92 120.75 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 4.2 mp0 -81.53 149.94 65.79 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.325 -0.682 0 C-N-CA 120.801 1.0 . . . . 0.0 109.786 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.407 ' CG1' ' H ' ' A' ' 2' ' ' LEU . 25.9 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.407 ' H ' ' CG1' ' A' ' 1' ' ' VAL . 83.8 mt -61.61 -46.46 89.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -100.25 165.57 11.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.477 0.656 . . . . 0.0 109.293 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.44 141.64 54.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -166.9 12.03 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ARG . 24.3 m120 -81.84 145.58 54.13 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.988 -1.301 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.53 56.46 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.344 1.363 . . . . 0.0 109.151 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ASN . 41.6 mtt-85 -143.43 156.55 44.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.958 -1.088 . . . . 0.0 109.894 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.74 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.74 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 44.6 m80 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 47' ' ' LEU . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.702 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 106' ' ' ASN . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 94.1 m-20 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.418 ' O ' ' OG ' ' A' ' 123' ' ' SER . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.427 ' C ' ' HG ' ' A' ' 139' ' ' SER . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 145' ' ' ASP . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 143' ' ' SER . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m -76.89 80.73 3.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.448 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 77.3 mt-30 -73.91 135.66 43.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.695 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 34.5 m120 -154.34 66.98 5.5 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 80.42 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.246 1.297 . . . . 0.0 110.06 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.62 139.38 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -0.965 . . . . 0.0 109.168 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -81.52 149.04 63.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.414 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 121.034 1.156 . . . . 0.0 110.483 179.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.315 0.579 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.558 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -88.53 1.55 54.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.4 p -88.78 164.73 15.11 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.8 -1.187 . . . . 0.0 109.545 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' A' ' 6' ' ' ASN . 88.0 tt0 -71.27 156.91 38.98 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.434 -0.791 . . . . 0.0 109.15 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.79 7.23 0.27 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.5 m120 -156.28 75.92 4.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.426 -1.043 . . . . 0.0 108.654 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.07 -177.6 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.42 1.414 . . . . 0.0 110.772 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -138.72 174.68 10.27 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 47' ' ' LEU . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.413 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.1 m-80 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 159' ' ' ILE . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m -77.77 54.93 1.3 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.23 112.32 9.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 110.186 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 167' ' ' VAL . 72.6 m-80 -159.98 70.89 3.12 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.1 38.04 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 121.673 1.582 . . . . 0.0 110.3 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 165' ' ' ASN . 52.4 t -93.39 139.5 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -0.926 . . . . 0.0 109.924 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -80.15 146.6 63.22 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 108.734 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.324 -0.756 0 C-N-CA 121.154 1.236 . . . . 0.0 110.149 179.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 2' ' ' LEU . 1.2 tm? -85.39 115.63 23.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -97.07 144.83 26.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.342 -0.849 . . . . 0.0 109.842 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.4 143.69 51.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.338 -0.851 . . . . 0.0 108.787 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.65 -90.19 1.6 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -158.18 150.1 17.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.227 -1.161 . . . . 0.0 108.99 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.25 119.74 7.1 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.915 1.077 . . . . 0.0 109.614 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -94.58 167.07 11.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.545 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 18' ' ' ILE . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 24' ' ' ASP . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' THR . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 47' ' ' LEU . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.545 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.671 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.0 OUTLIER -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.554 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.554 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' NE2' ' A' ' 147' ' ' GLN . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.516 ' NE2' ' OD2' ' A' ' 145' ' ' ASP . 50.4 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 94.3 2.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.89 135.21 54.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.834 0.826 . . . . 0.0 110.082 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -153.74 151.43 25.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.82 100.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 120.681 0.921 . . . . 0.0 110.401 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.6 t -89.97 120.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.323 -0.861 . . . . 0.0 108.937 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 64.6 mm-40 -103.79 -30.18 0.21 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.243 -0.911 . . . . 0.0 112.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 4.7 Cg_exo . . . . . 0 CA--C 1.535 0.547 0 CA-C-O 117.969 -0.93 . . . . 0.0 109.71 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 tp -69.47 135.67 50.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -95.91 153.1 17.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.158 -0.964 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.17 139.6 56.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.032 -1.042 . . . . 0.0 108.633 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.12 -156.14 48.54 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' CG ' ' OE1' ' A' ' 86' ' ' GLN . 7.2 m-80 -76.28 149.83 82.25 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.107 -1.231 . . . . 0.0 109.309 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.74 136.03 69.79 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -88.6 168.16 12.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 108.515 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.524 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.692 ' H ' ' HZ3' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.466 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.692 ' HZ3' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 59' ' ' ILE . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' OE1' ' CG ' ' A' ' 6' ' ' ASN . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 102' ' ' ARG . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.663 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.597 ' CG ' HD22 ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.432 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 132' ' ' ILE . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -74.99 54.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -77.66 58.02 1.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.477 -0.765 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -154.97 68.3 5.44 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.47 67.85 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.705 1.604 . . . . 0.0 109.418 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.82 138.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -79.79 151.28 73.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.326 -0.648 0 C-N-CA 121.125 1.216 . . . . 0.0 109.54 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.295 0.569 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.99 140.22 52.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.8 p -92.78 146.48 23.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 109.407 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.99 134.77 48.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.428 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.78 -99.29 0.81 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 8' ' ' ARG . 12.9 m120 -157.56 78.84 3.53 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.55 60.68 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.402 1.401 . . . . 0.0 109.865 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 6' ' ' ASN . 99.2 mtt180 -144.92 137.95 26.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.149 . . . . 0.0 109.027 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.708 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.708 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 18' ' ' ILE . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD21 ' A' ' 111' ' ' ASN . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.3 m120 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.435 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -74.1 66.04 1.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.37 135.76 47.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.54 68.85 6.48 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.42 130.47 26.88 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.577 1.518 . . . . 0.0 110.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.41 137.81 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.37 150.0 69.85 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.219 -0.925 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.325 -0.68 0 C-N-CA 120.945 1.097 . . . . 0.0 109.765 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.82 147.08 45.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.377 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 p -97.51 128.32 44.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.225 -0.922 . . . . 0.0 109.333 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.81 146.0 49.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 109.665 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.1 -52.19 1.25 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 8' ' ' ARG . 72.4 m-80 -158.51 79.78 3.03 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.999 -1.295 . . . . 0.0 110.436 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.84 37.84 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.254 1.303 . . . . 0.0 109.626 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -149.33 161.18 42.58 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.64 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 32.0 m170 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.556 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.433 ' O ' ' OG1' ' A' ' 45' ' ' THR . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.64 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.556 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.403 ' N ' ' HH ' ' A' ' 140' ' ' TYR . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.55 ' HG ' ' N ' ' A' ' 130' ' ' THR . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.55 ' N ' ' HG ' ' A' ' 129' ' ' SER . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.403 ' HH ' ' N ' ' A' ' 111' ' ' ASN . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.6 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 159' ' ' ILE . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m -76.74 87.51 3.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -71.34 121.14 17.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -157.53 70.74 4.33 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.442 -0.787 . . . . 0.0 109.136 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.61 111.34 1.86 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.424 1.416 . . . . 0.0 110.159 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.2 139.91 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -79.88 148.63 68.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 108.833 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 C--N 1.324 -0.734 0 C-N-CA 120.938 1.092 . . . . 0.0 109.757 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.81 140.1 55.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.033 -1.042 . . . . 0.0 108.843 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.7 p -93.37 143.1 26.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.68 139.12 53.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.626 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.21 -85.54 0.81 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -158.66 151.23 17.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.228 -1.16 . . . . 0.0 109.199 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.42 126.78 23.38 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.993 1.128 . . . . 0.0 109.712 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -88.4 160.59 17.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.835 . . . . 0.0 109.88 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.703 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.703 ' HD1' ' HG1' ' A' ' 12' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.591 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.591 ' H ' ' HG1' ' A' ' 22' ' ' THR . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.413 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.476 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.453 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.582 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 109' ' ' GLU . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.6 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 159' ' ' ILE . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m -72.55 82.17 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.25 136.24 46.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.704 . . . . 0.0 110.007 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' VAL . 19.8 m120 -154.26 152.16 25.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -62.85 48.9 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.067 1.178 . . . . 0.0 109.941 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 165' ' ' ASN . 79.1 t -90.04 120.05 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.894 -1.129 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -80.52 149.15 67.79 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 109.043 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--N 1.324 -0.712 0 C-N-CA 120.946 1.097 . . . . 0.0 109.712 179.62 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.132 0.492 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.06 123.63 30.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.8 p -89.39 151.84 21.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.344 -0.848 . . . . 0.0 109.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.89 135.97 51.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.889 -1.132 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 175.48 50.7 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -78.02 125.56 85.14 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.318 . . . . 0.0 108.233 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -66.51 99.35 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.688 0.925 . . . . 0.0 110.366 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -88.55 148.26 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 108.919 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.478 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 45' ' ' THR . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 130' ' ' THR . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.491 ' N ' ' HG ' ' A' ' 129' ' ' SER . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 153' ' ' ILE . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 159' ' ' ILE . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m -77.24 81.9 3.73 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -76.13 92.53 3.23 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 108.506 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -156.74 68.83 4.56 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 89.15 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.499 1.466 . . . . 0.0 109.72 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.07 140.82 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 108.966 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -79.53 148.19 69.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.03 -1.044 . . . . 0.0 108.62 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--N 1.325 -0.69 0 C-N-CA 121.142 1.228 . . . . 0.0 110.037 -179.596 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.3 mm? -60.06 -39.68 86.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -87.66 167.47 13.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -69.56 130.64 42.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.05 -1.031 . . . . 0.0 109.096 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.35 -178.25 53.78 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -78.63 130.74 70.01 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.259 -1.142 . . . . 0.0 109.086 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.91 102.56 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -136.95 158.18 45.04 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 15.0 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.8 m170 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.525 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.43 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' H ' ' HG1' ' A' ' 15' ' ' THR . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 59' ' ' ILE . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.454 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.438 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 129' ' ' SER . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.459 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 159' ' ' ILE . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m -75.44 87.74 2.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -73.7 107.29 5.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.61 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.684 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 1.7 m-80 -159.28 -38.56 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.281 -0.887 . . . . 0.0 112.059 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.684 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.3 Cg_endo -68.24 75.31 0.73 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 N-CA-C 109.259 -1.093 . . . . 0.0 109.259 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.74 113.5 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.136 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.66 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 8.0 mm100 -106.96 -30.2 0.19 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.6 -0.687 . . . . 0.0 112.14 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.9 Cg_endo . . . . . 0 C--N 1.326 -0.609 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -46.4 89.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.6 p -97.0 166.66 11.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.287 -0.883 . . . . 0.0 109.17 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.06 129.77 39.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.174 -0.953 . . . . 0.0 109.018 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.24 -155.12 52.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.83 149.25 77.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -1.183 . . . . 0.0 109.037 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.34 174.13 0.82 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.078 1.185 . . . . 0.0 109.486 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.04 154.76 44.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.116 -0.99 . . . . 0.0 109.102 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.535 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 18' ' ' ILE . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 47' ' ' LEU . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.535 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.3 m120 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.562 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.545 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.545 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 153' ' ' ILE . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m -76.32 72.26 3.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -81.14 113.53 19.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.718 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 65.8 m-80 -159.44 -34.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.8 . . . . 0.0 112.709 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.718 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 5.5 Cg_exo -64.94 101.99 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.691 0.925 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.4 m -82.15 149.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.424 -0.798 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.8 149.59 71.03 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.685 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.322 -0.862 0 C-N-CA 120.983 1.122 . . . . 0.0 109.791 179.502 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -13.07 35.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.806 -1.184 . . . . 0.0 109.455 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.1 p -96.31 156.32 16.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -72.83 126.71 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.61 -166.54 54.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.7 150.2 81.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.97 -1.312 . . . . 0.0 108.763 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.57 97.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -140.92 137.89 33.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.481 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.594 ' HG ' ' N ' ' A' ' 130' ' ' THR . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.594 ' N ' ' HG ' ' A' ' 129' ' ' SER . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 153' ' ' ILE . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 159' ' ' ILE . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.453 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m -74.36 81.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.36 101.52 5.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -155.05 68.9 5.53 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.381 -0.824 . . . . 0.0 108.969 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.33 86.13 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.297 1.331 . . . . 0.0 109.614 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.78 139.69 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.198 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 12.5 mp0 -83.5 149.8 58.55 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 C-N-CA 121.094 1.196 . . . . 0.0 110.214 179.414 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.01 -50.01 75.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -98.43 161.46 13.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.885 . . . . 0.0 108.814 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.15 131.37 45.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.044 . . . . 0.0 109.617 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.58 -159.13 52.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -77.07 145.54 73.67 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.022 -1.281 . . . . 0.0 108.857 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.38 157.59 35.24 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 N-CA-C 109.016 -1.186 . . . . 0.0 109.016 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.1 155.8 44.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.151 -0.968 . . . . 0.0 108.937 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.585 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 47' ' ' LEU . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.585 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 60' ' ' MET . 72.6 tp60 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 102' ' ' ARG . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m -77.76 88.44 4.0 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.85 125.73 27.54 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.037 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -154.94 72.62 5.81 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.64 56.1 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.759 1.639 . . . . 0.0 110.066 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.1 144.9 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.851 -1.156 . . . . 0.0 110.079 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -80.02 148.95 69.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.766 0 C-N-CA 120.939 1.093 . . . . 0.0 109.562 179.177 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.9 tp -66.76 147.83 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.176 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.4 p -89.18 139.49 30.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 0.0 108.613 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.32 80.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 0.0 110.325 -179.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.02 96.0 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.641 178.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -154.31 65.99 5.17 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.44 . . . . 0.0 110.63 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.38 82.18 2.31 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.615 1.543 . . . . 0.0 109.832 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -146.01 141.29 27.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 50.3 m170 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.44 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 45' ' ' THR . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 124' ' ' LEU . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' A' ' 123' ' ' SER . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.456 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 159' ' ' ILE . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m -75.53 60.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -73.62 130.25 39.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.903 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 167' ' ' VAL . 71.2 m-80 -158.64 70.14 3.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.02 38.12 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.502 1.468 . . . . 0.0 110.006 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 165' ' ' ASN . 26.8 m -84.08 139.88 16.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.51 147.76 56.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--N 1.322 -0.842 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 179.445 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.03 -39.96 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 108.84 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' A' ' 4' ' ' GLU . 7.7 p -131.83 -154.13 0.6 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.634 -0.666 . . . . 0.0 109.437 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 6' ' ' ASN . 52.5 tp10 -65.85 155.39 36.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.74 23.09 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.003 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.627 ' H ' ' C ' ' A' ' 4' ' ' GLU . 52.5 m-80 -154.23 67.41 5.67 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.924 -1.339 . . . . 0.0 109.014 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.11 92.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 121.377 1.385 . . . . 0.0 109.738 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 -142.64 150.03 39.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 108.749 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.496 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 18' ' ' ILE . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' HZ2' ' A' ' 36' ' ' LYS . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HZ2' ' CD2' ' A' ' 32' ' ' HIS . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 47' ' ' LEU . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.484 ' C ' ' HG ' ' A' ' 163' ' ' SER . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 47' ' ' LEU . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.496 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' CB ' ' HZ1' ' A' ' 51' ' ' LYS . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 159' ' ' ILE . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.484 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 24.2 m -77.2 84.51 3.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' ND2' ' A' ' 165' ' ' ASN . 97.9 mt-30 -73.12 135.02 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 164' ' ' GLN . 23.0 m-80 -157.54 149.43 17.31 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 108.723 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.83 130.52 40.81 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.92 120.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.213 -0.93 . . . . 0.0 109.2 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -78.06 149.63 76.79 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.148 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.326 -0.639 0 C-N-CA 120.828 1.019 . . . . 0.0 109.761 179.614 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.85 -9.25 54.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.952 . . . . 0.0 108.945 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.4 p -94.34 169.85 9.92 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.22 83.63 1.36 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.126 -0.984 . . . . 0.0 109.572 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' O ' ' ND2' ' A' ' 6' ' ' ASN . . . 49.92 30.4 15.55 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 5' ' ' GLY . 27.1 m-80 -158.11 68.76 3.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.4 . . . . 0.0 110.214 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -73.71 48.07 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.68 1.586 . . . . 0.0 109.936 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -148.49 157.34 43.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.933 -1.104 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 18' ' ' ILE . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.475 ' N ' ' HG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.4 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.4 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 153' ' ' ILE . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.449 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.475 ' HG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m -76.35 86.5 3.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.34 134.36 44.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 109.89 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 167' ' ' VAL . 33.7 m-80 -154.03 68.96 6.2 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.319 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.48 79.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.297 1.331 . . . . 0.0 109.313 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASN . 7.8 p -85.91 144.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -78.69 148.71 73.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.236 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 C-N-CA 121.07 1.18 . . . . 0.0 109.746 179.338 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt -86.89 -74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.974 . . . . 0.0 108.852 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.0 p -100.62 124.15 45.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.799 . . . . 0.0 109.303 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -72.05 136.36 46.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 109.104 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -62.22 0.38 Allowed Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -155.03 76.55 5.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.924 -1.339 . . . . 0.0 109.717 -179.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.83 154.2 67.77 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.581 1.52 . . . . 0.0 110.131 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 -92.4 154.56 18.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' O ' ' NE2' ' A' ' 157' ' ' GLN . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.494 ' N ' HD21 ' A' ' 71' ' ' ASN . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.582 HD22 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.582 ' NE ' HD22 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.571 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HE ' HD21 ' A' ' 111' ' ' ASN . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 145' ' ' ASP . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' SER . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 3.2 mm-40 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m -70.7 91.29 0.81 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.19 135.2 56.08 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.809 0.814 . . . . 0.0 110.312 -178.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 167' ' ' VAL . 34.7 m120 -154.68 93.81 2.79 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.3 43.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 121.497 1.464 . . . . 0.0 110.907 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 165' ' ' ASN . 10.5 p -88.56 148.23 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.74 149.97 71.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 120.992 -1.067 . . . . 0.0 109.716 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.326 -0.638 0 C-N-CA 120.879 1.053 . . . . 0.0 109.791 179.237 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.8 mt -70.05 139.85 52.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 109.725 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 p -94.67 165.49 12.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.373 -0.829 . . . . 0.0 109.49 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.75 134.38 47.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.086 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.89 -175.94 54.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 8' ' ' ARG . 32.7 m120 -80.01 125.82 81.0 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.12 -1.224 . . . . 0.0 109.001 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.57 51.66 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 N-CA-C 109.672 -0.934 . . . . 0.0 109.672 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 6' ' ' ASN . 98.2 mtt180 -140.28 141.74 35.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.002 -1.061 . . . . 0.0 109.067 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 18' ' ' ILE . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.5 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.701 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 6.0 m -72.97 84.41 1.26 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 98.7 mt-30 -71.02 135.9 48.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.725 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 5.7 m-80 -152.73 -34.84 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 0.0 113.322 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.725 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.6 Cg_endo -68.2 76.59 0.67 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 N-CA-C 109.415 -1.033 . . . . 0.0 109.415 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.84 120.03 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.804 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.65 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 11.4 mt-30 -104.25 -32.01 0.21 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.395 -0.816 . . . . 0.0 112.269 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.3 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 118.012 -0.912 . . . . 0.0 109.91 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 2' ' ' LEU . 3.1 tm? -62.02 -40.9 97.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.135 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.7 p -97.09 123.87 40.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.4 127.19 32.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.056 . . . . 0.0 108.394 178.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.87 -126.52 17.73 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -79.14 150.71 74.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.17 -1.194 . . . . 0.0 108.292 179.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.37 99.53 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -144.6 148.88 34.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.213 -0.929 . . . . 0.0 109.089 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 18' ' ' ILE . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.406 ' O ' ' OG1' ' A' ' 45' ' ' THR . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 61' ' ' ILE . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.682 ' H ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.512 ' O ' ' C ' ' A' ' 109' ' ' GLU . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.44 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' OH ' ' OD1' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m -75.02 58.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -72.71 136.77 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.356 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.63 69.42 8.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.057 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.39 143.99 78.39 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.502 1.468 . . . . 0.0 109.44 179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 t -89.99 122.09 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 0.0 110.053 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -82.82 150.12 61.44 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.376 -0.827 . . . . 0.0 108.899 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 C--N 1.325 -0.678 0 C-N-CA 120.803 1.002 . . . . 0.0 109.885 179.736 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.74 140.11 58.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -90.79 -151.07 0.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.239 -0.913 . . . . 0.0 109.324 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.621 ' C ' ' H ' ' A' ' 6' ' ' ASN . 82.0 tt0 -65.15 153.77 39.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.11 29.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.519 -0.848 . . . . 0.0 110.982 -179.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.621 ' H ' ' C ' ' A' ' 4' ' ' GLU . 9.4 m120 -155.41 65.42 4.41 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.31 . . . . 0.0 108.965 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -64.66 128.58 21.41 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.351 1.368 . . . . 0.0 109.871 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 44.7 mtm-85 -145.24 150.07 36.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.275 -0.891 . . . . 0.0 108.917 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.43 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 18' ' ' ILE . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 22' ' ' THR . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.43 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.41 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.469 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.469 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.41 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -79.0 83.85 5.06 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.51 135.78 44.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.721 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -155.58 69.94 5.35 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.117 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.34 84.28 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.345 1.363 . . . . 0.0 109.254 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.96 140.06 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.957 -1.089 . . . . 0.0 109.855 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.05 148.34 63.84 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.322 -0.835 0 C-N-CA 120.904 1.07 . . . . 0.0 109.633 179.415 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.5 mp -68.82 -28.33 66.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.189 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.5 p -91.19 158.8 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.567 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.97 139.71 52.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.99 -157.02 53.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -77.54 148.65 77.17 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 0.0 108.55 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 140.8 96.52 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.941 1.094 . . . . 0.0 109.855 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HG2' ' A' ' 8' ' ' ARG . 56.4 mtt-85 -86.87 166.89 14.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.586 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 18' ' ' ILE . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.586 ' H ' ' HG1' ' A' ' 15' ' ' THR . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.52 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.525 HD22 ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' CG ' HD22 ' A' ' 106' ' ' ASN . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 123' ' ' SER . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 124' ' ' LEU . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' A' ' 123' ' ' SER . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 134' ' ' ALA . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 165' ' ' ASN . 10.9 m -79.11 82.05 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.36 33.19 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.078 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 163' ' ' SER . 66.7 m-80 -157.1 73.46 4.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.058 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.23 88.09 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.136 1.224 . . . . 0.0 109.277 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.74 145.51 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.0 147.31 65.49 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 108.701 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.906 1.071 . . . . 0.0 109.804 179.511 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.55 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 45' ' ' THR . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 44' ' ' VAL . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 83' ' ' HIS . 2.9 m-70 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.55 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.443 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 10.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.474 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.695 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.469 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 27' ' ' ARG . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.457 HD22 ' NE ' ' A' ' 108' ' ' ARG . 31.1 p30 -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.457 ' NE ' HD22 ' A' ' 106' ' ' ASN . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.405 HG22 HH12 ' A' ' 114' ' ' ARG . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HG2' HH11 ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 HG23 ' A' ' 45' ' ' THR . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 44' ' ' VAL . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' VAL . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' ARG . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 107' ' ' PHE . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 105' ' ' ASN . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.441 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 29' ' ' ASP . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.615 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' NE ' HD21 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.467 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 153' ' ' ILE . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.662 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.662 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 44' ' ' VAL . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 HG23 ' A' ' 45' ' ' THR . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.558 HG23 HG23 ' A' ' 44' ' ' VAL . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 52' ' ' VAL . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.595 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 25.6 p30 -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 28.2 m120 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.487 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 22' ' ' THR . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 27' ' ' ARG . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.405 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 140' ' ' TYR . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.0 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' ND2' ' A' ' 105' ' ' ASN . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 45' ' ' THR . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 HG23 ' A' ' 44' ' ' VAL . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 24' ' ' ASP . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' HD13 ' A' ' 25' ' ' LEU . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.455 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.455 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 8' ' ' ARG . 52.4 mtt-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.606 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 49' ' ' PHE . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.606 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 69' ' ' ARG . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.673 HD21 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.673 ' NE ' HD21 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 8' ' ' ARG . 41.6 mtt-85 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 121.468 0.652 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 40' ' ' LEU . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.403 ' CH2' HD22 ' A' ' 148' ' ' LEU . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.545 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.0 p-10 -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 10.2 m120 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.403 HD22 ' CH2' ' A' ' 41' ' ' TRP . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 45' ' ' THR . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 44' ' ' VAL . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 52' ' ' VAL . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.489 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.489 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.597 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 3.6 m120 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.768 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 45' ' ' THR . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 44' ' ' VAL . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.768 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.553 ' ND2' ' CD1' ' A' ' 142' ' ' PHE . 30.4 p-10 -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.571 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 51' ' ' LYS . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' H ' ' HZ2' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.55 ' HZ2' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' NH1' HG22 ' A' ' 104' ' ' THR . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.456 HG22 ' NH1' ' A' ' 102' ' ' ARG . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 30.0 p30 -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.437 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.445 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' THR . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' HE ' ' A' ' 17' ' ' ARG . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.4 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.58 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 22' ' ' THR . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.58 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.46 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.46 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.8 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.161 0.505 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD13 ' ND2' ' A' ' 105' ' ' ASN . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 44' ' ' VAL . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 40' ' ' LEU . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.67 HD22 ' HD2' ' A' ' 108' ' ' ARG . 16.8 p30 -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.67 ' HD2' HD22 ' A' ' 106' ' ' ASN . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 133' ' ' GLY . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.4 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 52' ' ' VAL . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 35.7 p-10 -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 159' ' ' ILE . 33.2 mmt180 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.538 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 141' ' ' THR . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' NH1' ' A' ' 8' ' ' ARG . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 45' ' ' THR . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 44' ' ' VAL . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 52' ' ' VAL . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.4 m-20 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.412 ' HE2' ' HE2' ' A' ' 122' ' ' HIS . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.412 ' HE2' ' HE2' ' A' ' 118' ' ' HIS . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' OH ' ' N ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 158' ' ' ALA . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 154' ' ' ASP . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' VAL . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.426 HH12 HG22 ' A' ' 104' ' ' THR . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.426 HG22 HH12 ' A' ' 102' ' ' ARG . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.466 HD22 ' NE ' ' A' ' 108' ' ' ARG . 20.3 p30 -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NE ' HD22 ' A' ' 106' ' ' ASN . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.453 ' CB ' ' NH1' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' ND2' ' A' ' 105' ' ' ASN . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG23 HG23 ' A' ' 45' ' ' THR . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.489 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' OE1' ' SD ' ' A' ' 60' ' ' MET . 12.5 tp-100 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' OE1' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' NH1' HG22 ' A' ' 104' ' ' THR . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' NH1' ' A' ' 102' ' ' ARG . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' A' ' 25' ' ' LEU . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.488 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.488 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG22 ' NH1' ' A' ' 114' ' ' ARG . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 5.8 m-70 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 148' ' ' LEU . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 41' ' ' TRP . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.678 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 ' CE ' ' A' ' 60' ' ' MET . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CH2' HD22 ' A' ' 148' ' ' LEU . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.678 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 52' ' ' VAL . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.416 ' CE ' HH21 ' A' ' 17' ' ' ARG . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.621 ' CE1' ' HE2' ' A' ' 122' ' ' HIS . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HE2' ' CE1' ' A' ' 118' ' ' HIS . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.539 HD22 ' CH2' ' A' ' 41' ' ' TRP . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.0 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 162' ' ' ARG . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.508 0.67 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' OD1' ' A' ' 105' ' ' ASN . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HD13 ' A' ' 25' ' ' LEU . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 45' ' ' THR . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 44' ' ' VAL . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 142' ' ' PHE . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.55 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 141' ' ' THR . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 140' ' ' TYR . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.45 ' HB2' ' HE ' ' A' ' 114' ' ' ARG . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 14.2 mm100 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.442 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.509 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.418 HD22 ' HG2' ' A' ' 108' ' ' ARG . 42.6 p-10 -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.418 ' HG2' HD22 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.49 ' CE1' HD21 ' A' ' 47' ' ' LEU . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 162' ' ' ARG . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' THR . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 HG23 HG23 ' A' ' 44' ' ' VAL . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.611 HD22 ' CD ' ' A' ' 108' ' ' ARG . 34.7 p-10 -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.611 ' CD ' HD22 ' A' ' 106' ' ' ASN . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 ' OH ' ' A' ' 21' ' ' TYR . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.466 ' OH ' HD12 ' A' ' 18' ' ' ILE . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 22' ' ' THR . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 93.1 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CE1' ' HE2' ' A' ' 68' ' ' HIS . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.404 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.475 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.475 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.3 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 8' ' ' ARG . 56.4 mtt-85 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.405 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.535 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.415 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.415 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 156' ' ' ILE . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.724 0.773 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.15 -49.93 75.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.134 . . . . 0.0 109.055 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.1 p -99.17 140.95 32.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.494 -0.754 . . . . 0.0 109.639 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.64 139.76 53.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.17 -146.51 50.43 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.29 149.14 72.07 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.265 . . . . 0.0 108.689 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -62.43 106.06 0.46 Allowed 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.089 1.193 . . . . 0.0 109.831 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -95.65 156.01 16.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.167 -0.958 . . . . 0.0 108.844 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.55 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 45' ' ' THR . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 44' ' ' VAL . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.55 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.443 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 10.4 m -75.57 65.92 1.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.05 135.36 46.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.437 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -156.29 76.44 4.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.791 . . . . 0.0 109.716 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.72 105.99 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.138 1.225 . . . . 0.0 109.676 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.52 138.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 110.438 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.27 149.97 53.62 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.537 0.657 0 C-N-CA 120.925 1.083 . . . . 0.0 109.961 178.709 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.72 146.6 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.333 -0.854 . . . . 0.0 108.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.3 p -88.76 164.29 15.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -67.02 139.23 57.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.336 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.99 -165.27 37.85 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 8' ' ' ARG . 20.1 m-20 -77.91 133.13 66.12 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.181 -1.188 . . . . 0.0 108.763 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' HH11 ' A' ' 8' ' ' ARG . 4.8 Cg_endo -63.15 20.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 120.958 1.105 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 6' ' ' ASN . 10.0 mpt_? -98.04 165.79 11.74 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -0.892 . . . . 0.0 108.894 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.474 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.695 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.469 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m -76.65 62.83 2.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 93.1 mt-30 -70.77 136.22 48.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 108.805 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 12.6 m120 -152.56 149.49 22.69 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 108.761 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.1 168.04 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.59 135.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.262 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -80.29 150.25 70.57 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.823 1.015 . . . . 0.0 109.693 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.749 0.785 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.9 mt -86.47 -72.25 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 109.506 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.3 p -93.03 152.48 19.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 109.614 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.99 140.5 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.839 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.93 -157.9 53.64 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -77.25 149.98 79.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.259 -1.142 . . . . 0.0 109.013 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.4 -178.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.075 1.184 . . . . 0.0 110.007 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -145.71 151.58 38.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.367 -0.833 . . . . 0.0 108.906 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 27' ' ' ARG . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.457 HD22 ' NE ' ' A' ' 108' ' ' ARG . 31.1 p30 -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.457 ' NE ' HD22 ' A' ' 106' ' ' ASN . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.405 HG22 HH12 ' A' ' 114' ' ' ARG . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m -73.81 73.98 1.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 93.1 mt-30 -74.71 135.86 41.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.818 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 164' ' ' GLN . 73.8 m-20 -152.76 68.03 6.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.283 -0.885 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.9 110.62 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.478 1.452 . . . . 0.0 110.147 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.07 144.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.2 150.08 73.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 108.476 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.322 -0.848 0 C-N-CA 120.878 1.052 . . . . 0.0 110.045 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -79.61 129.18 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.0 p -97.7 -174.27 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.658 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.6 tt0 -67.74 172.37 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.19 38.6 0.09 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 4' ' ' GLU . 27.7 m120 -157.68 66.3 3.57 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.309 -1.112 . . . . 0.0 108.948 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.78 130.98 33.23 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.535 1.49 . . . . 0.0 110.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 -88.55 171.6 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 HG23 ' A' ' 45' ' ' THR . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 44' ' ' VAL . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' VAL . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' ARG . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 107' ' ' PHE . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m -77.35 66.14 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -73.89 130.27 39.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.058 -1.027 . . . . 0.0 108.328 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -155.11 91.37 2.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.08 -1.013 . . . . 0.0 109.819 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.76 144.24 99.48 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 120.849 1.032 . . . . 0.0 109.543 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -81.32 149.17 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.648 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -78.95 149.42 73.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.205 -0.935 . . . . 0.0 108.87 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 C-N-CA 120.842 1.028 . . . . 0.0 109.865 179.791 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.318 0.58 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.28 -39.64 87.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.493 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.9 p -91.35 170.05 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -69.02 136.39 52.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 108.989 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.49 -163.61 53.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 81.3 m-20 -78.43 147.94 72.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 108.816 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.63 145.85 93.81 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 121.323 1.348 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 62.7 mtm-85 -148.04 149.6 32.39 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.445 -0.785 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 105' ' ' ASN . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.441 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 29' ' ' ASP . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.615 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.615 ' NE ' HD21 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.467 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m -77.87 56.07 1.5 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.51 136.51 42.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.051 -1.03 . . . . 0.0 109.532 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 167' ' ' VAL . 74.6 m-80 -153.38 67.38 6.16 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.994 . . . . 0.0 110.432 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.39 41.52 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.248 1.298 . . . . 0.0 109.683 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 165' ' ' ASN . 5.1 t -85.87 144.89 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.956 . . . . 0.0 109.328 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -128.27 78.27 75.79 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.42 -0.8 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.073 1.182 . . . . 0.0 109.7 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 1' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.29 0.567 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.72 140.02 57.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.107 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 6.2 p -97.13 126.56 42.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.239 -0.913 . . . . 0.0 109.241 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -71.09 139.97 50.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 110.179 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.05 -26.9 6.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.334 -0.854 . . . . 0.0 111.007 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . 12.4 m120 -160.29 66.6 2.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.787 -1.42 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.83 110.94 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.322 1.348 . . . . 0.0 109.739 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -92.37 147.82 22.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 109.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 153' ' ' ILE . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.662 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.662 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 44' ' ' VAL . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -77.89 88.05 4.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.433 ' NE2' ' O ' ' A' ' 162' ' ' ARG . 24.7 mp0 -67.51 128.89 38.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 108.726 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.29 70.62 5.01 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.39 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.16 119.97 7.56 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.267 1.311 . . . . 0.0 109.868 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.03 131.74 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.377 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -80.06 150.05 70.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 120.794 0.996 . . . . 0.0 109.854 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 2' ' ' LEU . 2.1 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.46 0.648 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 1' ' ' VAL . 0.6 OUTLIER -165.69 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.9 p -93.69 170.14 9.8 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.318 -1.489 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.639 ' C ' ' H ' ' A' ' 6' ' ' ASN . 80.0 tt0 -69.71 165.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.85 22.13 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 4' ' ' GLU . 66.4 m-80 -153.82 67.69 5.99 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.257 . . . . 0.0 108.409 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.74 94.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.465 1.444 . . . . 0.0 110.142 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -143.43 145.95 33.05 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 HG23 ' A' ' 45' ' ' THR . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.558 HG23 HG23 ' A' ' 44' ' ' VAL . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 52' ' ' VAL . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.595 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 25.6 p30 -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 28.2 m120 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.487 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 165' ' ' ASN . 19.4 m -74.76 88.43 2.25 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -71.29 43.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.217 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 163' ' ' SER . 73.4 m-20 -153.36 104.95 2.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -53.73 106.6 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.572 0.848 . . . . 0.0 109.912 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.32 143.58 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 109.653 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -78.33 147.83 73.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.322 -0.834 0 C-N-CA 120.914 1.076 . . . . 0.0 109.789 179.56 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.1 mp -69.38 146.58 51.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.127 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.6 p -91.15 151.53 20.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.72 139.71 53.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.572 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 6' ' ' ASN . . . 100.2 -101.32 2.32 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 83.0 m-20 -157.33 106.04 1.86 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 109.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.11 139.92 86.14 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.574 0.849 . . . . 0.0 110.164 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -90.68 172.38 8.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 22' ' ' THR . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 27' ' ' ARG . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.405 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 140' ' ' TYR . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.0 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m -75.06 53.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.24 136.27 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -152.03 147.87 20.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.947 -1.095 . . . . 0.0 109.449 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.74 108.64 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.218 1.279 . . . . 0.0 109.926 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.44 140.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 109.536 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.24 149.83 70.0 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 108.695 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.324 -0.732 0 C-N-CA 120.993 1.129 . . . . 0.0 110.172 179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.94 152.21 41.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -90.66 160.7 15.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.023 . . . . 0.0 109.786 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.43 136.0 55.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.39 -0.819 . . . . 0.0 109.345 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.89 -176.79 39.38 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 8' ' ' ARG . 9.3 m120 -82.81 124.04 77.48 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.218 -1.166 . . . . 0.0 109.332 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.84 75.73 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 108.803 -1.268 . . . . 0.0 108.803 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 6' ' ' ASN . 97.9 mtt180 -146.14 152.32 39.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' ND2' ' A' ' 105' ' ' ASN . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 45' ' ' THR . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 HG23 ' A' ' 44' ' ' VAL . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 24' ' ' ASP . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' HD13 ' A' ' 25' ' ' LEU . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.455 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.455 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 165' ' ' ASN . 56.1 m -76.82 88.0 3.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -71.65 37.28 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.823 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 163' ' ' SER . 14.8 m120 -149.65 69.49 9.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.214 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -67.43 55.97 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.465 1.443 . . . . 0.0 109.691 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 165' ' ' ASN . 57.7 t -82.35 146.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.905 -1.122 . . . . 0.0 108.768 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.36 149.66 69.3 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 108.987 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 120.835 1.024 . . . . 0.0 109.479 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -67.96 122.55 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 108.826 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.421 ' OG1' ' C ' ' A' ' 6' ' ' ASN . 31.9 p -100.01 124.9 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.392 -0.818 . . . . 0.0 109.376 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -78.05 103.16 7.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.93 19.61 72.39 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.659 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' C ' ' OG1' ' A' ' 3' ' ' THR . 47.5 m-80 -156.68 63.17 3.09 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.664 -1.492 . . . . 0.0 110.271 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.44 129.02 27.95 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.444 1.429 . . . . 0.0 110.045 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 8' ' ' ARG . 52.4 mtt-85 -91.52 150.33 21.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.367 -0.833 . . . . 0.0 109.186 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.606 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 49' ' ' PHE . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.606 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 69' ' ' ARG . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.673 HD21 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.673 ' NE ' HD21 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m -76.64 83.46 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -74.03 127.84 33.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -157.81 151.54 19.43 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.0 108.712 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.5 135.48 70.54 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 N-CA-C 109.387 -1.044 . . . . 0.0 109.387 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 79.9 t -89.92 120.75 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 21.5 mp0 -81.53 149.94 65.79 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.325 -0.682 0 C-N-CA 120.801 1.0 . . . . 0.0 109.786 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 2' ' ' LEU . 25.9 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.597 ' N ' HG12 ' A' ' 1' ' ' VAL . 83.8 mt -61.61 -46.46 89.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -100.25 165.57 11.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.477 0.656 . . . . 0.0 109.293 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.44 141.64 54.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -166.9 12.03 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ARG . 24.3 m120 -81.84 145.58 54.13 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.988 -1.301 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.53 56.46 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.344 1.363 . . . . 0.0 109.151 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ASN . 41.6 mtt-85 -143.43 156.55 44.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.958 -1.088 . . . . 0.0 109.894 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 40' ' ' LEU . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.403 ' CH2' HD22 ' A' ' 148' ' ' LEU . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.545 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.0 p-10 -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 10.2 m120 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.403 HD22 ' CH2' ' A' ' 41' ' ' TRP . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m -76.89 80.73 3.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -73.91 135.66 43.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.695 . . . . 0.0 110.136 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -154.34 66.98 5.5 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 80.42 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.246 1.297 . . . . 0.0 110.06 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.62 139.38 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -0.965 . . . . 0.0 109.168 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -81.52 149.04 63.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.414 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 121.034 1.156 . . . . 0.0 110.483 179.714 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.315 0.579 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -88.53 1.55 54.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.4 p -88.78 164.73 15.11 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.8 -1.187 . . . . 0.0 109.545 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 6' ' ' ASN . 88.0 tt0 -71.27 156.91 38.98 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.434 -0.791 . . . . 0.0 109.15 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.79 7.23 0.27 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.5 m120 -156.28 75.92 4.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.426 -1.043 . . . . 0.0 108.654 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.07 -177.6 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.42 1.414 . . . . 0.0 110.772 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -138.72 174.68 10.27 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 45' ' ' THR . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 44' ' ' VAL . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 52' ' ' VAL . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.597 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 3.6 m120 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m -77.77 54.93 1.3 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.23 112.32 9.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 110.186 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 167' ' ' VAL . 72.6 m-80 -159.98 70.89 3.12 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.1 38.04 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 121.673 1.582 . . . . 0.0 110.3 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.532 ' H ' ' C ' ' A' ' 165' ' ' ASN . 52.4 t -93.39 139.5 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -0.926 . . . . 0.0 109.924 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -80.15 146.6 63.22 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 108.734 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.324 -0.756 0 C-N-CA 121.154 1.236 . . . . 0.0 110.149 179.637 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 3' ' ' THR . 1.2 tm? -85.39 115.63 23.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 ' N ' HD13 ' A' ' 2' ' ' LEU . 43.7 p -97.07 144.83 26.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.342 -0.849 . . . . 0.0 109.842 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.4 143.69 51.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.338 -0.851 . . . . 0.0 108.787 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.65 -90.19 1.6 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -158.18 150.1 17.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.227 -1.161 . . . . 0.0 108.99 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.25 119.74 7.1 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.915 1.077 . . . . 0.0 109.614 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -94.58 167.07 11.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.768 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 45' ' ' THR . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 44' ' ' VAL . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.768 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.553 ' ND2' ' CD1' ' A' ' 142' ' ' PHE . 30.4 p-10 -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.571 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 94.3 2.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.89 135.21 54.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.834 0.826 . . . . 0.0 110.082 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 167' ' ' VAL . 67.5 m-20 -153.74 151.43 25.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.82 100.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 120.681 0.921 . . . . 0.0 110.401 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 165' ' ' ASN . 16.6 t -89.97 120.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.323 -0.861 . . . . 0.0 108.937 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 64.6 mm-40 -103.79 -30.18 0.21 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.243 -0.911 . . . . 0.0 112.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 4.7 Cg_exo . . . . . 0 CA--C 1.535 0.547 0 CA-C-O 117.969 -0.93 . . . . 0.0 109.71 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 tp -69.47 135.67 50.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -95.91 153.1 17.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.158 -0.964 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.17 139.6 56.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.032 -1.042 . . . . 0.0 108.633 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.12 -156.14 48.54 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' CG ' ' OE1' ' A' ' 86' ' ' GLN . 7.2 m-80 -76.28 149.83 82.25 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.107 -1.231 . . . . 0.0 109.309 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.74 136.03 69.79 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -88.6 168.16 12.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 108.515 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 51' ' ' LYS . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' H ' ' HZ2' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.55 ' HZ2' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' OE1' ' CG ' ' A' ' 6' ' ' ASN . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' NH1' HG22 ' A' ' 104' ' ' THR . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.456 HG22 ' NH1' ' A' ' 102' ' ' ARG . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.406 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 30.0 p30 -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.437 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.437 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -74.99 54.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -77.66 58.02 1.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.477 -0.765 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -154.97 68.3 5.44 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.47 67.85 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.705 1.604 . . . . 0.0 109.418 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.82 138.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -79.79 151.28 73.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.326 -0.648 0 C-N-CA 121.125 1.216 . . . . 0.0 109.54 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.295 0.569 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.99 140.22 52.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.4 ' H ' ' HG3' ' A' ' 7' ' ' PRO . 40.8 p -92.78 146.48 23.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 109.407 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.99 134.77 48.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.428 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.78 -99.29 0.81 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 8' ' ' ARG . 12.9 m120 -157.56 78.84 3.53 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HG3' ' H ' ' A' ' 3' ' ' THR . 1.4 Cg_endo -63.55 60.68 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.402 1.401 . . . . 0.0 109.865 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 6' ' ' ASN . 99.2 mtt180 -144.92 137.95 26.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.149 . . . . 0.0 109.027 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' THR . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' HE ' ' A' ' 17' ' ' ARG . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.4 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -74.1 66.04 1.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.37 135.76 47.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.54 68.85 6.48 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.42 130.47 26.88 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.577 1.518 . . . . 0.0 110.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.41 137.81 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.37 150.0 69.85 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.219 -0.925 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.325 -0.68 0 C-N-CA 120.945 1.097 . . . . 0.0 109.765 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.82 147.08 45.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.377 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 p -97.51 128.32 44.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.225 -0.922 . . . . 0.0 109.333 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.81 146.0 49.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 109.665 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.1 -52.19 1.25 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 8' ' ' ARG . 72.4 m-80 -158.51 79.78 3.03 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.999 -1.295 . . . . 0.0 110.436 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.84 37.84 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.254 1.303 . . . . 0.0 109.626 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -149.33 161.18 42.58 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.58 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 22' ' ' THR . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.58 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.8 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m -76.74 87.51 3.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -71.34 121.14 17.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -157.53 70.74 4.33 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.442 -0.787 . . . . 0.0 109.136 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.61 111.34 1.86 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.424 1.416 . . . . 0.0 110.159 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.2 139.91 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -79.88 148.63 68.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 108.833 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 C--N 1.324 -0.734 0 C-N-CA 120.938 1.092 . . . . 0.0 109.757 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.81 140.1 55.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.033 -1.042 . . . . 0.0 108.843 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.7 p -93.37 143.1 26.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.68 139.12 53.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.626 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.21 -85.54 0.81 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -158.66 151.23 17.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.228 -1.16 . . . . 0.0 109.199 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.42 126.78 23.38 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.993 1.128 . . . . 0.0 109.712 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -88.4 160.59 17.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.835 . . . . 0.0 109.88 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD13 ' ND2' ' A' ' 105' ' ' ASN . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 44' ' ' VAL . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 40' ' ' LEU . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.67 HD22 ' HD2' ' A' ' 108' ' ' ARG . 16.8 p30 -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.67 ' HD2' HD22 ' A' ' 106' ' ' ASN . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 133' ' ' GLY . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.4 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m -72.55 82.17 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.25 136.24 46.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.704 . . . . 0.0 110.007 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 167' ' ' VAL . 19.8 m120 -154.26 152.16 25.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -62.85 48.9 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.067 1.178 . . . . 0.0 109.941 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 165' ' ' ASN . 79.1 t -90.04 120.05 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.894 -1.129 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -80.52 149.15 67.79 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 109.043 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--N 1.324 -0.712 0 C-N-CA 120.946 1.097 . . . . 0.0 109.712 179.62 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.132 0.492 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -85.06 123.63 30.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.618 ' N ' HD13 ' A' ' 2' ' ' LEU . 43.8 p -89.39 151.84 21.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.344 -0.848 . . . . 0.0 109.303 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.89 135.97 51.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.889 -1.132 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 175.48 50.7 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -78.02 125.56 85.14 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.318 . . . . 0.0 108.233 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -66.51 99.35 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.688 0.925 . . . . 0.0 110.366 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -88.55 148.26 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 108.919 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 52' ' ' VAL . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 35.7 p-10 -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m -77.24 81.9 3.73 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -76.13 92.53 3.23 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 108.506 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -156.74 68.83 4.56 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 89.15 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.499 1.466 . . . . 0.0 109.72 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.07 140.82 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 108.966 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -79.53 148.19 69.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.03 -1.044 . . . . 0.0 108.62 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--N 1.325 -0.69 0 C-N-CA 121.142 1.228 . . . . 0.0 110.037 -179.596 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.671 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.3 mm? -60.06 -39.68 86.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -87.66 167.47 13.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -69.56 130.64 42.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.05 -1.031 . . . . 0.0 109.096 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.35 -178.25 53.78 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -78.63 130.74 70.01 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.259 -1.142 . . . . 0.0 109.086 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.91 102.56 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 159' ' ' ILE . 33.2 mmt180 -136.95 158.18 45.04 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.538 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.401 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 141' ' ' THR . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' NH1' ' A' ' 8' ' ' ARG . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m -75.44 87.74 2.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -73.7 107.29 5.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.61 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.78 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 2.2 m120 -159.28 -38.56 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.281 -0.887 . . . . 0.0 112.059 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.78 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.3 Cg_endo -68.24 75.31 0.73 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 N-CA-C 109.259 -1.093 . . . . 0.0 109.259 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.74 113.5 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.136 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.66 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 8.0 mm100 -106.96 -30.2 0.19 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.6 -0.687 . . . . 0.0 112.14 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.9 Cg_endo . . . . . 0 C--N 1.326 -0.609 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -46.4 89.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.6 p -97.0 166.66 11.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.287 -0.883 . . . . 0.0 109.17 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.06 129.77 39.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.174 -0.953 . . . . 0.0 109.018 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.24 -155.12 52.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.83 149.25 77.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -1.183 . . . . 0.0 109.037 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.34 174.13 0.82 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.078 1.185 . . . . 0.0 109.486 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.04 154.76 44.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.116 -0.99 . . . . 0.0 109.102 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 45' ' ' THR . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 44' ' ' VAL . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 52' ' ' VAL . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.4 m-20 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.423 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' OH ' ' N ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 158' ' ' ALA . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 154' ' ' ASP . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m -76.32 72.26 3.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -81.14 113.53 19.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.822 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 65.8 m-80 -159.44 -34.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.8 . . . . 0.0 112.709 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 5.5 Cg_exo -64.94 101.99 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.691 0.925 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 167' ' ' VAL . 9.4 m -82.15 149.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.424 -0.798 . . . . 0.0 109.481 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.8 149.59 71.03 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.685 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.322 -0.862 0 C-N-CA 120.983 1.122 . . . . 0.0 109.791 179.502 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 3' ' ' THR . 7.0 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -13.07 35.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.806 -1.184 . . . . 0.0 109.455 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 1' ' ' VAL . 51.1 p -96.31 156.32 16.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -72.83 126.71 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.61 -166.54 54.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.7 150.2 81.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.97 -1.312 . . . . 0.0 108.763 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.57 97.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -140.92 137.89 33.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' VAL . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.426 HH12 HG22 ' A' ' 104' ' ' THR . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.426 HG22 HH12 ' A' ' 102' ' ' ARG . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.466 HD22 ' NE ' ' A' ' 108' ' ' ARG . 20.3 p30 -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NE ' HD22 ' A' ' 106' ' ' ASN . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.453 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m -74.36 81.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.36 101.52 5.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -155.05 68.9 5.53 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.381 -0.824 . . . . 0.0 108.969 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.33 86.13 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.297 1.331 . . . . 0.0 109.614 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 167' ' ' VAL . 2.8 m -91.78 139.69 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 12.5 mp0 -83.5 149.8 58.55 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 C-N-CA 121.094 1.196 . . . . 0.0 110.214 179.414 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.01 -50.01 75.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -98.43 161.46 13.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.885 . . . . 0.0 108.814 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.15 131.37 45.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.044 . . . . 0.0 109.617 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.58 -159.13 52.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -77.07 145.54 73.67 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.022 -1.281 . . . . 0.0 108.857 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.38 157.59 35.24 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 N-CA-C 109.016 -1.186 . . . . 0.0 109.016 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.1 155.8 44.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.151 -0.968 . . . . 0.0 108.937 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' ND2' ' A' ' 105' ' ' ASN . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG23 HG23 ' A' ' 45' ' ' THR . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.489 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' OE1' ' SD ' ' A' ' 60' ' ' MET . 12.5 tp-100 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' OE1' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' NH1' HG22 ' A' ' 104' ' ' THR . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' NH1' ' A' ' 102' ' ' ARG . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' A' ' 25' ' ' LEU . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG22 ' NH1' ' A' ' 114' ' ' ARG . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m -77.76 88.44 4.0 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.85 125.73 27.54 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.037 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 167' ' ' VAL . 67.0 m-80 -154.94 72.62 5.81 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.64 56.1 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.759 1.639 . . . . 0.0 110.066 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' ASN . 85.4 t -84.1 144.9 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.851 -1.156 . . . . 0.0 110.079 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -80.02 148.95 69.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.766 0 C-N-CA 120.939 1.093 . . . . 0.0 109.562 179.177 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 2' ' ' LEU . 3.0 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.486 ' N ' HG22 ' A' ' 1' ' ' VAL . 65.9 tp -66.76 147.83 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.176 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.4 p -89.18 139.49 30.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 0.0 108.613 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.32 80.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 0.0 110.325 -179.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.02 96.0 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.641 178.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -154.31 65.99 5.17 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.44 . . . . 0.0 110.63 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.38 82.18 2.31 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.615 1.543 . . . . 0.0 109.832 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -146.01 141.29 27.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 5.8 m-70 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 148' ' ' LEU . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.423 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 41' ' ' TRP . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m -75.53 60.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -73.62 130.25 39.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.903 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 167' ' ' VAL . 71.2 m-80 -158.64 70.14 3.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.02 38.12 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.502 1.468 . . . . 0.0 110.006 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ASN . 26.8 m -84.08 139.88 16.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.51 147.76 56.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--N 1.322 -0.842 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 179.445 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.03 -39.96 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 108.84 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 p -131.83 -154.13 0.6 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.634 -0.666 . . . . 0.0 109.437 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 6' ' ' ASN . 52.5 tp10 -65.85 155.39 36.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.74 23.09 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.003 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 4' ' ' GLU . 52.5 m-80 -154.23 67.41 5.67 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.924 -1.339 . . . . 0.0 109.014 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.11 92.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 121.377 1.385 . . . . 0.0 109.738 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 -142.64 150.03 39.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 108.749 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.678 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 ' CE ' ' A' ' 60' ' ' MET . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CH2' HD22 ' A' ' 148' ' ' LEU . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.678 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 52' ' ' VAL . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.416 ' CE ' HH21 ' A' ' 17' ' ' ARG . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.539 HD22 ' CH2' ' A' ' 41' ' ' TRP . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.0 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 162' ' ' ARG . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.2 m -77.2 84.51 3.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -73.12 135.02 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -157.54 149.43 17.31 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 108.723 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.83 130.52 40.81 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.92 120.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.213 -0.93 . . . . 0.0 109.2 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -78.06 149.63 76.79 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.148 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.326 -0.639 0 C-N-CA 120.828 1.019 . . . . 0.0 109.761 179.614 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.85 -9.25 54.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.952 . . . . 0.0 108.945 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.4 p -94.34 169.85 9.92 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.22 83.63 1.36 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.126 -0.984 . . . . 0.0 109.572 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' O ' ' ND2' ' A' ' 6' ' ' ASN . . . 49.92 30.4 15.55 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 5' ' ' GLY . 27.1 m-80 -158.11 68.76 3.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.4 . . . . 0.0 110.214 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -73.71 48.07 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.68 1.586 . . . . 0.0 109.936 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -148.49 157.34 43.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.933 -1.104 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' OD1' ' A' ' 105' ' ' ASN . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HD13 ' A' ' 25' ' ' LEU . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.425 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m -76.35 86.5 3.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -73.34 134.36 44.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 109.89 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 167' ' ' VAL . 17.2 m120 -154.03 68.96 6.2 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.319 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.48 79.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.297 1.331 . . . . 0.0 109.313 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASN . 7.8 p -85.91 144.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -78.69 148.71 73.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.236 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 C-N-CA 121.07 1.18 . . . . 0.0 109.746 179.338 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.437 ' H ' HG23 ' A' ' 1' ' ' VAL . 45.7 mt -86.89 -74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.974 . . . . 0.0 108.852 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.0 p -100.62 124.15 45.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.799 . . . . 0.0 109.303 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -72.05 136.36 46.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 109.104 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -62.22 0.38 Allowed Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -155.03 76.55 5.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.924 -1.339 . . . . 0.0 109.717 -179.394 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.83 154.2 67.77 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.581 1.52 . . . . 0.0 110.131 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 -92.4 154.56 18.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 45' ' ' THR . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 44' ' ' VAL . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 142' ' ' PHE . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 141' ' ' THR . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 140' ' ' TYR . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.45 ' HB2' ' HE ' ' A' ' 114' ' ' ARG . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 14.2 mm100 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m -70.7 91.29 0.81 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.19 135.2 56.08 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.809 0.814 . . . . 0.0 110.312 -178.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 167' ' ' VAL . 34.7 m120 -154.68 93.81 2.79 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.3 43.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 121.497 1.464 . . . . 0.0 110.907 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 165' ' ' ASN . 10.5 p -88.56 148.23 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.74 149.97 71.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 120.992 -1.067 . . . . 0.0 109.716 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.326 -0.638 0 C-N-CA 120.879 1.053 . . . . 0.0 109.791 179.237 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.8 mt -70.05 139.85 52.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 109.725 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 p -94.67 165.49 12.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.373 -0.829 . . . . 0.0 109.49 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.75 134.38 47.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.086 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.89 -175.94 54.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ARG . 32.7 m120 -80.01 125.82 81.0 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.12 -1.224 . . . . 0.0 109.001 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.57 51.66 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 N-CA-C 109.672 -0.934 . . . . 0.0 109.672 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' ASN . 98.2 mtt180 -140.28 141.74 35.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.002 -1.061 . . . . 0.0 109.067 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.5 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.442 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.418 HD22 ' HG2' ' A' ' 108' ' ' ARG . 42.6 p-10 -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.418 ' HG2' HD22 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.49 ' CE1' HD21 ' A' ' 47' ' ' LEU . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 162' ' ' ARG . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 6.0 m -72.97 84.41 1.26 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 98.7 mt-30 -71.02 135.9 48.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.824 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 5.7 m-80 -152.73 -34.84 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 0.0 113.322 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.824 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.6 Cg_endo -68.2 76.59 0.67 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 N-CA-C 109.415 -1.033 . . . . 0.0 109.415 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.84 120.03 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.804 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.65 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 11.4 mt-30 -104.25 -32.01 0.21 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.395 -0.816 . . . . 0.0 112.269 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.3 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 118.012 -0.912 . . . . 0.0 109.91 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.661 HD13 ' C ' ' A' ' 2' ' ' LEU . 3.1 tm? -62.02 -40.9 97.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.135 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.7 p -97.09 123.87 40.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.4 127.19 32.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.056 . . . . 0.0 108.394 178.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.87 -126.52 17.73 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -79.14 150.71 74.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.17 -1.194 . . . . 0.0 108.292 179.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.37 99.53 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -144.6 148.88 34.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.213 -0.929 . . . . 0.0 109.089 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' THR . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 HG23 HG23 ' A' ' 44' ' ' VAL . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.611 HD22 ' CD ' ' A' ' 108' ' ' ARG . 34.7 p-10 -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.611 ' CD ' HD22 ' A' ' 106' ' ' ASN . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m -75.02 58.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -72.71 136.77 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.356 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.63 69.42 8.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.057 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.39 143.99 78.39 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.502 1.468 . . . . 0.0 109.44 179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 t -89.99 122.09 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 0.0 110.053 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -82.82 150.12 61.44 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.376 -0.827 . . . . 0.0 108.899 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 C--N 1.325 -0.678 0 C-N-CA 120.803 1.002 . . . . 0.0 109.885 179.736 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.74 140.11 58.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -90.79 -151.07 0.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.239 -0.913 . . . . 0.0 109.324 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 6' ' ' ASN . 82.0 tt0 -65.15 153.77 39.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.11 29.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.519 -0.848 . . . . 0.0 110.982 -179.091 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 4' ' ' GLU . 9.4 m120 -155.41 65.42 4.41 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.31 . . . . 0.0 108.965 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -64.66 128.58 21.41 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.351 1.368 . . . . 0.0 109.871 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 44.7 mtm-85 -145.24 150.07 36.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.275 -0.891 . . . . 0.0 108.917 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 ' OH ' ' A' ' 21' ' ' TYR . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.466 ' OH ' HD12 ' A' ' 18' ' ' ILE . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 22' ' ' THR . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 93.1 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.404 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.448 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.469 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.469 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.448 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.3 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -79.0 83.85 5.06 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.51 135.78 44.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.721 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -155.58 69.94 5.35 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.117 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.34 84.28 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.345 1.363 . . . . 0.0 109.254 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.96 140.06 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.957 -1.089 . . . . 0.0 109.855 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.05 148.34 63.84 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.322 -0.835 0 C-N-CA 120.904 1.07 . . . . 0.0 109.633 179.415 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.5 mp -68.82 -28.33 66.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.189 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.5 p -91.19 158.8 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.567 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.97 139.71 52.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.99 -157.02 53.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -77.54 148.65 77.17 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 0.0 108.55 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 140.8 96.52 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.941 1.094 . . . . 0.0 109.855 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 8' ' ' ARG . 56.4 mtt-85 -86.87 166.89 14.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.52 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.415 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.415 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 156' ' ' ILE . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 165' ' ' ASN . 10.9 m -79.11 82.05 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.36 33.19 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.078 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 163' ' ' SER . 66.7 m-80 -157.1 73.46 4.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.058 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.23 88.09 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.136 1.224 . . . . 0.0 109.277 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.74 145.51 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.0 147.31 65.49 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 108.701 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.906 1.071 . . . . 0.0 109.804 179.511 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.55 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 45' ' ' THR . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 44' ' ' VAL . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.55 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.443 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 10.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.752 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.562 ' CG ' HD21 ' A' ' 106' ' ' ASN . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.474 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.695 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.469 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 27' ' ' ARG . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.576 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.405 HG22 HH12 ' A' ' 114' ' ' ARG . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HG2' HH11 ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 HG23 ' A' ' 45' ' ' THR . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 44' ' ' VAL . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' VAL . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' ARG . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 107' ' ' PHE . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 105' ' ' ASN . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.441 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 29' ' ' ASP . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.615 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' NE ' HD21 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.467 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 153' ' ' ILE . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.662 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.662 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 44' ' ' VAL . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 HG23 ' A' ' 45' ' ' THR . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.558 HG23 HG23 ' A' ' 44' ' ' VAL . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 52' ' ' VAL . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.557 ' CG ' HD21 ' A' ' 106' ' ' ASN . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 80.9 m-20 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.487 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 22' ' ' THR . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 27' ' ' ARG . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.789 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.509 ' CG ' HD21 ' A' ' 106' ' ' ASN . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.405 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 140' ' ' TYR . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.8 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' ND2' ' A' ' 105' ' ' ASN . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 45' ' ' THR . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 HG23 ' A' ' 44' ' ' VAL . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 24' ' ' ASP . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' HD13 ' A' ' 25' ' ' LEU . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.455 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.455 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 8' ' ' ARG . 52.4 mtt-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.606 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 49' ' ' PHE . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.606 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 69' ' ' ARG . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.673 HD21 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.673 ' NE ' HD21 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 8' ' ' ARG . 41.6 mtt-85 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 121.468 0.652 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.518 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 44.6 m80 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 40' ' ' LEU . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.403 ' CH2' HD22 ' A' ' 148' ' ' LEU . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.788 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 94.1 m-20 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.403 HD22 ' CH2' ' A' ' 41' ' ' TRP . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 45' ' ' THR . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 44' ' ' VAL . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 52' ' ' VAL . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.489 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.489 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 111' ' ' ASN . 1.1 m-80 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.768 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 45' ' ' THR . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 44' ' ' VAL . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.768 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.73 HD22 ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.571 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' NE2' ' A' ' 147' ' ' GLN . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.516 ' NE2' ' OD2' ' A' ' 145' ' ' ASP . 50.4 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 51' ' ' LYS . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' H ' ' HZ2' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.55 ' HZ2' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' NH1' HG22 ' A' ' 104' ' ' THR . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.456 HG22 ' NH1' ' A' ' 102' ' ' ARG . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.778 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.636 ' CG ' HD21 ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.437 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.445 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' THR . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' HE ' ' A' ' 17' ' ' ARG . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.59 ' C ' HD22 ' A' ' 111' ' ' ASN . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.644 ' N ' HD22 ' A' ' 111' ' ' ASN . 1.3 m120 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 32.0 m170 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.58 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 22' ' ' THR . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.58 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.46 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.46 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.6 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.161 0.505 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD13 ' ND2' ' A' ' 105' ' ' ASN . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 44' ' ' VAL . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 40' ' ' LEU . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 109' ' ' GLU . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.612 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 133' ' ' GLY . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.6 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 52' ' ' VAL . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.776 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 159' ' ' ILE . 33.2 mmt180 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 15.0 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.8 m170 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.538 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.432 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 141' ' ' THR . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' NH1' ' A' ' 8' ' ' ARG . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 45' ' ' THR . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 44' ' ' VAL . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 52' ' ' VAL . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.3 m120 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.412 ' HE2' ' HE2' ' A' ' 122' ' ' HIS . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.412 ' HE2' ' HE2' ' A' ' 118' ' ' HIS . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' OH ' ' N ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 158' ' ' ALA . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 154' ' ' ASP . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' VAL . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.426 HH12 HG22 ' A' ' 104' ' ' THR . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.426 HG22 HH12 ' A' ' 102' ' ' ARG . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.544 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.429 ' H ' ' ND2' ' A' ' 106' ' ' ASN . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.453 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' ND2' ' A' ' 105' ' ' ASN . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG23 HG23 ' A' ' 45' ' ' THR . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.489 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 60' ' ' MET . 72.6 tp60 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' NH1' HG22 ' A' ' 104' ' ' THR . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' NH1' ' A' ' 102' ' ' ARG . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' A' ' 25' ' ' LEU . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.428 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.4 t-160 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.488 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.488 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG22 ' NH1' ' A' ' 114' ' ' ARG . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 50.3 m170 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 148' ' ' LEU . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.425 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 41' ' ' TRP . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.678 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 ' CE ' ' A' ' 60' ' ' MET . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CH2' HD22 ' A' ' 148' ' ' LEU . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.678 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 52' ' ' VAL . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.416 ' CE ' HH21 ' A' ' 17' ' ' ARG . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.621 ' CE1' ' HE2' ' A' ' 122' ' ' HIS . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HE2' ' CE1' ' A' ' 118' ' ' HIS . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.539 HD22 ' CH2' ' A' ' 41' ' ' TRP . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 162' ' ' ARG . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.508 0.67 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' OD1' ' A' ' 105' ' ' ASN . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HD13 ' A' ' 25' ' ' LEU . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' O ' ' NE2' ' A' ' 157' ' ' GLN . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 44' ' ' VAL . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.515 ' N ' HD22 ' A' ' 71' ' ' ASN . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 142' ' ' PHE . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.55 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.55 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 141' ' ' THR . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 140' ' ' TYR . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.45 ' HB2' ' HE ' ' A' ' 114' ' ' ARG . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 3.2 mm-40 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.509 ' NE2' ' ND1' ' A' ' 96' ' ' HIS . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.442 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.509 ' ND1' ' NE2' ' A' ' 68' ' ' HIS . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.802 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.607 ' CG ' HD21 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.49 ' CE1' HD21 ' A' ' 47' ' ' LEU . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 162' ' ' ARG . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' THR . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 HG23 HG23 ' A' ' 44' ' ' VAL . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.771 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.512 ' O ' ' C ' ' A' ' 109' ' ' GLU . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 . . . . . 0 N--CA 1.497 1.879 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 ' OH ' ' A' ' 21' ' ' TYR . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.466 ' OH ' HD12 ' A' ' 18' ' ' ILE . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 22' ' ' THR . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.405 ' CE1' ' HE2' ' A' ' 68' ' ' HIS . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.404 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.475 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.475 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 8' ' ' ARG . 56.4 mtt-85 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD13 HD21 ' A' ' 105' ' ' ASN . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.405 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.535 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 25' ' ' LEU . 80.7 m-20 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.546 ' CG ' HD21 ' A' ' 106' ' ' ASN . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.415 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.415 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 156' ' ' ILE . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 1' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.724 0.773 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.15 -49.93 75.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.134 . . . . 0.0 109.055 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.1 p -99.17 140.95 32.58 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.494 -0.754 . . . . 0.0 109.639 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.64 139.76 53.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.17 -146.51 50.43 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.29 149.14 72.07 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.265 . . . . 0.0 108.689 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -62.43 106.06 0.46 Allowed 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.089 1.193 . . . . 0.0 109.831 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -95.65 156.01 16.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.167 -0.958 . . . . 0.0 108.844 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.16 127.59 33.19 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.099 -1.001 . . . . 0.0 109.046 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.26 -26.74 52.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 109.686 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -84.52 147.26 27.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.93 . . . . 0.0 109.795 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.9 p -90.8 -4.57 56.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -125.38 138.61 54.04 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.0 mt -130.49 160.27 34.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.312 -0.867 . . . . 0.0 109.916 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -122.89 158.76 29.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -147.06 155.82 42.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.091 -1.006 . . . . 0.0 109.951 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 34.0 ttt-85 -145.77 139.17 26.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.92 117.69 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -65.7 -39.99 91.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.115 -0.991 . . . . 0.0 110.542 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -164.07 154.41 15.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.859 -1.151 . . . . 0.0 110.187 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.33 128.73 48.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.324 -0.86 . . . . 0.0 108.95 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -75.86 140.82 71.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.067 -1.021 . . . . 0.0 108.903 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.71 2.3 0.42 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 120.773 0.982 . . . . 0.0 110.058 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -62.73 -40.13 96.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.066 -1.021 . . . . 0.0 109.43 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.3 mt -142.14 151.04 57.69 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.35 151.77 58.41 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 N-CA-C 109.197 -1.116 . . . . 0.0 109.197 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -67.17 -30.47 70.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 109.209 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.95 82.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.398 -0.814 . . . . 0.0 109.666 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.56 -30.62 37.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.87 -42.1 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.859 -1.151 . . . . 0.0 109.211 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -59.64 -41.53 90.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.12 -0.988 . . . . 0.0 109.013 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -60.25 -48.98 79.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.408 -0.808 . . . . 0.0 109.57 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.61 80.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.049 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.12 -43.32 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.06 -43.24 95.54 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.025 -1.047 . . . . 0.0 109.653 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.05 -39.85 95.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.43 71.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.923 -1.111 . . . . 0.0 110.493 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 0.0 110.089 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.71 -40.84 96.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.023 . . . . 0.0 110.062 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.93 -43.81 94.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.28 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.55 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.4 m95 -69.94 -40.5 75.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -70.19 -28.61 65.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -0.848 . . . . 0.0 109.916 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.07 -39.34 85.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 110.744 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.611 HG23 HG23 ' A' ' 45' ' ' THR . 17.2 m -102.65 11.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.15 -0.968 . . . . 0.0 110.749 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 44' ' ' VAL . 63.4 p -144.0 148.5 42.25 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 120.975 -1.078 . . . . 0.0 109.119 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.99 6.84 1.23 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 120.882 1.055 . . . . 0.0 109.576 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.4 mt -74.78 151.65 39.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.013 . . . . 0.0 109.277 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -132.4 145.23 51.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.422 -0.799 . . . . 0.0 109.601 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.74 127.05 44.48 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.5 m -123.99 132.06 53.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.581 -0.7 . . . . 0.0 110.14 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.1 141.73 43.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 109.414 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.1 132.01 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 t -90.57 -4.22 57.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.133 -0.98 . . . . 0.0 110.195 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -153.72 158.86 41.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.096 -1.003 . . . . 0.0 109.543 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.18 169.96 46.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -83.78 140.24 32.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 109.243 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.01 155.85 20.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.52 -0.737 . . . . 0.0 109.505 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.85 -40.19 87.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 109.81 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -117.09 118.09 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 96.9 mmm -101.73 129.09 47.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.51 129.94 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.526 -0.734 . . . . 0.0 109.562 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.1 p -149.98 169.13 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 109.809 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -116.65 138.44 51.44 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.32 165.34 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.317 -0.865 . . . . 0.0 110.101 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -130.82 149.59 52.39 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.48 -0.763 . . . . 0.0 110.32 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.35 -149.72 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -68.23 129.57 40.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.093 . . . . 0.0 109.415 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.528 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 10.7 p-80 -130.9 59.57 1.67 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.641 -0.662 . . . . 0.0 109.784 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.5 mtt180 56.22 48.34 17.53 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.782 -0.574 . . . . 0.0 110.614 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.8 m-20 -140.65 162.36 35.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -89.51 9.05 28.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.177 -0.952 . . . . 0.0 109.723 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -135.04 70.07 70.13 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.42 -0.8 . . . . 0.0 109.719 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 150.74 85.85 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.717 1.611 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.01 135.9 38.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 109.149 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -98.16 68.87 1.98 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.249 -0.907 . . . . 0.0 109.34 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 66.36 -173.38 24.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.14 3.72 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.453 1.435 . . . . 0.0 110.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.56 171.08 27.41 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.66 -162.69 45.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -70.66 152.66 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -1.164 . . . . 0.0 109.314 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -90.38 -5.67 55.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.0 108.983 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.12 176.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.82 168.54 14.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.887 -1.133 . . . . 0.0 109.767 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.28 163.45 37.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.9 160.25 14.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.545 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -65.53 150.28 96.19 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.035 -1.041 . . . . 0.0 108.93 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -58.24 105.01 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.238 1.292 . . . . 0.0 110.429 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.61 172.54 40.37 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -64.66 -178.25 0.68 Allowed 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 121.573 1.515 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.34 -127.0 42.83 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.66 -9.07 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -1.064 . . . . 0.0 110.154 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.93 137.77 48.5 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.85 30.26 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -63.63 151.62 41.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.906 -1.35 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.58 121.56 15.64 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -108.95 148.19 31.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.15 133.85 55.54 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -70.08 107.28 3.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -79.32 -0.13 31.26 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.89 -28.54 61.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.604 -1.31 . . . . 0.0 109.484 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 53.1 mp0 -85.61 159.92 19.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -90.18 119.82 30.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.052 -1.03 . . . . 0.0 108.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -88.17 139.84 30.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.721 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.6 p -139.61 171.46 14.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.538 -0.726 . . . . 0.0 109.898 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -122.73 24.38 9.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.643 -0.66 . . . . 0.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 108' ' ' ARG . 2.5 p30 -148.92 -164.39 2.02 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.641 -1.287 . . . . 0.0 110.925 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -55.36 3.5 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.447 -0.783 . . . . 0.0 111.727 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 7.2 mmt-85 -59.45 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.699 -1.251 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.73 -59.62 4.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.0 112.236 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -139.45 157.55 45.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.756 -1.215 . . . . 0.0 111.239 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -100.6 122.22 42.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.9 -42.59 94.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.007 -1.058 . . . . 0.0 110.563 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -59.95 -40.7 89.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.08 -1.012 . . . . 0.0 111.144 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -59.85 -43.12 94.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.801 -1.187 . . . . 0.0 109.971 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.8 -42.39 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.972 -1.08 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.65 -47.47 84.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.191 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.26 88.01 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.376 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -60.03 -43.66 95.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 109.512 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 79.2 mt-10 -60.38 -40.01 89.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.235 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.22 -37.76 84.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.34 -44.39 93.49 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -68.31 -40.05 81.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.24 . . . . 0.0 109.315 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.0 m -60.17 -39.78 87.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.1 mt -79.77 1.17 27.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.53 82.31 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.737 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.49 141.79 39.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.888 -1.36 . . . . 0.0 108.562 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.7 m -108.79 169.2 8.82 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.439 -0.788 . . . . 0.0 110.539 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -59.16 170.82 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 t -150.09 163.27 38.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.7 p -92.68 6.24 48.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.185 -0.947 . . . . 0.0 109.364 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -85.07 110.67 19.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.76 -26.77 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.293 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.05 2.4 65.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.191 -1.182 . . . . 0.0 109.442 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 137' ' ' TYR . 87.7 mt -69.34 -32.46 71.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.65 19.98 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.414 -0.804 . . . . 0.0 110.03 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.481 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.4 t80 -64.88 134.82 96.17 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.854 -1.154 . . . . 0.0 108.214 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.69 -45.0 42.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 120.738 0.959 . . . . 0.0 111.318 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 t -85.18 134.4 34.16 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.734 -1.229 . . . . 0.0 110.577 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -69.67 139.98 53.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.684 -0.635 . . . . 0.0 109.396 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -151.07 140.19 21.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 109.093 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -78.14 116.81 18.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.702 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 m -112.95 2.4 15.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.588 -0.695 . . . . 0.0 109.639 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.05 -107.56 2.47 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.95 145.27 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.05 -1.265 . . . . 0.0 109.112 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.34 119.69 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.929 . . . . 0.0 109.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -137.61 152.47 49.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.457 -0.777 . . . . 0.0 109.424 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.55 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.7 mt -76.38 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 109.228 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.05 156.76 17.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.748 . . . . 0.0 109.354 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -59.42 -39.75 84.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -59.23 -39.99 84.5 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.555 -0.716 . . . . 0.0 109.27 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -75.12 -40.39 59.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.941 -1.099 . . . . 0.0 109.622 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.24 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.05 -39.66 86.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.97 -53.15 45.12 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.084 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.97 -36.33 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.795 -1.415 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -66.36 -39.61 89.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.016 -1.052 . . . . 0.0 109.518 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.09 93.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.994 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.33 -50.15 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 0.0 109.108 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -95.2 -71.21 0.68 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.43 -168.92 34.85 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -86.51 150.12 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.222 -1.163 . . . . 0.0 109.268 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.443 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 10.4 m -75.57 65.92 1.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 110.103 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.05 135.36 46.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.437 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -156.29 76.44 4.55 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.434 -0.791 . . . . 0.0 109.716 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.72 105.99 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.138 1.225 . . . . 0.0 109.676 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.52 138.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 110.438 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -85.27 149.97 53.62 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.453 -0.779 . . . . 0.0 109.699 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.537 0.657 0 C-N-CA 120.925 1.083 . . . . 0.0 109.961 178.709 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.72 146.6 52.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.333 -0.854 . . . . 0.0 108.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 52.3 p -88.76 164.29 15.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -67.02 139.23 57.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.31 -0.869 . . . . 0.0 109.336 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.99 -165.27 37.85 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 8' ' ' ARG . 20.1 m-20 -77.91 133.13 66.12 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.181 -1.188 . . . . 0.0 108.763 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' HH11 ' A' ' 8' ' ' ARG . 4.8 Cg_endo -63.15 20.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 120.958 1.105 . . . . 0.0 111.137 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 6' ' ' ASN . 10.0 mpt_? -98.04 165.79 11.74 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.273 -0.892 . . . . 0.0 108.894 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -65.09 132.24 48.66 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -79.2 -15.0 58.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -85.37 143.43 28.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 109.371 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.0 p -91.21 -4.2 56.26 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -122.86 120.88 34.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.51 160.54 17.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.309 -0.87 . . . . 0.0 110.011 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.7 p -131.94 155.54 47.75 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.03 150.53 36.17 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.127 -0.983 . . . . 0.0 109.934 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 17' ' ' ARG . 49.8 ttt-85 -146.46 136.68 23.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.92 123.97 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 0.0 108.968 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.73 -40.02 91.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.838 . . . . 0.0 110.084 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -163.3 161.16 24.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.17 . . . . 0.0 110.396 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -108.91 131.84 54.64 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -71.74 139.23 83.12 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.096 -1.002 . . . . 0.0 108.447 179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.38 0.41 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 N-CA-C 109.116 -1.148 . . . . 0.0 109.116 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.3 m-20 -64.88 -40.05 94.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -140.04 150.01 60.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.08 152.6 70.35 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -66.87 -29.61 69.55 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.88 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -79.26 -33.28 43.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.995 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.29 -42.93 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.939 -1.101 . . . . 0.0 109.242 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 46.2 t0 -59.88 -41.56 91.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -60.04 -45.35 93.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.74 88.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.277 -0.889 . . . . 0.0 110.269 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.55 -45.19 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.981 -1.075 . . . . 0.0 109.988 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.29 -41.32 93.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.252 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.98 -40.04 94.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.072 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.79 -47.73 82.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.491 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.6 m-85 -60.13 -40.27 89.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.846 -1.159 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -61.12 -40.1 92.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.914 -1.117 . . . . 0.0 110.174 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.1 -40.91 91.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -73.21 -39.95 65.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.199 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.4 t -69.45 -39.67 77.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.408 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.67 -27.53 28.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 111.109 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.68 10.1 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.109 -0.994 . . . . 0.0 110.586 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 13.8 p -147.53 151.0 38.66 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.944 -1.097 . . . . 0.0 109.106 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.18 4.34 1.62 Allowed 'Trans proline' 0 C--O 1.213 -0.75 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 73.3 mt -73.61 146.31 44.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -130.02 145.07 51.64 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.722 . . . . 0.0 109.281 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 88.3 m-85 -120.33 131.53 54.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.462 -0.773 . . . . 0.0 109.57 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -124.89 130.05 51.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 109.737 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -76.91 138.57 39.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 0.0 108.726 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.26 131.22 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -93.37 -5.59 49.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.251 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.17 158.1 43.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.902 . . . . 0.0 109.283 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.81 -178.84 47.13 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -83.92 139.24 32.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -1.209 . . . . 0.0 109.607 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.12 138.12 42.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.382 -0.823 . . . . 0.0 108.977 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -60.12 -40.68 90.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.008 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.93 117.4 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.363 -0.835 . . . . 0.0 109.866 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.5 mtt -101.96 137.16 40.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.369 -0.832 . . . . 0.0 109.441 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -117.3 133.48 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -144.23 155.28 43.8 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 110.268 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -111.77 132.26 54.77 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.13 160.39 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 41.8 mtm-85 -124.43 134.67 53.01 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.663 -0.648 . . . . 0.0 109.915 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -142.71 4.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.95 129.74 40.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -1.009 . . . . 0.0 109.754 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.0 p-80 -137.56 58.43 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.552 -0.717 . . . . 0.0 109.616 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.2 mtt-85 56.8 52.41 9.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.619 -0.675 . . . . 0.0 110.479 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 76.4 m-20 -142.85 162.12 36.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.299 -0.876 . . . . 0.0 109.271 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -89.42 9.4 26.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 t -136.39 68.66 61.39 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.275 -0.891 . . . . 0.0 109.941 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.95 149.65 87.76 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.21 1.273 . . . . 0.0 109.435 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -76.51 131.67 39.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -97.27 63.95 1.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.271 -0.893 . . . . 0.0 109.353 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 75.66 -177.41 49.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.21 4.83 0.2 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 121.672 1.581 . . . . 0.0 110.244 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.44 174.31 30.73 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.13 -158.89 48.52 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -70.65 152.22 44.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 109.582 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.2 -4.91 56.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.145 -0.972 . . . . 0.0 109.17 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.77 -178.14 0.85 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.38 -0.825 . . . . 0.0 109.387 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -167.97 162.87 13.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.62 158.97 43.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.222 -0.923 . . . . 0.0 109.362 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -92.52 155.56 17.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.322 -0.861 . . . . 0.0 109.155 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -62.1 149.93 85.17 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.45 -0.782 . . . . 0.0 109.724 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.82 102.96 0.11 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 121.088 1.192 . . . . 0.0 109.993 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.52 165.96 33.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.92 168.6 8.59 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.087 1.191 . . . . 0.0 109.466 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.83 -124.8 15.33 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.138 -1.029 . . . . 0.0 111.122 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -80.06 -7.92 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.777 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 137.47 50.27 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.34 -17.58 50.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.75 125.01 23.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.937 -1.331 . . . . 0.0 109.674 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.33 129.54 47.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -112.51 137.25 51.0 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.336 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 45.3 m-85 -115.41 137.09 52.42 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.536 -0.727 . . . . 0.0 110.352 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.4 100.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -77.87 -8.53 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 110.676 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -76.41 -13.81 60.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.781 -1.199 . . . . 0.0 108.672 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -90.52 155.84 18.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.67 -0.644 . . . . 0.0 109.339 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -90.51 107.07 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 108.633 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -86.0 149.86 24.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.201 -0.937 . . . . 0.0 109.613 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -132.63 159.77 38.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -112.6 26.36 10.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.439 -0.788 . . . . 0.0 109.19 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.752 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -143.84 -163.48 1.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.04 12.02 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.561 -0.712 . . . . 0.0 110.759 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.562 ' CG ' HD21 ' A' ' 106' ' ' ASN . 25.8 mmt180 -58.11 -166.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.728 -1.233 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.8 -57.81 11.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.466 -0.771 . . . . 0.0 112.523 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -111.89 130.64 55.76 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.029 -1.045 . . . . 0.0 111.825 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.11 119.3 38.1 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.09 -44.18 95.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 110.541 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -60.02 -40.26 88.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 111.334 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 141' ' ' THR . 15.8 mmm180 -56.33 -43.47 79.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.696 -1.252 . . . . 0.0 109.82 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -72.64 -39.77 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.894 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.74 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 109.757 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.82 89.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.47 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.474 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 86.5 t60 -60.06 -47.84 84.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.81 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.9 mt-10 -60.95 -40.26 92.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.241 -0.912 . . . . 0.0 109.94 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.28 -39.78 94.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.65 -41.78 75.23 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -67.67 -40.06 84.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 108.774 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.7 t -58.46 -30.11 66.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.82 . . . . 0.0 109.204 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -83.59 -2.3 55.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.338 -0.852 . . . . 0.0 109.861 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.95 11.04 62.06 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.592 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.2 mt -81.09 146.39 30.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.93 -1.335 . . . . 0.0 109.175 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 128' ' ' HIS . 40.7 m -107.21 159.31 16.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.452 -0.78 . . . . 0.0 108.925 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' SER . 75.0 m80 -48.45 176.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -149.7 158.47 44.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.313 -0.867 . . . . 0.0 109.499 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.0 p -99.95 4.64 45.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.263 -0.898 . . . . 0.0 110.077 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -83.86 124.85 31.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.031 -1.043 . . . . 0.0 109.818 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.9 -38.06 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.114 -0.991 . . . . 0.0 110.227 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -72.72 2.54 31.6 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.05 -1.072 . . . . 0.0 110.537 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.09 137.25 35.44 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.975 -1.309 . . . . 0.0 109.697 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 137' ' ' TYR . 68.6 mt -69.94 -30.2 67.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.474 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 96.2 mmm -70.59 21.31 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.73 -0.606 . . . . 0.0 110.581 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.8 t80 -63.31 138.51 97.37 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.017 -1.052 . . . . 0.0 108.199 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.03 -59.16 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 120.673 0.916 . . . . 0.0 110.727 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 91.1 p -81.2 165.21 21.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.184 -0.948 . . . . 0.0 110.532 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -66.83 149.35 50.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.598 -0.689 . . . . 0.0 109.265 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.695 ' H ' HH21 ' A' ' 114' ' ' ARG . 76.9 p -149.78 164.25 35.79 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.127 -0.983 . . . . 0.0 109.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -158.19 111.99 2.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 109.039 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -100.46 10.06 41.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.359 -0.838 . . . . 0.0 110.146 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.92 1.52 67.48 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 27.6 t0 -159.92 169.89 22.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -1.168 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.469 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.5 t -134.32 98.55 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.441 -0.787 . . . . 0.0 109.07 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -138.47 159.88 40.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.0 109.002 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.52 152.09 39.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 108.735 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.28 165.1 11.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.395 -0.816 . . . . 0.0 109.552 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -60.05 -39.86 87.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.44 -0.788 . . . . 0.0 109.049 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -59.81 -40.23 87.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.68 -42.93 39.84 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.108 . . . . 0.0 109.819 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.8 -50.03 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -61.97 -39.76 93.27 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.638 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.69 -52.57 49.93 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.859 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.67 -39.75 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.666 -1.49 . . . . 0.0 109.708 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -67.83 -39.09 83.92 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.267 -0.896 . . . . 0.0 109.422 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.07 87.79 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.128 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.73 -48.0 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.241 -0.912 . . . . 0.0 109.48 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.05 -66.66 0.89 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.135 -0.978 . . . . 0.0 109.547 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 152.67 -167.86 31.58 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.15 152.79 21.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.161 -1.199 . . . . 0.0 109.835 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.1 m -76.65 62.83 2.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.368 -0.832 . . . . 0.0 110.337 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 27.4 mt-30 -70.77 136.22 48.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.008 . . . . 0.0 108.805 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 12.6 m120 -152.56 149.49 22.69 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 108.761 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.1 168.04 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.122 -1.145 . . . . 0.0 109.122 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 75.7 t -85.59 135.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.262 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -80.29 150.25 70.57 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.823 1.015 . . . . 0.0 109.693 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.749 0.785 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.9 mt -86.47 -72.25 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 109.506 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.3 p -93.03 152.48 19.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 109.614 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -69.99 140.5 52.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.839 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.93 -157.9 53.64 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -77.25 149.98 79.8 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.259 -1.142 . . . . 0.0 109.013 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.4 -178.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.075 1.184 . . . . 0.0 110.007 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -145.71 151.58 38.23 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.367 -0.833 . . . . 0.0 108.906 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -69.81 127.8 34.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.08 -1.013 . . . . 0.0 109.088 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.7 -33.47 62.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -83.87 149.85 26.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.0 p -92.69 -5.18 51.9 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 13.3 m80 -119.53 129.36 54.64 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.0 mt -130.44 161.1 32.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 109.106 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -125.04 158.8 32.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.566 -0.709 . . . . 0.0 109.242 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.65 159.16 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.0 109.297 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -143.24 135.88 27.5 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.48 114.46 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -62.84 -40.03 96.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.977 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -164.62 161.63 21.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.724 -1.235 . . . . 0.0 110.085 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.56 130.47 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.63 -0.669 . . . . 0.0 109.264 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.2 t -78.02 143.02 65.18 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.033 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.74 1.24 1.9 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 N-CA-C 109.572 -0.972 . . . . 0.0 109.572 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 79.9 m-20 -63.43 -40.04 96.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.515 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -142.93 150.02 51.59 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.14 153.19 47.36 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 120.748 0.966 . . . . 0.0 109.615 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 27' ' ' ARG . 18.5 ptt-85 -66.88 -30.17 70.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 110.073 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -76.82 -33.24 57.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.036 -1.04 . . . . 0.0 109.588 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.54 -43.96 77.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -59.92 -45.26 93.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 109.543 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.9 -46.15 91.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.3 83.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.342 -0.849 . . . . 0.0 109.803 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mm -70.01 -46.23 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.246 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -61.05 -40.09 92.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.28 -40.08 96.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.325 -0.86 . . . . 0.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 109.743 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.99 -40.54 89.54 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.99 . . . . 0.0 109.57 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.95 -41.01 97.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.01 -41.27 91.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 109.896 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -74.33 -42.87 58.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 109.98 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -39.91 77.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.65 -25.6 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.323 -0.86 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.8 m -109.6 8.77 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.223 -0.923 . . . . 0.0 110.377 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -145.7 150.63 43.97 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.994 -1.066 . . . . 0.0 108.856 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.01 6.04 1.2 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 120.995 1.13 . . . . 0.0 109.67 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.3 mt -75.06 144.68 42.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.167 -0.958 . . . . 0.0 109.817 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.4 p -130.35 144.1 51.18 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -120.02 133.83 55.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.412 -0.805 . . . . 0.0 109.684 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -119.98 130.0 54.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.555 -0.716 . . . . 0.0 109.716 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -79.47 144.4 34.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.369 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 52' ' ' VAL . 33.6 m -127.69 130.15 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.431 -0.793 . . . . 0.0 109.071 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -91.75 -4.04 55.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.61 156.64 42.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.87 167.61 37.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -82.01 167.89 18.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -1.059 . . . . 0.0 109.35 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.02 158.2 44.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.281 -0.887 . . . . 0.0 109.197 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.96 -40.62 89.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.122 -0.986 . . . . 0.0 109.481 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.2 mt -113.0 110.6 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.438 -0.788 . . . . 0.0 109.224 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.3 mtp -100.38 127.13 46.77 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.301 -0.874 . . . . 0.0 109.257 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.58 129.79 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -150.14 170.28 19.3 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.02 -1.05 . . . . 0.0 110.501 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.6 139.54 50.4 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 m -134.87 164.43 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.237 -0.914 . . . . 0.0 110.508 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.04 138.95 53.76 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 109.772 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.05 3.47 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -70.83 131.85 44.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.533 -0.981 . . . . 0.0 110.196 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 20.6 p-80 -132.68 57.01 1.81 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.546 -0.721 . . . . 0.0 109.283 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.0 mtt180 54.05 49.37 18.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.424 -0.798 . . . . 0.0 109.606 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 12.7 m-20 -135.64 165.14 26.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.381 -0.824 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -90.17 8.46 32.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.251 -0.906 . . . . 0.0 110.465 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.2 t -137.38 67.98 53.78 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.138 -0.976 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.78 145.49 86.44 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.359 1.372 . . . . 0.0 109.609 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -75.44 135.87 40.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.159 -0.963 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -98.33 60.73 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.218 -0.926 . . . . 0.0 109.375 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.18 -177.03 50.57 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.19 -0.59 1.35 Allowed 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.353 1.369 . . . . 0.0 109.419 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.86 175.19 31.01 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.2 -159.95 37.85 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.071 -1.253 . . . . 0.0 109.979 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.72 151.23 45.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.25 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.23 -13.07 31.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 176.73 1.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 109.324 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -167.65 170.5 10.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.715 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.95 166.63 27.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.249 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -96.44 163.61 12.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 2.2 mp0 -66.58 148.39 98.68 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.097 -1.002 . . . . 0.0 109.02 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.17 115.25 2.44 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.207 1.271 . . . . 0.0 110.225 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.15 169.58 42.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.28 176.99 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 121.432 1.421 . . . . 0.0 109.981 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.13 -132.2 23.37 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.7 -8.64 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.805 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.78 147.46 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.24 -18.98 37.81 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -66.59 157.27 32.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.27 . . . . 0.0 110.265 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.77 10.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -103.88 140.71 37.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.368 -0.833 . . . . 0.0 110.067 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.546 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 34.7 m-85 -115.51 135.56 53.97 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.576 -0.703 . . . . 0.0 109.133 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.55 111.85 4.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -78.88 -9.7 59.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.89 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.04 -14.72 58.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.953 -1.092 . . . . 0.0 109.653 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.69 159.95 21.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -92.85 110.79 22.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 0.0 109.182 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -93.35 136.0 34.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.848 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.5 p -131.42 160.01 36.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 109.185 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -109.31 27.12 9.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 109.626 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.576 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.02 -162.16 1.46 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.984 -1.072 . . . . 0.0 110.334 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 108' ' ' ARG . 55.4 p90 -71.92 5.32 2.7 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 0.0 111.83 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.9 mtt180 -58.14 -156.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.655 -1.278 . . . . 0.0 111.094 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -45.22 -64.98 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -140.85 147.41 38.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.815 -1.178 . . . . 0.0 110.584 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.38 124.25 39.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.0 -40.03 79.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.471 -0.768 . . . . 0.0 110.908 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -59.97 -40.66 89.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.976 -1.078 . . . . 0.0 111.057 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 114' ' ' ARG . 44.8 mtt-85 -59.97 -42.1 93.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.755 -1.215 . . . . 0.0 110.97 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.61 -40.11 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.746 -1.221 . . . . 0.0 109.639 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.01 82.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.985 -1.072 . . . . 0.0 109.209 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.1 86.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.634 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -60.62 -49.92 75.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.275 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.5 mt-10 -60.05 -40.02 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.893 -1.129 . . . . 0.0 109.372 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.53 -39.97 94.75 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.167 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -51.2 -41.18 46.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -65.72 -39.55 91.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -1.084 . . . . 0.0 108.979 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -59.89 -33.59 72.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.33 -0.93 38.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.583 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.52 11.36 71.73 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.086 -1.054 . . . . 0.0 110.784 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.54 149.07 36.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.881 -1.364 . . . . 0.0 108.997 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -109.95 158.72 17.93 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.505 -0.747 . . . . 0.0 109.949 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -55.08 173.44 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.368 -0.833 . . . . 0.0 108.997 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.8 t -154.13 160.35 41.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.23 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 79.8 p -95.27 12.04 30.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 109.542 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -84.0 116.45 22.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 109.187 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.0 -40.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.81 5.78 11.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.094 -1.051 . . . . 0.0 110.99 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.49 139.44 34.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.962 -1.317 . . . . 0.0 109.742 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.6 mt -69.98 -24.82 63.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.051 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.5 mmm -70.78 16.76 0.08 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.2 t80 -67.02 135.66 94.07 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.174 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -45.55 29.77 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.007 1.138 . . . . 0.0 111.206 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 m -84.12 149.26 26.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.751 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -68.99 144.38 54.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.558 -0.714 . . . . 0.0 109.753 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.1 p -152.06 137.37 17.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.373 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -80.94 130.01 34.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.018 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 96.2 p -107.95 143.75 36.17 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.61 -43.82 97.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -131.17 151.26 51.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.554 -0.968 . . . . 0.0 109.19 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.405 HG22 HH12 ' A' ' 114' ' ' ARG . 77.0 t -93.57 98.56 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.181 -0.95 . . . . 0.0 109.692 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -144.03 159.71 42.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.394 -0.816 . . . . 0.0 108.82 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.96 159.23 32.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 108.859 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.89 158.85 15.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.232 -0.918 . . . . 0.0 109.143 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.98 -40.08 87.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 108.999 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.91 -41.5 91.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.312 -0.867 . . . . 0.0 109.517 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -76.66 -41.28 46.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -0.975 . . . . 0.0 109.829 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.54 -49.94 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.088 -1.007 . . . . 0.0 109.833 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -53.31 45.91 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.092 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.9 -39.97 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.88 -1.365 . . . . 0.0 109.65 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.4 mt-30 -67.4 -38.2 84.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.088 -1.008 . . . . 0.0 108.909 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.05 87.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.411 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.4 -50.75 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.52 -68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.265 -0.897 . . . . 0.0 109.768 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.61 -160.36 29.55 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HG2' HH11 ' A' ' 162' ' ' ARG . 34.3 mtt-85 -88.47 170.09 11.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.276 -1.132 . . . . 0.0 109.353 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.3 m -73.81 73.98 1.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 108.607 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 93.1 mt-30 -74.71 135.86 41.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.818 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 164' ' ' GLN . 73.8 m-20 -152.76 68.03 6.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.283 -0.885 . . . . 0.0 109.498 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.9 110.62 1.34 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.478 1.452 . . . . 0.0 110.147 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.4 m -84.07 144.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.2 150.08 73.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 108.476 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.322 -0.848 0 C-N-CA 120.878 1.052 . . . . 0.0 110.045 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -79.61 129.18 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 75.0 p -97.7 -174.27 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.517 -0.739 . . . . 0.0 109.658 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.6 tt0 -67.74 172.37 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.19 38.6 0.09 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 4' ' ' GLU . 27.7 m120 -157.68 66.3 3.57 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.309 -1.112 . . . . 0.0 108.948 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.78 130.98 33.23 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 121.535 1.49 . . . . 0.0 110.252 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 8' ' ' ARG . 7.2 mmt-85 -88.55 171.6 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -65.58 119.53 11.27 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.977 -1.077 . . . . 0.0 108.582 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.09 -13.3 57.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -86.04 147.56 26.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -0.942 . . . . 0.0 110.032 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 p -94.0 -5.06 48.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -120.93 131.35 54.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -131.74 159.21 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.314 -0.866 . . . . 0.0 109.168 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.3 p -129.94 155.36 46.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.427 -0.795 . . . . 0.0 109.042 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -145.81 158.97 43.82 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -145.15 135.71 24.33 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.41 -0.806 . . . . 0.0 110.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -91.02 116.55 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -67.21 -39.71 86.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.126 -0.984 . . . . 0.0 110.629 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -160.59 156.02 25.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 109.983 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.31 133.24 48.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 t -76.7 142.43 70.12 Favored Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.086 -1.009 . . . . 0.0 109.037 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -63.16 0.9 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 120.79 0.993 . . . . 0.0 109.559 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 22' ' ' THR . 85.4 m-20 -62.95 -41.62 99.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.93 . . . . 0.0 109.852 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -142.74 150.2 52.85 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.61 157.15 33.35 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -67.01 -31.38 71.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.0 110.12 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.89 84.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 109.685 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.06 -38.59 61.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 109.492 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.08 -46.99 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 109.553 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -56.64 -44.21 81.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.776 -1.202 . . . . 0.0 108.884 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.99 -48.36 82.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.11 86.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.179 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.0 -39.97 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.56 -42.76 88.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -64.72 -39.96 94.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.033 -1.042 . . . . 0.0 110.611 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.94 -53.3 59.5 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.615 -1.303 . . . . 0.0 109.565 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -60.06 -43.81 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.966 -1.083 . . . . 0.0 109.782 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -61.82 -40.64 95.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 110.063 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -60.02 -39.96 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.972 -1.08 . . . . 0.0 109.706 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.92 -41.4 71.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.923 -1.111 . . . . 0.0 110.032 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.9 t -71.71 -27.8 63.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.875 . . . . 0.0 110.498 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.05 -40.04 88.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.885 . . . . 0.0 111.131 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 HG23 ' A' ' 45' ' ' THR . 5.5 m -103.01 12.28 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.068 -1.02 . . . . 0.0 110.354 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 44' ' ' VAL . 43.9 p -143.81 149.19 45.53 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.119 -0.988 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.57 8.9 0.47 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 N-CA-C 109.293 -1.08 . . . . 0.0 109.293 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 45' ' ' THR . 91.2 mt -74.98 146.08 41.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.46 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.9 p -132.07 144.43 50.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -124.28 135.64 53.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.448 -0.782 . . . . 0.0 109.905 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -120.03 129.94 54.48 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.659 0.742 . . . . 0.0 109.81 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -80.09 131.78 35.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' VAL . 14.1 m -121.04 131.72 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.383 -0.823 . . . . 0.0 108.808 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -88.34 -14.94 36.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 110.287 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -145.72 160.9 41.05 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.096 -1.003 . . . . 0.0 109.284 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.7 164.31 39.96 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -82.52 134.05 35.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.239 . . . . 0.0 109.219 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.01 156.28 18.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.251 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.5 mt -111.35 116.02 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.0 125.61 47.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -0.971 . . . . 0.0 109.488 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -114.7 129.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.0 p -145.1 159.51 42.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.0 110.012 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -113.02 130.05 56.28 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.34 160.04 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.33 -0.856 . . . . 0.0 110.747 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.16 137.03 54.97 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.361 0.6 . . . . 0.0 109.452 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.47 -151.7 2.0 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.71 131.46 45.62 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.567 -0.961 . . . . 0.0 110.343 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.5 p-80 -132.57 62.99 1.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.645 -0.66 . . . . 0.0 109.471 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.1 mtt180 56.15 49.3 15.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 99.8 m-20 -139.49 160.74 39.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 109.314 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -89.87 8.85 30.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.4 t -137.16 69.94 55.91 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.317 -0.864 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.6 158.64 52.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.569 1.513 . . . . 0.0 109.355 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -76.8 146.39 37.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -96.34 70.78 2.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 109.275 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 62.63 -173.48 9.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.16 0.28 1.38 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.47 1.447 . . . . 0.0 109.94 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.05 173.54 25.56 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.32 -160.33 30.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -70.37 155.02 41.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.17 . . . . 0.0 108.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.03 -10.15 45.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.043 -1.036 . . . . 0.0 109.516 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.08 177.94 1.84 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -165.78 169.06 15.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.804 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.38 164.43 34.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.937 . . . . 0.0 109.87 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -95.34 168.87 10.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -65.79 148.87 98.01 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 108.699 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.28 130.46 36.12 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.004 1.136 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.6 169.83 30.7 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 -172.69 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.43 1.42 . . . . 0.0 109.495 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.57 -130.88 51.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.91 -7.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.973 . . . . 0.0 109.96 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.17 136.06 49.89 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.96 -15.43 60.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -68.32 151.83 46.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -1.163 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.16 126.37 18.5 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.173 -0.954 . . . . 0.0 109.537 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -106.76 135.56 48.1 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.484 -0.76 . . . . 0.0 109.961 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.492 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.4 m-85 -106.68 137.93 43.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 109.364 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -67.06 97.3 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -76.61 -7.26 54.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 110.779 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -78.62 -20.23 50.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.704 -1.247 . . . . 0.0 109.129 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -87.81 164.4 15.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.413 -0.804 . . . . 0.0 109.649 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' ARG . 10.0 tpt180 -92.1 114.81 27.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.185 -0.947 . . . . 0.0 109.054 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -89.48 134.86 33.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 108.986 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.8 p -137.57 170.04 16.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.291 -0.88 . . . . 0.0 110.045 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.74 25.85 9.72 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.746 -0.596 . . . . 0.0 110.443 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 108' ' ' ARG . 8.5 p30 -147.33 -164.95 2.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.831 -1.168 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 63.3 t80 -58.11 2.28 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.783 -0.573 . . . . 0.0 111.295 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 107' ' ' PHE . 5.3 mmt-85 -57.58 -162.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.635 -1.291 . . . . 0.0 109.548 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -49.08 -59.99 3.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.94 -1.1 . . . . 0.0 112.269 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -140.37 158.77 43.51 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.839 -1.163 . . . . 0.0 110.367 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 22.7 m120 -98.8 119.79 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.83 -43.23 94.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.404 -0.81 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.78 -50.25 74.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.925 -1.109 . . . . 0.0 111.346 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 68.4 ttt180 -60.0 -42.84 95.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.078 . . . . 0.0 110.857 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.03 -40.14 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.832 -1.168 . . . . 0.0 109.544 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.54 95.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 108.763 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.77 85.01 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.16 -44.97 94.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.565 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.492 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 74.5 mt-10 -60.28 -41.36 93.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.963 -1.085 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.1 -39.77 94.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 108.875 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.02 -39.62 63.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.31 -40.01 89.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -1.038 . . . . 0.0 109.06 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 89.3 p -65.53 -24.49 67.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.595 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.41 -2.64 58.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.92 10.74 74.93 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.56 146.78 38.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.032 -1.275 . . . . 0.0 109.163 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.3 m -106.68 168.28 9.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.589 -0.695 . . . . 0.0 110.007 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.53 170.99 5.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 109.653 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.7 t -149.94 159.98 43.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.268 -0.895 . . . . 0.0 109.685 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.2 p -97.38 10.0 40.83 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.308 -0.87 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -83.39 121.99 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.123 -0.985 . . . . 0.0 109.549 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.9 mt -59.94 -37.93 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.53 5.35 16.36 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.118 -1.039 . . . . 0.0 110.99 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 139.53 32.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.916 -1.344 . . . . 0.0 109.726 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.9 mt -67.62 -33.47 75.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.077 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 45.9 mtp -73.45 29.6 0.07 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.532 -0.73 . . . . 0.0 110.367 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' H ' ' C ' ' A' ' 135' ' ' LEU . 26.5 t80 -66.33 136.47 95.15 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.28 -58.03 1.87 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 120.942 1.095 . . . . 0.0 111.479 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 79.9 p -82.48 157.42 23.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.817 -1.177 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -84.32 146.53 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.203 -0.935 . . . . 0.0 109.574 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.0 p -151.92 149.42 28.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.304 -0.873 . . . . 0.0 109.566 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -80.99 129.76 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 0.0 109.574 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.406 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 22.4 m -118.58 147.65 43.49 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.588 -0.695 . . . . 0.0 109.559 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.89 -83.99 0.08 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.75 144.64 26.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -1.123 . . . . 0.0 109.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 25.2 t -93.17 109.46 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -139.56 156.01 47.15 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.58 153.1 39.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.89 . . . . 0.0 109.478 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.3 162.57 12.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.55 -0.719 . . . . 0.0 109.694 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.95 -39.38 85.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.402 -0.811 . . . . 0.0 109.034 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.27 -39.99 80.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -76.69 -43.84 36.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 109.905 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.72 -50.19 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 109.903 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.27 -40.2 93.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.969 -1.082 . . . . 0.0 110.057 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.12 -49.42 53.5 Favored Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.21 -0.931 . . . . 0.0 111.319 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -69.96 -36.02 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.685 -1.479 . . . . 0.0 109.562 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.56 -39.52 81.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 109.312 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.53 -50.13 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.275 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -95.69 -68.8 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.157 -0.964 . . . . 0.0 109.556 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.99 -159.16 29.41 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG2' HH11 ' A' ' 162' ' ' ARG . 43.9 mtt-85 -89.42 145.33 25.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.362 -1.081 . . . . 0.0 108.869 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.1 m -77.35 66.14 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 110.042 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.415 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 96.8 mm-40 -73.89 130.27 39.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.058 -1.027 . . . . 0.0 108.328 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 25.1 m120 -155.11 91.37 2.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.08 -1.013 . . . . 0.0 109.819 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.76 144.24 99.48 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 120.849 1.032 . . . . 0.0 109.543 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -81.32 149.17 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 109.648 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -78.95 149.42 73.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.205 -0.935 . . . . 0.0 108.87 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 CA--C 1.537 0.625 0 C-N-CA 120.842 1.028 . . . . 0.0 109.865 179.791 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.318 0.58 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.28 -39.64 87.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.493 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.9 p -91.35 170.05 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -69.02 136.39 52.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 108.989 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.49 -163.61 53.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 19.6 m120 -78.43 147.94 72.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.071 -1.252 . . . . 0.0 108.816 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.63 145.85 93.81 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 121.323 1.348 . . . . 0.0 110.482 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.563 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 62.7 mtm-85 -148.04 149.6 32.39 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.445 -0.785 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -68.37 127.78 34.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.834 -1.166 . . . . 0.0 109.154 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -74.43 -25.73 59.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.901 . . . . 0.0 109.9 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.1 147.7 26.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.808 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.3 p -91.43 -3.08 57.02 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.7 m80 -126.08 135.94 52.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -130.8 160.69 33.64 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.558 -0.714 . . . . 0.0 109.805 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.0 p -130.55 154.36 47.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.508 -0.745 . . . . 0.0 109.006 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -143.1 152.88 42.33 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.043 -1.036 . . . . 0.0 110.479 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -144.08 137.16 27.37 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -90.78 120.16 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.31 -39.31 92.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.097 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -164.05 156.96 17.76 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.948 -1.095 . . . . 0.0 110.144 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -102.57 136.89 41.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.4 t -73.94 139.03 76.29 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 108.813 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -62.78 3.65 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.356 -1.055 . . . . 0.0 109.356 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.1 m-20 -68.22 -40.07 82.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.837 . . . . 0.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -139.84 150.97 64.54 Favored Pre-proline 0 N--CA 1.503 2.22 0 O-C-N 121.26 -0.9 . . . . 0.0 108.689 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.87 152.05 73.1 Favored 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.085 1.19 . . . . 0.0 109.899 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -63.71 -34.36 77.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.054 -1.028 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.98 85.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.016 -1.052 . . . . 0.0 110.25 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' HD22 ' A' ' 105' ' ' ASN . 98.7 m-20 -78.18 -34.33 49.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.117 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.99 -45.32 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 109.335 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -59.73 -39.96 86.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.8 -50.15 74.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.847 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.94 94.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.24 -0.912 . . . . 0.0 110.9 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.0 mm -69.93 -39.42 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.038 -1.039 . . . . 0.0 109.826 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -58.23 -43.63 87.85 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.04 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -66.52 -34.7 78.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.856 -1.152 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.14 -51.59 68.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.589 -1.319 . . . . 0.0 109.402 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -60.06 -41.18 91.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 0.0 109.608 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -64.01 -40.91 97.4 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.15 -44.89 94.63 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.781 -1.199 . . . . 0.0 110.475 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -71.14 -41.23 70.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.538 -1.351 . . . . 0.0 109.808 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -67.35 -38.53 84.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.099 -1.0 . . . . 0.0 110.172 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -56.23 -23.31 35.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.152 -0.967 . . . . 0.0 111.083 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.6 10.13 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.03 -1.044 . . . . 0.0 110.483 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 p -149.09 150.08 31.27 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.857 -1.152 . . . . 0.0 109.676 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.46 6.87 0.8 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 121.684 1.59 . . . . 0.0 110.244 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.73 148.75 40.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.936 -1.102 . . . . 0.0 108.713 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.467 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 79.0 p -127.47 143.74 51.15 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -128.23 127.17 42.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 109.454 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.0 m -120.53 130.09 54.09 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.635 0.731 . . . . 0.0 109.79 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -76.73 142.44 40.45 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.42 131.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.389 -0.819 . . . . 0.0 108.987 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -92.94 -4.13 53.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 109.655 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.46 159.88 44.16 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.121 -0.987 . . . . 0.0 110.356 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.87 176.6 51.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.75 143.63 29.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -1.142 . . . . 0.0 109.158 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -111.06 147.14 35.45 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.75 -39.99 82.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 119.97 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.395 -0.816 . . . . 0.0 109.755 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.4 mtp -104.66 131.67 51.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.4 mt -115.18 134.28 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.2 p -148.69 158.96 44.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 110.003 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -111.93 131.22 55.52 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.19 160.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.384 -0.823 . . . . 0.0 110.921 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -118.01 139.24 51.48 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.652 -0.655 . . . . 0.0 110.134 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.2 -142.66 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -67.62 130.13 42.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.937 . . . . 0.0 110.418 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.472 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.9 p-80 -137.69 60.62 1.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.437 -0.789 . . . . 0.0 109.898 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 53.0 55.46 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 22.2 p-10 -143.3 164.03 31.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.75 . . . . 0.0 109.205 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -91.34 9.23 32.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.171 -0.956 . . . . 0.0 109.85 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -136.61 69.78 59.74 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.54 145.0 75.09 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 121.346 1.364 . . . . 0.0 108.824 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.08 137.33 41.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.078 -1.014 . . . . 0.0 109.63 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -99.02 59.25 1.16 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.062 -1.024 . . . . 0.0 109.681 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 90.16 -178.21 43.23 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.48 4.65 0.56 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.312 1.341 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.18 176.13 26.55 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.49 -155.86 36.33 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -71.21 150.66 45.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.245 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 -8.67 50.1 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.27 -178.76 1.21 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.518 -0.739 . . . . 0.0 109.096 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -166.97 164.67 16.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.125 -0.984 . . . . 0.0 108.963 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.65 168.69 20.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.16 -0.963 . . . . 0.0 109.297 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.18 162.92 12.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.189 -0.944 . . . . 0.0 109.516 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -60.87 146.68 86.58 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.912 -1.117 . . . . 0.0 108.738 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.35 104.59 0.26 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.02 1.147 . . . . 0.0 109.401 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.29 171.61 43.63 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.112 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.12 -166.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 121.53 1.487 . . . . 0.0 109.666 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 53.44 -134.76 41.92 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -76.33 -6.09 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.403 -1.057 . . . . 0.0 109.609 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.2 148.35 48.55 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.54 -24.88 9.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.83 156.2 24.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.151 -1.205 . . . . 0.0 110.175 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.12 124.86 14.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.442 -0.786 . . . . 0.0 109.58 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -107.92 137.05 46.6 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.4 -0.812 . . . . 0.0 110.431 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 42.6 m-85 -109.76 138.58 45.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.483 -0.76 . . . . 0.0 109.481 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -66.51 104.7 1.31 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 109.244 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -79.9 -10.0 59.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.74 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -76.6 -16.13 59.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.776 -1.203 . . . . 0.0 109.288 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -88.4 158.42 18.39 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.826 . . . . 0.0 108.811 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.441 HH21 HH12 ' A' ' 108' ' ' ARG . 68.5 ttt180 -86.75 115.53 24.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.49 139.47 31.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.418 -0.801 . . . . 0.0 109.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.0 p -135.4 155.05 51.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.156 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 29' ' ' ASP . 98.1 m-20 -110.35 29.92 7.25 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.362 -0.836 . . . . 0.0 108.907 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.615 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.4 p30 -139.91 -163.34 1.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' ARG . 98.2 m-85 -81.15 9.72 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.855 . . . . 0.0 111.172 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.615 ' NE ' HD21 ' A' ' 106' ' ' ASN . 74.3 mtm180 -58.0 -154.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.961 -1.087 . . . . 0.0 110.547 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -48.96 -59.65 3.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.944 -1.098 . . . . 0.0 112.179 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -135.87 139.93 43.75 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.816 -1.178 . . . . 0.0 109.844 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -93.39 123.11 36.46 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.05 -41.6 83.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.08 -1.012 . . . . 0.0 110.285 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.18 -42.09 94.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.952 -1.092 . . . . 0.0 110.674 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.467 HH12 ' CD2' ' A' ' 135' ' ' LEU . 19.9 mmm180 -59.1 -47.38 85.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.924 -1.11 . . . . 0.0 110.054 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.21 -41.47 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 109.383 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.13 -44.53 79.28 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.034 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.49 87.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 109.32 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -60.28 -47.32 86.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.453 -0.779 . . . . 0.0 110.393 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 67.0 mt-10 -62.76 -40.0 95.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.599 -1.313 . . . . 0.0 109.211 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.05 -40.22 97.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 108.86 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.13 57.08 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -65.05 -40.14 94.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -1.166 . . . . 0.0 109.388 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.5 p -65.85 -23.33 66.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.57 -4.26 59.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 108.925 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.49 65.77 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.98 139.27 40.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 0.0 109.008 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.8 m -105.55 179.44 4.27 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.361 -0.837 . . . . 0.0 109.919 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -73.82 169.09 18.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.789 . . . . 0.0 108.929 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 t -149.97 170.36 19.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.8 p -98.58 5.2 48.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.291 -0.88 . . . . 0.0 109.523 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -84.26 114.35 21.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -59.63 -32.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.196 -0.94 . . . . 0.0 110.245 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.75 4.55 28.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.132 -1.032 . . . . 0.0 110.632 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.63 141.83 29.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.159 -1.2 . . . . 0.0 109.368 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' CD2' HH12 ' A' ' 114' ' ' ARG . 86.7 mt -69.94 -27.71 64.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.367 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.2 mmm -72.74 6.25 2.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 109.59 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 139' ' ' SER . 16.3 t80 -64.79 117.54 39.51 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.361 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -65.18 54.07 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 120.985 1.123 . . . . 0.0 110.935 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.2 OUTLIER -156.04 113.5 3.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.749 -1.219 . . . . 0.0 109.079 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -68.98 140.11 55.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.101 -0.999 . . . . 0.0 108.961 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 p -148.77 162.0 40.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.041 -1.037 . . . . 0.0 109.184 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -74.77 120.01 19.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.184 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.5 t -120.02 133.59 55.49 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.568 -0.708 . . . . 0.0 109.637 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -85.95 0.21 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -90.51 148.35 22.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.238 . . . . 0.0 108.819 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.01 111.78 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.151 -0.968 . . . . 0.0 109.421 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -139.32 157.11 46.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.724 . . . . 0.0 109.721 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.8 mt -77.59 157.93 30.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 109.315 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.22 159.77 15.26 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.331 -0.855 . . . . 0.0 109.48 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.51 -40.02 85.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 109.131 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -57.03 -40.03 75.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.807 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.43 -41.57 39.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.216 -0.928 . . . . 0.0 110.011 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.24 -50.09 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.722 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.65 -40.0 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.2 -56.47 25.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.957 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.43 -39.65 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.063 -1.257 . . . . 0.0 110.243 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.3 -40.06 93.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.974 -1.079 . . . . 0.0 109.143 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.8 90.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 108.976 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.39 -48.49 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.128 -0.983 . . . . 0.0 109.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -97.13 -64.69 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.41 -174.79 34.19 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.092 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -88.02 146.76 25.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.595 -0.944 . . . . 0.0 109.572 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 m -77.87 56.07 1.5 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.668 -0.645 . . . . 0.0 110.311 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.51 136.51 42.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.051 -1.03 . . . . 0.0 109.532 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 167' ' ' VAL . 74.6 m-80 -153.38 67.38 6.16 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.109 -0.994 . . . . 0.0 110.432 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.39 41.52 0.14 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.248 1.298 . . . . 0.0 109.683 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 165' ' ' ASN . 5.1 t -85.87 144.89 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.171 -0.956 . . . . 0.0 109.328 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -128.27 78.27 75.79 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.42 -0.8 . . . . 0.0 109.875 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.073 1.182 . . . . 0.0 109.7 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 1' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.29 0.567 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.72 140.02 57.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.107 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 6.2 p -97.13 126.56 42.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.239 -0.913 . . . . 0.0 109.241 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -71.09 139.97 50.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 110.179 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.05 -26.9 6.38 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.334 -0.854 . . . . 0.0 111.007 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . 12.4 m120 -160.29 66.6 2.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.787 -1.42 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.83 110.94 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.322 1.348 . . . . 0.0 109.739 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -92.37 147.82 22.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 109.177 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -67.0 135.56 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.85 -35.0 62.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 110.339 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.26 147.85 27.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.022 . . . . 0.0 110.175 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.7 p -91.71 -4.77 54.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -119.97 133.49 55.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -132.76 159.8 38.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 108.984 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.0 p -126.69 156.45 41.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -142.41 153.65 43.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.273 -0.892 . . . . 0.0 110.057 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 17' ' ' ARG . 32.1 ttt-85 -145.15 131.81 19.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.593 -0.692 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.75 119.97 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.91 -40.13 96.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 110.269 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -166.16 165.91 17.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.961 -1.087 . . . . 0.0 109.981 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.89 133.95 52.61 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -74.65 146.98 84.13 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 108.817 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.4 0.93 1.5 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 N-CA-C 109.521 -0.992 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 91.3 m-20 -65.79 -39.94 91.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.376 -0.828 . . . . 0.0 110.259 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.2 mt -141.86 151.73 60.43 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 0.0 108.863 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.74 149.67 86.58 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.35 -1.058 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -67.29 -31.15 71.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.107 -0.996 . . . . 0.0 109.488 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.9 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.83 -33.28 46.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.01 -40.24 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.0 -40.61 89.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.968 -1.082 . . . . 0.0 109.028 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -60.7 -47.1 87.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.427 -0.796 . . . . 0.0 109.28 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.6 80.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.492 -0.755 . . . . 0.0 109.985 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.95 -45.4 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.596 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.1 -44.27 94.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -63.01 -40.09 96.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.3 86.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.683 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -59.93 -40.11 87.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.01 -40.99 91.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.106 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.15 -45.27 93.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.952 -1.092 . . . . 0.0 110.068 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.415 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -70.65 -40.02 73.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.022 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.19 -39.98 82.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.892 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -55.01 -27.54 45.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.46 HG11 ' CD1' ' A' ' 153' ' ' ILE . 15.4 m -106.31 9.44 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.068 -1.02 . . . . 0.0 110.462 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.5 p -150.04 150.3 29.5 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.885 -1.135 . . . . 0.0 109.35 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.15 5.82 1.33 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.101 1.201 . . . . 0.0 109.628 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.1 mt -72.49 149.41 44.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.0 p -131.76 145.27 51.51 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.476 -0.765 . . . . 0.0 109.284 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.04 129.61 50.63 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -120.01 130.05 54.55 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.579 0.704 . . . . 0.0 110.471 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -75.63 136.12 40.46 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.6 m -121.51 129.98 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.491 -0.756 . . . . 0.0 109.317 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -89.63 -8.23 52.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 109.461 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -152.52 158.76 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.37 173.51 46.03 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.03 160.01 26.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 108.811 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.6 146.07 52.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.347 -0.846 . . . . 0.0 109.586 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.774 . . . . 0.0 109.942 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -118.67 119.88 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.479 -0.763 . . . . 0.0 109.358 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.2 mmm -102.12 129.31 48.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.24 -0.912 . . . . 0.0 109.437 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -115.39 129.4 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.8 p -150.0 165.4 32.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.991 -1.068 . . . . 0.0 110.546 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.95 139.78 50.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.06 167.59 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.113 -0.992 . . . . 0.0 110.671 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -123.19 139.99 53.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.633 -0.667 . . . . 0.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.11 -146.49 1.46 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 28.1 t0 -67.92 137.03 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.487 -1.007 . . . . 0.0 109.698 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 30.7 p-80 -138.08 55.51 1.76 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 109.482 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 56.05 52.09 10.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 49.4 t0 -139.93 162.26 35.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.451 -0.781 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.531 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 44.8 p-10 -88.69 9.98 22.39 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -135.15 66.75 67.84 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 0.0 109.804 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -66.69 142.19 62.97 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.435 1.423 . . . . 0.0 109.435 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -76.03 134.63 40.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.104 -0.997 . . . . 0.0 109.283 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -101.36 62.4 0.95 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 109.882 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.06 -171.37 55.05 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.14 1.57 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 121.529 1.486 . . . . 0.0 110.005 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.08 176.46 29.37 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.17 -163.07 51.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -70.54 151.28 45.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -1.102 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.8 mt -92.37 -8.77 43.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.08 168.97 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.385 -0.822 . . . . 0.0 109.466 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -167.7 170.71 10.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 0.0 109.503 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.78 165.45 29.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.246 -0.909 . . . . 0.0 109.719 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.05 170.06 9.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.399 -0.813 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -68.21 147.19 98.3 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.004 . . . . 0.0 109.286 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -57.95 104.05 0.16 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 121.169 1.246 . . . . 0.0 110.138 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.54 162.23 33.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.93 176.96 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.26 1.307 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.9 -131.29 33.8 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -77.64 -13.03 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -1.097 . . . . 0.0 110.051 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.68 141.48 47.52 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.91 -16.11 57.69 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.38 130.29 42.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.67 129.86 53.81 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.455 -0.778 . . . . 0.0 109.256 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -114.06 126.21 54.85 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.451 -0.78 . . . . 0.0 109.817 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -108.39 135.08 50.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.328 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -69.15 110.84 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -77.31 -9.82 59.06 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.865 . . . . 0.0 109.477 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.9 -17.55 58.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.991 -1.068 . . . . 0.0 109.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -84.87 156.17 21.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.422 -0.799 . . . . 0.0 109.244 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.662 ' NH2' HH22 ' A' ' 108' ' ' ARG . 69.4 ttt180 -89.01 107.29 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 108.384 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.47 143.37 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 110.1 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.5 p -134.98 155.62 50.44 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.01 32.81 4.82 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 5.4 p30 -144.93 -163.86 1.8 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' ARG . 86.4 m-85 -79.41 13.54 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.392 -0.818 . . . . 0.0 110.252 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.662 HH22 ' NH2' ' A' ' 102' ' ' ARG . 21.3 mmm-85 -57.01 -161.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.18 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -49.96 -59.13 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.46 -0.775 . . . . 0.0 111.683 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.464 ' O ' ' OG1' ' A' ' 104' ' ' THR . 80.7 m-85 -120.04 139.91 51.81 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.962 -1.086 . . . . 0.0 110.807 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -97.38 110.04 22.67 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.84 -40.58 84.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 0.0 110.012 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.92 -50.0 75.49 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' NH1' ' OG ' ' A' ' 143' ' ' SER . 69.3 ttt180 -60.08 -42.42 94.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.039 -1.038 . . . . 0.0 109.899 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.01 -40.56 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.133 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.94 87.03 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.511 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.04 85.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.49 -0.756 . . . . 0.0 109.753 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 38.7 t60 -59.99 -49.87 75.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.586 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.3 -40.14 95.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.182 -0.949 . . . . 0.0 109.409 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.73 -38.43 90.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.317 -0.864 . . . . 0.0 108.871 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.3 -41.36 92.96 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CE1' ' SD ' ' A' ' 136' ' ' MET . 74.2 m-70 -67.06 -39.99 87.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -1.198 . . . . 0.0 108.786 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.3 t -52.9 -30.11 32.36 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.7 -2.16 49.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.48 26.03 44.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.1 154.8 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.027 -1.279 . . . . 0.0 109.158 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.7 m -108.38 159.93 16.27 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.382 -0.823 . . . . 0.0 110.247 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -70.09 160.37 32.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.492 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.0 164.4 35.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.15 -0.969 . . . . 0.0 110.145 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.4 p -97.01 13.66 28.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.508 -0.745 . . . . 0.0 109.323 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.56 117.4 21.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.334 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.05 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.28 1.92 23.5 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.21 136.06 37.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.88 -1.365 . . . . 0.0 109.459 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.9 -29.41 66.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.579 ' SD ' ' CE1' ' A' ' 122' ' ' HIS . 42.9 tpp -66.99 2.97 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 109.678 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -60.48 135.87 91.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.648 -1.283 . . . . 0.0 107.851 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -62.05 -38.24 58.53 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.237 1.291 . . . . 0.0 111.367 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -82.32 127.88 33.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.018 -1.052 . . . . 0.0 110.528 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -74.12 149.88 40.81 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.414 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 43.4 p -146.97 152.85 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -78.97 118.79 21.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.52 -0.737 . . . . 0.0 109.453 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.491 ' OG ' ' NH1' ' A' ' 114' ' ' ARG . 75.4 m -120.1 131.86 55.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.556 -0.715 . . . . 0.0 109.531 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -47.17 -87.38 0.01 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 46.7 t0 -95.21 149.34 21.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.155 -1.203 . . . . 0.0 108.62 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 68.7 t -94.48 109.88 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.945 . . . . 0.0 109.665 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -138.26 159.42 42.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.463 -0.773 . . . . 0.0 109.011 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.3 mt -75.39 156.39 35.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.002 -1.062 . . . . 0.0 108.684 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.08 15.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.355 -0.841 . . . . 0.0 108.797 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -59.39 -37.11 77.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -0.916 . . . . 0.0 109.745 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.07 -39.87 66.69 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.035 -1.04 . . . . 0.0 108.728 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -76.32 -40.09 52.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 109.448 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 44' ' ' VAL . 5.9 mm -60.65 -50.93 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.218 -0.927 . . . . 0.0 109.473 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.24 -40.06 94.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.85 -50.03 44.46 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.059 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.26 -37.98 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.897 -1.355 . . . . 0.0 110.008 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -66.19 -39.94 90.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.91 -1.119 . . . . 0.0 109.646 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.068 -1.02 . . . . 0.0 109.545 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -50.0 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 109.57 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.1 -68.73 0.79 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.119 -0.988 . . . . 0.0 109.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.2 -155.78 26.41 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 85.5 mtm180 -89.42 149.1 23.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.29 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -77.89 88.05 4.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.433 ' NE2' ' O ' ' A' ' 162' ' ' ARG . 24.7 mp0 -67.51 128.89 38.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 108.726 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.29 70.62 5.01 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.39 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.16 119.97 7.56 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.267 1.311 . . . . 0.0 109.868 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.03 131.74 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.377 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -80.06 150.05 70.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 120.794 0.996 . . . . 0.0 109.854 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 2' ' ' LEU . 2.1 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.46 0.648 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 1' ' ' VAL . 0.6 OUTLIER -165.69 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.9 p -93.69 170.14 9.8 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.318 -1.489 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.639 ' C ' ' H ' ' A' ' 6' ' ' ASN . 80.0 tt0 -69.71 165.92 20.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.85 22.13 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 4' ' ' GLU . 66.4 m-80 -153.82 67.69 5.99 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.257 . . . . 0.0 108.409 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.74 94.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.465 1.444 . . . . 0.0 110.142 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -143.43 145.95 33.05 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -69.97 123.33 21.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.907 -1.121 . . . . 0.0 109.148 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 49.6 mp0 -77.38 -25.29 50.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.857 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -79.76 147.29 31.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.08 -3.91 56.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.264 -0.898 . . . . 0.0 108.986 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -125.75 140.08 52.98 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -136.14 160.23 39.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.1 p -130.62 156.22 45.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 108.919 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -146.36 160.76 41.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.103 -0.998 . . . . 0.0 109.806 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -146.24 137.25 24.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.006 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.4 mt -90.96 119.28 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.86 -40.0 87.75 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.123 -0.986 . . . . 0.0 109.953 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -166.34 166.78 16.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.092 . . . . 0.0 110.15 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -111.55 138.18 48.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.54 -0.725 . . . . 0.0 109.129 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -79.29 144.14 61.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.54 -0.18 2.27 Favored 'Trans proline' 0 N--CA 1.48 0.699 0 C-N-CA 120.913 1.076 . . . . 0.0 109.4 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -65.27 -40.0 93.34 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.222 -0.924 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.0 mt -143.42 149.98 49.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.91 155.02 46.41 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 120.851 1.034 . . . . 0.0 109.547 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.3 ptt-85 -67.14 -32.24 73.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.65 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -44.65 87.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.359 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -77.47 -37.87 50.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.72 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.37 -42.48 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.095 -1.003 . . . . 0.0 109.163 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -58.47 -43.99 89.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.304 -0.873 . . . . 0.0 108.995 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -59.99 -40.24 88.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.393 -0.817 . . . . 0.0 109.876 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.53 92.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.06 -47.63 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.489 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.02 -42.15 93.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -62.1 -40.0 94.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.096 -1.002 . . . . 0.0 110.42 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -60.04 -40.75 90.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.922 -1.111 . . . . 0.0 109.95 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.93 -40.05 91.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 110.104 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.09 -42.13 93.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.106 -0.996 . . . . 0.0 110.037 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -72.51 -40.05 67.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.934 -1.104 . . . . 0.0 109.77 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -70.05 -26.72 64.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.0 110.183 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -59.96 -39.94 87.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.594 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 HG23 ' A' ' 45' ' ' THR . 33.2 m -105.08 12.08 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.094 -1.004 . . . . 0.0 110.923 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.558 HG23 HG23 ' A' ' 44' ' ' VAL . 43.7 p -142.66 147.56 42.91 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.939 -1.101 . . . . 0.0 109.265 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.0 7.21 1.77 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.072 1.181 . . . . 0.0 109.811 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.04 148.12 44.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.067 -1.021 . . . . 0.0 109.392 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.6 p -129.86 141.36 50.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.489 -0.757 . . . . 0.0 109.099 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.06 135.24 55.01 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.514 -0.741 . . . . 0.0 109.775 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.4 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.53 -0.731 . . . . 0.0 110.149 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -82.66 132.63 35.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.455 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 52' ' ' VAL . 15.0 m -120.0 129.47 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.356 -0.84 . . . . 0.0 109.182 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 t -92.1 -4.0 54.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.228 -0.92 . . . . 0.0 110.043 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.65 151.61 37.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.125 -0.984 . . . . 0.0 109.836 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.64 171.25 47.6 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -82.52 140.36 33.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -1.12 . . . . 0.0 109.284 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.32 159.42 17.45 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.556 -0.715 . . . . 0.0 109.803 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.09 -39.93 87.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.809 . . . . 0.0 110.11 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.2 mt -118.91 121.15 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.1 mmm -98.75 133.89 42.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.0 109.633 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.98 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.5 p -150.16 166.9 28.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 109.617 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.4 138.84 50.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.685 -0.634 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.23 160.11 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.456 -0.778 . . . . 0.0 110.614 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -120.37 136.04 54.84 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.647 -0.658 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.68 -146.06 0.86 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -62.62 133.83 55.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.608 -0.937 . . . . 0.0 109.95 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -136.98 55.17 1.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.52 -0.738 . . . . 0.0 109.506 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.4 mtt-85 56.17 44.92 24.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.724 -0.61 . . . . 0.0 110.2 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -134.15 164.77 26.61 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -89.11 9.71 24.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.976 -1.078 . . . . 0.0 110.127 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -133.3 69.96 77.5 Favored Pre-proline 0 N--CA 1.502 2.126 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.78 146.44 66.23 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 C-N-CA 121.571 1.514 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -76.33 141.19 41.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.005 . . . . 0.0 109.438 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -97.31 62.1 1.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.176 -0.952 . . . . 0.0 109.733 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.96 -174.82 48.06 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -61.93 -0.06 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.436 1.424 . . . . 0.0 109.947 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -107.1 175.69 20.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.1 -151.18 21.91 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.87 144.23 52.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -1.064 . . . . 0.0 109.658 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -93.27 -12.4 30.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 108.848 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.14 179.94 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 109.318 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -169.21 169.68 9.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.263 -0.898 . . . . 0.0 109.227 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.87 160.16 42.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 109.098 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -93.17 154.04 18.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.234 -0.916 . . . . 0.0 109.362 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -61.86 147.9 88.71 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 108.636 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.19 113.07 1.18 Allowed 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.144 1.229 . . . . 0.0 110.157 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.35 167.51 40.28 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -66.45 175.73 4.8 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.159 1.239 . . . . 0.0 109.239 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.65 -123.88 23.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.598 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 tt -81.44 -8.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -1.083 . . . . 0.0 110.617 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.04 140.66 47.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.731 -1.223 . . . . 0.0 110.219 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.3 -20.56 25.71 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.283 -1.128 . . . . 0.0 110.669 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -63.49 129.99 42.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.857 -1.379 . . . . 0.0 109.904 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.08 122.56 45.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -107.55 131.21 54.59 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 47.5 m-85 -111.48 134.18 53.24 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.535 -0.728 . . . . 0.0 109.744 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -70.04 112.64 6.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -79.36 -10.05 59.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 110.223 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -77.43 -11.8 59.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.881 -1.137 . . . . 0.0 108.919 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.84 152.56 22.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 109.486 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 109' ' ' GLU . 44.7 ttp180 -91.53 114.9 27.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.104 -0.998 . . . . 0.0 108.547 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -92.95 144.07 25.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.418 -0.801 . . . . 0.0 110.69 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 74.7 p -135.48 168.69 18.76 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.439 -0.788 . . . . 0.0 109.374 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -121.74 28.96 7.37 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.601 -0.687 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.73 -162.61 1.57 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.022 -1.049 . . . . 0.0 109.842 -179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -74.08 15.9 0.28 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.92 . . . . 0.0 110.697 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.557 ' CG ' HD21 ' A' ' 106' ' ' ASN . 19.3 mmt180 -61.69 -163.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.824 -1.173 . . . . 0.0 110.273 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 93.8 mt-10 -52.75 -59.15 4.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 84.8 m-85 -132.9 149.02 52.29 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 120.793 -1.192 . . . . 0.0 111.48 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 80.9 m-20 -109.68 124.42 51.17 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -59.96 -40.1 87.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.161 -0.962 . . . . 0.0 110.563 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.3 -41.38 88.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.461 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' CZ ' ' H ' ' A' ' 143' ' ' SER . 60.2 mtt-85 -60.06 -40.04 88.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.826 -1.171 . . . . 0.0 110.283 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.38 -39.98 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.807 -1.183 . . . . 0.0 108.906 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.4 85.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.67 90.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.12 -47.25 86.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 90.0 mt-10 -60.86 -40.04 91.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.759 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.79 -38.79 92.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.039 -1.038 . . . . 0.0 108.769 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.93 -42.84 81.58 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.275 . . . . 0.0 109.401 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.0 p -60.92 -25.6 66.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.118 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.97 -5.77 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -0.832 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.22 12.9 61.01 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.06 150.6 33.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.308 . . . . 0.0 108.799 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.6 m -106.47 157.04 17.95 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.397 -0.814 . . . . 0.0 110.063 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -54.79 170.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.802 . . . . 0.0 108.999 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -151.51 160.36 43.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 109.429 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.5 p -97.16 10.14 40.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.823 . . . . 0.0 108.838 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -83.93 115.2 22.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 109.777 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.07 -40.07 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.426 -0.796 . . . . 0.0 110.543 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.72 3.19 13.04 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.602 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.58 139.56 33.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.065 -1.256 . . . . 0.0 109.149 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -69.94 -25.13 63.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.1 mmm -73.21 13.61 0.41 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.388 -0.82 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 135' ' ' LEU . 13.7 t80 -65.9 133.12 94.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.0 108.652 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -60.63 -33.73 93.09 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 121.271 1.314 . . . . 0.0 111.664 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.2 t -83.12 142.31 31.34 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.624 -1.298 . . . . 0.0 109.904 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -80.49 130.04 34.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.564 -0.71 . . . . 0.0 110.381 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.2 p -151.67 116.17 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 1.2 p90 -81.89 129.96 34.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.982 -1.074 . . . . 0.0 110.283 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.487 ' H ' ' CZ ' ' A' ' 114' ' ' ARG . 97.4 p -98.01 159.49 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.349 -0.845 . . . . 0.0 108.811 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.13 97.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -128.3 140.29 51.95 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.576 -0.955 . . . . 0.0 108.797 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.22 109.95 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.917 -1.114 . . . . 0.0 109.399 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -141.28 157.87 44.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.325 -0.86 . . . . 0.0 109.571 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.65 156.86 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.834 . . . . 0.0 108.977 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.88 161.61 14.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.404 -0.81 . . . . 0.0 108.817 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.87 -40.11 87.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.158 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.6 t0 -59.95 -40.59 89.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -75.09 -40.02 60.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.915 -1.116 . . . . 0.0 109.68 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -60.06 -49.94 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 109.36 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.09 87.63 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.959 -1.088 . . . . 0.0 110.094 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.87 -52.72 50.61 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.234 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.36 -35.54 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.858 -1.378 . . . . 0.0 109.734 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.7 mt-30 -69.05 -39.53 79.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.038 -1.039 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.53 89.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 109.976 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -67.03 -49.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.141 -0.975 . . . . 0.0 109.801 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -95.42 -66.25 0.92 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.952 . . . . 0.0 108.922 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.55 -174.41 34.99 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.6 mtt-85 -91.19 146.13 24.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 108.935 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 165' ' ' ASN . 19.4 m -74.76 88.43 2.25 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.11 -0.994 . . . . 0.0 109.074 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -71.29 43.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.217 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 163' ' ' SER . 73.4 m-20 -153.36 104.95 2.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -53.73 106.6 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.572 0.848 . . . . 0.0 109.912 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.32 143.58 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 109.653 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -78.33 147.83 73.05 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--N 1.322 -0.834 0 C-N-CA 120.914 1.076 . . . . 0.0 109.789 179.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.1 mp -69.38 146.58 51.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.127 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.6 p -91.15 151.53 20.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.31 -0.869 . . . . 0.0 108.951 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.72 139.71 53.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.572 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' O ' ' OD1' ' A' ' 6' ' ' ASN . . . 100.2 -101.32 2.32 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 83.0 m-20 -157.33 106.04 1.86 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 109.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.11 139.92 86.14 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.574 0.849 . . . . 0.0 110.164 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -90.68 172.38 8.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.305 -0.872 . . . . 0.0 109.105 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.17 120.76 13.3 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -80.8 -11.02 59.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.897 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.31 140.97 28.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.171 -0.955 . . . . 0.0 110.113 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.7 p -92.19 -5.25 52.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.295 -0.878 . . . . 0.0 108.794 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -123.69 138.28 54.56 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.4 mt -135.41 160.82 37.24 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.156 -0.965 . . . . 0.0 109.793 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.7 p -131.5 161.78 31.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.607 -0.683 . . . . 0.0 109.299 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.39 158.04 43.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -141.39 136.97 31.94 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.268 -0.895 . . . . 0.0 109.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -90.97 118.93 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.37 -39.99 92.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.191 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -166.53 158.83 13.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 109.81 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -100.99 128.81 46.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.497 -0.752 . . . . 0.0 109.041 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 22' ' ' THR . 1.4 t -79.53 143.56 59.57 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.33 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -63.88 0.83 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.687 0 C-N-CA 120.826 1.017 . . . . 0.0 109.459 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 95.9 m-20 -64.11 -40.03 95.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.255 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.5 mt -144.01 150.98 51.21 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -61.57 159.87 30.44 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 120.891 1.061 . . . . 0.0 109.803 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 27' ' ' ARG . 6.0 ptm180 -67.8 -32.11 72.44 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.226 -0.921 . . . . 0.0 108.936 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.86 -38.68 82.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.29 -33.56 29.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.964 -1.085 . . . . 0.0 110.092 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.37 -49.95 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.197 -0.939 . . . . 0.0 110.473 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 35.1 p-10 -58.42 -40.14 81.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.79 -1.194 . . . . 0.0 109.477 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.507 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.1 t60 -60.11 -47.53 85.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.579 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 110.151 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.7 mm -70.6 -49.35 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.925 -1.109 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.11 -42.65 95.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -60.49 -39.97 89.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.424 -0.797 . . . . 0.0 109.698 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.52 89.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -59.85 -40.02 87.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.058 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -60.04 -42.43 94.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.357 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.11 -43.45 95.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.913 -1.117 . . . . 0.0 109.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -72.44 -39.93 67.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 109.749 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.1 t -68.56 -28.31 66.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 109.815 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -59.83 -39.8 86.32 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.376 -0.828 . . . . 0.0 110.335 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 18.9 m -106.8 18.0 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.15 -0.969 . . . . 0.0 110.875 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 80.6 p -145.06 146.44 30.86 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.683 -1.261 . . . . 0.0 109.645 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -70.16 10.23 0.57 Allowed 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 121.075 1.183 . . . . 0.0 109.277 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -76.71 150.85 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 110.353 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -129.87 144.31 51.25 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.4 m-85 -126.42 128.58 47.22 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.226 -0.921 . . . . 0.0 110.487 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -121.27 129.93 53.4 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.486 0.66 . . . . 0.0 109.288 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -80.73 130.1 34.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.023 -1.048 . . . . 0.0 109.255 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.36 129.13 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.349 -0.845 . . . . 0.0 108.801 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -95.1 0.71 54.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.8 160.02 42.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.083 -1.011 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.89 175.36 44.05 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -80.46 156.39 26.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.099 -1.236 . . . . 0.0 108.696 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.38 49.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.707 . . . . 0.0 109.097 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -59.58 -40.0 85.95 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.285 -0.884 . . . . 0.0 109.767 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.91 120.03 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.483 -0.76 . . . . 0.0 109.415 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.74 138.2 39.03 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.353 -0.842 . . . . 0.0 109.647 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -119.91 129.94 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -149.13 159.91 43.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.879 -1.138 . . . . 0.0 110.477 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.9 131.37 56.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.61 161.35 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 121.287 -0.883 . . . . 0.0 110.676 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CB ' ' NH1' ' A' ' 65' ' ' ARG . 10.5 mtp-105 -127.19 145.35 50.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.657 . . . . 0.0 109.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.62 -148.36 4.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.61 129.63 38.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -1.061 . . . . 0.0 109.608 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.507 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 47.2 p-80 -134.79 64.23 1.6 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.514 -0.741 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 52.97 53.29 12.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 30.7 p-10 -140.44 161.1 38.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.475 -0.766 . . . . 0.0 109.162 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -95.38 7.64 45.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.934 . . . . 0.0 109.806 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.3 m -137.8 69.52 51.26 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.336 -0.852 . . . . 0.0 109.772 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.23 149.57 85.25 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.576 1.517 . . . . 0.0 110.032 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -75.1 149.91 38.97 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.1 -1.0 . . . . 0.0 108.494 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.32 75.81 1.64 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 109.144 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.37 -177.99 53.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.68 -1.94 5.65 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.375 1.383 . . . . 0.0 109.291 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.17 43.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 -166.92 54.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -71.29 151.31 44.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.227 -1.161 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.4 mt -91.27 -10.44 41.48 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.12 178.81 1.07 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -167.89 172.57 8.91 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.092 -1.005 . . . . 0.0 109.847 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.43 42.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.15 157.43 18.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.93 149.04 75.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.251 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.3 113.84 1.77 Allowed 'Trans proline' 0 C--N 1.326 -0.646 0 C-N-CA 121.007 1.138 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.48 173.21 45.97 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.89 177.59 1.8 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.655 1.57 . . . . 0.0 109.786 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.65 -132.11 26.78 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.274 -0.965 . . . . 0.0 110.752 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -77.73 -7.83 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.622 -0.928 . . . . 0.0 109.979 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.15 140.71 41.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.73 -20.43 35.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.74 128.86 37.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.256 . . . . 0.0 109.815 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.29 125.05 50.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.52 -0.738 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -106.88 131.07 54.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.369 -0.832 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.78 136.88 50.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.364 -0.835 . . . . 0.0 110.612 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -69.02 100.75 1.27 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.578 -0.701 . . . . 0.0 109.209 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -79.73 -5.95 56.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.209 -0.932 . . . . 0.0 110.937 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.97 -23.75 58.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.485 -1.384 . . . . 0.0 109.771 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -88.64 161.87 16.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 108.719 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 102' ' ' ARG . 36.4 ttm-85 -89.09 119.13 29.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -92.92 135.66 33.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.578 -0.701 . . . . 0.0 110.578 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 p -131.55 167.51 19.27 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.71 26.69 9.67 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.512 -0.743 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.789 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.18 -164.47 2.02 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.807 -1.183 . . . . 0.0 110.919 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 77.4 t80 -62.92 2.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.722 -0.611 . . . . 0.0 111.266 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.509 ' CG ' HD21 ' A' ' 106' ' ' ASN . 98.4 mtt180 -57.86 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.51 -1.368 . . . . 0.0 109.781 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -46.25 -59.91 2.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 112.035 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -136.37 148.98 48.12 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.879 -1.138 . . . . 0.0 110.625 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.74 115.22 27.07 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 109.25 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.15 -44.02 95.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.664 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -60.07 -39.85 87.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 110.209 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -59.22 -45.57 90.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.06 -1.025 . . . . 0.0 109.796 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.09 -39.91 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.25 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.09 69.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.023 -1.048 . . . . 0.0 109.128 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.28 -41.36 88.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.004 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.405 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 63.5 t60 -60.07 -44.89 94.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.0 -39.87 95.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.65 -38.05 83.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.927 . . . . 0.0 109.288 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.91 92.24 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -64.84 -39.96 94.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.078 -1.248 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.9 m -58.46 -30.81 67.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.13 -5.48 58.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.242 -0.911 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.45 62.43 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -77.29 142.6 39.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -1.214 . . . . 0.0 109.034 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -108.77 156.42 19.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.378 -0.826 . . . . 0.0 109.832 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -49.6 175.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.85 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.7 t -150.05 161.01 43.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.6 p -93.42 4.46 53.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.523 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -83.01 122.28 28.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.03 -39.89 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.419 -0.801 . . . . 0.0 110.344 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 7.28 5.25 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.743 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.78 137.19 37.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.056 -1.261 . . . . 0.0 109.731 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.05 -33.49 73.66 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 109.714 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 43.1 mtp -73.85 12.0 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 111.09 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 139' ' ' SER . 28.0 t80 -64.95 137.03 97.02 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 120.685 -1.259 . . . . 0.0 108.318 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.95 39.94 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 121.038 1.159 . . . . 0.0 111.405 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' TYR . 15.7 p -155.35 147.01 23.12 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.586 -1.321 . . . . 0.0 109.49 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.504 ' O ' HG23 ' A' ' 141' ' ' THR . 40.0 t80 -77.99 116.13 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.994 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 140' ' ' TYR . 30.7 p -159.31 149.32 18.95 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -166.39 152.46 8.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.747 -1.22 . . . . 0.0 109.791 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.8 m -90.66 174.32 7.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.353 -0.842 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -50.02 -33.2 21.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -118.08 139.63 50.94 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.607 -0.937 . . . . 0.0 108.751 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.7 t -93.79 113.42 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.09 -1.006 . . . . 0.0 109.097 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.37 160.05 40.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 0.0 109.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.6 mt -75.56 159.33 31.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.93 161.6 13.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.81 -39.99 86.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.984 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -76.8 -41.32 44.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.987 -1.07 . . . . 0.0 109.734 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.49 -49.95 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.15 -40.18 92.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.045 -1.034 . . . . 0.0 110.424 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.41 -51.68 54.64 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.881 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.8 tp -69.94 -37.39 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.948 -1.324 . . . . 0.0 110.011 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.8 mt-30 -66.41 -40.04 89.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.33 -40.62 91.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.14 -49.52 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.07 -1.019 . . . . 0.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -95.23 -66.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.6 -164.68 32.21 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -84.79 161.6 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.991 . . . . 0.0 109.139 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.4 m -75.06 53.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.972 -1.08 . . . . 0.0 110.57 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.24 136.27 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -152.03 147.87 20.54 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.947 -1.095 . . . . 0.0 109.449 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.74 108.64 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.218 1.279 . . . . 0.0 109.926 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.44 140.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.19 -0.944 . . . . 0.0 109.536 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.24 149.83 70.0 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.971 . . . . 0.0 108.695 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.324 -0.732 0 C-N-CA 120.993 1.129 . . . . 0.0 110.172 179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.94 152.21 41.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 109.056 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 73.3 p -90.66 160.7 15.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.064 -1.023 . . . . 0.0 109.786 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.43 136.0 55.92 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.39 -0.819 . . . . 0.0 109.345 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.89 -176.79 39.38 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 8' ' ' ARG . 9.3 m120 -82.81 124.04 77.48 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.218 -1.166 . . . . 0.0 109.332 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.84 75.73 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 108.803 -1.268 . . . . 0.0 108.803 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 6' ' ' ASN . 97.9 mtt180 -146.14 152.32 39.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.125 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -68.4 131.85 46.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.119 -0.988 . . . . 0.0 108.623 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.01 -17.88 56.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -90.08 140.77 29.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 109.112 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.6 p -88.59 -3.68 58.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -127.69 138.62 52.86 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.2 mt -134.5 160.42 38.07 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.291 -0.881 . . . . 0.0 109.392 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -129.05 160.79 31.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.343 -0.848 . . . . 0.0 108.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -145.14 157.32 44.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.221 -0.925 . . . . 0.0 109.447 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -144.8 135.84 24.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.471 -0.768 . . . . 0.0 110.181 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.2 118.02 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.97 -39.6 83.3 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 111.012 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -164.39 153.96 13.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.866 -1.146 . . . . 0.0 110.637 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.29 132.83 48.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -74.87 147.66 84.16 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.033 -1.042 . . . . 0.0 109.438 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.81 1.09 3.54 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 N-CA-C 109.047 -1.174 . . . . 0.0 109.047 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 94.2 m-20 -64.4 -39.81 94.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.443 -0.786 . . . . 0.0 110.229 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' ND2' ' A' ' 105' ' ' ASN . 74.0 mt -140.57 150.34 60.17 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.349 -0.844 . . . . 0.0 108.817 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.18 144.37 59.34 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 120.757 0.971 . . . . 0.0 109.583 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.37 -32.62 73.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 109.254 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.0 -39.45 85.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.37 -29.31 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.955 . . . . 0.0 110.998 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.11 -51.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.347 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 32.7 p-10 -57.1 -34.35 68.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.628 -1.295 . . . . 0.0 109.427 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.521 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 7.9 t60 -60.13 -47.7 84.82 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.261 -0.899 . . . . 0.0 109.602 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -39.22 80.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.025 -1.047 . . . . 0.0 109.473 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mm -69.63 -40.12 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.459 -0.776 . . . . 0.0 109.106 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.75 -43.2 94.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 110.041 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.01 -37.94 89.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.628 -1.295 . . . . 0.0 109.704 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -50.68 72.85 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.849 -1.157 . . . . 0.0 109.483 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -60.68 -41.09 94.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.902 -1.124 . . . . 0.0 109.97 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.2 -44.73 95.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.512 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.05 -41.71 92.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.069 -1.02 . . . . 0.0 110.335 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -73.71 -40.05 63.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.811 -1.181 . . . . 0.0 110.069 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.3 t -70.1 -38.79 75.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -54.47 -28.83 47.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 110.77 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG23 HG23 ' A' ' 45' ' ' THR . 33.1 m -109.62 10.56 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 O-C-N 121.19 -0.944 . . . . 0.0 110.707 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 HG23 ' A' ' 44' ' ' VAL . 69.1 p -146.14 147.11 30.53 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 120.836 -1.165 . . . . 0.0 109.498 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.85 7.92 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 121.174 1.249 . . . . 0.0 109.474 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 45' ' ' THR . 86.3 mt -74.11 151.38 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.0 p -130.99 145.3 52.0 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.09 129.3 48.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.456 -0.778 . . . . 0.0 109.57 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.2 m -120.14 129.84 54.33 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -81.83 144.15 31.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.14 -0.975 . . . . 0.0 109.502 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.5 135.73 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.4 -0.812 . . . . 0.0 109.892 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -91.45 -8.7 47.02 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.252 -0.905 . . . . 0.0 110.245 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -148.88 158.44 44.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.995 -1.065 . . . . 0.0 109.896 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.46 169.64 45.09 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -82.98 135.96 34.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.129 . . . . 0.0 109.442 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.91 25.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.403 -0.81 . . . . 0.0 108.947 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.71 -41.63 91.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.311 -0.868 . . . . 0.0 109.757 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.64 115.64 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -0.79 . . . . 0.0 109.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.06 130.54 46.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.338 -0.851 . . . . 0.0 109.996 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -118.9 127.06 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.558 -0.714 . . . . 0.0 109.308 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.97 160.02 43.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.41 134.28 55.1 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.09 162.42 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 121.135 -0.978 . . . . 0.0 111.116 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 65' ' ' ARG . 43.4 mtm-85 -122.61 138.18 54.67 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.67 -0.644 . . . . 0.0 110.225 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.37 -145.03 45.09 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.199 -0.938 . . . . 0.0 110.878 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -62.66 134.64 56.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.709 -0.877 . . . . 0.0 109.611 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -131.92 65.01 1.58 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.484 -0.76 . . . . 0.0 109.473 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.3 mtt180 51.72 46.58 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.85 . . . . 0.0 109.436 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.544 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 81.0 m-20 -143.16 160.67 40.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -92.42 9.39 34.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.403 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.5 m -132.18 71.45 79.73 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.479 -0.763 . . . . 0.0 109.879 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 157.86 50.69 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.526 1.484 . . . . 0.0 109.845 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.23 151.08 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.365 -0.834 . . . . 0.0 109.426 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -127.29 74.46 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.535 -0.728 . . . . 0.0 109.325 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.83 178.16 48.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.67 1.99 1.5 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.477 1.451 . . . . 0.0 109.746 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -85.93 177.13 49.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.5 -165.36 52.12 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -70.39 149.39 47.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -1.195 . . . . 0.0 110.03 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.9 mt -93.08 -11.1 33.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.582 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.04 171.68 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.109 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -166.34 170.95 12.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 110.171 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.44 161.09 39.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 108.958 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -92.98 170.36 9.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -67.33 149.77 98.23 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.223 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.67 115.05 2.54 Favored 'Trans proline' 0 C--N 1.325 -0.704 0 C-N-CA 120.936 1.091 . . . . 0.0 109.866 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.36 167.57 35.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -173.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.617 1.544 . . . . 0.0 110.405 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.11 -131.32 50.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.3 tt -80.36 -9.42 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.968 . . . . 0.0 110.169 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.98 136.03 50.88 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.78 -15.45 59.08 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.54 125.32 24.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.033 -1.275 . . . . 0.0 110.521 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.04 123.16 43.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.417 -0.802 . . . . 0.0 108.944 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -108.66 135.34 50.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.339 -0.851 . . . . 0.0 110.22 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 39.5 m-85 -114.88 127.98 56.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.669 -0.645 . . . . 0.0 109.764 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -68.43 105.48 2.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.405 -0.81 . . . . 0.0 109.146 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' OE2' ' OD2' ' A' ' 24' ' ' ASP . 37.5 tp10 -75.55 1.21 14.86 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.528 -0.732 . . . . 0.0 110.015 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -73.35 -37.86 65.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.578 -1.326 . . . . 0.0 110.29 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 57.3 mp0 -83.42 159.67 21.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.928 -1.107 . . . . 0.0 109.6 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -91.52 123.31 34.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -88.28 147.57 24.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.3 p -133.24 161.83 33.42 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.476 -0.765 . . . . 0.0 109.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' ND2' HD13 ' A' ' 25' ' ' LEU . 95.4 m-20 -111.63 31.98 5.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -145.37 -161.11 1.24 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.946 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -84.06 13.29 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.124 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.19 -161.17 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.079 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -43.25 -59.73 1.97 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 112.008 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.5 m-85 -133.83 147.79 51.25 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.656 -1.277 . . . . 0.0 111.064 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -99.54 120.51 39.76 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.03 -41.28 91.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 110.2 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -59.7 -47.96 83.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.35 -0.844 . . . . 0.0 111.93 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.585 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.78 -39.9 86.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.765 -1.209 . . . . 0.0 110.658 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.44 -39.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 108.901 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.17 70.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.693 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.16 -42.02 94.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.025 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.455 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 71.1 t60 -59.94 -46.97 87.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 0.0 109.953 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -60.56 -40.08 90.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.773 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -67.3 -31.48 71.81 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.14 97.57 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -66.63 -39.29 88.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.348 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 m -60.04 -37.92 81.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.71 -2.0 41.0 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 10.88 63.64 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 120.113 -1.042 . . . . 0.0 110.719 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.92 145.02 38.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.691 -1.476 . . . . 0.0 109.142 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -109.34 156.96 19.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.555 -0.716 . . . . 0.0 110.004 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -51.61 177.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.0 t -149.96 165.6 32.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.084 -1.01 . . . . 0.0 109.691 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.4 p -98.67 6.33 47.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -83.71 116.84 22.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 108.889 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.83 -40.21 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 110.145 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.27 10.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.372 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.66 142.31 27.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.882 -1.364 . . . . 0.0 109.402 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.87 -27.21 65.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.136 -0.978 . . . . 0.0 108.631 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.455 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.1 mmm -76.49 7.42 4.49 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.792 -0.568 . . . . 0.0 110.192 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -65.99 135.07 95.13 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.06 -1.025 . . . . 0.0 109.184 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.76 -44.43 49.71 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 121.396 1.397 . . . . 0.0 111.863 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.2 t -79.36 134.63 36.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.542 -1.349 . . . . 0.0 110.067 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -75.02 131.15 40.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 0.0 110.787 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.585 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.5 p -154.68 178.64 9.89 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 142' ' ' PHE . 33.0 p90 -165.0 126.29 2.05 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.616 -1.303 . . . . 0.0 109.868 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.1 p -89.14 8.5 29.69 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.152 -0.967 . . . . 0.0 109.191 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.94 -15.1 63.88 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -129.15 127.75 42.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.62 -0.929 . . . . 0.0 108.656 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -98.09 104.22 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -142.27 160.03 41.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.09 -1.007 . . . . 0.0 109.214 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.15 155.4 39.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 108.76 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.34 158.15 16.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.43 -38.84 72.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.88 . . . . 0.0 109.86 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -59.09 -39.99 83.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.021 -1.049 . . . . 0.0 108.809 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.19 -40.01 71.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.851 . . . . 0.0 108.783 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.15 -50.46 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.514 -0.741 . . . . 0.0 109.985 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.6 -40.1 90.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.948 -1.095 . . . . 0.0 109.297 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -52.83 39.93 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.456 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.0 -39.66 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.772 -1.428 . . . . 0.0 110.212 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -65.71 -40.22 92.01 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.07 92.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.95 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.65 -50.73 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.957 -1.089 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -99.62 -66.39 0.91 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.255 -0.903 . . . . 0.0 109.068 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.03 -169.23 34.13 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -86.46 152.52 22.61 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.442 -1.034 . . . . 0.0 108.713 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 165' ' ' ASN . 56.1 m -76.82 88.0 3.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.045 -1.034 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -71.65 37.28 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.823 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 163' ' ' SER . 14.8 m120 -149.65 69.49 9.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.044 -1.035 . . . . 0.0 109.214 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -67.43 55.97 0.61 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.465 1.443 . . . . 0.0 109.691 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 165' ' ' ASN . 57.7 t -82.35 146.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.905 -1.122 . . . . 0.0 108.768 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.36 149.66 69.3 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 108.987 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 120.835 1.024 . . . . 0.0 109.479 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -67.96 122.55 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 108.826 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.421 ' OG1' ' C ' ' A' ' 6' ' ' ASN . 31.9 p -100.01 124.9 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.392 -0.818 . . . . 0.0 109.376 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -78.05 103.16 7.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 6' ' ' ASN . . . 78.93 19.61 72.39 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.659 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 5' ' ' GLY . 28.4 m120 -156.68 63.17 3.09 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.664 -1.492 . . . . 0.0 110.271 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.44 129.02 27.95 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.444 1.429 . . . . 0.0 110.045 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 8' ' ' ARG . 52.4 mtt-85 -91.52 150.33 21.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.367 -0.833 . . . . 0.0 109.186 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -68.34 128.44 36.6 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -81.72 -11.52 59.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.884 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -87.24 143.39 27.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.8 p -90.95 -5.0 56.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.606 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -120.89 125.01 46.38 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 49' ' ' PHE . 80.3 mt -118.19 156.0 29.52 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.506 -0.746 . . . . 0.0 109.407 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -130.71 155.29 46.87 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -145.62 154.67 42.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.129 -0.982 . . . . 0.0 109.446 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.1 ttt-85 -141.12 131.36 24.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.984 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -88.57 119.27 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.6 tt0 -66.93 -39.97 87.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 82.3 m-20 -159.48 158.65 32.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.019 -1.051 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.52 140.06 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 109.231 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -78.42 139.36 59.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 109.608 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.45 -2.11 6.74 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.777 0.984 . . . . 0.0 109.702 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.55 -40.05 94.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.971 . . . . 0.0 109.691 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.7 mt -136.6 148.91 65.59 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.57 151.37 38.75 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 120.876 1.051 . . . . 0.0 109.704 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -66.59 -30.11 70.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 109.898 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.06 84.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.948 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -78.58 -27.74 45.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.1 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -70.03 -42.27 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.994 -1.066 . . . . 0.0 109.646 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -59.71 -42.31 92.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.88 . . . . 0.0 109.442 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -44.31 94.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 109.898 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.02 -45.97 86.05 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.235 -0.915 . . . . 0.0 109.448 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -70.3 -48.56 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.435 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -59.91 -41.75 92.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 110.253 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.3 -40.74 95.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.333 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.28 67.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.925 -1.109 . . . . 0.0 110.254 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 34.2 m-85 -59.85 -40.12 87.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.968 -1.083 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -62.44 -41.08 98.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.041 -1.037 . . . . 0.0 109.745 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.85 -40.7 93.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.132 -0.98 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -72.85 -40.16 65.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.969 -1.082 . . . . 0.0 109.527 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 t -69.14 -38.84 79.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 0.0 110.055 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.04 -30.06 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.482 -0.761 . . . . 0.0 110.496 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.9 8.02 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.144 -0.973 . . . . 0.0 111.019 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 47' ' ' LEU . 18.1 p -145.32 149.89 42.79 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.838 -1.164 . . . . 0.0 108.788 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.71 6.48 0.98 Allowed 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 120.975 1.117 . . . . 0.0 109.585 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 89.9 mt -71.84 144.69 49.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.272 -0.893 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.606 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 11.5 p -128.42 141.26 51.46 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 92.3 m-85 -120.07 137.95 53.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.6 -0.688 . . . . 0.0 109.533 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.4 m -132.87 129.16 38.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 110.021 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -78.12 144.81 36.13 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.05 135.8 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.241 -0.912 . . . . 0.0 108.824 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.68 -9.05 48.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -154.81 158.92 40.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.941 -1.099 . . . . 0.0 109.761 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.95 172.48 47.32 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -79.85 160.2 26.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -1.076 . . . . 0.0 109.143 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.52 154.75 51.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.376 -0.828 . . . . 0.0 109.334 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.357 -0.84 . . . . 0.0 109.807 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.33 119.58 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.508 -0.745 . . . . 0.0 109.426 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.7 mmm -100.19 129.5 46.21 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -117.62 129.67 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.51 -0.744 . . . . 0.0 109.039 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.5 p -147.48 159.3 43.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.085 -1.009 . . . . 0.0 110.47 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -113.04 133.83 54.8 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -136.75 169.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.174 -0.954 . . . . 0.0 110.367 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -130.87 141.15 50.29 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.558 -0.714 . . . . 0.0 110.545 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.42 -143.55 3.44 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.6 t0 -59.95 136.71 58.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.498 -1.001 . . . . 0.0 109.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.4 p-80 -133.49 45.44 2.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 69' ' ' ARG . 21.3 mmt-85 57.36 48.02 15.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.765 -0.584 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.8 m-20 -139.67 168.92 18.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 42.0 p-10 -89.7 9.84 25.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 109.629 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -132.5 69.94 79.7 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.426 -0.796 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.12 156.44 62.81 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.444 1.429 . . . . 0.0 109.805 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -76.98 143.59 39.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 110.144 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -103.22 71.18 1.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.552 -0.717 . . . . 0.0 109.224 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 64.2 -173.41 15.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.65 1.08 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.373 1.382 . . . . 0.0 109.314 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.71 -179.13 34.97 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 -157.23 46.58 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.97 148.87 48.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -1.119 . . . . 0.0 109.197 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.93 -10.78 43.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.077 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.62 176.23 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -165.26 169.25 16.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 0.0 109.764 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.52 167.0 25.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 109.432 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.62 161.53 13.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.449 -0.782 . . . . 0.0 109.469 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -66.81 148.72 98.72 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.22 -0.925 . . . . 0.0 109.236 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.34 100.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.154 1.236 . . . . 0.0 109.996 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.45 169.55 33.88 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -63.58 171.21 7.19 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.449 1.432 . . . . 0.0 109.521 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.58 -128.05 20.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -80.54 -7.09 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -1.075 . . . . 0.0 110.079 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.67 139.04 48.73 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.19 -17.55 46.58 Favored Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.305 -1.115 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -66.52 159.74 26.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -1.211 . . . . 0.0 109.817 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.46 122.47 15.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -106.97 141.56 37.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.458 -0.776 . . . . 0.0 109.777 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 66.0 m-85 -119.71 139.93 51.48 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.538 -0.726 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -68.94 105.09 2.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.659 -0.65 . . . . 0.0 109.379 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -79.21 -10.36 59.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.1 -1.0 . . . . 0.0 110.923 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -78.19 -17.83 56.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.721 -1.237 . . . . 0.0 109.613 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.05 159.26 20.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.824 . . . . 0.0 109.341 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.2 OUTLIER -90.34 111.54 22.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 108.746 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -90.09 146.64 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 109.508 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -129.96 160.99 31.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 109.851 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -107.4 24.67 12.51 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.673 HD21 ' NE ' ' A' ' 108' ' ' ARG . 5.5 p30 -144.11 -163.03 1.58 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.87 -0.39 38.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.816 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.673 ' NE ' HD21 ' A' ' 106' ' ' ASN . 86.0 mtm180 -56.45 175.86 0.1 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.97 -1.081 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.1 mt-10 -4.42 -80.55 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -127.33 135.8 51.04 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.239 -0.913 . . . . 0.0 110.541 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -95.45 118.9 33.0 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.0 -39.84 83.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.734 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -59.26 -45.24 91.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.246 -0.909 . . . . 0.0 110.624 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 141' ' ' THR . 57.4 mtp180 -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.112 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.16 -40.03 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.033 -1.042 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.22 93.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.69 89.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -59.86 -47.64 84.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.354 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 80.5 mt-10 -64.05 -39.85 95.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 0.0 109.753 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.9 -33.04 73.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.13 -0.981 . . . . 0.0 108.844 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.4 97.84 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -66.89 -40.04 87.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -1.155 . . . . 0.0 109.068 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 p -59.46 -27.83 66.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.39 -2.53 56.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -0.839 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.18 7.05 68.23 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.41 140.96 41.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.951 -1.323 . . . . 0.0 109.279 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.3 m -108.99 159.56 16.73 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.456 -0.778 . . . . 0.0 109.471 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -50.34 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 109.868 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 48.0 t -151.11 161.61 42.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 32.3 p -91.97 2.28 56.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.176 -0.952 . . . . 0.0 109.62 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -81.51 116.31 21.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 108.891 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.1 mt -59.9 -40.1 81.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.42 -0.8 . . . . 0.0 109.735 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.64 6.19 2.81 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.31 141.75 28.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.91 -1.347 . . . . 0.0 109.238 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.3 mt -68.75 -38.03 79.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 0.0 109.755 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 53.8 mtp -70.76 19.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 110.55 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.2 t80 -63.92 136.61 96.8 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.15 -51.94 9.47 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 120.947 1.098 . . . . 0.0 111.137 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.2 m -84.29 146.76 27.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.901 -1.124 . . . . 0.0 110.346 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 141' ' ' THR . 50.6 t80 -73.42 154.68 39.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 108.979 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.523 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 46.2 p -149.35 148.55 29.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.0 109.232 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -80.29 117.54 21.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.216 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 75.1 m -118.54 133.53 55.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 109.253 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.3 -85.81 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -96.17 154.29 17.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -1.192 . . . . 0.0 108.938 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.77 114.49 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.082 -1.011 . . . . 0.0 109.782 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -138.77 155.2 48.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.451 -0.781 . . . . 0.0 109.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.37 157.9 34.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.969 -1.082 . . . . 0.0 108.832 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.91 150.38 21.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -55.13 -39.61 69.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.406 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 28.6 t0 -55.05 -38.46 68.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.4 -39.54 62.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 108.985 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.1 mm -60.09 -50.24 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.6 -40.13 94.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.898 -1.126 . . . . 0.0 109.938 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.2 -49.59 56.58 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.01 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -70.01 -39.16 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.307 . . . . 0.0 110.098 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -65.57 -40.11 92.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 109.831 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.55 97.72 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 109.798 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 90.6 mt -64.25 -49.99 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.365 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -97.52 -71.44 0.68 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.353 -0.842 . . . . 0.0 109.52 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 155.65 -169.53 33.45 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.2 mtt-85 -88.85 148.26 23.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -1.164 . . . . 0.0 109.139 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 m -76.64 83.46 3.29 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -74.03 127.84 33.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -157.81 151.54 19.43 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.0 108.712 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.5 135.48 70.54 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 N-CA-C 109.387 -1.044 . . . . 0.0 109.387 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 79.9 t -89.92 120.75 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 4.2 mp0 -81.53 149.94 65.79 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.325 -0.682 0 C-N-CA 120.801 1.0 . . . . 0.0 109.786 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 2' ' ' LEU . 25.9 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.597 ' N ' HG12 ' A' ' 1' ' ' VAL . 83.8 mt -61.61 -46.46 89.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.974 -1.079 . . . . 0.0 109.028 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.6 p -100.25 165.57 11.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.477 0.656 . . . . 0.0 109.293 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.44 141.64 54.0 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.0 -166.9 12.03 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ARG . 24.3 m120 -81.84 145.58 54.13 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.988 -1.301 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.53 56.46 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.344 1.363 . . . . 0.0 109.151 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ASN . 41.6 mtt-85 -143.43 156.55 44.69 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.958 -1.088 . . . . 0.0 109.894 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -72.61 129.14 37.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.955 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -81.44 -11.85 59.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 108.933 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -87.46 146.09 25.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.132 -0.98 . . . . 0.0 110.317 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.7 p -94.19 -8.06 40.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.518 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 44.6 m80 -124.63 126.05 45.13 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -115.74 163.47 15.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 p -133.07 159.46 40.01 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -146.99 159.33 43.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -147.81 131.02 16.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.409 -0.807 . . . . 0.0 109.938 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.36 120.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 0.0 108.516 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 98.2 mt-10 -67.32 -40.0 85.9 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.099 -1.001 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 74.5 m-80 -159.37 152.77 22.5 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.025 -1.047 . . . . 0.0 110.723 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.54 129.87 45.74 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -69.7 145.53 94.93 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.724 -1.235 . . . . 0.0 109.332 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -64.31 -1.08 3.38 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 121.052 1.168 . . . . 0.0 110.091 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -63.67 -40.03 95.81 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 109.546 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -143.89 150.4 49.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.24 161.12 27.96 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -69.94 -30.1 67.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.461 -0.774 . . . . 0.0 109.686 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.25 -41.67 89.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 110.101 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -83.4 -34.85 25.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.066 -1.021 . . . . 0.0 110.319 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.89 -49.18 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.528 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.1 p-10 -57.0 -40.02 75.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.755 -1.215 . . . . 0.0 109.559 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 83.2 t60 -60.25 -44.78 94.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.946 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.55 -41.23 85.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 109.368 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.0 mm -70.06 -45.67 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.548 -0.72 . . . . 0.0 109.189 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -59.97 -40.33 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.064 -1.023 . . . . 0.0 109.514 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.45 -39.92 92.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 0.0 109.938 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.75 77.53 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.904 -1.122 . . . . 0.0 110.417 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -60.11 -39.5 86.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.827 -1.17 . . . . 0.0 109.301 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mt-30 -60.31 -40.36 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.772 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 40' ' ' LEU . 82.8 mt -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.544 -1.348 . . . . 0.0 110.315 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.403 ' CH2' HD22 ' A' ' 148' ' ' LEU . 85.7 m95 -72.56 -42.27 64.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.226 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -67.69 -29.4 68.66 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.189 -0.945 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 94.5 m-20 -57.72 -39.9 78.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.588 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 45' ' ' THR . 5.6 m -102.61 15.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.211 -0.93 . . . . 0.0 110.644 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.495 HG23 HG23 ' A' ' 44' ' ' VAL . 47.9 p -144.27 146.84 34.81 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.064 -1.023 . . . . 0.0 109.344 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.73 4.29 2.27 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -72.76 149.94 43.25 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 82.8 p -136.79 146.69 46.01 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -125.29 128.81 48.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.39 -0.819 . . . . 0.0 109.096 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.6 m -121.89 131.62 54.13 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.764 0.792 . . . . 0.0 109.302 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -75.66 148.3 38.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.0 m -130.04 130.11 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 109.334 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 t -90.39 -4.16 57.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.369 -0.832 . . . . 0.0 110.467 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -156.43 159.29 38.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.085 -1.009 . . . . 0.0 108.939 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.57 44.87 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.36 150.5 31.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -1.156 . . . . 0.0 109.643 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.78 149.38 41.59 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.575 0.702 . . . . 0.0 109.427 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.16 -40.65 86.24 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -113.91 119.83 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.359 -0.838 . . . . 0.0 109.307 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.2 mmm -101.85 125.33 48.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.219 -0.926 . . . . 0.0 109.507 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -111.98 129.57 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.7 p -148.13 164.08 35.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.923 -1.111 . . . . 0.0 110.339 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.75 136.13 53.35 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.55 165.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.344 -0.848 . . . . 0.0 111.303 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.2 mtm-85 -125.78 136.51 53.23 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.417 0.627 . . . . 0.0 109.838 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.61 -144.11 3.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.2 t0 -70.78 130.97 43.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -1.004 . . . . 0.0 109.757 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 7.6 p-80 -131.85 51.67 2.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 0.0 109.339 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 56.98 45.37 21.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.776 -0.577 . . . . 0.0 110.385 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -129.76 170.32 14.0 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.0 109.219 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -89.17 9.08 26.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 109.356 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -138.78 72.41 41.77 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.016 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -70.91 138.97 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.236 1.291 . . . . 0.0 109.294 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -74.69 150.29 39.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.349 -0.844 . . . . 0.0 109.686 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -127.56 73.28 1.43 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.552 -0.717 . . . . 0.0 109.752 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 86.31 176.68 49.76 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -64.99 1.06 2.09 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.485 1.456 . . . . 0.0 109.706 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.53 179.47 30.55 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.43 -155.01 43.08 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.47 145.99 48.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.467 -1.02 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.0 mt -97.35 -14.71 21.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.5 170.99 3.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.61 172.03 14.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.42 161.76 40.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.102 -0.999 . . . . 0.0 109.422 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -94.18 158.87 15.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -66.39 148.23 98.63 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.192 -0.942 . . . . 0.0 109.257 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -52.39 107.01 0.16 Allowed 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 121.181 1.254 . . . . 0.0 109.58 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.06 169.28 37.4 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.489 -1.338 . . . . 0.0 109.874 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.47 174.1 3.01 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.54 1.493 . . . . 0.0 110.059 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.59 -130.31 45.85 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.2 tt -75.8 -6.0 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.458 -1.024 . . . . 0.0 110.741 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.51 139.83 44.2 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.278 -1.439 . . . . 0.0 109.708 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.35 -22.9 13.53 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.22 139.32 57.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.073 -1.251 . . . . 0.0 109.671 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.64 135.83 53.67 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.45 -0.781 . . . . 0.0 110.139 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -116.05 126.48 53.84 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 50.7 m-85 -105.94 130.04 53.96 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.509 -0.744 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -64.75 114.02 4.17 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.304 -0.872 . . . . 0.0 109.615 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.88 -7.49 58.76 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.415 -0.803 . . . . 0.0 109.925 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.63 -20.31 54.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.49 -1.381 . . . . 0.0 109.584 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -83.77 153.04 24.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 108.998 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -92.32 111.64 23.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 108.681 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -86.17 138.72 31.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.475 -0.766 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 35.1 p -133.01 169.33 16.99 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.451 -0.781 . . . . 0.0 109.814 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -114.3 24.94 11.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.474 -0.766 . . . . 0.0 109.989 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.788 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.48 -165.03 2.17 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.872 -1.142 . . . . 0.0 110.696 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 84.2 t80 -63.91 4.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.628 -0.67 . . . . 0.0 111.541 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.36 -165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.67 -1.269 . . . . 0.0 110.681 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.07 -59.72 2.46 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.544 -0.722 . . . . 0.0 112.422 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -138.25 155.08 48.97 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.817 -1.177 . . . . 0.0 111.96 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 94.1 m-20 -108.01 119.0 38.23 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.93 -42.85 94.89 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 109.679 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -59.82 -46.53 88.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 111.374 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' NH1' ' CE2' ' A' ' 140' ' ' TYR . 7.0 mtp-105 -59.92 -41.09 90.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.671 -1.268 . . . . 0.0 110.266 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.59 -40.17 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 108.888 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.5 91.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.72 -46.97 86.15 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.079 -1.013 . . . . 0.0 109.346 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -60.14 -46.2 90.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.515 -0.74 . . . . 0.0 109.493 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.542 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 92.5 mt-10 -60.98 -42.41 98.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.183 -0.948 . . . . 0.0 110.319 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.64 -38.41 90.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.43 -40.61 94.52 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -67.08 -39.94 86.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.017 -1.284 . . . . 0.0 108.406 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.5 p -59.03 -28.96 66.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.61 2.18 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 110.056 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.0 3.81 75.87 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.231 -0.985 . . . . 0.0 110.821 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.57 135.25 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.765 -1.432 . . . . 0.0 109.312 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -110.41 163.57 13.55 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.749 0.785 . . . . 0.0 110.535 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -49.49 168.96 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.478 -0.764 . . . . 0.0 109.492 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 t -151.33 163.59 38.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -92.42 6.29 47.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -0.813 . . . . 0.0 110.017 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -81.65 120.94 25.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.007 -1.058 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.55 -40.67 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.22 6.5 10.51 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.164 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.83 138.54 34.23 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.959 -1.318 . . . . 0.0 110.06 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.11 -26.54 64.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.072 -1.017 . . . . 0.0 108.787 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.5 mmm -73.06 7.28 2.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.602 -0.686 . . . . 0.0 110.0 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 139' ' ' SER . 25.6 t80 -65.37 132.98 95.3 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.94 -1.1 . . . . 0.0 108.706 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.71 40.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.439 1.426 . . . . 0.0 111.839 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -154.28 115.6 4.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.155 -1.591 . . . . 0.0 109.994 179.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CE2' ' NH1' ' A' ' 114' ' ' ARG . 61.9 t80 -66.62 134.22 51.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 0.0 109.149 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.511 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 20.5 p -155.2 144.21 20.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.987 -1.071 . . . . 0.0 109.479 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -76.35 117.71 18.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 108.64 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.2 m -100.28 -2.32 34.02 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.164 -0.96 . . . . 0.0 110.072 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.34 -27.13 3.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -159.96 149.96 18.38 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.393 -1.063 . . . . 0.0 109.693 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.4 t -98.35 111.36 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.207 -0.933 . . . . 0.0 109.997 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -136.02 145.79 46.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.403 HD22 ' CH2' ' A' ' 41' ' ' TRP . 86.4 mt -74.76 149.91 39.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.066 -1.021 . . . . 0.0 108.854 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.44 164.94 11.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.307 -0.871 . . . . 0.0 110.034 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.7 -40.69 88.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.65 -40.43 87.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.975 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.06 -40.03 54.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.834 -1.166 . . . . 0.0 109.146 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.95 -49.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -61.54 -39.94 92.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.055 -1.028 . . . . 0.0 110.009 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.38 62.59 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.442 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.39 -38.68 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.566 -1.549 . . . . 0.0 109.215 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.67 -39.88 88.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.98 81.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.117 -0.99 . . . . 0.0 109.365 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.14 -49.64 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.947 -1.096 . . . . 0.0 110.052 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -98.75 -64.56 1.03 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.72 -167.14 30.4 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.77 149.25 22.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.238 . . . . 0.0 109.031 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.8 m -76.89 80.73 3.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 108.844 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.448 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 77.3 mt-30 -73.91 135.66 43.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.589 -0.695 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 34.5 m120 -154.34 66.98 5.5 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 109.684 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 80.42 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.246 1.297 . . . . 0.0 110.06 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.62 139.38 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -0.965 . . . . 0.0 109.168 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -81.52 149.04 63.95 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.414 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 121.034 1.156 . . . . 0.0 110.483 179.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.315 0.579 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.674 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -88.53 1.55 54.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.4 p -88.78 164.73 15.11 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.8 -1.187 . . . . 0.0 109.545 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 6' ' ' ASN . 88.0 tt0 -71.27 156.91 38.98 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.434 -0.791 . . . . 0.0 109.15 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.79 7.23 0.27 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.5 m120 -156.28 75.92 4.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.426 -1.043 . . . . 0.0 108.654 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.07 -177.6 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.42 1.414 . . . . 0.0 110.772 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -138.72 174.68 10.27 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -59.86 129.17 40.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.946 -1.096 . . . . 0.0 108.894 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.94 -28.59 61.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.392 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.876 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.1 p -91.58 -4.78 54.96 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -129.38 139.01 51.83 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -134.33 160.1 38.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.358 -0.839 . . . . 0.0 109.531 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -127.6 154.86 44.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -141.69 154.21 45.18 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.123 -0.986 . . . . 0.0 110.266 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.1 ttt-85 -141.76 135.55 29.84 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.459 -0.775 . . . . 0.0 109.551 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.34 119.55 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -65.97 -39.85 90.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.919 -1.113 . . . . 0.0 110.676 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -164.18 160.81 21.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.89 -1.131 . . . . 0.0 110.44 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -106.99 137.97 44.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.471 -0.768 . . . . 0.0 109.302 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 22' ' ' THR . 0.7 OUTLIER -77.1 147.04 76.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 108.999 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.17 1.75 1.81 Allowed 'Trans proline' 0 C--N 1.325 -0.7 0 C-N-CA 120.857 1.038 . . . . 0.0 109.978 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.9 -40.83 91.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.948 -1.095 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 43.7 mt -140.67 151.68 63.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.504 -0.747 . . . . 0.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.33 151.38 79.71 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.009 1.14 . . . . 0.0 109.211 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -63.01 -31.62 72.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.847 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.21 -37.57 75.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.95 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -79.93 -30.47 39.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.112 -0.993 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.86 -47.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.46 -40.21 78.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.966 . . . . 0.0 109.63 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -60.21 -53.39 58.32 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.675 0.75 . . . . 0.0 110.342 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -45.82 91.38 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.58 -0.7 . . . . 0.0 110.813 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -69.47 -39.76 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.992 -1.068 . . . . 0.0 109.877 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.85 -44.39 94.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -61.79 -38.98 90.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.836 . . . . 0.0 110.019 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.9 67.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.824 -1.172 . . . . 0.0 109.402 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.05 -42.04 93.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.66 -42.62 97.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.896 -1.127 . . . . 0.0 109.738 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.89 -40.42 88.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.963 -1.086 . . . . 0.0 110.405 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -72.26 -40.92 67.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.037 . . . . 0.0 109.608 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 t -69.13 -34.03 74.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -54.72 -30.79 57.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.279 -0.888 . . . . 0.0 111.466 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 45' ' ' THR . 19.8 m -109.94 11.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.129 -0.982 . . . . 0.0 110.669 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 44' ' ' VAL . 32.0 p -143.31 145.95 34.27 Favored Pre-proline 0 N--CA 1.501 2.108 0 O-C-N 121.034 -1.041 . . . . 0.0 109.185 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.57 5.63 0.93 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.994 1.129 . . . . 0.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 45' ' ' THR . 83.3 mt -74.88 147.97 40.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 109.539 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.6 p -127.58 140.78 51.9 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.2 127.44 50.01 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.363 -0.836 . . . . 0.0 109.399 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -120.39 129.96 54.17 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.587 -0.696 . . . . 0.0 110.312 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -78.17 143.34 37.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 108.84 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 52' ' ' VAL . 33.6 m -126.62 129.81 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.269 -0.894 . . . . 0.0 108.931 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 t -88.87 -7.0 56.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.151 -0.968 . . . . 0.0 109.968 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -151.01 168.21 25.27 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.27 -0.894 . . . . 0.0 108.994 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.09 177.46 51.86 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -80.51 158.8 25.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.779 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.29 135.7 45.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.679 -0.638 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.69 -40.09 86.71 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.189 -0.944 . . . . 0.0 110.364 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.6 111.94 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.45 -0.782 . . . . 0.0 109.661 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 31.0 mtt -101.09 132.58 46.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.457 -0.777 . . . . 0.0 110.146 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -111.21 132.94 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.56 -0.713 . . . . 0.0 109.374 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.7 p -146.4 160.05 42.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.062 -1.023 . . . . 0.0 110.022 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -112.95 131.57 55.69 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.06 164.04 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 O-C-N 121.164 -0.96 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.15 136.62 54.93 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.386 0.612 . . . . 0.0 110.104 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.52 -149.27 2.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -66.13 129.97 41.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.917 . . . . 0.0 108.984 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -133.93 66.15 1.56 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.18 50.07 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 51.8 t0 -141.75 151.29 42.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 56.3 t30 -89.1 9.49 25.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.071 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m -132.48 66.47 76.96 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.966 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.05 156.2 56.29 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.243 1.295 . . . . 0.0 109.209 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -76.34 142.77 41.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.097 -1.002 . . . . 0.0 109.584 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -96.49 71.51 2.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.275 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 63.19 -165.4 26.96 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.11 1.03 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 121.611 1.54 . . . . 0.0 109.498 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -98.1 173.67 27.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.56 -167.07 48.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -70.2 156.45 39.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.727 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -90.76 -7.27 52.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.103 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.81 179.63 1.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.793 . . . . 0.0 109.396 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -167.3 172.77 9.48 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 109.186 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.02 167.79 27.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.148 -0.97 . . . . 0.0 109.902 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.92 165.72 11.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.265 -0.897 . . . . 0.0 109.071 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 25.9 mp0 -68.75 149.4 97.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.995 -1.065 . . . . 0.0 109.661 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.28 105.24 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.043 1.162 . . . . 0.0 110.114 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.51 168.18 40.4 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.44 -173.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.452 1.434 . . . . 0.0 109.441 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.81 -132.93 43.82 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.751 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.82 -2.05 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.661 -0.905 . . . . 0.0 109.508 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.02 145.38 48.36 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.94 -25.65 8.49 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.16 152.18 33.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.05 -1.265 . . . . 0.0 109.676 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.63 127.52 27.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.485 -0.759 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -106.56 135.74 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.65 . . . . 0.0 110.348 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -112.5 136.52 51.92 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.581 -0.699 . . . . 0.0 109.601 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -65.8 100.72 0.57 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.288 -0.882 . . . . 0.0 109.394 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -78.94 -8.89 59.28 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.863 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -74.4 -23.65 59.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.13 161.14 19.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.041 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -92.2 119.0 31.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.984 -1.072 . . . . 0.0 109.17 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -89.15 139.27 30.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.599 -0.688 . . . . 0.0 110.174 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.2 p -135.28 166.07 23.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -115.83 34.52 4.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 3.0 p30 -149.15 -165.03 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.597 -0.689 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 108' ' ' ARG . 51.4 p90 -75.57 9.57 2.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.932 -1.105 . . . . 0.0 110.383 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' PHE . 99.0 mtt180 -58.8 -156.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.988 -1.07 . . . . 0.0 110.337 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 108' ' ' ARG . 99.8 mt-10 -47.45 -60.26 2.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.107 -0.996 . . . . 0.0 111.545 -177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -140.53 145.76 37.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.874 -1.141 . . . . 0.0 110.664 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 111' ' ' ASN . 1.1 m-80 -99.5 115.07 28.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.63 -39.66 85.03 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.481 -0.762 . . . . 0.0 111.064 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -59.18 -47.77 84.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 111.287 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -60.01 -42.41 94.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.53 -1.356 . . . . 0.0 110.122 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.3 -40.0 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.036 -1.04 . . . . 0.0 109.555 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.31 -50.03 70.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.029 -1.044 . . . . 0.0 109.214 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.62 -40.01 86.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.4 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -59.68 -49.19 78.69 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.071 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -60.11 -40.27 89.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 109.18 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.89 -39.92 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.737 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.98 -41.78 85.44 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -64.3 -39.72 94.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 108.617 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.5 m -56.15 -30.19 61.83 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.402 -0.811 . . . . 0.0 108.862 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 74.1 mt -83.68 0.06 48.61 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.56 73.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.39 148.02 39.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.814 -1.403 . . . . 0.0 109.68 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.3 m -109.01 157.53 18.59 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.443 0.64 . . . . 0.0 109.636 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -54.71 171.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.559 -0.713 . . . . 0.0 109.807 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.9 t -151.15 168.41 24.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.1 p -95.52 9.45 40.06 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.13 -0.982 . . . . 0.0 110.158 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.71 118.23 22.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.029 -1.045 . . . . 0.0 108.989 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.36 -40.0 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 110.317 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.89 3.18 29.38 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.946 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.78 136.78 33.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.911 -1.347 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.1 mt -69.71 -28.94 66.25 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.6 mmm -71.73 16.22 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.448 -0.783 . . . . 0.0 109.431 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 135' ' ' LEU . 18.8 t80 -62.98 137.03 96.93 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.36 -47.37 27.75 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 120.753 0.969 . . . . 0.0 111.147 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.7 m -87.48 152.44 22.22 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.913 -1.117 . . . . 0.0 110.754 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -72.51 140.11 47.99 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.5 p -143.97 142.63 30.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.139 -0.976 . . . . 0.0 109.119 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -80.29 124.58 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.529 -0.732 . . . . 0.0 110.06 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 144' ' ' GLY . 46.5 t -118.43 121.02 39.3 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -49.35 -90.92 0.01 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.0 147.07 35.02 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.0 108.499 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.08 106.28 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.083 -1.011 . . . . 0.0 109.457 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.9 155.67 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.439 -0.788 . . . . 0.0 109.295 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 154.1 34.88 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.139 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.97 161.67 13.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.342 -0.849 . . . . 0.0 109.224 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -59.67 -39.98 86.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.06 -40.79 90.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -77.36 -41.56 39.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.108 -0.995 . . . . 0.0 109.447 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.35 -48.94 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 109.187 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.89 -40.16 92.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.24 -52.15 53.62 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.354 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -69.51 -39.81 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.861 -1.376 . . . . 0.0 109.675 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -66.29 -39.77 89.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.652 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.4 92.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.1 mt -65.32 -49.75 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -97.13 -66.75 0.88 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.141 -0.974 . . . . 0.0 109.508 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.09 -178.99 35.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -88.08 149.36 24.0 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.277 . . . . 0.0 109.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.1 m -77.77 54.93 1.3 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.23 112.32 9.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 110.186 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 167' ' ' VAL . 72.6 m-80 -159.98 70.89 3.12 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.1 38.04 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 121.673 1.582 . . . . 0.0 110.3 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.532 ' H ' ' C ' ' A' ' 165' ' ' ASN . 52.4 t -93.39 139.5 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.219 -0.926 . . . . 0.0 109.924 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -80.15 146.6 63.22 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 108.734 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.324 -0.756 0 C-N-CA 121.154 1.236 . . . . 0.0 110.149 179.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 3' ' ' THR . 1.2 tm? -85.39 115.63 23.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 ' N ' HD13 ' A' ' 2' ' ' LEU . 43.7 p -97.07 144.83 26.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.342 -0.849 . . . . 0.0 109.842 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.4 143.69 51.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.338 -0.851 . . . . 0.0 108.787 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.65 -90.19 1.6 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -158.18 150.1 17.27 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.227 -1.161 . . . . 0.0 108.99 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.25 119.74 7.1 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.915 1.077 . . . . 0.0 109.614 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -94.58 167.07 11.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -67.81 120.75 14.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 108.392 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.54 -15.54 51.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.975 -1.078 . . . . 0.0 109.912 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -87.57 141.28 28.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 109.682 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -88.95 -5.33 58.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.768 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 95.8 m-70 -122.91 129.86 52.12 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.43 161.41 30.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.458 -0.776 . . . . 0.0 109.801 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 64.8 p -128.47 158.46 38.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -144.92 154.89 43.07 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -143.69 132.62 22.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -88.06 117.75 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 0.0 108.596 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -39.68 91.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 110.069 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.82 154.81 20.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.86 -1.15 . . . . 0.0 109.982 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -94.35 143.81 26.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -0.855 . . . . 0.0 109.154 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' THR . 5.9 t -69.59 128.94 91.84 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.81 -1.75 5.5 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 N-CA-C 109.247 -1.097 . . . . 0.0 109.247 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -67.41 -72.69 0.16 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.04 148.09 34.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.03 159.36 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -69.76 -28.44 65.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.956 -1.09 . . . . 0.0 109.284 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.92 -39.53 85.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -84.65 -29.21 25.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 110.502 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -71.26 -50.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.907 -1.121 . . . . 0.0 110.369 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 38.0 p-10 -56.26 -38.71 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.3 t60 -59.98 -48.14 82.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.81 90.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.08 -43.15 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.25 -40.37 90.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.753 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.59 -40.02 95.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.31 -0.869 . . . . 0.0 110.522 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.29 83.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.863 -1.148 . . . . 0.0 110.405 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -59.75 -40.72 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.087 . . . . 0.0 110.121 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -60.32 -41.74 94.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.87 -41.89 96.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.38 -0.825 . . . . 0.0 110.866 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -70.33 -41.9 72.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.914 -1.116 . . . . 0.0 110.42 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.5 t -70.78 -27.43 63.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.107 -0.996 . . . . 0.0 110.881 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.69 86.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 111.163 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.477 HG23 HG23 ' A' ' 45' ' ' THR . 32.8 m -103.49 17.52 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.141 -0.974 . . . . 0.0 110.584 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.477 HG23 HG23 ' A' ' 44' ' ' VAL . 71.7 p -148.32 147.59 26.27 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.055 -1.028 . . . . 0.0 109.439 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.19 4.74 1.78 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 121.182 1.255 . . . . 0.0 109.511 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.73 148.14 42.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.943 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.768 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.1 p -129.99 144.95 51.61 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -125.68 127.13 45.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.808 . . . . 0.0 109.744 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -120.41 130.08 54.2 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.574 -0.704 . . . . 0.0 110.079 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -76.11 139.6 41.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.341 -0.849 . . . . 0.0 109.474 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -126.09 133.96 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.454 -0.779 . . . . 0.0 109.091 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -93.1 -8.13 43.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.157 -0.964 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -145.55 157.88 43.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.0 109.943 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 167.52 43.63 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -83.59 134.77 34.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -1.145 . . . . 0.0 109.121 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.48 148.23 27.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.419 -0.8 . . . . 0.0 109.336 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -60.01 -40.28 88.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -111.02 113.08 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 0.0 109.593 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 mtp -103.93 134.34 47.38 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.68 129.86 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.483 -0.761 . . . . 0.0 109.414 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -149.6 169.34 21.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -116.08 139.64 50.09 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.9 162.06 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.344 -0.848 . . . . 0.0 110.368 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -130.35 143.82 51.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.691 -0.631 . . . . 0.0 109.664 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.35 -146.17 3.27 Favored Glycine 0 N--CA 1.493 2.468 0 O-C-N 121.392 -0.817 . . . . 0.0 111.068 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -68.99 130.01 41.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.85 -0.794 . . . . 0.0 109.917 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 5.1 p-80 -132.97 57.2 1.81 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.564 -0.71 . . . . 0.0 109.264 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 86.0 mtm180 55.41 49.7 16.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 88.1 m-20 -140.05 160.49 39.81 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -90.74 7.62 38.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.154 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 m -135.07 69.96 69.97 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 109.82 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.11 158.86 41.69 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 121.272 1.315 . . . . 0.0 110.215 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.09 150.56 38.8 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.38 -0.825 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -135.7 76.24 1.6 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 68.5 -177.85 24.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.02 2.46 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.792 1.661 . . . . 0.0 110.076 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -90.99 169.85 34.01 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.58 -166.07 51.96 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -70.43 150.32 46.34 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.283 -1.128 . . . . 0.0 108.509 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.49 -6.11 57.81 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.18 177.14 2.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -165.83 163.5 18.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 163.24 36.06 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -92.65 162.06 14.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.158 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -63.45 148.98 92.85 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.0 109.341 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 105.38 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.258 1.305 . . . . 0.0 110.554 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.73 168.06 40.42 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -176.96 0.18 Allowed 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.37 1.38 . . . . 0.0 109.978 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.49 -128.72 38.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.94 -9.31 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -1.109 . . . . 0.0 110.357 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.23 142.57 44.59 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.11 -17.53 46.31 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -67.47 130.0 41.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.97 -1.312 . . . . 0.0 110.175 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 123.55 48.26 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.437 -0.79 . . . . 0.0 109.583 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -107.66 129.78 54.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.369 -0.832 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -110.3 138.55 46.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.489 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -70.15 101.84 1.94 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.554 -0.716 . . . . 0.0 109.73 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.8 -8.98 59.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.367 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -76.65 -15.05 59.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.793 -1.192 . . . . 0.0 109.307 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -88.43 166.36 14.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.773 . . . . 0.0 109.842 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -88.94 109.96 20.69 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -92.66 133.2 36.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.3 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.9 p -136.92 164.11 29.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.762 . . . . 0.0 109.104 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.69 32.14 6.32 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 109.603 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.4 p30 -150.18 -165.03 2.16 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.106 -0.996 . . . . 0.0 110.855 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 108' ' ' ARG . 90.7 m-85 -66.17 5.67 0.5 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.483 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.5 mmt-85 -57.11 -160.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.994 -1.067 . . . . 0.0 110.647 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -50.01 -59.96 3.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.014 -1.054 . . . . 0.0 111.216 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' O ' ' OG1' ' A' ' 104' ' ' THR . 87.1 m-85 -138.3 145.3 41.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.03 -1.044 . . . . 0.0 109.846 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.73 HD22 ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -95.89 122.24 38.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 108.512 178.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -58.62 -36.89 74.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.587 -0.696 . . . . 0.0 110.603 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -58.76 -49.32 78.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.058 -1.027 . . . . 0.0 111.986 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.571 HH12 ' C ' ' A' ' 141' ' ' THR . 70.4 ttt180 -60.19 -40.37 89.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.266 -1.521 . . . . 0.0 110.193 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 54.4 t -69.73 -40.16 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.86 -1.15 . . . . 0.0 109.093 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.4 74.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.0 108.473 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.38 84.31 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.381 -0.825 . . . . 0.0 109.061 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -58.91 -49.52 77.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 110.128 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 18.2 mp0 -62.8 -39.93 95.78 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.643 -1.285 . . . . 0.0 108.703 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.82 -37.76 87.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.476 -0.765 . . . . 0.0 108.994 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.07 96.21 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -69.46 -39.28 77.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -1.101 . . . . 0.0 109.563 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.0 p -58.76 -26.58 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.89 -3.16 58.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.186 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.77 76.09 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.66 150.0 36.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.725 -1.456 . . . . 0.0 109.124 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -109.62 158.09 18.4 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.438 -0.789 . . . . 0.0 109.893 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -52.24 172.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.415 -0.803 . . . . 0.0 110.116 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.0 t -148.79 160.6 43.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.323 -0.861 . . . . 0.0 109.37 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -94.25 3.66 54.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.371 -0.831 . . . . 0.0 110.259 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -81.47 121.98 26.95 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.047 -1.033 . . . . 0.0 109.25 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -38.4 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.61 -0.681 . . . . 0.0 109.864 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.14 4.5 8.2 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.614 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.22 138.34 33.05 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.927 -1.337 . . . . 0.0 109.531 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' TYR . 67.3 mt -69.98 -31.4 69.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 108.993 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.77 12.11 0.55 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.524 -0.735 . . . . 0.0 109.552 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 23.2 t80 -64.36 136.15 96.64 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.8 -39.7 79.35 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 121.162 1.241 . . . . 0.0 111.88 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.3 m -85.42 133.38 34.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.634 -1.291 . . . . 0.0 110.588 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -73.03 132.58 43.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.529 -0.732 . . . . 0.0 109.33 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.571 ' C ' HH12 ' A' ' 114' ' ' ARG . 27.0 p -155.74 71.26 0.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 108.878 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.403 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 73.9 t80 -77.44 138.37 39.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.177 -0.952 . . . . 0.0 110.457 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.0 p -171.33 141.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.38 -124.27 12.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' NE2' ' A' ' 147' ' ' GLN . 41.7 p-10 -123.12 168.62 12.15 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.529 -0.983 . . . . 0.0 109.369 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.66 112.95 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 0.0 109.202 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.516 ' NE2' ' OD2' ' A' ' 145' ' ' ASP . 50.4 mt-30 -133.19 150.98 51.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.05 152.04 40.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.315 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.31 162.82 12.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.0 -40.2 84.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 108.876 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.72 -41.18 90.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.16 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -76.13 -41.64 49.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.817 -1.177 . . . . 0.0 110.005 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.55 -49.93 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.746 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.41 -40.2 90.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.846 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.38 -50.84 63.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.195 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -69.64 -37.19 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.033 -1.275 . . . . 0.0 109.661 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -69.01 -39.95 78.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.144 -0.972 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.91 89.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.973 -1.079 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.75 -48.15 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -100.81 -56.75 2.25 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.106 -0.996 . . . . 0.0 110.215 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.63 174.04 33.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.93 145.92 24.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -1.14 . . . . 0.0 109.181 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.7 m -73.89 94.3 2.29 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.89 135.21 54.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.834 0.826 . . . . 0.0 110.082 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 167' ' ' VAL . 14.3 m120 -153.74 151.43 25.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.82 100.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 120.681 0.921 . . . . 0.0 110.401 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 165' ' ' ASN . 16.6 t -89.97 120.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.323 -0.861 . . . . 0.0 108.937 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 64.6 mm-40 -103.79 -30.18 0.21 Allowed Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.243 -0.911 . . . . 0.0 112.086 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 4.7 Cg_exo . . . . . 0 CA--C 1.535 0.547 0 CA-C-O 117.969 -0.93 . . . . 0.0 109.71 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 tp -69.47 135.67 50.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.1 p -95.91 153.1 17.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.158 -0.964 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.17 139.6 56.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.032 -1.042 . . . . 0.0 108.633 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.12 -156.14 48.54 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.406 ' CG ' ' OE1' ' A' ' 86' ' ' GLN . 7.2 m-80 -76.28 149.83 82.25 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.107 -1.231 . . . . 0.0 109.309 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.74 136.03 69.79 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -88.6 168.16 12.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 108.515 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.08 123.68 21.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.966 -1.084 . . . . 0.0 109.956 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -78.56 -18.08 55.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -87.06 143.18 27.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.026 -1.047 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.6 p -89.32 -4.49 58.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -127.87 141.09 51.66 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.7 mt -134.03 158.65 43.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.641 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.5 p -128.49 156.4 43.31 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -146.44 158.66 43.92 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.063 -1.023 . . . . 0.0 109.981 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 51' ' ' LYS . 46.1 ttt-85 -142.79 135.58 27.98 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.677 -0.639 . . . . 0.0 110.359 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' H ' ' HZ2' ' A' ' 51' ' ' LYS . 96.6 mt -94.42 120.91 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.366 -0.834 . . . . 0.0 108.864 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.35 -39.9 89.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.811 -1.18 . . . . 0.0 110.527 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -163.93 166.08 22.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.807 -1.183 . . . . 0.0 110.376 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.41 140.19 40.74 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -79.21 144.56 62.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.899 -1.126 . . . . 0.0 109.185 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -62.76 -1.58 2.79 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 N-CA-C 109.38 -1.046 . . . . 0.0 109.38 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 22' ' ' THR . 98.0 m-20 -64.27 -40.09 95.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.897 . . . . 0.0 109.387 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -143.51 150.53 51.43 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.232 -0.917 . . . . 0.0 109.158 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.06 163.41 19.72 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 120.955 1.103 . . . . 0.0 109.334 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -69.4 -30.05 67.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 109.842 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.03 86.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 110.534 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.7 -31.97 36.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 64.0 t -70.32 -42.77 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.11 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.37 -42.95 92.82 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.0 109.546 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -62.16 -48.06 81.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.37 -0.831 . . . . 0.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -48.08 83.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 110.467 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.05 -44.46 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.66 -1.275 . . . . 0.0 109.327 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -60.46 -41.16 93.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -62.59 -40.58 97.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.286 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.19 70.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.056 . . . . 0.0 110.877 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -59.27 -40.36 85.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.802 -1.186 . . . . 0.0 109.378 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.97 -41.09 95.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.893 -1.13 . . . . 0.0 110.511 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.88 -41.6 91.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.894 -1.129 . . . . 0.0 109.927 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 97.4 m95 -70.59 -40.25 73.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.858 -1.151 . . . . 0.0 109.264 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.4 t -69.86 -29.48 66.72 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.129 -0.982 . . . . 0.0 110.059 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.01 -33.97 72.72 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.867 . . . . 0.0 110.687 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -106.94 10.25 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.358 -0.839 . . . . 0.0 110.962 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.2 p -148.15 147.91 27.71 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.765 -1.209 . . . . 0.0 109.255 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.78 8.26 0.47 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.071 1.181 . . . . 0.0 110.024 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 97.3 mt -73.73 147.37 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.967 -1.083 . . . . 0.0 109.308 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.8 p -129.07 141.6 51.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.55 133.33 55.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.517 -0.739 . . . . 0.0 109.071 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.873 0.844 . . . . 0.0 110.808 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.55 ' HZ2' ' H ' ' A' ' 18' ' ' ILE . 46.7 tptt -80.4 133.62 35.92 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.741 -0.599 . . . . 0.0 109.773 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.51 134.45 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -91.84 -2.28 56.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 110.77 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -161.93 165.13 27.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.065 . . . . 0.0 109.232 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.3 166.6 42.12 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -82.47 139.64 33.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.991 -1.3 . . . . 0.0 109.325 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.92 154.5 23.0 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.703 -0.623 . . . . 0.0 109.424 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.87 -40.27 88.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.178 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.31 116.2 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mmm -101.93 135.22 43.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.133 -0.98 . . . . 0.0 109.196 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.24 130.08 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.8 p -147.1 158.58 43.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 110.009 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.92 134.13 52.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.4 167.02 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.131 -0.981 . . . . 0.0 110.955 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.05 145.06 50.09 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.69 -0.632 . . . . 0.0 110.194 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.22 -141.91 0.74 Allowed Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -75.09 132.2 41.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.494 -1.004 . . . . 0.0 110.06 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.557 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 23.6 p-80 -134.69 59.76 1.72 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.433 -0.792 . . . . 0.0 109.696 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.9 mtt-85 54.31 50.11 17.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.49 -0.757 . . . . 0.0 110.692 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.557 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 87.3 m-20 -140.18 166.46 24.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 109.007 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -90.1 10.31 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.01 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.7 t -135.83 64.75 57.64 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.167 -0.958 . . . . 0.0 110.312 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.78 141.32 89.95 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.628 1.552 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -76.74 151.5 36.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -134.98 77.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 73.77 177.68 35.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.59 5.05 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.304 1.336 . . . . 0.0 109.695 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -88.75 171.01 38.94 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.73 -163.99 54.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -71.15 154.1 41.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -1.136 . . . . 0.0 109.676 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.45 -9.81 48.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.13 -0.981 . . . . 0.0 109.0 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.88 175.19 2.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -163.85 169.38 18.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.045 -1.034 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 162.04 38.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -94.56 168.8 10.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' OE1' ' CG ' ' A' ' 6' ' ' ASN . 64.5 mm-40 -69.98 150.28 96.31 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.568 -0.707 . . . . 0.0 109.212 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.87 103.7 0.17 Allowed 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 121.317 1.345 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.6 166.18 38.34 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.93 -172.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.532 1.488 . . . . 0.0 109.668 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.99 -129.74 44.12 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.07 -4.23 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.487 -1.007 . . . . 0.0 110.322 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.89 140.92 47.17 Favored Glycine 0 N--CA 1.495 2.628 0 O-C-N 120.893 -1.129 . . . . 0.0 110.312 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.23 54.16 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 158.0 34.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.274 -1.133 . . . . 0.0 110.858 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.21 118.85 10.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.449 -0.782 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -103.82 136.82 42.78 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.629 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.6 142.69 40.36 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.538 0.685 . . . . 0.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -68.01 102.4 1.29 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 0.0 109.446 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -74.7 -12.12 60.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.121 -0.987 . . . . 0.0 110.46 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.07 -20.08 58.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.919 -1.113 . . . . 0.0 109.786 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -85.87 152.85 22.66 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.481 -0.762 . . . . 0.0 109.258 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' NH1' HG22 ' A' ' 104' ' ' THR . 31.4 ttt-85 -91.67 116.54 28.96 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.919 -1.113 . . . . 0.0 109.26 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -89.36 138.65 31.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.5 -0.75 . . . . 0.0 109.982 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.456 HG22 ' NH1' ' A' ' 102' ' ' ARG . 27.5 p -134.19 162.52 31.92 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.336 -0.853 . . . . 0.0 110.363 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -121.27 31.96 6.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.674 -0.641 . . . . 0.0 109.642 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.778 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.34 -164.97 2.1 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 109.829 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -64.11 6.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 111.691 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.636 ' CG ' HD21 ' A' ' 106' ' ' ASN . 28.2 mmt180 -60.43 -165.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 111.304 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.84 -57.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -124.3 141.05 52.38 Favored 'General case' 0 N--CA 1.514 2.734 0 O-C-N 120.779 -1.2 . . . . 0.0 112.122 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.12 114.64 26.9 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.68 -40.44 87.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 110.952 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -59.16 -46.65 87.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.767 -1.208 . . . . 0.0 110.762 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 141' ' ' THR . 55.6 ttt180 -63.09 -40.36 97.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.008 -1.057 . . . . 0.0 111.218 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.9 -41.36 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.87 -1.144 . . . . 0.0 109.578 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -0.961 . . . . 0.0 108.685 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.6 -43.1 93.82 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.437 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 36.8 t60 -59.85 -44.09 94.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.622 -0.674 . . . . 0.0 109.499 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -60.16 -40.19 89.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.33 -39.04 91.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.315 -0.866 . . . . 0.0 109.559 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.64 -41.2 73.36 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.27 -39.14 86.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -1.169 . . . . 0.0 109.435 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -59.72 -33.69 71.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 109.296 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.0 -4.42 49.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.95 . . . . 0.0 109.131 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.99 11.65 63.04 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.5 mt -78.62 145.38 34.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.325 . . . . 0.0 109.134 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.0 m -105.92 162.99 13.09 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.498 -0.751 . . . . 0.0 109.734 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -55.72 170.21 0.29 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.268 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -145.94 159.22 43.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 109.08 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -95.14 3.36 54.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.26 -0.9 . . . . 0.0 110.636 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -84.51 128.15 34.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.809 -1.182 . . . . 0.0 109.747 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.02 -39.81 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.038 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.18 6.2 4.34 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.77 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.96 139.52 32.86 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.018 -1.283 . . . . 0.0 110.23 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.4 mt -68.01 -37.63 81.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.465 -0.772 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.437 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 46.0 mtp -72.34 23.47 0.05 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.721 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.4 t80 -63.78 138.84 97.5 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.929 -1.107 . . . . 0.0 108.173 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.57 -44.03 35.0 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 121.196 1.264 . . . . 0.0 111.272 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.2 t -85.51 133.59 34.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 110.367 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.66 143.38 49.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.604 -0.685 . . . . 0.0 109.779 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 44.6 p -147.59 148.11 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -82.82 131.96 35.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.04 -1.038 . . . . 0.0 110.104 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 26.3 t -118.21 130.03 55.84 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.56 -42.37 99.14 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -126.61 136.62 52.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.68 -0.894 . . . . 0.0 108.824 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -96.36 111.83 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.257 -0.902 . . . . 0.0 109.132 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -139.07 154.67 48.21 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.343 -0.848 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.18 148.02 42.05 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.207 -0.933 . . . . 0.0 108.993 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.13 163.22 13.02 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.133 -0.979 . . . . 0.0 108.712 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.99 -39.9 83.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.403 -0.811 . . . . 0.0 109.451 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -59.24 -40.6 86.41 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.966 -1.084 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.77 -40.34 63.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.813 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.03 -50.3 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.709 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.74 -53.44 41.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.148 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -69.42 -40.19 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.686 -1.479 . . . . 0.0 109.705 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.0 mt-30 -66.15 -38.84 89.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 108.945 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.53 91.03 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 109.612 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.08 -47.5 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.951 -1.093 . . . . 0.0 110.018 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.6 -62.51 1.23 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.135 -0.978 . . . . 0.0 109.64 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.58 -178.41 30.57 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -90.83 147.45 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -1.182 . . . . 0.0 108.948 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 64.3 m -74.99 54.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -77.66 58.02 1.73 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.477 -0.765 . . . . 0.0 110.195 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -154.97 68.3 5.44 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.47 67.85 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.705 1.604 . . . . 0.0 109.418 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.82 138.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -79.79 151.28 73.66 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.326 -0.648 0 C-N-CA 121.125 1.216 . . . . 0.0 109.54 179.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.295 0.569 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.99 140.22 52.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.4 ' H ' ' HG3' ' A' ' 7' ' ' PRO . 40.8 p -92.78 146.48 23.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.27 -0.894 . . . . 0.0 109.407 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.99 134.77 48.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.097 -1.002 . . . . 0.0 109.428 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.78 -99.29 0.81 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 8' ' ' ARG . 12.9 m120 -157.56 78.84 3.53 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.242 -1.152 . . . . 0.0 109.546 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HG3' ' H ' ' A' ' 3' ' ' THR . 1.4 Cg_endo -63.55 60.68 0.2 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.402 1.401 . . . . 0.0 109.865 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 6' ' ' ASN . 99.2 mtt180 -144.92 137.95 26.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.149 . . . . 0.0 109.027 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -68.28 137.32 54.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.258 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -73.16 -34.89 66.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 109.835 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 16.6 mp0 -87.84 147.74 24.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 0.0 110.608 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.5 p -91.41 -4.79 55.3 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 33.5 m80 -117.63 130.02 56.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.55 161.59 28.43 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.441 -0.787 . . . . 0.0 108.895 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.2 p -129.71 159.11 37.49 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.69 154.74 42.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 37.9 ttm180 -144.94 136.79 25.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.594 -0.691 . . . . 0.0 109.499 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.59 118.97 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.017 -1.052 . . . . 0.0 108.445 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.7 tt0 -65.86 -40.0 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.158 -0.964 . . . . 0.0 109.953 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.8 m-20 -160.07 154.86 24.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.146 -0.971 . . . . 0.0 109.982 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.96 130.82 47.02 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' THR . 2.0 t -71.12 138.76 84.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 109.239 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -65.02 0.36 2.65 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 120.794 0.996 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -64.16 -40.05 95.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 109.684 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -140.84 150.13 58.67 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.88 155.1 29.05 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 27' ' ' ARG . 17.4 ptt-85 -68.66 -29.99 68.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.13 88.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -0.817 . . . . 0.0 110.049 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -77.89 -35.73 50.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.05 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.02 -41.79 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.003 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.4 -43.77 88.74 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.018 -1.051 . . . . 0.0 109.37 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.33 -44.64 95.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.337 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.3 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.408 -0.808 . . . . 0.0 109.822 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.19 -44.62 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.277 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.06 -42.4 94.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.331 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -63.63 -39.98 95.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.293 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.15 78.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.971 -1.081 . . . . 0.0 110.368 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -59.77 -39.96 86.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.878 -1.139 . . . . 0.0 109.126 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.825 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.05 -43.41 95.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.985 -1.072 . . . . 0.0 109.842 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -72.91 -39.99 65.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 t -69.9 -38.74 76.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.308 -0.87 . . . . 0.0 110.815 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -51.39 -28.1 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.932 . . . . 0.0 111.089 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.9 11.06 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 O-C-N 121.041 -1.037 . . . . 0.0 111.187 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 47' ' ' LEU . 5.3 p -148.49 151.47 36.39 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 120.818 -1.176 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.87 8.41 0.59 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.084 1.19 . . . . 0.0 109.514 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.9 mt -73.3 145.29 46.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.665 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 34.2 p -129.97 142.58 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -122.12 127.99 50.76 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.3 m -121.09 129.98 53.55 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -77.94 135.46 37.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.083 -1.011 . . . . 0.0 108.58 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' HE ' ' A' ' 17' ' ' ARG . 33.9 m -122.49 132.99 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.344 -0.847 . . . . 0.0 109.569 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 t -92.44 -10.97 36.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.373 -0.829 . . . . 0.0 109.815 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 12.9 pt-20 -150.05 163.44 38.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.022 -1.049 . . . . 0.0 110.303 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.527 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 90.52 -170.56 35.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -86.45 125.45 33.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.155 -1.203 . . . . 0.0 109.454 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.8 131.2 46.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.089 -1.007 . . . . 0.0 108.702 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.08 -41.73 93.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.636 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.11 117.73 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.3 mtt -102.58 135.3 44.46 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -116.56 130.01 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -145.39 159.96 42.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.085 -1.009 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -110.28 130.97 55.45 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.5 162.78 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.353 -0.842 . . . . 0.0 110.976 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -120.37 142.03 49.54 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.566 0.698 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.66 -146.85 2.38 Favored Glycine 0 N--CA 1.496 2.68 0 O-C-N 121.564 -0.71 . . . . 0.0 111.358 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.21 129.21 39.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.577 -0.954 . . . . 0.0 109.836 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.474 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 8.3 p-80 -131.24 53.03 2.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.643 -0.661 . . . . 0.0 109.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 54.2 54.86 8.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.441 -0.787 . . . . 0.0 109.742 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.3 p-10 -142.51 170.45 15.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.124 -0.985 . . . . 0.0 109.38 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.07 9.0 26.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.158 -0.964 . . . . 0.0 109.461 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.9 t -136.37 68.94 61.74 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.446 -0.783 . . . . 0.0 109.483 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.25 128.17 17.96 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.424 1.416 . . . . 0.0 109.326 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -73.43 141.56 46.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.062 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -139.72 79.93 1.74 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.66 179.74 51.6 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.24 1.0 1.05 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.586 1.524 . . . . 0.0 109.765 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -89.16 169.88 36.88 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.99 -172.36 55.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -71.44 156.11 39.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -1.137 . . . . 0.0 109.215 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.4 mt -90.16 -10.61 43.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.49 179.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -0.768 . . . . 0.0 109.03 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -166.9 169.83 12.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.629 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.76 160.22 41.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.309 -0.869 . . . . 0.0 109.493 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -94.06 167.6 11.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.641 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -62.61 145.14 95.54 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.074 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.35 103.24 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.985 1.123 . . . . 0.0 109.542 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.48 169.35 42.24 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.132 -1.509 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -178.5 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 122.032 1.821 . . . . 0.0 110.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.22 -125.38 35.87 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -86.88 -9.85 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.323 -1.104 . . . . 0.0 110.106 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.92 139.39 47.41 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.14 -20.92 30.55 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 121.322 -1.105 . . . . 0.0 110.419 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.12 155.61 23.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.928 -1.337 . . . . 0.0 109.716 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.21 123.49 18.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 109.414 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -108.16 136.68 47.43 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 0.0 110.09 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 48.1 m-85 -110.9 141.17 44.66 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.647 -0.658 . . . . 0.0 110.042 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.62 99.4 0.59 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.777 . . . . 0.0 109.109 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -77.73 -8.86 58.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.775 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -75.89 -24.63 55.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.669 -1.269 . . . . 0.0 109.333 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.28 164.64 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -93.37 119.02 32.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 109.701 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -92.64 136.11 33.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.18 -0.95 . . . . 0.0 109.331 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 66.8 p -131.19 164.05 26.39 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.453 -0.779 . . . . 0.0 109.71 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -115.71 32.56 6.01 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.5 p30 -146.96 -161.18 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.165 -0.959 . . . . 0.0 110.526 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.9 p90 -74.34 5.24 4.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.224 -0.922 . . . . 0.0 110.602 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 107' ' ' PHE . 56.8 mtt-85 -56.79 -161.43 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.897 -1.127 . . . . 0.0 110.621 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.82 -59.36 3.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 112.633 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.59 ' C ' HD22 ' A' ' 111' ' ' ASN . 92.8 m-85 -134.74 149.02 50.4 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 111.347 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.644 ' N ' HD22 ' A' ' 111' ' ' ASN . 1.3 m120 -104.1 116.51 32.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.02 -41.51 92.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.169 -0.957 . . . . 0.0 111.356 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -59.99 -45.34 93.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.768 -1.208 . . . . 0.0 110.254 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 143' ' ' SER . 61.4 mtt-85 -60.22 -42.97 96.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.84 -1.163 . . . . 0.0 109.75 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -71.58 -40.06 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.062 . . . . 0.0 108.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -49.95 75.52 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.304 -0.872 . . . . 0.0 108.955 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.37 73.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.386 -0.821 . . . . 0.0 109.338 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -60.04 -44.96 94.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.162 -0.961 . . . . 0.0 109.177 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.6 mt-10 -62.27 -39.95 94.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -62.15 -39.44 92.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 108.649 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.14 -44.45 83.78 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -66.09 -37.84 86.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -1.166 . . . . 0.0 109.19 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.9 m -60.06 -36.85 78.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.385 -0.822 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.49 -1.38 37.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.426 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.02 13.18 69.6 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.925 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.14 144.62 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.722 -1.457 . . . . 0.0 108.844 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 54.3 m -102.58 168.99 8.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.345 -0.847 . . . . 0.0 109.668 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -62.2 170.86 2.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -150.6 161.58 42.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 109.531 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 78.9 p -96.43 8.61 43.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.302 -0.874 . . . . 0.0 110.062 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -84.1 120.69 26.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 109.682 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.06 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.448 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.03 4.59 5.62 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.854 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.35 138.7 33.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.988 -1.301 . . . . 0.0 109.718 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 137' ' ' TYR . 79.7 mt -70.01 -27.28 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.563 -0.711 . . . . 0.0 110.085 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.4 mmm -71.99 17.61 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.267 -0.896 . . . . 0.0 110.535 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 135' ' ' LEU . 17.3 t80 -65.07 135.08 96.18 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.742 -1.223 . . . . 0.0 108.967 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.17 -42.71 63.46 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 121.082 1.188 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.4 t -84.97 140.8 30.8 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.807 -1.183 . . . . 0.0 110.628 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -69.8 144.11 52.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 p -149.99 135.76 18.47 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.169 -0.957 . . . . 0.0 109.231 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.46 130.05 34.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.401 -0.812 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.477 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 29.7 t -121.23 140.05 52.56 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.54 -42.39 97.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -132.18 149.11 52.47 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.343 -1.092 . . . . 0.0 109.245 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.34 110.0 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -138.83 151.92 47.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.324 -0.86 . . . . 0.0 109.617 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.13 151.8 36.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.32 165.59 11.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.179 -0.95 . . . . 0.0 109.793 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -59.15 -40.11 84.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.656 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -77.06 -41.98 40.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.062 -1.024 . . . . 0.0 109.621 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.69 -50.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -60.01 -40.04 87.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.354 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.17 44.14 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.205 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.89 -39.32 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.816 -1.402 . . . . 0.0 109.768 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -68.01 -38.76 82.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -0.964 . . . . 0.0 109.057 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.28 88.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 0.0 109.686 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.03 -49.28 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.009 . . . . 0.0 109.639 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -96.3 -67.61 0.84 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.0 109.746 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.75 179.28 33.48 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -90.41 146.15 24.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -1.133 . . . . 0.0 109.007 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -74.1 66.04 1.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.398 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -71.37 135.76 47.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.56 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.54 68.85 6.48 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.42 130.47 26.88 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.577 1.518 . . . . 0.0 110.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.41 137.81 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.37 150.0 69.85 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.219 -0.925 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 C--N 1.325 -0.68 0 C-N-CA 120.945 1.097 . . . . 0.0 109.765 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.82 147.08 45.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 109.377 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 p -97.51 128.32 44.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.225 -0.922 . . . . 0.0 109.333 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.81 146.0 49.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 0.0 109.665 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.1 -52.19 1.25 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 8' ' ' ARG . 72.4 m-80 -158.51 79.78 3.03 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.999 -1.295 . . . . 0.0 110.436 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.84 37.84 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.254 1.303 . . . . 0.0 109.626 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -149.33 161.18 42.58 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -64.5 129.35 39.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.894 -1.129 . . . . 0.0 108.621 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.13 -24.54 51.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 109.722 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -82.57 149.07 27.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.784 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -92.15 -4.35 54.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.91 . . . . 0.0 108.959 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 32.0 m170 -124.1 138.84 54.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.52 160.01 36.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.3 p -127.99 159.15 35.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.641 -0.662 . . . . 0.0 109.325 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -146.54 154.64 41.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.188 -0.945 . . . . 0.0 109.771 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.58 HH22 ' C ' ' A' ' 54' ' ' GLU . 40.7 ttm180 -147.49 135.82 21.6 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.78 124.82 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.188 -0.945 . . . . 0.0 108.946 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -66.25 -40.01 89.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.709 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -162.45 157.34 22.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.776 -1.202 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.73 130.14 54.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.66 -0.65 . . . . 0.0 109.54 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 22' ' ' THR . 1.1 t -76.15 144.56 75.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 108.871 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.34 -0.66 4.49 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 N-CA-C 109.496 -1.001 . . . . 0.0 109.496 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.84 -40.06 96.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.2 mt -138.17 147.98 58.06 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.32 144.61 90.75 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 120.917 1.078 . . . . 0.0 109.549 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.5 -33.19 74.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 109.592 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.96 87.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.423 -0.798 . . . . 0.0 110.19 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -78.78 -27.76 44.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.057 -1.027 . . . . 0.0 109.858 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -43.83 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -60.02 -40.77 90.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.987 -1.07 . . . . 0.0 108.975 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.15 -43.25 95.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.263 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.87 76.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.436 -0.79 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.2 -45.31 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -0.9 . . . . 0.0 109.538 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.08 -43.34 95.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 109.956 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.47 -40.13 93.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.307 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.15 -50.49 71.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.972 -1.08 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 39.4 m-85 -59.9 -40.09 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.856 -1.153 . . . . 0.0 109.706 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.02 -40.37 89.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.08 -42.4 94.54 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.03 -1.044 . . . . 0.0 108.88 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -73.27 -40.0 64.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.6 t -68.17 -39.95 82.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -52.78 -29.87 29.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.943 . . . . 0.0 110.442 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.24 10.44 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.924 . . . . 0.0 110.56 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.5 p -146.75 149.85 37.74 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 0.0 109.419 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 3.69 2.14 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.08 1.187 . . . . 0.0 109.258 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.3 mt -74.4 146.35 43.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.0 p -130.3 143.55 50.84 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.6 m-85 -122.31 130.17 52.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.441 -0.787 . . . . 0.0 109.645 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.0 m -130.29 132.59 45.96 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.623 -0.673 . . . . 0.0 109.763 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -76.21 142.8 41.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.197 -0.94 . . . . 0.0 108.755 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 7.2 m -121.46 132.2 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.399 -0.813 . . . . 0.0 109.338 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -93.1 -6.95 46.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.58 ' C ' HH22 ' A' ' 17' ' ' ARG . 98.7 mt-10 -146.62 152.34 38.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.952 -1.092 . . . . 0.0 109.404 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 88.92 177.97 46.27 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -85.41 145.82 27.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.022 -1.281 . . . . 0.0 109.022 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.11 143.48 33.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.817 . . . . 0.0 108.919 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.08 -40.0 83.88 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.243 -0.911 . . . . 0.0 109.055 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.29 120.01 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.658 . . . . 0.0 109.531 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.5 mmm -99.78 128.11 45.9 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.433 -0.792 . . . . 0.0 109.413 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.96 129.97 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.396 -0.815 . . . . 0.0 108.996 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 59.6 p -149.12 158.32 44.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.052 . . . . 0.0 110.334 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.73 137.14 52.04 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -140.03 169.7 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 120.989 -1.069 . . . . 0.0 110.619 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -134.88 159.38 41.59 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.626 -0.671 . . . . 0.0 109.573 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.52 -159.99 0.46 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 60.9 t0 -69.66 130.04 41.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -1.092 . . . . 0.0 109.113 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 34.6 p-80 -130.43 63.64 1.56 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.461 -0.774 . . . . 0.0 109.74 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 52.89 50.71 17.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.517 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 11.2 t70 -142.64 159.51 42.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.37 -0.831 . . . . 0.0 109.239 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 69.4 m-80 -90.5 8.97 31.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.206 -0.934 . . . . 0.0 110.107 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 m -133.6 65.64 71.87 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.266 -0.896 . . . . 0.0 110.151 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.57 146.08 97.22 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.344 1.363 . . . . 0.0 109.776 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -75.52 149.4 38.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.108 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 9.9 t70 -133.52 72.61 1.48 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.372 -0.83 . . . . 0.0 109.927 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.93 -179.64 48.69 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -65.28 -4.88 10.08 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.712 1.608 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.66 179.59 35.84 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.98 -166.92 50.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.39 145.41 51.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -1.168 . . . . 0.0 109.549 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.6 mt -91.11 -5.89 54.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -0.887 . . . . 0.0 109.195 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.94 178.42 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.285 -0.884 . . . . 0.0 109.42 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -166.62 169.3 13.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.7 162.01 40.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.176 -0.953 . . . . 0.0 110.019 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.91 164.17 12.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.392 -0.818 . . . . 0.0 109.346 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -63.44 147.99 94.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.16 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.09 110.65 0.8 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.867 1.045 . . . . 0.0 109.458 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.92 167.94 40.88 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.257 -1.449 . . . . 0.0 110.209 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 121.903 1.735 . . . . 0.0 110.178 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.97 -128.58 45.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -82.14 -11.13 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -1.033 . . . . 0.0 110.271 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.15 144.06 28.87 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.92 -23.29 10.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.73 139.02 58.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.251 . . . . 0.0 109.52 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.5 127.44 52.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.557 -0.714 . . . . 0.0 109.233 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -109.6 130.46 55.51 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.44 -0.787 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -110.16 132.22 54.36 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.552 -0.718 . . . . 0.0 109.59 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -69.41 106.47 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 110.028 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -79.13 4.04 15.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.144 -0.973 . . . . 0.0 109.748 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.93 -39.23 69.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.632 -1.293 . . . . 0.0 108.984 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -82.98 161.17 21.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 108.63 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -86.95 124.74 33.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -92.23 135.33 34.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.479 -0.763 . . . . 0.0 109.677 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.7 p -131.34 162.4 30.17 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.0 109.027 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.59 30.32 7.21 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.82 -162.94 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 109.789 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.45 ' O ' ' O ' ' A' ' 108' ' ' ARG . 53.1 p90 -78.6 11.09 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.297 -0.877 . . . . 0.0 111.093 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' PHE . 57.7 mtt-85 -58.74 -156.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.009 -1.057 . . . . 0.0 109.699 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -47.56 -59.74 3.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.019 -1.051 . . . . 0.0 111.565 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.7 m-85 -137.52 144.58 42.23 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.799 -1.188 . . . . 0.0 111.155 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -96.07 115.93 28.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.389 -0.819 . . . . 0.0 108.9 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.9 -40.71 89.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -60.02 -48.47 81.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.096 -1.003 . . . . 0.0 110.566 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 40.1 ttm-85 -60.02 -43.09 95.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.976 -1.078 . . . . 0.0 110.255 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.04 -40.25 78.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.086 -1.009 . . . . 0.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.7 -40.41 87.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 108.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.9 84.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -60.16 -50.06 75.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 110.203 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 5.0 mp0 -63.6 -40.02 95.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.966 -1.084 . . . . 0.0 110.063 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 97.8 mt -63.14 -39.1 93.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.009 . . . . 0.0 109.0 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.26 -39.93 90.98 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -64.55 -39.98 94.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 109.188 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.0 t -60.1 -32.48 71.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.838 . . . . 0.0 109.24 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.41 -2.1 44.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 109.268 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.56 55.5 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.003 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.26 150.48 31.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.865 -1.373 . . . . 0.0 109.239 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -104.86 160.28 15.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 109.751 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -68.57 166.16 17.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.362 -0.836 . . . . 0.0 109.596 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 t -150.0 159.98 43.98 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 68.6 p -98.71 10.36 41.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.279 -0.888 . . . . 0.0 110.193 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -82.08 125.52 30.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.013 -1.054 . . . . 0.0 109.383 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.99 -39.94 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 109.877 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.8 3.54 5.06 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.678 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.15 135.78 39.32 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.969 -1.312 . . . . 0.0 109.488 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -68.61 -24.84 64.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -0.925 . . . . 0.0 108.516 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 64.2 mmm -71.31 -5.37 31.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.555 -0.715 . . . . 0.0 109.127 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 139' ' ' SER . 21.2 t80 -63.39 124.37 84.09 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 108.544 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -63.69 66.85 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 120.889 1.06 . . . . 0.0 110.835 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 137' ' ' TYR . 2.1 p -157.82 116.89 3.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.669 -1.269 . . . . 0.0 109.306 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -76.81 127.52 32.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.1 p -151.22 131.64 13.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.083 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -80.04 126.36 30.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -109.24 143.67 38.39 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.81 97.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -127.56 133.74 49.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.551 -0.97 . . . . 0.0 109.242 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -95.75 111.92 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.248 -0.908 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -138.62 156.95 47.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.396 -0.815 . . . . 0.0 109.423 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 156.88 37.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 108.743 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.4 162.06 13.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.92 -39.99 87.31 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 50.2 t0 -60.01 -40.08 88.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.545 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.07 -41.35 59.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -50.03 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.59 -40.07 90.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 110.209 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.55 -52.11 37.22 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.252 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -67.16 -39.96 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.855 -1.379 . . . . 0.0 109.696 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.6 mt-30 -67.48 -37.42 82.86 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.54 89.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 109.656 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.78 -50.06 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.133 -0.979 . . . . 0.0 109.836 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -96.97 -65.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 0.0 109.377 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 150.75 -168.72 30.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -92.1 143.38 26.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 m -76.74 87.51 3.37 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -71.34 121.14 17.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -157.53 70.74 4.33 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.442 -0.787 . . . . 0.0 109.136 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.61 111.34 1.86 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.424 1.416 . . . . 0.0 110.159 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -84.2 139.91 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -79.88 148.63 68.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 108.833 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 C--N 1.324 -0.734 0 C-N-CA 120.938 1.092 . . . . 0.0 109.757 179.882 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.81 140.1 55.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.033 -1.042 . . . . 0.0 108.843 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.7 p -93.37 143.1 26.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.68 139.12 53.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.375 -0.828 . . . . 0.0 109.626 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.21 -85.54 0.81 Allowed Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -158.66 151.23 17.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.228 -1.16 . . . . 0.0 109.199 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.42 126.78 23.38 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.993 1.128 . . . . 0.0 109.712 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -88.4 160.59 17.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.835 . . . . 0.0 109.88 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.37 133.37 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 108.696 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.62 -30.28 61.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.388 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -86.06 143.45 28.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.12 -0.987 . . . . 0.0 110.558 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -91.36 -5.64 54.21 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 55.7 m80 -121.2 130.06 53.52 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.2 mt -132.62 161.27 34.34 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.262 -0.899 . . . . 0.0 109.493 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.6 p -127.04 160.67 30.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -144.9 158.74 43.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.981 -1.075 . . . . 0.0 109.807 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -144.4 139.97 28.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.212 -0.93 . . . . 0.0 110.332 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.92 116.2 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -67.88 -40.1 83.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.974 -1.078 . . . . 0.0 110.038 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -163.67 159.14 21.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -101.84 127.87 48.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.369 -0.832 . . . . 0.0 109.702 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t -66.65 139.39 95.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -65.05 -0.23 3.15 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 120.676 0.917 . . . . 0.0 109.984 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.97 -40.07 94.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 0.0 109.828 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD13 ' ND2' ' A' ' 105' ' ' ASN . 91.7 mt -141.47 150.83 59.05 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.34 -0.85 . . . . 0.0 108.749 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.08 162.77 15.73 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.977 1.118 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -27.53 64.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 0.0 109.886 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.95 -38.19 81.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.178 -0.951 . . . . 0.0 110.322 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -86.83 -32.56 20.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.946 -1.096 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.7 t -70.1 -46.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.057 -1.027 . . . . 0.0 110.183 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 34.9 p-10 -57.57 -39.67 77.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.946 -1.096 . . . . 0.0 109.258 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.1 t60 -60.06 -44.73 94.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.058 . . . . 0.0 108.977 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.2 92.36 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.088 -1.008 . . . . 0.0 109.18 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.0 mm -72.95 -52.03 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -0.973 . . . . 0.0 109.953 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.99 -40.52 89.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.056 -1.027 . . . . 0.0 110.039 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.82 -39.99 95.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 110.421 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.05 81.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.016 -1.052 . . . . 0.0 110.462 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -59.86 -39.91 86.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.206 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.17 -43.55 95.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.948 . . . . 0.0 110.109 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 44' ' ' VAL . 89.3 mt -60.28 -41.92 94.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.069 -1.019 . . . . 0.0 110.318 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -70.84 -42.9 69.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.08 -1.013 . . . . 0.0 109.812 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 t -69.13 -40.11 78.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -55.04 -30.49 59.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.067 -1.021 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 40' ' ' LEU . 35.3 m -108.35 12.57 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -148.18 149.72 33.04 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.79 -1.194 . . . . 0.0 109.056 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.27 3.79 2.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 120.829 1.019 . . . . 0.0 109.69 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.16 149.79 38.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.096 -1.003 . . . . 0.0 109.358 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.54 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 25.6 p -130.96 145.99 52.22 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.436 -0.79 . . . . 0.0 109.221 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.96 130.57 51.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.513 -0.742 . . . . 0.0 109.678 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -119.95 129.92 54.54 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.694 0.759 . . . . 0.0 109.753 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -79.15 141.12 37.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.724 -0.61 . . . . 0.0 109.879 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' VAL . 34.2 m -123.07 130.02 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.2 t -90.12 -1.89 58.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -155.93 159.84 39.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.326 -0.859 . . . . 0.0 109.08 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.37 171.69 48.25 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.83 163.54 23.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -1.022 . . . . 0.0 109.539 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.26 44.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.801 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.91 -41.29 91.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.5 mt -112.42 112.82 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.787 . . . . 0.0 109.529 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 74.1 mtp -102.62 130.56 49.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.25 -0.906 . . . . 0.0 109.822 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -107.8 129.01 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.0 p -149.96 165.84 31.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.026 -1.046 . . . . 0.0 110.293 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.81 136.91 53.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.19 161.86 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 121.207 -0.933 . . . . 0.0 110.973 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -126.74 145.76 50.48 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.77 -0.581 . . . . 0.0 109.616 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.86 -149.76 0.18 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.45 133.44 55.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.596 -0.944 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 4.9 p-80 -138.13 54.15 1.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.367 -0.833 . . . . 0.0 110.041 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 98.1 mtt180 54.37 49.77 17.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.31 -0.869 . . . . 0.0 110.104 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -141.83 164.0 31.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.41 -0.806 . . . . 0.0 109.02 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -89.56 9.14 27.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -133.47 69.2 77.09 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.33 -0.856 . . . . 0.0 110.197 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.3 139.23 53.99 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.351 1.367 . . . . 0.0 109.155 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -76.46 150.35 36.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.072 -1.017 . . . . 0.0 108.881 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -139.34 77.37 1.61 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.275 -0.89 . . . . 0.0 109.635 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.22 179.1 50.8 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -1.65 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.585 1.524 . . . . 0.0 109.671 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.24 177.6 44.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.21 54.28 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -71.56 149.55 45.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -1.115 . . . . 0.0 109.233 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.16 -3.27 55.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 109.052 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.4 172.71 2.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.043 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.76 165.87 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.062 -1.023 . . . . 0.0 109.328 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.52 165.54 28.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.29 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -94.75 160.67 14.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.197 -0.94 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.99 149.48 98.17 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.094 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.55 103.75 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.021 1.148 . . . . 0.0 109.825 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 165.78 34.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.07 174.19 2.67 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.374 1.382 . . . . 0.0 109.822 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.64 -129.08 27.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.9 -8.64 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -1.091 . . . . 0.0 110.167 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.9 138.15 47.82 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.311 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -18.25 49.26 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.84 129.98 41.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.876 -1.367 . . . . 0.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.65 132.15 46.19 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.451 -0.781 . . . . 0.0 109.574 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -116.43 137.82 51.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.507 -0.746 . . . . 0.0 109.279 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 28.5 m-85 -116.03 135.51 53.89 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.51 -0.744 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.91 106.72 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.964 . . . . 0.0 109.221 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -75.5 -1.64 25.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.868 . . . . 0.0 110.105 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.26 -37.45 63.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.627 -1.296 . . . . 0.0 110.223 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 55.7 mp0 -81.16 154.81 26.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.922 -1.111 . . . . 0.0 109.787 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 102' ' ' ARG . 0.9 OUTLIER -91.41 119.89 31.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -87.9 147.72 24.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.819 . . . . 0.0 110.378 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -131.95 168.85 17.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.716 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -109.9 26.54 10.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.684 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -145.36 -165.05 2.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.369 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.0 p90 -75.6 -8.6 57.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 110.483 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 109' ' ' GLU . 98.2 mtt180 -56.91 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.906 -1.121 . . . . 0.0 109.419 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.7 mt-10 -3.22 -93.1 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.8 149.61 47.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 109.39 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -93.54 120.15 33.46 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.98 -43.78 94.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.684 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -59.88 -40.02 87.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.772 -1.205 . . . . 0.0 110.368 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -59.57 -42.39 92.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 109.751 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.06 -40.3 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.274 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.9 83.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.49 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.36 -44.63 92.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.98 -45.59 92.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 0.0 109.73 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 91.9 mt-10 -61.98 -39.94 93.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.62 -39.31 94.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.251 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.11 96.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -64.86 -40.04 94.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.993 -1.299 . . . . 0.0 109.111 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.7 p -64.91 -25.62 67.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -1.72 57.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.211 -0.931 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.74 12.15 67.04 Favored Glycine 0 N--CA 1.495 2.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -76.92 149.03 36.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.897 -1.355 . . . . 0.0 108.997 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.6 m -107.2 161.77 14.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.544 -0.722 . . . . 0.0 110.162 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -60.19 170.46 1.27 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.0 109.726 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -151.44 154.8 37.31 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.238 -0.914 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.1 p -99.8 10.02 42.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.273 -0.892 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.29 127.32 33.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.018 . . . . 0.0 109.724 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 133' ' ' GLY . 18.7 tt -59.97 -38.41 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -76.53 4.43 50.45 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.931 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.97 141.07 29.83 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.008 -1.29 . . . . 0.0 109.649 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.5 mt -69.58 -36.05 75.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.4 mtp -72.95 34.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.047 -1.033 . . . . 0.0 110.655 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.8 t80 -64.95 135.27 96.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.01 -56.83 2.43 Favored 'Trans proline' 0 C--N 1.323 -0.772 0 C-N-CA 120.605 0.87 . . . . 0.0 111.009 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.2 p -83.91 163.5 19.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -85.48 134.08 34.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.505 -0.747 . . . . 0.0 109.313 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.8 p -153.15 126.13 8.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 109.231 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -80.1 130.11 35.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.7 t -141.11 99.31 3.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.403 -0.811 . . . . 0.0 109.375 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.61 -148.23 4.72 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -79.94 169.78 17.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.317 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.45 111.81 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 109.448 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -137.91 159.82 40.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.503 -0.748 . . . . 0.0 109.207 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.82 151.73 39.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.02 164.91 11.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.415 -0.803 . . . . 0.0 109.743 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -59.85 -39.86 86.59 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -58.61 -40.07 82.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.486 -0.759 . . . . 0.0 109.445 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -76.83 -41.88 42.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 109.849 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.39 -50.02 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.884 -1.135 . . . . 0.0 109.572 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.1 -41.38 96.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.95 -50.92 57.56 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.008 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -37.27 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.939 -1.33 . . . . 0.0 109.97 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.6 mt-30 -67.87 -40.03 83.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.941 -1.1 . . . . 0.0 109.711 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.62 96.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.241 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.3 mt -66.44 -50.06 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.0 109.729 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.91 -67.73 0.84 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 0.0 108.65 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.93 179.94 36.89 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.437 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 12.0 mtp-105 -92.32 148.57 22.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.205 . . . . 0.0 109.071 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 71.5 m -72.55 82.17 1.1 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.241 -0.912 . . . . 0.0 109.041 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -72.25 136.24 46.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.704 . . . . 0.0 110.007 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 167' ' ' VAL . 19.8 m120 -154.26 152.16 25.77 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -62.85 48.9 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.067 1.178 . . . . 0.0 109.941 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 165' ' ' ASN . 79.1 t -90.04 120.05 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.894 -1.129 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -80.52 149.15 67.79 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 109.043 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--N 1.324 -0.712 0 C-N-CA 120.946 1.097 . . . . 0.0 109.712 179.62 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.132 0.492 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -85.06 123.63 30.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.618 ' N ' HD13 ' A' ' 2' ' ' LEU . 43.8 p -89.39 151.84 21.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.344 -0.848 . . . . 0.0 109.303 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.89 135.97 51.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.889 -1.132 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.85 175.48 50.7 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -78.02 125.56 85.14 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.318 . . . . 0.0 108.233 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -66.51 99.35 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.688 0.925 . . . . 0.0 110.366 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -88.55 148.26 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 108.919 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -70.05 120.43 15.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.941 -1.1 . . . . 0.0 108.794 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 56.3 mp0 -80.87 -11.33 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.061 -1.024 . . . . 0.0 109.28 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -85.72 142.7 28.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.147 -0.971 . . . . 0.0 109.998 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.9 p -89.35 -3.98 58.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 108.601 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -129.61 135.09 48.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.55 -0.719 . . . . 0.0 109.099 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.3 mt -127.18 158.47 37.02 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.1 p -131.21 153.18 49.74 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -143.88 159.19 42.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.065 -1.022 . . . . 0.0 110.142 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 17' ' ' ARG . 33.8 ttt-85 -146.53 131.61 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.469 -0.769 . . . . 0.0 109.725 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.8 mt -87.86 119.19 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.3 tt0 -67.02 -40.17 87.21 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.013 -1.055 . . . . 0.0 110.056 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.78 151.32 19.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.188 -0.945 . . . . 0.0 110.972 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.12 124.12 42.5 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.3 t -67.05 141.16 96.35 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 120.936 -1.102 . . . . 0.0 108.916 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.53 3.73 1.02 Allowed 'Trans proline' 0 N--CA 1.482 0.824 0 C-N-CA 121.042 1.161 . . . . 0.0 109.761 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.0 m-20 -64.78 -39.86 94.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -142.96 151.06 55.21 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.311 -0.868 . . . . 0.0 108.709 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.66 145.91 87.39 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 N-CA-C 109.456 -1.017 . . . . 0.0 109.456 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -62.56 -30.12 71.08 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.468 -0.77 . . . . 0.0 109.478 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.08 78.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 0.0 109.618 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -79.89 -37.98 33.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.79 -45.86 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.309 -0.87 . . . . 0.0 109.275 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -59.21 -42.13 90.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.816 -1.178 . . . . 0.0 109.151 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.25 -46.38 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 109.542 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.63 92.88 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.572 -0.705 . . . . 0.0 109.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -70.47 -40.27 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.333 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.28 -40.67 91.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 109.716 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -65.21 -40.05 93.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.56 81.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.697 -1.252 . . . . 0.0 109.095 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 31.7 m-85 -59.57 -41.59 90.55 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.05 -1.031 . . . . 0.0 108.995 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.44 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 82.5 mm-40 -63.43 -41.98 98.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.182 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.79 -46.51 88.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.955 -1.091 . . . . 0.0 110.643 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.64 -38.28 73.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.222 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -68.54 -39.03 81.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 109.783 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 21.0 m120 -56.36 -26.21 52.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.0 110.918 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.84 7.02 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.169 -0.957 . . . . 0.0 110.734 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.8 p -149.42 150.8 32.19 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 0.0 109.15 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.21 8.21 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.29 1.327 . . . . 0.0 110.879 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.35 149.98 42.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.844 -1.16 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -130.11 143.54 50.85 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 93.0 m-85 -121.69 135.84 54.95 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.335 -0.853 . . . . 0.0 109.782 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.3 m -126.38 128.38 46.95 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.469 -0.769 . . . . 0.0 110.105 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -79.2 141.48 37.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 52' ' ' VAL . 32.9 m -124.98 130.05 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.237 -0.914 . . . . 0.0 108.712 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -87.92 -9.48 53.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.217 -0.927 . . . . 0.0 110.024 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -149.02 156.67 42.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.82 170.46 47.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -80.78 165.16 22.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.655 -0.909 . . . . 0.0 109.18 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.95 160.08 39.71 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 0.0 109.289 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -59.34 -40.67 87.11 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.46 119.11 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.715 . . . . 0.0 109.558 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.3 mtp -101.68 130.14 47.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.032 . . . . 0.0 108.765 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.4 mt -114.39 131.08 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.613 -0.68 . . . . 0.0 109.344 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -146.77 162.81 37.78 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.181 -0.95 . . . . 0.0 110.247 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -114.14 132.87 55.92 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.27 159.98 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.275 -0.89 . . . . 0.0 110.186 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.5 138.65 53.71 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.351 -0.843 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.01 -151.43 0.57 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 47.3 t0 -62.8 136.6 57.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -1.016 . . . . 0.0 109.655 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 14.8 p-80 -135.63 52.2 2.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.334 -0.854 . . . . 0.0 109.706 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 68.1 mtp180 53.79 47.73 23.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.486 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 60.0 m-20 -138.07 178.2 7.3 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.285 -0.884 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -92.1 11.82 24.16 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.481 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 t -137.74 72.23 49.3 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.019 -1.05 . . . . 0.0 110.04 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -71.79 124.58 10.31 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.613 1.542 . . . . 0.0 109.605 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -73.64 144.41 45.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -139.76 79.37 1.71 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 83.76 175.72 51.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.26 9.42 0.14 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.906 1.737 . . . . 0.0 109.96 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -87.15 165.11 35.65 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.9 -166.55 54.39 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -70.32 153.63 42.81 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.188 -1.183 . . . . 0.0 109.451 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.47 -4.9 57.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.18 177.36 1.91 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -166.17 170.12 13.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.115 -0.99 . . . . 0.0 109.645 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.21 165.13 30.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.18 162.49 13.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 109.304 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 26.7 mp0 -65.0 148.38 97.84 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.092 -1.005 . . . . 0.0 109.429 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 109.85 0.56 Allowed 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 121.231 1.288 . . . . 0.0 110.651 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.0 168.74 41.86 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -61.33 178.99 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.753 1.635 . . . . 0.0 109.695 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.01 -132.15 36.57 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.54 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.03 -8.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.998 . . . . 0.0 110.483 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.91 137.72 50.17 Favored Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.082 -1.011 . . . . 0.0 110.671 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.07 -17.67 52.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.23 140.18 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.708 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.93 127.55 49.07 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.543 -0.723 . . . . 0.0 109.305 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -109.68 132.88 53.73 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.312 -0.868 . . . . 0.0 110.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.425 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 49.5 m-85 -106.8 134.38 50.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.44 -0.788 . . . . 0.0 109.269 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -66.27 99.5 0.54 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -73.93 -8.72 57.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.873 . . . . 0.0 111.054 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.37 -19.82 57.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.092 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -86.21 159.18 19.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.249 -0.907 . . . . 0.0 110.53 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -88.18 112.16 22.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.132 -0.98 . . . . 0.0 109.502 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -94.14 140.51 29.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 32.0 p -130.72 169.35 15.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.581 -0.699 . . . . 0.0 109.387 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -118.32 25.37 10.35 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.531 -0.73 . . . . 0.0 109.346 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.776 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -150.06 -165.02 2.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.114 -0.991 . . . . 0.0 110.674 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 108' ' ' ARG . 37.1 p90 -65.75 7.6 0.24 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.732 -0.605 . . . . 0.0 112.168 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' PHE . 94.4 mtt180 -57.41 -163.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -47.58 -59.46 3.24 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -0.957 . . . . 0.0 112.582 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.7 m-85 -126.45 147.14 49.85 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.913 -1.117 . . . . 0.0 110.756 -177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 97.9 m-20 -97.8 111.75 23.92 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.139 -0.976 . . . . 0.0 108.724 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.7 -43.74 90.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.026 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -59.29 -44.21 92.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.926 -1.109 . . . . 0.0 111.023 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 141' ' ' THR . 65.5 ttt180 -59.88 -42.76 94.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.634 -1.291 . . . . 0.0 110.726 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.4 t -68.98 -40.27 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 109.006 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.97 75.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -0.809 . . . . 0.0 109.449 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.97 80.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -59.62 -49.4 77.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.5 mt-10 -61.61 -39.92 92.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.065 -1.022 . . . . 0.0 109.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.77 -35.35 79.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.311 -0.868 . . . . 0.0 108.901 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.28 -40.49 95.96 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -67.92 -39.8 83.46 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -1.126 . . . . 0.0 108.538 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 p -57.74 -28.49 63.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 108.858 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.47 -4.22 57.1 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.261 -0.899 . . . . 0.0 109.198 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.05 10.38 69.15 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.01 149.19 39.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.022 -1.281 . . . . 0.0 109.218 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.0 m -107.46 158.26 17.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.319 -0.863 . . . . 0.0 109.58 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -51.61 173.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.529 -0.732 . . . . 0.0 109.753 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.7 t -149.42 159.23 44.46 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.008 -1.057 . . . . 0.0 109.881 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.8 p -98.0 4.37 49.36 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.224 -0.923 . . . . 0.0 110.894 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -82.03 123.27 28.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.697 -1.252 . . . . 0.0 109.191 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.83 -38.63 77.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.773 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.71 5.47 5.86 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.53 136.86 38.84 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.073 -1.251 . . . . 0.0 110.224 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 mt -69.31 -25.31 64.16 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -73.68 13.86 0.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.47 -0.768 . . . . 0.0 109.753 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -63.76 136.21 96.62 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.93 -46.7 24.43 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 120.782 0.988 . . . . 0.0 110.919 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 t -85.57 141.03 30.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.38 146.03 53.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.21 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.522 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 47.4 p -145.64 158.7 43.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.09 -1.006 . . . . 0.0 109.414 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -78.03 128.26 33.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.1 t -123.66 120.31 32.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.499 -0.751 . . . . 0.0 109.149 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.67 -48.99 62.32 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -124.13 140.28 53.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.737 -0.86 . . . . 0.0 108.873 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.52 110.11 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.099 -1.001 . . . . 0.0 109.298 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.68 154.31 47.47 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.02 158.87 31.4 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.22 . . . . 0.0 109.151 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.01 160.19 14.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.364 -0.835 . . . . 0.0 109.86 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -60.34 -39.1 85.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.56 -43.6 93.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.037 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.4 -39.91 58.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.111 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -61.86 -50.35 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.219 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.17 -39.7 91.14 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 110.345 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.59 62.69 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.322 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -70.01 -37.44 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.796 -1.414 . . . . 0.0 109.342 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.0 mt-30 -68.5 -39.66 81.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.692 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -37.83 81.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.298 -0.876 . . . . 0.0 109.303 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.27 -46.63 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.383 -0.823 . . . . 0.0 109.741 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -95.92 -70.71 0.7 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 108.683 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.79 -177.0 40.51 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 162' ' ' ARG . 42.7 mtt-85 -90.05 142.08 28.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.085 -1.244 . . . . 0.0 109.037 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.6 m -77.24 81.9 3.73 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.491 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -76.13 92.53 3.23 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 108.506 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -156.74 68.83 4.56 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.65 89.15 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.499 1.466 . . . . 0.0 109.72 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.07 140.82 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.096 -1.003 . . . . 0.0 108.966 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -79.53 148.19 69.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.03 -1.044 . . . . 0.0 108.62 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--N 1.325 -0.69 0 C-N-CA 121.142 1.228 . . . . 0.0 110.037 -179.596 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.671 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.3 mm? -60.06 -39.68 86.86 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -87.66 167.47 13.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -69.56 130.64 42.99 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.05 -1.031 . . . . 0.0 109.096 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.35 -178.25 53.78 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -78.63 130.74 70.01 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.259 -1.142 . . . . 0.0 109.086 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.91 102.56 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.63 -0.95 . . . . 0.0 109.63 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' A' ' 159' ' ' ILE . 33.2 mmt180 -136.95 158.18 45.04 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -66.29 130.0 41.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.968 . . . . 0.0 109.132 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -73.43 -34.86 65.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 0.0 110.298 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 15.0 pt20 -85.39 151.69 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 p -90.93 -4.47 56.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.932 . . . . 0.0 108.941 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 54.8 m170 -111.82 121.34 44.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.65 162.1 14.47 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.5 p -132.9 154.29 50.54 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -146.27 159.54 43.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.051 -1.03 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -144.28 130.19 19.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.21 -0.931 . . . . 0.0 110.326 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -88.7 112.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -66.73 -39.34 87.92 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.598 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -163.53 152.26 13.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 110.17 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.01 129.5 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.354 -0.841 . . . . 0.0 108.979 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -70.76 144.27 90.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 108.656 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.89 2.26 2.71 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 N-CA-C 109.574 -0.972 . . . . 0.0 109.574 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -61.46 -41.21 96.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -142.45 150.17 53.67 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.19 147.95 81.04 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.964 1.11 . . . . 0.0 109.691 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 27' ' ' ARG . 5.1 ptm180 -60.4 -27.87 67.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.73 -35.46 72.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.2 -0.938 . . . . 0.0 109.783 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -83.14 -33.8 26.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.94 -1.1 . . . . 0.0 109.882 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -70.57 -49.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 111.047 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 30.9 p-10 -55.62 -44.53 77.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.906 -1.121 . . . . 0.0 109.446 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.538 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 64.9 t60 -59.96 -47.42 85.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 110.047 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.59 81.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.999 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -70.64 -47.16 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.53 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -61.87 -40.61 95.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.18 -37.58 87.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 109.685 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.76 88.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -59.57 -39.93 85.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.021 -1.049 . . . . 0.0 109.067 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.96 -43.06 95.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.882 -1.136 . . . . 0.0 109.696 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.04 -41.19 91.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.977 -1.077 . . . . 0.0 110.083 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 45' ' ' THR . 79.2 m95 -72.42 -41.14 66.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.07 -1.019 . . . . 0.0 109.804 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.6 t -70.26 -39.76 74.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -51.88 -29.96 21.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.44 -0.788 . . . . 0.0 111.304 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -107.84 8.0 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.045 -1.035 . . . . 0.0 111.061 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.4 p -149.74 150.89 31.64 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 120.802 -1.186 . . . . 0.0 109.078 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.84 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.118 1.212 . . . . 0.0 109.811 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 45' ' ' THR . 96.5 mt -72.63 144.82 47.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.251 -0.906 . . . . 0.0 109.788 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 67.3 p -130.46 144.42 51.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.73 130.02 51.98 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 0.0 109.783 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.9 m -123.83 129.42 51.0 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.614 -0.678 . . . . 0.0 109.95 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.29 141.03 40.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 109.075 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.6 m -126.71 130.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.376 -0.828 . . . . 0.0 108.899 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 t -91.01 -3.36 57.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.046 -1.034 . . . . 0.0 109.973 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -146.87 153.74 40.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.91 -1.119 . . . . 0.0 109.724 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.56 170.99 47.72 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -85.63 141.15 30.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.308 -1.113 . . . . 0.0 109.035 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.93 154.74 21.16 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.333 -0.854 . . . . 0.0 109.695 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 95.9 m-20 -59.72 -40.88 89.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.444 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -118.32 113.22 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.675 -0.641 . . . . 0.0 109.385 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.61 133.2 45.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 109.776 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.59 130.39 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.644 -0.66 . . . . 0.0 109.315 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.8 p -148.23 155.47 41.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.0 109.975 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.76 134.16 52.72 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.61 170.35 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.101 -0.999 . . . . 0.0 110.664 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -130.82 146.33 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 109.691 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.15 -147.4 4.64 Favored Glycine 0 N--CA 1.494 2.505 0 O-C-N 121.278 -0.888 . . . . 0.0 110.971 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 50.9 t0 -67.06 132.89 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 41.3 p-80 -137.47 59.22 1.68 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.545 -0.722 . . . . 0.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 51.5 mtt-85 53.69 51.39 15.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.0 109.206 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 46.7 t0 -140.63 153.4 46.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 32.9 m120 -89.46 8.79 29.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.39 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -137.5 70.14 53.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.441 -0.787 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.31 156.51 62.83 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.35 1.367 . . . . 0.0 109.775 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -75.96 134.16 40.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 0.0 109.118 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -104.88 60.7 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.462 -0.774 . . . . 0.0 109.659 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 85.24 -178.85 50.74 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.87 5.97 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.343 1.362 . . . . 0.0 110.289 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -96.74 179.78 34.42 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.61 -164.64 54.68 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -70.83 150.7 45.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.104 -1.233 . . . . 0.0 109.031 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.15 -11.28 47.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 108.925 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 170.86 3.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.543 -0.723 . . . . 0.0 109.105 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -166.83 171.96 10.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.66 165.24 30.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.55 161.84 15.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.446 -0.784 . . . . 0.0 110.075 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.4 150.03 86.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.97 112.44 1.1 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.285 1.324 . . . . 0.0 110.188 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.32 167.24 39.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.248 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.89 171.81 3.43 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.677 1.584 . . . . 0.0 109.681 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.09 -131.11 17.35 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -79.11 -10.46 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.489 -1.007 . . . . 0.0 109.967 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -52.27 139.25 30.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.25 -19.56 34.64 Favored Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.324 -1.104 . . . . 0.0 110.553 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -64.86 131.13 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.903 -1.351 . . . . 0.0 109.896 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.95 129.5 55.44 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.426 -0.797 . . . . 0.0 109.507 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -109.78 129.62 55.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.376 -0.828 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 35.0 m-85 -108.41 131.45 54.76 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.425 -0.797 . . . . 0.0 109.922 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -67.7 95.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -74.48 -8.29 55.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.34 -0.85 . . . . 0.0 110.74 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -75.25 -21.57 58.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.43 -1.418 . . . . 0.0 110.029 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -88.35 164.3 15.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -91.86 117.51 29.86 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.958 -1.088 . . . . 0.0 109.543 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -93.24 140.54 29.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.374 -0.829 . . . . 0.0 110.312 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 79.8 p -128.59 169.86 13.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.49 -0.756 . . . . 0.0 109.391 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -116.19 30.38 7.38 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -145.92 -164.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.445 -0.785 . . . . 0.0 109.799 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 108' ' ' ARG . 49.6 p90 -81.37 11.35 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.444 -0.785 . . . . 0.0 110.853 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 107' ' ' PHE . 69.0 mtt-85 -58.26 -155.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.033 -1.042 . . . . 0.0 110.17 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -44.83 -59.97 2.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.346 -0.846 . . . . 0.0 111.553 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 97.0 m-85 -136.61 144.28 44.0 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.955 -1.091 . . . . 0.0 110.849 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.51 115.87 31.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.23 -45.5 93.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.897 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -59.95 -43.73 94.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.908 -1.12 . . . . 0.0 110.73 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 141' ' ' THR . 60.4 ttt180 -59.92 -40.84 90.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.712 -1.242 . . . . 0.0 109.97 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.42 -40.15 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.369 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.41 87.13 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.002 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.23 87.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.162 -0.961 . . . . 0.0 108.664 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.401 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 55.0 t60 -61.59 -45.33 94.57 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.539 -0.725 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 87.1 mt-10 -61.97 -40.0 94.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.977 -1.077 . . . . 0.0 108.968 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.9 mt -63.49 -37.9 89.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.566 -0.709 . . . . 0.0 109.423 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.92 94.73 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -64.67 -40.17 94.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 109.302 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.7 p -66.99 -25.54 66.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.06 -0.7 56.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.881 . . . . 0.0 108.981 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.16 7.65 82.94 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.88 148.88 37.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.906 -1.349 . . . . 0.0 108.777 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.0 m -112.29 171.65 7.39 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.427 -0.796 . . . . 0.0 110.142 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -63.12 168.29 4.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.377 -0.827 . . . . 0.0 109.364 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 t -147.46 163.09 37.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.036 -1.04 . . . . 0.0 109.889 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -94.26 4.61 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.483 -0.761 . . . . 0.0 109.985 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -82.57 120.25 25.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.112 -0.992 . . . . 0.0 108.93 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.14 -40.7 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.54 5.95 9.61 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.736 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.7 136.68 35.79 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.925 -1.338 . . . . 0.0 109.824 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.4 mt -69.66 -30.92 68.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 92.0 mmm -72.29 19.8 0.07 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.854 . . . . 0.0 110.326 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -60.08 138.17 91.14 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 0.0 108.161 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.03 -60.09 0.73 Allowed 'Trans proline' 0 N--CA 1.48 0.679 0 C-N-CA 120.951 1.1 . . . . 0.0 111.243 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -80.73 155.78 26.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.167 -0.958 . . . . 0.0 110.63 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 141' ' ' THR . 58.9 t80 -85.31 128.7 34.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.347 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.534 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 24.6 p -155.57 132.06 10.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.412 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -80.91 125.89 30.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -120.99 -0.67 9.99 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.461 -0.774 . . . . 0.0 110.08 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 139.1 -135.17 7.16 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.8 t0 -78.25 167.42 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -1.009 . . . . 0.0 109.616 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 87.7 t -96.09 108.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.139 -0.975 . . . . 0.0 109.572 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.73 157.78 45.19 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.362 -0.836 . . . . 0.0 108.985 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.96 157.44 33.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.889 -1.132 . . . . 0.0 109.266 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.74 149.79 25.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.366 -0.834 . . . . 0.0 108.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -54.2 -36.34 63.35 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.975 -1.078 . . . . 0.0 108.445 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.36 -40.07 81.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -73.4 -40.23 64.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.129 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.0 mm -60.15 -49.74 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.065 -1.022 . . . . 0.0 108.89 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.21 -39.92 88.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.945 -1.097 . . . . 0.0 109.741 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.55 -50.05 46.16 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.644 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -68.43 -39.62 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.731 -1.453 . . . . 0.0 109.967 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.6 mt-30 -66.43 -38.54 87.66 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.15 88.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.329 -0.857 . . . . 0.0 109.698 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' NH1' ' A' ' 8' ' ' ARG . 92.1 mt -66.85 -50.19 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.955 -1.09 . . . . 0.0 109.595 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -98.41 -65.65 0.95 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.238 -0.914 . . . . 0.0 109.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.12 -171.18 33.91 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -97.05 140.08 32.1 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -1.075 . . . . 0.0 109.548 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 m -75.44 87.74 2.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -73.7 107.29 5.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.61 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.78 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 1.7 m-80 -159.28 -38.56 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.281 -0.887 . . . . 0.0 112.059 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.78 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.3 Cg_endo -68.24 75.31 0.73 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 N-CA-C 109.259 -1.093 . . . . 0.0 109.259 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.74 113.5 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.136 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.66 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 8.0 mm100 -106.96 -30.2 0.19 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.6 -0.687 . . . . 0.0 112.14 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.9 Cg_endo . . . . . 0 C--N 1.326 -0.609 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 80.9 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -46.4 89.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.6 p -97.0 166.66 11.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.287 -0.883 . . . . 0.0 109.17 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.06 129.77 39.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.174 -0.953 . . . . 0.0 109.018 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.24 -155.12 52.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.83 149.25 77.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.189 -1.183 . . . . 0.0 109.037 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.34 174.13 0.82 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.078 1.185 . . . . 0.0 109.486 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.04 154.76 44.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.116 -0.99 . . . . 0.0 109.102 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.01 122.82 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.576 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.91 -14.0 55.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.402 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -86.98 144.22 27.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.288 -0.883 . . . . 0.0 109.613 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.6 p -91.07 -4.57 56.2 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 108.771 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.521 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 84.2 m-70 -121.15 131.57 54.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -130.29 160.46 33.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.6 p -132.44 161.07 34.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 109.672 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -145.35 156.28 43.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -144.95 131.91 20.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.238 -0.914 . . . . 0.0 110.145 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.73 120.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.97 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.364 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -163.36 156.89 19.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.965 -1.084 . . . . 0.0 109.803 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -102.14 129.95 48.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.449 -0.782 . . . . 0.0 109.037 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -70.78 142.05 87.92 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.097 -1.002 . . . . 0.0 108.74 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -63.55 0.22 2.02 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 120.707 0.938 . . . . 0.0 110.077 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 22' ' ' THR . 81.1 m-20 -63.29 -39.99 96.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.037 -1.04 . . . . 0.0 109.682 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.9 mt -139.95 150.24 61.64 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.37 153.22 61.65 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 N-CA-C 109.29 -1.081 . . . . 0.0 109.29 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -65.42 -34.15 77.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.368 -0.833 . . . . 0.0 110.519 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.945 . . . . 0.0 110.576 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -79.44 -31.44 42.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.638 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.98 -43.34 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.44 -41.51 89.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 109.124 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.13 -46.76 88.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.62 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.11 84.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.709 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.9 mm -69.83 -47.65 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.127 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.08 -39.93 87.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.486 -0.759 . . . . 0.0 109.687 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -61.98 -39.94 93.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.283 -0.886 . . . . 0.0 110.329 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.28 88.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.069 -1.019 . . . . 0.0 110.342 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -59.99 -39.98 87.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.948 -1.095 . . . . 0.0 109.723 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.67 -41.97 96.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.074 -1.016 . . . . 0.0 109.961 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.62 -40.56 92.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.174 -0.953 . . . . 0.0 110.34 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -72.97 -41.35 64.48 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.994 -1.066 . . . . 0.0 109.972 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.0 t -70.03 -25.83 63.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.305 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.99 -40.03 87.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.981 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG23 HG23 ' A' ' 45' ' ' THR . 5.8 m -104.24 13.57 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.105 -0.997 . . . . 0.0 110.679 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.502 HG23 HG23 ' A' ' 44' ' ' VAL . 39.6 p -143.85 145.44 30.65 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.88 -1.138 . . . . 0.0 109.324 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.76 7.02 1.09 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.19 -1.119 . . . . 0.0 109.19 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 45' ' ' THR . 92.1 mt -73.3 149.66 42.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.424 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.1 p -131.65 141.83 49.71 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.56 -0.713 . . . . 0.0 109.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -121.85 134.45 54.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.512 -0.743 . . . . 0.0 109.128 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.7 m -128.19 135.5 49.81 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.742 0.782 . . . . 0.0 110.825 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -77.52 138.3 39.12 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 52' ' ' VAL . 25.3 m -124.72 128.56 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.289 -0.882 . . . . 0.0 109.091 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.5 t -93.18 -7.21 45.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.316 -0.865 . . . . 0.0 109.756 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.88 159.93 42.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.55 171.32 45.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.3 149.97 27.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -1.15 . . . . 0.0 108.934 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.74 149.21 38.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.532 -0.73 . . . . 0.0 109.657 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -59.94 -39.94 87.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.848 . . . . 0.0 109.686 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -116.31 118.8 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.444 -0.785 . . . . 0.0 109.582 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.2 mmm -100.41 131.22 46.46 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.806 . . . . 0.0 109.145 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.37 131.76 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 109.656 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.1 p -149.51 163.66 37.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.937 . . . . 0.0 110.324 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.41 134.96 52.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.99 165.05 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.128 -0.982 . . . . 0.0 110.811 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -124.37 132.57 53.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.749 -0.594 . . . . 0.0 109.928 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.89 -145.81 3.95 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.364 -0.835 . . . . 0.0 111.019 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 51.0 t0 -63.76 135.77 56.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.529 -0.983 . . . . 0.0 110.149 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -138.13 57.95 1.69 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.562 -0.711 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 53.14 53.87 11.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.982 . . . . 0.0 109.068 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 40.3 t0 -141.52 160.6 39.8 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.3 m120 -88.48 8.98 25.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.002 -1.061 . . . . 0.0 109.4 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 m -135.14 70.03 69.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.474 -0.766 . . . . 0.0 109.375 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -69.02 144.4 57.82 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 121.54 1.493 . . . . 0.0 109.724 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -75.64 139.01 41.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 109.85 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -104.21 65.23 0.79 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.73 -173.38 55.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.47 3.97 0.31 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.5 1.466 . . . . 0.0 109.743 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -93.11 173.76 34.86 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.82 -161.86 51.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.45 152.46 43.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.894 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.01 -9.6 48.02 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.97 164.54 2.31 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.59 170.05 16.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.888 -1.132 . . . . 0.0 109.719 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.4 168.9 20.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.361 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.11 166.99 11.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.369 -0.832 . . . . 0.0 109.386 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.9 mp0 -66.44 148.96 98.4 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.055 . . . . 0.0 109.107 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.63 108.67 0.56 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.109 1.206 . . . . 0.0 109.922 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 168.37 41.31 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.56 -177.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.319 1.346 . . . . 0.0 109.473 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.13 -130.48 41.72 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -81.43 -7.7 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.466 -1.02 . . . . 0.0 110.261 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.48 142.17 47.07 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.433 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.25 -22.48 23.02 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.61 150.52 40.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -1.231 . . . . 0.0 109.182 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.06 123.31 16.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.131 -0.98 . . . . 0.0 109.235 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -108.87 139.17 44.08 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.501 -0.749 . . . . 0.0 110.167 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.529 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.0 m-85 -111.55 135.59 51.92 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.57 -0.707 . . . . 0.0 109.205 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -66.72 103.17 1.04 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.102 -0.999 . . . . 0.0 109.17 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -77.94 -8.85 58.67 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.527 -0.733 . . . . 0.0 110.561 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -75.87 -21.62 56.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.848 -1.158 . . . . 0.0 109.105 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -88.34 159.46 18.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -92.13 114.79 27.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.086 -1.009 . . . . 0.0 109.071 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.22 144.65 25.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.351 -0.843 . . . . 0.0 109.967 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.6 p -129.89 157.58 41.88 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.548 -0.72 . . . . 0.0 109.105 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -109.98 25.41 11.82 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -145.37 -164.72 2.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.0 109.782 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -69.99 -6.99 37.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.6 mtt180 -55.67 176.27 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.829 -1.169 . . . . 0.0 110.237 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -2.45 -90.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.7 m-85 -120.01 140.68 50.6 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.369 -0.832 . . . . 0.0 110.37 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 140' ' ' TYR . 44.6 t30 -81.18 110.66 16.88 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.06 -40.23 84.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.921 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -59.89 -45.13 93.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 0.0 110.625 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 64.4 ttt180 -60.0 -42.57 94.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.886 -1.134 . . . . 0.0 110.174 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.06 -40.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.057 . . . . 0.0 109.908 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -44.41 86.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.873 -1.142 . . . . 0.0 108.731 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.29 79.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.413 -0.805 . . . . 0.0 109.437 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.423 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 67.9 t60 -59.92 -49.99 75.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.843 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.529 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.8 mt-10 -62.26 -39.99 94.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.969 -1.082 . . . . 0.0 109.563 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.07 -38.85 92.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.156 -0.965 . . . . 0.0 109.14 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.17 -40.04 93.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.53 -39.98 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -1.192 . . . . 0.0 109.032 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.8 m -57.81 -30.55 65.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 108.628 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -84.04 0.24 48.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.454 -0.779 . . . . 0.0 109.383 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.29 8.12 78.6 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -76.69 139.68 40.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.343 . . . . 0.0 109.209 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 59.2 m -108.12 173.02 6.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.512 -0.742 . . . . 0.0 109.75 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.1 m170 -64.07 166.67 7.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -150.14 165.31 33.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -96.1 11.52 33.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.906 . . . . 0.0 109.829 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -81.54 120.65 25.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.0 -39.98 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.38 -0.825 . . . . 0.0 110.273 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.56 5.74 20.87 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.18 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.29 139.48 31.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.748 -1.442 . . . . 0.0 109.498 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 82.1 mt -69.95 -29.44 66.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.28 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.7 mtp -71.71 19.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.349 -0.845 . . . . 0.0 110.191 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' LEU . 16.1 t80 -64.81 135.28 96.32 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -57.87 -44.37 41.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 120.965 1.11 . . . . 0.0 111.572 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.5 t -83.82 136.51 34.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.941 -1.099 . . . . 0.0 110.982 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' OH ' ' N ' ' A' ' 111' ' ' ASN . 64.6 t80 -75.35 140.18 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 45.0 p -151.29 156.9 41.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.987 -1.071 . . . . 0.0 109.574 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -79.11 114.63 18.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 108.873 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.3 p -109.63 9.54 25.07 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.507 -0.745 . . . . 0.0 110.166 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 64.16 -115.87 8.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -78.18 157.29 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -1.153 . . . . 0.0 109.133 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.05 116.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.8 145.2 46.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.431 -0.793 . . . . 0.0 108.93 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.51 149.21 38.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.055 . . . . 0.0 108.76 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.92 169.44 8.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -59.62 -39.77 85.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 108.961 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.06 -44.56 83.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.727 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.97 -40.31 54.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.199 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.07 -48.8 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 158' ' ' ALA . 95.7 m-20 -60.66 -40.02 90.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.872 -1.142 . . . . 0.0 109.864 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.39 -53.45 44.11 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.261 -0.971 . . . . 0.0 110.731 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.5 tp -69.77 -39.91 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.326 . . . . 0.0 109.415 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -69.59 -35.25 75.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.032 -1.042 . . . . 0.0 109.138 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 154' ' ' ASP . . . -59.66 -40.07 86.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.149 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.96 -50.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 108.965 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -95.8 -72.7 0.62 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.42 -169.33 35.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -88.5 147.02 24.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -1.163 . . . . 0.0 109.192 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.1 m -76.32 72.26 3.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -81.14 113.53 19.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.0 109.99 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.822 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 65.8 m-80 -159.44 -34.43 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.8 . . . . 0.0 112.709 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.822 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 5.5 Cg_exo -64.94 101.99 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.691 0.925 . . . . 0.0 109.77 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 167' ' ' VAL . 9.4 m -82.15 149.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.424 -0.798 . . . . 0.0 109.481 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -79.8 149.59 71.03 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.873 . . . . 0.0 108.685 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 C--N 1.322 -0.862 0 C-N-CA 120.983 1.122 . . . . 0.0 109.791 179.502 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 3' ' ' THR . 7.0 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -13.07 35.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.806 -1.184 . . . . 0.0 109.455 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 1' ' ' VAL . 51.1 p -96.31 156.32 16.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.212 -0.93 . . . . 0.0 109.636 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -72.83 126.71 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.516 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.61 -166.54 54.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -76.7 150.2 81.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.97 -1.312 . . . . 0.0 108.763 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -54.57 97.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.809 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -140.92 137.89 33.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -68.61 137.56 54.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 108.694 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.99 -35.27 66.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.076 -1.015 . . . . 0.0 110.053 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -85.57 147.91 26.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.023 -1.048 . . . . 0.0 110.071 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.7 p -91.26 -4.88 55.52 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 108.788 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.492 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 36.8 m80 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -126.23 160.0 31.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.494 -0.754 . . . . 0.0 109.792 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.9 p -125.04 153.88 42.18 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -145.46 156.2 43.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.568 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 17' ' ' ARG . 35.3 ttt-85 -147.29 138.35 23.74 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.39 -0.819 . . . . 0.0 110.244 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -91.2 118.14 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.95 -40.11 94.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.383 -0.823 . . . . 0.0 110.918 -178.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -165.03 150.15 9.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.715 -1.241 . . . . 0.0 110.444 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.7 135.42 40.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.542 -0.724 . . . . 0.0 109.816 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 22' ' ' THR . 0.6 OUTLIER -79.32 143.61 60.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 109.159 179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -63.9 1.37 1.51 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.913 1.075 . . . . 0.0 109.783 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.0 m-20 -63.75 -40.99 98.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.049 -1.032 . . . . 0.0 109.261 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -143.41 150.54 51.8 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -61.02 156.79 42.38 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 120.659 0.906 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -68.65 -29.99 68.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 109.455 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.87 87.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.021 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.79 -37.37 59.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.714 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.07 -41.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.57 -42.51 92.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.649 -1.282 . . . . 0.0 108.78 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -60.21 -49.48 77.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.477 -0.764 . . . . 0.0 109.444 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -49.41 77.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -0.763 . . . . 0.0 110.261 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -69.99 -43.35 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.455 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.6 tt0 -60.07 -46.03 90.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.232 -0.917 . . . . 0.0 110.305 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -60.49 -37.77 82.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.272 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.9 96.56 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -59.95 -41.25 91.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.68 -1.263 . . . . 0.0 109.826 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 3.2 mp0 -60.8 -39.91 90.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.779 -1.2 . . . . 0.0 110.04 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.9 mt -60.14 -46.01 91.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.952 -1.093 . . . . 0.0 110.024 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -72.38 -40.02 67.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.975 -1.078 . . . . 0.0 110.188 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.2 t -69.85 -39.93 76.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.261 -0.899 . . . . 0.0 110.422 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.93 -29.06 18.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 110.569 -178.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 m -107.13 10.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.188 -0.945 . . . . 0.0 110.591 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 47' ' ' LEU . 16.8 p -148.81 149.21 29.96 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.744 -1.222 . . . . 0.0 109.976 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.83 8.8 0.31 Allowed 'Trans proline' 0 N--CA 1.482 0.842 0 C-N-CA 121.414 1.409 . . . . 0.0 110.221 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 45' ' ' THR . 81.9 mt -75.81 146.32 40.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.0 109.59 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -129.59 145.02 51.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.84 136.96 55.04 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.4 -0.813 . . . . 0.0 109.125 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -119.99 130.04 54.57 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.651 0.738 . . . . 0.0 109.998 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -77.27 130.94 37.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' VAL . 18.8 m -128.44 127.97 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -93.82 -3.62 51.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -149.08 161.17 42.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.966 -1.084 . . . . 0.0 109.494 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.86 173.26 49.78 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -84.01 145.7 28.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.438 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 146.03 47.5 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.537 0.684 . . . . 0.0 109.315 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.78 -42.31 93.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 110.206 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.0 mt -109.6 110.09 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.3 -0.875 . . . . 0.0 109.781 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -99.2 133.85 42.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.232 -0.918 . . . . 0.0 108.924 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.56 129.97 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.6 p -149.35 158.97 44.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.952 -1.093 . . . . 0.0 110.047 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.41 141.39 41.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.6 165.01 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.318 -0.864 . . . . 0.0 110.547 -178.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 66' ' ' GLY . 88.4 mtm180 -127.62 140.1 52.32 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.769 -0.582 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 40.25 -137.57 1.59 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.38 129.8 38.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.502 -0.999 . . . . 0.0 110.608 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 37.4 p-80 -134.49 57.97 1.79 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.518 -0.739 . . . . 0.0 109.58 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 54.48 56.72 6.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.342 -0.849 . . . . 0.0 109.972 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 25.8 p-10 -145.19 168.14 21.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.158 -0.964 . . . . 0.0 109.534 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.3 9.02 35.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 109.882 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.5 m -136.44 68.63 61.05 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.263 -0.898 . . . . 0.0 109.886 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.45 142.47 72.14 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.144 1.229 . . . . 0.0 109.015 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.39 134.1 39.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.832 -1.168 . . . . 0.0 109.237 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -99.64 61.52 1.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.848 . . . . 0.0 109.036 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 82.56 -176.41 53.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.52 3.79 0.33 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 121.823 1.682 . . . . 0.0 110.23 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.35 176.19 35.3 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.86 -157.05 52.27 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -71.34 149.99 45.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -1.209 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.18 -4.69 57.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.328 -0.857 . . . . 0.0 109.178 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -176.27 177.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.95 161.61 10.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.988 -1.07 . . . . 0.0 109.492 179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.59 167.63 21.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.346 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.11 163.51 13.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.648 -0.657 . . . . 0.0 109.57 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -67.46 149.02 98.57 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -60.1 99.55 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 C-N-CA 120.87 1.047 . . . . 0.0 110.051 -179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.47 172.61 33.63 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.12 173.68 3.82 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.512 1.475 . . . . 0.0 110.164 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.04 -134.6 40.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -71.56 -5.23 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.428 -1.043 . . . . 0.0 110.121 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.48 48.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.28 -24.61 6.14 Favored Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.055 -1.262 . . . . 0.0 110.226 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.77 154.07 34.52 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.182 -1.187 . . . . 0.0 110.468 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.52 123.38 14.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.201 -0.937 . . . . 0.0 109.521 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -108.13 148.98 29.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 110.112 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.543 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 31.6 m-85 -119.03 138.79 52.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.625 -0.672 . . . . 0.0 109.741 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -70.67 106.59 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -76.57 0.08 21.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.57 -0.706 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.53 -26.45 55.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.556 -1.34 . . . . 0.0 110.119 -179.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.7 mp0 -85.29 156.33 20.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 109.4 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.426 HH12 HG22 ' A' ' 104' ' ' THR . 44.5 ttt-85 -90.67 111.85 23.36 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 108.861 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -86.57 149.99 24.55 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.521 -0.737 . . . . 0.0 110.075 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.426 HG22 HH12 ' A' ' 102' ' ' ARG . 25.7 p -133.58 165.19 25.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.502 -0.749 . . . . 0.0 109.402 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.52 29.11 8.22 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.544 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -144.95 -164.06 1.84 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.312 179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 108' ' ' ARG . 54.6 p90 -75.78 10.8 1.61 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.094 -1.004 . . . . 0.0 111.338 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.429 ' H ' ' ND2' ' A' ' 106' ' ' ASN . 97.4 mtt180 -57.58 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.601 -1.312 . . . . 0.0 110.739 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -50.0 -58.73 4.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.687 -0.633 . . . . 0.0 112.596 -177.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -122.37 144.83 48.78 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.028 -1.045 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 87.2 m-20 -109.82 119.74 40.3 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.69 -44.26 93.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.047 -1.033 . . . . 0.0 110.434 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -59.48 -39.96 85.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -59.61 -49.4 77.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.03 -39.92 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.887 -1.133 . . . . 0.0 109.007 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.87 -47.14 83.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.99 85.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.145 -0.972 . . . . 0.0 109.831 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.55 -47.21 87.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.205 -0.934 . . . . 0.0 109.239 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.543 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 83.0 mt-10 -61.87 -40.06 94.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.289 -0.882 . . . . 0.0 109.252 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.96 -37.39 87.23 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.98 87.52 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -68.1 -39.76 82.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -1.188 . . . . 0.0 109.067 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.9 p -56.84 -29.27 62.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.1 -1.11 56.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.155 -0.965 . . . . 0.0 109.491 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.78 63.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.529 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.87 149.96 29.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.045 -1.268 . . . . 0.0 109.265 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.9 m -105.94 157.34 17.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.06 174.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.505 -0.747 . . . . 0.0 109.268 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t -150.59 168.07 25.38 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.192 -0.943 . . . . 0.0 109.687 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -98.59 5.71 47.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.216 -0.928 . . . . 0.0 110.43 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -83.61 118.22 23.68 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.017 -1.052 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -39.92 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 109.877 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.46 9.39 3.39 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.16 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 139.56 33.86 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.891 -1.358 . . . . 0.0 109.958 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.86 -25.77 63.89 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 97.0 mmm -74.44 0.5 14.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.501 -0.75 . . . . 0.0 109.948 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.39 135.24 95.22 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.917 -1.115 . . . . 0.0 108.713 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.98 -36.9 97.77 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 121.246 1.297 . . . . 0.0 112.195 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 t -85.02 140.45 31.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.613 -1.304 . . . . 0.0 110.825 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -70.2 148.43 48.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 109.737 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.3 p -151.68 173.45 14.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -160.05 106.06 1.57 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.0 p -98.22 0.51 45.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 0.0 110.265 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.62 67.24 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -135.26 124.78 25.01 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.391 -1.064 . . . . 0.0 108.726 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.43 105.28 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.016 -1.053 . . . . 0.0 109.352 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -139.91 159.55 41.93 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.53 160.29 29.6 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.16 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -100.13 156.07 17.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.02 -40.13 88.22 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.637 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -58.88 -39.92 82.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 109.642 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.28 -40.73 50.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.016 -1.053 . . . . 0.0 109.544 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -50.09 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.25 -0.906 . . . . 0.0 109.434 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.6 -40.14 90.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.091 -1.005 . . . . 0.0 110.724 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.37 -50.14 67.58 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.994 -178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.95 -37.04 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.75 -1.441 . . . . 0.0 109.911 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.2 mt-30 -65.23 -39.78 93.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.433 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.94 92.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.247 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.34 -50.03 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -97.32 -69.9 0.74 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.457 -0.777 . . . . 0.0 109.415 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.74 -166.39 32.36 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.453 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 10.8 mtp-105 -89.58 152.08 21.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -1.015 . . . . 0.0 108.833 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.8 m -74.36 81.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.792 -1.193 . . . . 0.0 108.99 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.36 101.52 5.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -155.05 68.9 5.53 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.381 -0.824 . . . . 0.0 108.969 179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.33 86.13 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.297 1.331 . . . . 0.0 109.614 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 167' ' ' VAL . 2.8 m -91.78 139.69 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 12.5 mp0 -83.5 149.8 58.55 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 C-N-CA 121.094 1.196 . . . . 0.0 110.214 179.414 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.01 -50.01 75.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.7 p -98.43 161.46 13.67 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.885 . . . . 0.0 108.814 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.15 131.37 45.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.029 -1.044 . . . . 0.0 109.617 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.58 -159.13 52.3 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -77.07 145.54 73.67 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.022 -1.281 . . . . 0.0 108.857 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.38 157.59 35.24 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 N-CA-C 109.016 -1.186 . . . . 0.0 109.016 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -143.1 155.8 44.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.151 -0.968 . . . . 0.0 108.937 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.0 119.18 12.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.478 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -83.12 -11.14 58.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -88.19 144.24 26.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.9 p -91.4 -4.45 55.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 75.5 m80 -127.41 133.25 50.0 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.1 mt -133.89 159.88 39.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.29 -0.881 . . . . 0.0 108.849 -179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -127.63 160.07 32.75 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.518 -0.738 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -146.72 157.35 43.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.32 -0.863 . . . . 0.0 109.747 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -148.53 133.82 18.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.864 . . . . 0.0 109.898 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.5 mt -89.46 121.74 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -68.16 -40.07 82.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.016 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -162.15 159.95 26.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.796 -1.19 . . . . 0.0 110.033 -179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.66 133.66 49.13 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -73.19 142.75 82.58 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.0 108.342 179.53 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -63.32 1.33 1.3 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 N-CA-C 109.205 -1.113 . . . . 0.0 109.205 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 22' ' ' THR . 93.4 m-20 -65.15 -39.9 93.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.867 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' ND2' ' A' ' 105' ' ' ASN . 81.7 mt -142.46 150.45 54.64 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.297 -0.877 . . . . 0.0 108.775 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.73 156.4 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 120.758 0.972 . . . . 0.0 109.883 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -68.53 -31.0 69.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.351 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.08 -41.45 92.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.44 -0.788 . . . . 0.0 110.684 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -79.67 -29.72 40.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.112 -0.992 . . . . 0.0 110.299 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.93 -40.15 78.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.336 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.11 -39.87 83.63 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.549 ' NE2' ' NZ ' ' A' ' 36' ' ' LYS . 54.5 t60 -59.93 -49.94 75.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 110.287 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.57 92.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.056 -1.027 . . . . 0.0 110.412 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.93 -39.94 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 109.831 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.02 -46.27 90.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' NZ ' ' NE2' ' A' ' 32' ' ' HIS . 75.2 mttt -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.771 -1.205 . . . . 0.0 110.608 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -53.28 59.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.933 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -60.15 -40.99 91.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.935 -1.103 . . . . 0.0 109.539 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.4 -43.51 98.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.658 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.93 -40.55 89.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.039 -1.038 . . . . 0.0 110.672 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -73.4 -40.01 64.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.88 -1.138 . . . . 0.0 110.507 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.5 t -69.97 -29.96 67.2 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.012 -1.055 . . . . 0.0 110.806 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.64 -39.39 84.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 110.46 -178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG23 HG23 ' A' ' 45' ' ' THR . 4.4 m -102.24 15.51 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.227 -0.921 . . . . 0.0 110.464 -179.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.489 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 48.5 p -145.91 145.83 26.44 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.971 -1.081 . . . . 0.0 109.353 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.45 6.34 0.96 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 120.99 1.127 . . . . 0.0 109.21 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -75.81 150.03 37.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 68.3 p -132.17 147.02 52.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.593 -0.692 . . . . 0.0 109.148 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.63 129.12 47.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.353 -0.842 . . . . 0.0 110.07 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.1 m -120.05 129.99 54.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.737 -0.602 . . . . 0.0 109.846 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -78.71 137.68 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.4 131.65 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.496 -0.753 . . . . 0.0 109.319 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 t -91.82 -5.08 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.181 -0.949 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -148.88 160.02 43.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.048 -1.033 . . . . 0.0 109.167 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.1 166.72 36.58 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 60' ' ' MET . 72.6 tp60 -81.66 139.29 35.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -1.039 . . . . 0.0 109.086 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.51 19.16 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.352 -0.843 . . . . 0.0 109.894 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -59.64 -40.19 86.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.24 116.98 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.852 . . . . 0.0 109.631 -179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 56' ' ' GLN . 89.8 mmm -100.18 134.57 42.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.179 -0.95 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.86 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.6 p -148.83 166.13 29.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -116.8 138.24 51.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.11 171.18 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.103 -0.998 . . . . 0.0 110.708 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -125.02 134.25 52.64 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.551 0.691 . . . . 0.0 110.209 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.2 -140.26 13.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 55.7 t0 -64.81 135.23 55.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.604 -0.939 . . . . 0.0 110.825 -178.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.477 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.8 p-80 -140.95 61.04 1.51 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.252 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 54.28 50.26 16.74 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.368 -0.832 . . . . 0.0 109.792 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 28.0 t0 -143.04 159.31 42.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.239 -0.913 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 25.8 m120 -90.21 9.47 28.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 109.921 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -136.81 69.8 58.42 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.912 . . . . 0.0 110.05 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.75 153.27 78.86 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 121.602 1.534 . . . . 0.0 110.204 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -77.59 140.13 39.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.35 -0.844 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.76 62.34 1.63 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.988 . . . . 0.0 109.211 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.92 -171.51 50.85 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.92 0.01 4.19 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.494 1.463 . . . . 0.0 109.184 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.27 -179.6 32.59 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.0 -154.87 45.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -72.25 149.22 44.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -1.145 . . . . 0.0 109.673 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.1 mt -92.52 -10.87 36.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.28 171.06 3.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.95 . . . . 0.0 108.794 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.45 170.19 16.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.054 -1.029 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.66 167.01 25.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.841 -179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.84 165.38 12.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 23.1 mp0 -68.41 150.56 97.65 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 0.0 109.155 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.48 111.83 0.91 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.192 1.261 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.74 162.75 35.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.04 -174.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.453 1.435 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -133.35 49.93 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.93 -10.01 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -1.006 . . . . 0.0 109.819 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.31 145.07 44.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.79 -16.13 52.0 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.76 159.96 29.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -1.215 . . . . 0.0 110.202 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.13 121.66 13.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.758 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -106.72 149.95 26.78 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.531 -0.731 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 33.3 m-85 -119.94 136.68 54.43 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.694 -0.629 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -66.1 108.2 2.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 108.871 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -73.09 -7.03 49.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 110.052 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.41 -14.22 57.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.798 -1.189 . . . . 0.0 110.012 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.31 151.18 25.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.04 -1.037 . . . . 0.0 109.169 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' NH1' HG22 ' A' ' 104' ' ' THR . 30.7 ttt-85 -88.59 107.78 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -86.83 148.64 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.152 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' NH1' ' A' ' 102' ' ' ARG . 41.0 p -137.14 164.26 28.88 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.445 -0.784 . . . . 0.0 109.976 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' A' ' 25' ' ' LEU . 86.7 m-20 -111.7 27.72 9.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 6.0 p30 -148.95 -162.92 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 110.065 -178.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -82.26 22.41 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.581 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.47 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 24.7 mmt180 -60.04 -162.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 109.601 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -51.85 -58.93 5.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 111.659 -178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.82 139.95 52.98 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.168 -0.958 . . . . 0.0 111.02 -178.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -105.67 116.55 32.14 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.71 -42.7 93.62 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 0.0 110.607 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.428 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.4 t-160 -59.74 -40.33 87.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.188 -0.945 . . . . 0.0 110.461 -178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 114' ' ' ARG . 21.2 mtt-85 -59.99 -45.0 94.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.554 -1.341 . . . . 0.0 110.086 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.44 -40.09 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.3 82.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.185 -0.947 . . . . 0.0 109.467 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.29 86.47 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.171 -0.956 . . . . 0.0 108.827 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.24 -45.09 94.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.342 -0.849 . . . . 0.0 109.291 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.55 -40.68 92.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 108.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 120' ' ' LEU . 89.5 mt -64.89 -38.55 91.34 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -50.62 -47.41 45.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -65.92 -40.07 91.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -1.184 . . . . 0.0 109.083 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -59.95 -35.84 75.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.282 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.6 mt -81.7 -0.52 43.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.34 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.52 13.04 80.99 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.799 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.6 mt -76.84 150.17 36.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.825 -1.397 . . . . 0.0 108.855 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.2 m -106.21 164.01 12.35 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.464 -0.772 . . . . 0.0 110.415 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -65.07 170.6 4.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.559 -0.713 . . . . 0.0 109.564 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.9 t -148.6 158.04 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.267 -0.895 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.5 p -94.67 9.04 40.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.205 -0.935 . . . . 0.0 109.873 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -84.33 125.86 32.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -0.968 . . . . 0.0 108.729 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 134' ' ' ALA . 95.1 mt -59.98 -39.96 81.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.131 -0.981 . . . . 0.0 109.669 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.89 8.78 2.26 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.592 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 132' ' ' ILE . . . -99.25 131.37 45.32 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.991 -1.299 . . . . 0.0 109.608 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' TYR . 91.7 mt -69.21 -34.36 74.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 108.884 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -71.62 20.05 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.554 -0.717 . . . . 0.0 110.562 -179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 24.1 t80 -61.61 135.97 94.37 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.31 -57.09 2.42 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 120.85 1.034 . . . . 0.0 111.515 -178.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.8 t -85.02 138.43 32.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.875 -1.14 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -61.0 139.86 57.95 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.4 p -150.58 164.66 35.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.131 -0.981 . . . . 0.0 109.384 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -77.34 128.86 35.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.392 -0.818 . . . . 0.0 109.261 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.9 t -120.97 13.97 11.45 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.454 -0.779 . . . . 0.0 109.679 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.38 -123.25 30.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -75.71 167.85 21.12 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -1.176 . . . . 0.0 108.228 179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG22 ' NH1' ' A' ' 114' ' ' ARG . 68.8 t -96.77 110.52 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.08 -1.013 . . . . 0.0 109.579 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -139.94 154.08 47.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -0.782 . . . . 0.0 109.073 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.9 mt -76.98 156.23 32.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.092 -1.005 . . . . 0.0 109.157 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.21 159.56 15.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.283 -0.886 . . . . 0.0 109.171 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.06 -38.64 79.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.71 -40.04 86.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.866 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -76.21 -42.73 45.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.995 -1.066 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -50.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.086 -1.009 . . . . 0.0 109.66 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.17 -40.04 96.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.985 -1.072 . . . . 0.0 110.214 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.43 -49.74 54.52 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.471 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -69.15 -38.97 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.89 -1.359 . . . . 0.0 110.156 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -65.2 -39.99 93.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 0.0 109.661 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.12 88.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.313 -0.867 . . . . 0.0 109.151 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.08 -50.02 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.612 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -96.35 -68.32 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.156 -0.965 . . . . 0.0 109.514 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.57 -161.77 31.56 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -93.98 143.87 25.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.297 -1.12 . . . . 0.0 109.82 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.489 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 5.2 m -77.76 88.44 4.0 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.85 125.73 27.54 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.037 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 167' ' ' VAL . 67.0 m-80 -154.94 72.62 5.81 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.0 109.46 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.64 56.1 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.759 1.639 . . . . 0.0 110.066 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' ASN . 85.4 t -84.1 144.9 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.851 -1.156 . . . . 0.0 110.079 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -80.02 148.95 69.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.766 0 C-N-CA 120.939 1.093 . . . . 0.0 109.562 179.177 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 2' ' ' LEU . 3.0 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.486 ' N ' HG22 ' A' ' 1' ' ' VAL . 65.9 tp -66.76 147.83 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.176 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.4 p -89.18 139.49 30.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -0.925 . . . . 0.0 108.613 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.32 80.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.013 . . . . 0.0 110.325 -179.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.48 40.02 96.0 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.641 178.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -154.31 65.99 5.17 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.44 . . . . 0.0 110.63 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.38 82.18 2.31 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 121.615 1.543 . . . . 0.0 109.832 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -146.01 141.29 27.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.755 -1.216 . . . . 0.0 109.627 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -69.02 149.71 48.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.972 -1.08 . . . . 0.0 108.968 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.6 -37.21 70.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -86.12 158.85 19.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.377 -0.827 . . . . 0.0 110.45 -178.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.6 p -99.91 -9.72 22.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 0.0 109.936 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.581 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 50.3 m170 -109.85 118.56 36.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.356 -0.84 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.7 mt -108.56 162.98 13.63 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.82 . . . . 0.0 110.571 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.7 p -135.97 158.2 44.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.36 160.24 41.37 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.949 -1.094 . . . . 0.0 110.119 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' NH1' ' N ' ' A' ' 54' ' ' GLU . 26.8 ttm-85 -144.99 129.26 17.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.63 -0.669 . . . . 0.0 109.601 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -89.6 119.28 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.42 -39.9 94.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.703 -178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -163.68 159.96 22.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.96 -1.088 . . . . 0.0 109.445 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.46 132.63 43.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.846 . . . . 0.0 109.337 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -71.65 134.38 84.11 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 108.871 179.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.21 1.15 1.73 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 N-CA-C 109.579 -0.97 . . . . 0.0 109.579 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.7 m-20 -63.75 -39.75 95.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 0.0 109.529 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.5 mt -139.53 151.0 65.57 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.18 154.04 30.31 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 N-CA-C 109.358 -1.055 . . . . 0.0 109.358 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.8 ptt-85 -69.1 -33.22 73.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 109.716 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.0 80.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.542 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -80.84 -36.45 31.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.444 -179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.02 -43.72 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.882 -178.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -59.4 -41.54 89.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.139 -0.975 . . . . 0.0 109.365 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -60.11 -41.25 92.15 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.323 -0.861 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.29 89.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.077 -1.015 . . . . 0.0 109.84 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.84 -45.29 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 0.0 109.201 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.61 -42.69 97.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.546 -0.721 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.69 -40.18 94.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.392 -0.817 . . . . 0.0 110.767 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.15 -49.52 69.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.122 . . . . 0.0 110.83 -179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 37.6 m-85 -58.72 -40.21 83.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.883 -1.135 . . . . 0.0 108.971 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -60.63 -40.95 93.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.11 -40.31 93.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.038 -1.039 . . . . 0.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 148' ' ' LEU . 91.9 m95 -73.34 -40.58 64.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.793 -1.192 . . . . 0.0 109.984 -178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.4 t -69.75 -35.76 75.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 0.0 110.289 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -54.17 -29.34 45.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.997 -1.065 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' OG ' ' A' ' 163' ' ' SER . 15.6 m -109.89 10.02 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.292 -0.88 . . . . 0.0 111.627 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.533 ' N ' ' OG ' ' A' ' 163' ' ' SER . 9.9 p -146.79 151.46 42.26 Favored Pre-proline 0 N--CA 1.507 2.388 0 O-C-N 120.525 -1.359 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.67 4.11 1.92 Allowed 'Trans proline' 0 N--CA 1.481 0.771 0 C-N-CA 121.318 1.345 . . . . 0.0 109.519 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.88 149.76 44.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.438 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 p -131.28 140.7 49.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.614 -0.678 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -120.82 134.08 55.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.522 -0.736 . . . . 0.0 109.598 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -120.66 129.97 53.92 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.548 0.689 . . . . 0.0 110.341 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -83.23 133.65 34.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.528 -0.732 . . . . 0.0 109.7 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.28 139.91 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -95.65 -12.8 24.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.987 -1.071 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.644 ' N ' ' NH1' ' A' ' 17' ' ' ARG . 97.5 mt-10 -148.89 162.36 40.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.953 -1.092 . . . . 0.0 110.165 -179.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 91.36 175.93 43.35 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.82 158.58 25.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -1.205 . . . . 0.0 109.029 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -139.68 150.56 45.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.77 -40.8 89.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 110.459 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -119.96 120.08 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.269 -0.894 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 83.9 mmm -102.97 130.52 50.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.426 -0.796 . . . . 0.0 109.371 179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.62 130.24 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.173 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.2 p -147.62 160.64 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.083 -1.011 . . . . 0.0 110.229 -179.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -110.17 136.04 50.02 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.82 164.88 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.228 -0.92 . . . . 0.0 110.92 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -127.94 141.28 51.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.641 -0.662 . . . . 0.0 110.034 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.95 -149.52 3.35 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.38 130.02 41.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 110.115 -179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 46.8 p-80 -138.49 64.77 1.48 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 54.28 51.36 14.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.445 -0.784 . . . . 0.0 109.215 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 48.3 t0 -139.88 151.83 45.96 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.3 m-20 -88.49 8.52 27.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.514 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.1 m -134.45 68.88 73.09 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.524 -0.735 . . . . 0.0 109.224 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.22 147.99 94.1 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.323 1.349 . . . . 0.0 109.534 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.87 149.59 37.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.368 -0.832 . . . . 0.0 109.632 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -138.82 79.35 1.73 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.834 . . . . 0.0 109.03 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.42 178.46 51.99 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.02 -0.28 3.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.594 1.529 . . . . 0.0 109.762 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.92 173.45 38.05 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.56 -165.08 49.56 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.42 147.56 47.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.212 -1.17 . . . . 0.0 109.281 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.03 -8.25 51.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -178.45 175.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -165.89 174.46 9.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.682 -1.261 . . . . 0.0 110.588 179.425 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.99 161.86 39.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.551 -0.718 . . . . 0.0 109.371 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.61 164.47 12.95 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.9 147.5 96.13 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.957 -1.089 . . . . 0.0 108.791 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.79 109.14 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.671 0 C-N-CA 121.139 1.226 . . . . 0.0 110.374 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.72 167.43 39.08 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -62.74 -176.72 0.27 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.23 1.286 . . . . 0.0 109.949 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.18 -121.58 26.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -82.3 -12.0 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.44 -1.036 . . . . 0.0 110.477 -179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.5 134.75 49.93 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 -18.33 57.53 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -64.33 154.26 35.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.28 . . . . 0.0 109.645 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.52 12.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -105.38 144.87 31.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.633 . . . . 0.0 110.459 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.1 m-85 -113.7 137.07 52.13 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.471 0.653 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -65.14 101.2 0.51 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.566 -0.708 . . . . 0.0 109.148 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -79.44 -10.01 59.72 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -0.962 . . . . 0.0 110.839 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -75.27 -20.69 59.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.55 -1.344 . . . . 0.0 109.46 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -86.28 161.78 18.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 108.867 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -92.32 115.46 28.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.028 . . . . 0.0 108.668 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -88.59 149.59 23.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.8 p -139.15 160.58 39.45 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -110.47 29.34 7.79 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.482 -0.761 . . . . 0.0 109.171 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -143.59 -165.01 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.338 -0.851 . . . . 0.0 110.469 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 108' ' ' ARG . 40.7 m-85 -80.45 11.81 3.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.6 mtt180 -57.04 -160.45 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 110.022 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -47.0 -59.67 2.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 111.82 -177.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.433 ' O ' ' OG1' ' A' ' 104' ' ' THR . 89.2 m-85 -129.99 136.3 49.26 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.983 -1.073 . . . . 0.0 111.526 -178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.32 113.04 24.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 tp -57.66 -42.05 82.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.0 110.632 -179.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -60.0 -45.28 93.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.171 -0.956 . . . . 0.0 110.964 -178.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' A' ' 114' ' ' ARG . 29.6 ttm-85 -57.84 -39.5 77.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.911 -1.118 . . . . 0.0 109.05 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.7 -40.0 78.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.379 -0.826 . . . . 0.0 109.349 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.17 89.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.185 -0.947 . . . . 0.0 109.229 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.91 86.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.994 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.423 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 67.9 t60 -60.21 -49.88 75.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.236 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 86.3 mt-10 -62.05 -40.13 94.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.808 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.56 -37.6 85.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.651 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.0 95.28 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -66.8 -39.9 87.93 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -1.215 . . . . 0.0 109.249 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.1 p -60.24 -27.56 67.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.057 179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.2 mt -83.78 -0.52 51.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 108.997 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.0 19.27 59.59 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.82 150.62 30.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.922 -1.34 . . . . 0.0 109.31 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.4 m -105.96 161.42 14.47 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -61.84 171.35 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.446 -0.784 . . . . 0.0 110.252 -179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 t -149.26 157.67 43.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.2 -0.937 . . . . 0.0 109.999 -179.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.6 p -99.97 10.09 41.86 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.413 -0.804 . . . . 0.0 110.469 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.03 125.07 31.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.039 -1.038 . . . . 0.0 109.423 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.79 -41.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.548 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 5.7 12.98 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.836 -1.173 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.15 133.35 40.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.77 -1.43 . . . . 0.0 109.485 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 137' ' ' TYR . 89.7 mt -70.0 -28.12 65.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.315 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.423 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 94.0 mmm -72.34 13.15 0.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.94 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 135' ' ' LEU . 19.4 t80 -61.83 137.08 95.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -55.48 -53.78 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 120.968 1.112 . . . . 0.0 111.219 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.2 m -83.03 148.0 27.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.128 -0.982 . . . . 0.0 110.981 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -67.05 149.49 50.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.529 -0.732 . . . . 0.0 109.334 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.0 p -145.74 152.07 38.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.059 -1.026 . . . . 0.0 109.851 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -79.3 120.31 23.58 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.661 -0.649 . . . . 0.0 109.319 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.8 t -128.59 130.07 46.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.83 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 45.3 t0 -86.82 157.52 19.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 109.133 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.559 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 95.5 t -97.41 109.44 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -139.42 159.93 41.01 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 41' ' ' TRP . 85.5 mt -75.41 155.65 36.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 109.644 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.24 150.83 20.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -56.27 -39.65 72.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 108.874 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -54.12 -38.15 65.09 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -76.62 -40.51 49.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.108 -0.995 . . . . 0.0 109.372 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.2 mm -60.91 -51.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.0 109.816 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.42 -40.41 94.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 110.435 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.15 -48.46 39.08 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.12 -178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -69.47 -39.36 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.819 -1.401 . . . . 0.0 109.549 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -65.15 -40.37 94.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.139 . . . . 0.0 109.053 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.02 92.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.242 -0.911 . . . . 0.0 109.616 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.2 mt -66.26 -50.93 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.166 -0.958 . . . . 0.0 109.935 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -95.77 -68.48 0.8 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 0.0 109.791 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.23 -167.18 33.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -86.14 156.33 20.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -1.098 . . . . 0.0 109.321 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 45' ' ' THR . 72.6 m -75.53 60.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.021 -1.049 . . . . 0.0 109.715 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -73.62 130.25 39.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.903 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 167' ' ' VAL . 71.2 m-80 -158.64 70.14 3.68 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.02 38.12 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.502 1.468 . . . . 0.0 110.006 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ASN . 26.8 m -84.08 139.88 16.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -82.51 147.76 56.88 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--N 1.322 -0.842 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 179.445 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.03 -39.96 87.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 108.84 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 p -131.83 -154.13 0.6 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.634 -0.666 . . . . 0.0 109.437 -179.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 6' ' ' ASN . 52.5 tp10 -65.85 155.39 36.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.426 -0.796 . . . . 0.0 108.869 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.74 23.09 0.04 OUTLIER Glycine 0 N--CA 1.496 2.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.003 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 4' ' ' GLU . 52.5 m-80 -154.23 67.41 5.67 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.924 -1.339 . . . . 0.0 109.014 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.11 92.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 121.377 1.385 . . . . 0.0 109.738 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HG2' HH11 ' A' ' 8' ' ' ARG . 35.5 mtt-85 -142.64 150.03 39.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.859 . . . . 0.0 108.749 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -67.7 124.32 22.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.098 -1.001 . . . . 0.0 109.213 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -77.19 -17.89 58.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.812 . . . . 0.0 109.87 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -88.54 146.53 25.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -0.953 . . . . 0.0 110.051 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -92.88 -4.84 52.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.678 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 92.5 m-70 -120.31 132.22 55.21 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.06 160.02 37.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.313 -0.867 . . . . 0.0 109.519 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -129.1 155.27 45.73 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -143.69 157.4 44.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.279 -0.888 . . . . 0.0 109.145 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH21 ' CE ' ' A' ' 60' ' ' MET . 40.8 ttp180 -143.34 133.07 23.83 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.349 -0.844 . . . . 0.0 110.538 -178.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.4 mt -88.08 118.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -66.58 -39.88 88.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -0.989 . . . . 0.0 110.26 -178.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -160.38 163.59 33.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 110.298 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -111.13 134.14 52.95 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.667 -0.646 . . . . 0.0 109.304 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -77.07 139.85 65.75 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.15 -0.969 . . . . 0.0 108.426 179.426 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.54 1.71 0.68 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 N-CA-C 109.651 -0.942 . . . . 0.0 109.651 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 22' ' ' THR . 96.0 m-20 -63.99 -39.91 95.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.675 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.8 mt -141.3 150.1 57.15 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.261 -0.899 . . . . 0.0 108.66 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.72 152.63 61.75 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 N-CA-C 108.899 -1.231 . . . . 0.0 108.899 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -68.64 -30.39 69.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.012 -1.055 . . . . 0.0 110.261 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.0 87.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 109.708 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -78.3 -32.46 49.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.9 t -70.32 -45.69 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.026 -1.046 . . . . 0.0 109.801 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.93 -40.14 87.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.031 -1.043 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -60.09 -45.34 93.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.004 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -43.94 94.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.816 . . . . 0.0 110.015 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.8 mm -70.03 -40.05 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.0 -45.82 91.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.602 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.059 -1.026 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.05 -52.63 64.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.179 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.7 m-85 -60.02 -40.82 90.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.949 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -60.33 -44.42 95.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.132 -0.98 . . . . 0.0 110.146 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.95 -42.06 93.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 110.041 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CH2' HD22 ' A' ' 148' ' ' LEU . 86.5 m95 -73.71 -41.48 62.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.959 -1.088 . . . . 0.0 109.926 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 t -68.72 -39.77 80.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.325 -0.859 . . . . 0.0 110.227 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -53.04 -29.94 32.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -0.808 . . . . 0.0 110.849 -179.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -106.31 9.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.074 -1.016 . . . . 0.0 110.871 -178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.9 p -150.15 150.45 29.59 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 120.808 -1.182 . . . . 0.0 109.212 179.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.39 7.5 0.38 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.226 1.284 . . . . 0.0 110.309 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 87.0 mt -75.02 149.08 39.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 0.0 109.718 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.678 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 30.4 p -133.37 149.06 51.86 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.422 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 97.9 m-85 -129.53 135.82 49.08 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.402 -0.811 . . . . 0.0 109.601 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.8 m -119.95 129.86 54.51 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.569 -0.707 . . . . 0.0 109.677 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -82.23 129.29 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.598 -0.689 . . . . 0.0 109.181 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 52' ' ' VAL . 27.6 m -127.29 128.55 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 108.733 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -92.41 -4.48 53.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 109.725 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -145.8 159.75 42.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 109.165 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.72 170.57 46.34 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -80.07 155.25 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -1.187 . . . . 0.0 109.063 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.64 143.63 45.62 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 109.139 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -59.93 -41.47 91.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.12 116.53 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.45 -0.781 . . . . 0.0 109.504 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.416 ' CE ' HH21 ' A' ' 17' ' ' ARG . 86.5 mmm -101.01 135.57 42.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.213 -0.929 . . . . 0.0 109.312 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -119.9 130.63 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.535 -0.728 . . . . 0.0 109.156 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.5 p -147.0 159.73 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.156 -0.965 . . . . 0.0 110.413 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -115.88 137.42 52.12 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.87 169.96 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.053 -1.029 . . . . 0.0 110.754 -178.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.64 135.38 52.1 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.436 0.636 . . . . 0.0 110.319 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.06 -145.07 4.5 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -64.67 137.31 57.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -1.002 . . . . 0.0 109.603 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 27.7 p-80 -137.72 65.84 1.47 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.468 -0.77 . . . . 0.0 109.938 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 99.2 mtt180 52.68 44.17 30.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.432 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 69' ' ' ARG . 6.7 m-20 -138.47 159.79 41.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.487 -0.758 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -90.7 9.01 31.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.294 -0.879 . . . . 0.0 109.896 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -132.42 70.03 79.84 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.65 158.32 46.76 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.507 1.472 . . . . 0.0 110.21 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.63 143.24 38.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -100.56 65.52 1.18 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.0 109.904 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.09 -173.43 48.42 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.33 -1.19 4.26 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.512 1.475 . . . . 0.0 109.855 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.78 176.13 31.91 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.46 -158.51 37.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.05 144.55 50.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -1.1 . . . . 0.0 109.224 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.6 mt -88.64 -6.33 57.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.138 -0.976 . . . . 0.0 108.627 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.7 175.88 1.98 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -166.04 170.65 13.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 109.73 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.97 167.84 23.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.581 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.2 161.83 13.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.522 -0.737 . . . . 0.0 109.227 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -62.81 147.2 93.99 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.112 -0.993 . . . . 0.0 108.882 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.02 113.19 1.32 Allowed 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.239 1.293 . . . . 0.0 110.257 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.92 170.56 43.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.4 -175.8 0.27 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 121.504 1.469 . . . . 0.0 109.883 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.02 -128.05 45.4 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.36 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 110.135 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.74 140.63 47.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.19 -18.14 47.06 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.73 152.91 44.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -1.204 . . . . 0.0 110.126 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 119.5 13.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 108.961 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -103.12 144.36 31.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.452 -0.78 . . . . 0.0 110.519 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -119.18 140.03 50.85 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.454 0.645 . . . . 0.0 109.789 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -68.36 103.75 1.7 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -79.0 -9.97 59.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -77.63 -19.99 54.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.89 -1.131 . . . . 0.0 108.711 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.78 160.43 21.23 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -88.19 110.3 20.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -90.66 134.63 34.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 46.7 p -133.89 156.48 48.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 109.361 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -108.9 33.31 4.31 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -147.07 -160.83 1.21 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.289 -0.882 . . . . 0.0 110.276 -178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 108' ' ' ARG . 11.9 m-85 -79.65 9.75 4.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.187 -0.946 . . . . 0.0 110.941 -178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' PHE . 97.3 mtt180 -58.51 -158.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.916 -1.115 . . . . 0.0 110.435 -179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -48.08 -59.76 3.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 111.967 -177.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -134.81 150.24 50.48 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.903 -1.123 . . . . 0.0 110.893 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 31.3 m-20 -101.66 119.6 39.03 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.534 -0.729 . . . . 0.0 109.063 179.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.04 -43.22 95.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.576 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.9 -45.49 92.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.916 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 114' ' ' ARG . 35.8 ttt-85 -59.95 -46.25 90.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.866 -1.146 . . . . 0.0 110.031 -179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 73.1 t -70.05 -39.91 77.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.02 -1.05 . . . . 0.0 109.068 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.05 78.48 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.69 86.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.5 -0.75 . . . . 0.0 109.226 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 77.9 t60 -60.03 -49.41 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.695 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 9.7 mp0 -64.16 -39.98 95.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.998 -1.064 . . . . 0.0 109.44 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.22 -40.05 94.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.051 -1.031 . . . . 0.0 108.956 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.95 -41.73 97.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.87 -40.01 94.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.087 -1.243 . . . . 0.0 108.782 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.5 m -56.99 -31.42 65.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.9 mt -81.22 -1.28 44.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 108.982 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.72 17.82 59.33 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.5 mt -78.06 149.79 33.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.841 -1.388 . . . . 0.0 108.963 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.2 m -104.92 170.01 8.12 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 110.416 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -69.92 171.59 9.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.578 -0.701 . . . . 0.0 109.568 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -150.29 156.35 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.183 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -99.04 9.94 42.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.367 -0.833 . . . . 0.0 109.636 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -84.96 124.53 31.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.3 mt -60.09 -40.02 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.8 3.04 10.14 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.706 -178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.73 140.56 31.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.984 -1.303 . . . . 0.0 109.159 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 137' ' ' TYR . 94.7 mt -69.08 -33.85 74.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.42 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.1 mtp -71.36 20.06 0.05 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 110.425 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.4 t80 -64.84 132.33 95.42 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.9 23.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 121.162 1.241 . . . . 0.0 111.994 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.4 t -156.79 128.91 7.35 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.359 -1.463 . . . . 0.0 110.173 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.02 135.72 57.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.583 -0.698 . . . . 0.0 109.77 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.8 p -153.42 120.73 5.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.169 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -81.07 129.82 34.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.1 m -143.57 97.66 3.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.45 -134.06 34.0 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.34 168.08 14.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 0.0 109.764 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.01 110.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 109.286 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -135.47 160.64 37.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.501 -0.749 . . . . 0.0 109.017 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.539 HD22 ' CH2' ' A' ' 41' ' ' TRP . 75.7 mt -75.01 158.12 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.68 152.64 22.89 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.187 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -54.33 -35.81 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -58.13 -39.94 80.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -74.25 -39.98 62.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.453 -0.779 . . . . 0.0 109.257 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.14 -50.06 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.092 -1.005 . . . . 0.0 109.538 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.91 -40.02 94.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 -179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.87 -53.51 40.29 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.88 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.878 -1.366 . . . . 0.0 109.976 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -66.29 -39.75 89.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.993 -1.067 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.08 87.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.108 -0.995 . . . . 0.0 108.839 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.12 -49.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.294 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -97.65 -68.85 0.78 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.236 -0.915 . . . . 0.0 109.822 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 154.94 -162.09 30.68 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 162' ' ' ARG . 45.5 mtt-85 -88.93 150.82 22.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.49 -1.006 . . . . 0.0 109.68 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.2 m -77.2 84.51 3.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' ND2' ' A' ' 165' ' ' ASN . 97.9 mt-30 -73.12 135.02 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 109.544 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 164' ' ' GLN . 23.0 m-80 -157.54 149.43 17.31 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 108.723 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.83 130.52 40.81 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.92 120.08 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.213 -0.93 . . . . 0.0 109.2 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -78.06 149.63 76.79 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 109.148 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.326 -0.639 0 C-N-CA 120.828 1.019 . . . . 0.0 109.761 179.614 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -87.85 -9.25 54.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.952 . . . . 0.0 108.945 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.4 p -94.34 169.85 9.92 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.22 83.63 1.36 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.126 -0.984 . . . . 0.0 109.572 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' O ' ' ND2' ' A' ' 6' ' ' ASN . . . 49.92 30.4 15.55 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 5' ' ' GLY . 27.1 m-80 -158.11 68.76 3.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.4 . . . . 0.0 110.214 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -73.71 48.07 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.68 1.586 . . . . 0.0 109.936 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -148.49 157.34 43.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.933 -1.104 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -70.93 138.38 50.02 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.36 -34.58 70.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.032 . . . . 0.0 110.151 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.59 145.86 27.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.05 -1.031 . . . . 0.0 109.485 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -90.12 -3.15 58.07 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -122.35 135.98 54.81 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.83 161.68 33.52 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.445 -0.784 . . . . 0.0 110.03 -178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.0 p -128.17 159.8 34.03 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -146.14 156.11 43.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.039 -1.038 . . . . 0.0 110.164 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -147.25 141.22 25.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.524 -0.735 . . . . 0.0 109.775 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.9 mt -95.04 121.7 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.469 -0.769 . . . . 0.0 109.035 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 69.8 mm-40 -68.21 -39.16 82.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.625 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.6 m-20 -159.22 164.15 35.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.064 . . . . 0.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.23 131.67 54.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -72.69 138.22 80.25 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.032 -1.042 . . . . 0.0 108.535 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.96 2.15 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 109.733 -0.91 . . . . 0.0 109.733 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 22' ' ' THR . 89.4 m-20 -65.35 -40.18 93.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.275 -0.891 . . . . 0.0 109.978 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' OD1' ' A' ' 105' ' ' ASN . 45.2 mt -141.17 150.14 57.7 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.17 148.5 89.4 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.067 1.178 . . . . 0.0 109.422 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.2 ptt180 -61.37 -28.21 69.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -60.12 -39.16 85.28 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.931 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -82.99 -30.07 28.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.111 -0.993 . . . . 0.0 110.241 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.65 -48.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.047 -1.033 . . . . 0.0 110.889 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.4 p-10 -56.24 -40.37 74.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.715 -1.241 . . . . 0.0 109.525 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -60.19 -45.05 94.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.41 65.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.443 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.44 -43.48 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 109.878 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -41.67 92.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.139 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.6 -40.16 96.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.826 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.74 87.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 110.171 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -59.93 -40.17 88.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.799 -1.188 . . . . 0.0 109.235 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.97 -41.13 95.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.058 -1.026 . . . . 0.0 110.636 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.6 -42.14 98.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 0.0 110.315 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -70.19 -40.25 74.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -39.44 76.91 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -51.5 -30.69 21.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.165 -0.959 . . . . 0.0 110.654 -178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.69 15.34 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.425 ' N ' ' OG ' ' A' ' 163' ' ' SER . 36.5 p -150.41 148.7 24.71 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.897 -1.127 . . . . 0.0 109.667 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.43 1.85 3.85 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.217 1.278 . . . . 0.0 109.823 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.31 148.95 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 109.103 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.6 p -129.82 147.55 51.61 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.66 129.74 47.72 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.276 -0.89 . . . . 0.0 109.738 -179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.0 m -120.2 129.77 54.25 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.445 -0.784 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -80.01 147.55 31.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.073 . . . . 0.0 108.652 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.95 132.4 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 O-C-N 121.089 -1.007 . . . . 0.0 108.744 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -90.12 -4.52 57.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.186 -0.946 . . . . 0.0 110.128 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -149.99 159.97 43.98 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.358 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 165.22 23.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -80.49 162.82 24.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.36 -1.083 . . . . 0.0 110.281 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.23 153.3 48.73 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.396 -0.815 . . . . 0.0 109.164 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.9 -43.58 94.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.149 -0.97 . . . . 0.0 110.118 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.2 106.91 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.266 -0.896 . . . . 0.0 108.786 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 76.9 mtp -99.73 136.16 40.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.362 -0.837 . . . . 0.0 109.524 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -119.89 129.44 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -145.52 157.9 43.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.101 -0.999 . . . . 0.0 110.356 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.35 133.82 54.95 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.54 168.85 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.118 -0.989 . . . . 0.0 109.893 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 51.9 mtt-85 -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.411 -0.806 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.84 -141.52 6.28 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -59.29 135.99 57.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 32.6 p-80 -133.84 48.19 2.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 56.78 53.96 7.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.532 -0.73 . . . . 0.0 109.182 -179.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 43.4 t0 -146.69 166.86 25.3 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.284 -0.885 . . . . 0.0 109.285 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 61.2 t30 -88.83 8.89 26.79 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 109.852 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.9 m -133.63 67.79 75.51 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.328 -0.857 . . . . 0.0 110.356 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.89 147.86 94.13 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.23 1.286 . . . . 0.0 109.75 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -72.92 136.88 45.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -104.75 66.1 0.77 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.426 -0.797 . . . . 0.0 109.261 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 77.01 -178.18 51.52 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.64 0.93 0.62 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.482 1.455 . . . . 0.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -99.13 -179.68 31.38 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.25 -158.59 47.93 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -71.83 152.22 42.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 109.395 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.57 -9.28 29.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.141 -0.974 . . . . 0.0 109.196 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.89 173.99 2.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -165.33 169.34 15.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.289 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.96 166.94 27.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.345 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -95.45 172.0 8.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.804 . . . . 0.0 109.256 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.4 mp0 -69.11 148.42 97.69 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.945 . . . . 0.0 108.847 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.5 93.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 121.212 1.275 . . . . 0.0 109.793 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.61 168.18 33.72 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.85 -174.4 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 C-N-CA 121.351 1.368 . . . . 0.0 109.597 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.62 -131.59 49.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -79.67 -7.87 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -1.156 . . . . 0.0 109.428 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.12 140.71 46.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.54 -14.66 60.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -68.6 159.51 31.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.293 . . . . 0.0 109.56 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -142.95 120.16 11.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.094 -1.004 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -104.47 145.81 29.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -121.07 139.34 53.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.546 -0.722 . . . . 0.0 109.841 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -64.6 102.0 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 109.307 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.521 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 64.9 tt0 -76.59 -3.57 38.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.631 -0.668 . . . . 0.0 110.101 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -77.38 -30.73 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.771 -1.206 . . . . 0.0 110.139 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -85.97 158.28 19.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 109.455 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.3 ttm-85 -89.32 120.62 30.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.943 . . . . 0.0 109.499 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -88.23 145.19 26.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.674 -0.641 . . . . 0.0 109.817 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -140.71 162.47 35.33 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HD13 ' A' ' 25' ' ' LEU . 32.2 m120 -109.98 31.76 5.61 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.4 p30 -148.37 -164.98 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.26 -0.9 . . . . 0.0 110.519 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.2 t80 -70.64 2.83 3.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.418 -0.801 . . . . 0.0 111.037 -178.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 107' ' ' PHE . 63.5 mtt-85 -58.38 -157.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.982 -1.074 . . . . 0.0 110.327 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -45.76 -60.09 2.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.244 -0.91 . . . . 0.0 112.546 -177.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -143.8 156.4 44.48 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.658 -1.276 . . . . 0.0 111.906 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 83.0 m-20 -101.23 117.42 34.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.931 -1.106 . . . . 0.0 110.584 -179.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -60.05 -40.08 88.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 0.0 110.144 -178.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -58.07 -50.68 72.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.007 . . . . 0.0 109.623 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.485 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 78.7 t -70.27 -43.59 78.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.036 -1.04 . . . . 0.0 108.772 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.33 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.61 -38.96 82.68 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.902 -1.124 . . . . 0.0 108.796 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 73.3 t60 -59.64 -51.48 69.64 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.485 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 24.7 mp0 -62.92 -39.95 96.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.633 -1.292 . . . . 0.0 109.324 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.34 -39.54 87.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.64 -40.73 95.1 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -64.82 -39.98 94.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.848 -1.383 . . . . 0.0 108.978 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.4 t -57.66 -30.52 65.48 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.5 mt -82.37 -6.79 59.5 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.22 11.16 60.17 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.0 mt -79.02 143.52 35.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.172 -1.193 . . . . 0.0 109.32 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 55.6 m -110.07 160.18 16.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.498 0.666 . . . . 0.0 110.074 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -50.82 172.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.625 -0.672 . . . . 0.0 109.647 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 t -150.29 162.38 40.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.327 -0.858 . . . . 0.0 108.969 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.7 p -95.61 -0.12 52.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -82.4 117.74 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.904 -1.122 . . . . 0.0 109.159 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -57.18 -31.12 36.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.537 -0.727 . . . . 0.0 109.937 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.48 7.03 13.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.77 142.2 28.33 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.162 -1.199 . . . . 0.0 109.573 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.8 mt -68.39 -39.7 81.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.812 . . . . 0.0 109.239 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.425 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 51.6 mtp -72.7 27.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.63 -0.669 . . . . 0.0 110.925 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 14.0 t80 -65.12 138.72 97.43 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -46.18 25.67 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 120.896 1.064 . . . . 0.0 110.69 -179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.3 m -84.99 142.96 29.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.902 -1.123 . . . . 0.0 109.975 -179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.53 136.73 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 108.528 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.5 p -151.07 127.65 10.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.933 -1.105 . . . . 0.0 110.163 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -82.91 132.67 35.15 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.1 m -141.94 88.19 2.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.052 -1.03 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.3 -136.87 11.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.08 169.8 17.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -1.08 . . . . 0.0 109.26 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.7 t -93.74 113.86 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.201 -0.937 . . . . 0.0 109.109 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.4 160.06 39.89 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.8 157.22 33.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.926 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.0 161.57 13.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.449 -0.782 . . . . 0.0 109.279 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.86 -39.14 84.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.396 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -59.3 -40.46 86.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 0.0 109.739 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -77.52 -42.54 35.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 110.181 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.71 -50.35 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.818 -1.176 . . . . 0.0 109.278 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -63.37 -39.87 95.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.315 -0.866 . . . . 0.0 109.728 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.92 -50.92 49.86 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.076 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.76 -38.11 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.839 -1.389 . . . . 0.0 110.047 -178.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.74 -40.04 84.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.956 -1.09 . . . . 0.0 109.685 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.11 91.33 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.805 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.9 mt -65.05 -51.28 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.039 . . . . 0.0 109.715 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.59 -71.15 0.67 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 109.759 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.05 -169.8 35.34 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 162' ' ' ARG . 22.9 mmm-85 -87.89 148.19 24.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 108.892 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 45' ' ' THR . 11.5 m -76.35 86.5 3.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 108.867 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.34 134.36 44.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.437 -0.79 . . . . 0.0 109.89 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 167' ' ' VAL . 33.7 m-80 -154.03 68.96 6.2 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.319 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.48 79.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.297 1.331 . . . . 0.0 109.313 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASN . 7.8 p -85.91 144.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -78.69 148.71 73.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.236 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 C-N-CA 121.07 1.18 . . . . 0.0 109.746 179.338 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.437 ' H ' HG23 ' A' ' 1' ' ' VAL . 45.7 mt -86.89 -74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.974 . . . . 0.0 108.852 179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.0 p -100.62 124.15 45.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.799 . . . . 0.0 109.303 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -72.05 136.36 46.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.915 . . . . 0.0 109.104 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -62.22 0.38 Allowed Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -155.03 76.55 5.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.924 -1.339 . . . . 0.0 109.717 -179.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.83 154.2 67.77 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.581 1.52 . . . . 0.0 110.131 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.417 ' HG3' ' NH1' ' A' ' 8' ' ' ARG . 39.2 mtm-85 -92.4 154.56 18.45 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -68.44 138.05 54.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.201 -0.937 . . . . 0.0 109.624 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.95 -34.75 62.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.349 -0.844 . . . . 0.0 110.554 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -80.04 152.9 29.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.877 -1.139 . . . . 0.0 109.721 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -92.54 -9.43 41.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.209 -0.932 . . . . 0.0 108.566 178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -124.01 130.94 53.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.9 mt -114.87 163.21 15.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.574 -0.704 . . . . 0.0 109.586 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -126.03 159.61 32.29 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -147.5 155.55 41.99 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.935 -1.103 . . . . 0.0 110.275 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.41 131.56 21.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.784 . . . . 0.0 109.803 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.94 117.74 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 108.771 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' OE1' ' O ' ' A' ' 61' ' ' ILE . 25.9 mp0 -68.42 -39.93 81.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.688 -179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -161.64 167.26 25.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 110.23 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.6 139.69 49.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -76.22 136.55 68.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.926 -1.109 . . . . 0.0 109.024 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.07 1.44 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 109.544 -0.983 . . . . 0.0 109.544 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 22' ' ' THR . 97.9 m-20 -62.88 -41.55 99.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.216 -0.927 . . . . 0.0 109.032 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.4 mt -141.25 151.03 60.42 Favored Pre-proline 0 N--CA 1.5 2.032 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.12 152.4 65.92 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 121.038 1.159 . . . . 0.0 110.5 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 27' ' ' ARG . 19.2 ptt-85 -60.45 -34.06 73.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.95 78.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.223 -0.923 . . . . 0.0 109.999 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.32 -36.01 58.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -70.9 -42.47 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.0 109.325 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -58.83 -41.71 87.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.992 -1.068 . . . . 0.0 109.508 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -60.5 -48.02 83.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.12 -0.987 . . . . 0.0 109.209 178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.16 82.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.581 -0.699 . . . . 0.0 110.084 -179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.97 -44.92 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.101 -0.999 . . . . 0.0 109.27 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.19 -43.82 95.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.18 -0.95 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.27 -0.894 . . . . 0.0 110.789 -179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.24 82.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 110.164 -179.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -59.89 -41.83 92.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.643 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -60.37 -40.39 90.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.21 -43.11 96.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.665 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -73.31 -42.2 62.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.987 . . . . 0.0 109.67 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.2 t -70.31 -29.12 65.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.316 -0.865 . . . . 0.0 110.713 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.68 -39.24 83.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 -179.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' O ' ' NE2' ' A' ' 157' ' ' GLN . 27.3 m -105.09 18.56 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.214 -0.929 . . . . 0.0 110.628 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 44' ' ' VAL . 69.7 p -145.05 146.97 32.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.945 -1.097 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -69.29 4.81 1.78 Allowed 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.088 1.192 . . . . 0.0 110.029 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.85 147.42 43.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 110.047 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -130.85 146.6 52.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -121.31 132.13 54.61 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.452 -0.78 . . . . 0.0 109.794 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -119.87 128.12 53.36 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.55 -0.719 . . . . 0.0 109.295 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -79.56 140.09 37.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.184 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.4 m -125.63 129.97 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.387 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.2 t -94.1 -8.6 39.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.117 -0.989 . . . . 0.0 109.91 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -145.46 160.05 42.17 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.138 -0.977 . . . . 0.0 109.653 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 177.36 51.85 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -80.02 160.01 26.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -1.194 . . . . 0.0 109.559 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.67 143.62 50.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.714 . . . . 0.0 109.2 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -60.07 -40.14 88.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.877 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.11 118.66 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.828 . . . . 0.0 109.374 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.4 mtp -101.01 135.22 42.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.2 -0.937 . . . . 0.0 109.411 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 96.3 mt -118.4 121.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.424 -0.797 . . . . 0.0 109.048 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 93.7 p -145.76 168.62 20.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.116 -0.99 . . . . 0.0 110.286 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -116.29 139.66 50.15 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -133.12 166.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.403 -0.811 . . . . 0.0 110.747 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -128.77 130.84 47.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.605 -0.684 . . . . 0.0 109.66 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.48 -139.96 6.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -68.41 128.68 37.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -1.0 . . . . 0.0 109.745 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.62 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 2.6 p-80 -134.76 65.11 1.58 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 69' ' ' ARG . 45.0 mtt-85 55.4 48.86 18.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.556 0.693 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.3 m-20 -138.41 158.1 44.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -92.04 8.07 39.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.284 -0.885 . . . . 0.0 109.259 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.515 ' N ' HD22 ' A' ' 71' ' ' ASN . 74.8 m -134.54 68.26 72.28 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.584 -0.698 . . . . 0.0 109.612 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.59 155.23 64.18 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.241 1.294 . . . . 0.0 109.807 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.32 144.7 42.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.146 -0.971 . . . . 0.0 109.632 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -100.8 60.27 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.428 -0.795 . . . . 0.0 109.453 -179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 84.84 -177.24 51.06 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.19 1.11 1.74 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.401 1.401 . . . . 0.0 109.138 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -94.36 176.4 35.47 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.37 -157.14 45.9 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -70.91 147.5 48.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.347 -1.09 . . . . 0.0 109.265 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -0.24 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 109.208 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -177.32 175.44 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.9 168.61 12.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.538 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.77 161.26 40.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.283 -0.885 . . . . 0.0 109.1 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.01 162.55 14.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 109.128 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.82 147.03 80.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.993 -1.067 . . . . 0.0 108.966 -179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -61.07 110.28 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.218 1.279 . . . . 0.0 110.07 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.12 172.95 44.66 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.42 179.57 0.63 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.412 1.408 . . . . 0.0 110.252 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.2 -127.0 41.68 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.15 -8.16 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.442 -1.034 . . . . 0.0 110.497 -178.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.42 136.61 42.34 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.582 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.26 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -64.61 131.44 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.259 . . . . 0.0 109.587 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.5 128.44 54.09 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -116.21 132.2 56.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.454 -0.779 . . . . 0.0 110.115 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.9 m-85 -111.03 133.37 53.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.497 -0.752 . . . . 0.0 109.79 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -70.06 106.35 3.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -76.61 -0.83 24.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 110.585 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -74.29 -33.22 63.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.577 -1.327 . . . . 0.0 110.105 -179.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 57.9 mp0 -81.95 156.36 24.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.925 -1.11 . . . . 0.0 109.614 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -90.66 120.05 31.41 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.463 -0.773 . . . . 0.0 109.097 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -88.56 147.01 24.81 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.199 -0.938 . . . . 0.0 110.567 -179.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.9 p -137.32 162.81 32.55 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -110.25 27.47 9.59 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.606 -0.684 . . . . 0.0 109.434 -179.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 108' ' ' ARG . 4.7 p30 -146.01 -164.48 1.97 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.24 -0.913 . . . . 0.0 109.694 -178.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -70.99 -3.14 17.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.071 -1.018 . . . . 0.0 111.02 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 106' ' ' ASN . 85.1 mtm180 -55.92 172.62 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.891 -1.13 . . . . 0.0 110.097 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.9 mt-10 -5.73 -77.47 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -139.72 155.89 47.09 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.108 -0.995 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 14.6 m-20 -104.44 122.67 46.0 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.72 -39.91 86.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.877 -1.14 . . . . 0.0 110.359 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -59.94 -44.58 94.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.9 -1.125 . . . . 0.0 110.513 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 142' ' ' PHE . 67.7 mtt-85 -60.0 -43.0 95.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.756 -1.215 . . . . 0.0 110.124 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -71.89 -40.18 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 108.881 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.91 94.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.89 86.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 108.979 179.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.04 -46.66 88.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.87 . . . . 0.0 109.684 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.521 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 84.6 mt-10 -62.67 -40.08 95.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 109.624 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.83 -37.01 85.07 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.062 -1.024 . . . . 0.0 108.603 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.11 97.99 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -62.82 -40.29 96.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.132 -1.217 . . . . 0.0 108.892 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -60.05 -37.02 78.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 108.921 178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.27 0.3 37.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 110.196 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.21 4.46 74.29 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.05 -1.071 . . . . 0.0 110.793 178.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.11 143.35 43.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.706 -1.467 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.4 m -104.29 176.12 5.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.536 -0.727 . . . . 0.0 109.991 -179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -62.21 -174.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.1 t -154.22 154.25 33.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.9 p -96.65 3.25 52.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.418 -0.802 . . . . 0.0 109.637 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.07 123.53 31.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.26 -40.1 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.351 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.7 1.69 28.32 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.687 -178.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.41 138.26 34.27 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.842 -1.387 . . . . 0.0 109.479 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 137' ' ' TYR . 77.1 mt -70.03 -28.75 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.824 . . . . 0.0 109.158 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.9 mmm -70.1 14.64 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.519 -0.738 . . . . 0.0 109.832 -178.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 135' ' ' LEU . 36.3 t80 -65.26 136.25 96.4 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.9 -43.9 54.86 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.023 1.149 . . . . 0.0 111.722 -179.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.7 p -82.37 162.07 22.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.736 -1.227 . . . . 0.0 110.419 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 141' ' ' THR . 67.8 t80 -88.29 129.72 35.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.768 -0.582 . . . . 0.0 109.844 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 140' ' ' TYR . 33.6 p -156.25 108.96 2.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 108.942 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.45 ' HB2' ' HE ' ' A' ' 114' ' ' ARG . 29.8 p90 -82.95 131.56 35.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 86.4 p -93.14 3.52 55.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 108.96 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.56 -31.08 3.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -121.54 129.97 53.23 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.12 106.55 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.07 -1.019 . . . . 0.0 110.012 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -140.6 150.46 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 72.1 mt -74.29 158.21 34.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 108.759 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.82 157.45 16.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.87 -40.04 87.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.286 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.57 -40.16 86.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -75.32 -40.19 58.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.87 -1.144 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.11 -49.86 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.221 -0.924 . . . . 0.0 109.549 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -59.92 -39.83 86.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.962 -1.086 . . . . 0.0 109.752 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.67 -56.71 22.73 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.174 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.3 -35.86 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.939 -1.33 . . . . 0.0 109.892 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 161' ' ' GLY . 3.2 mm-40 -67.65 -39.82 84.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.981 -1.075 . . . . 0.0 109.169 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.978 . . . . 0.0 110.117 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.01 -49.94 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.098 -1.001 . . . . 0.0 110.218 -179.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -96.82 -59.95 1.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.898 . . . . 0.0 109.415 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 143.6 173.29 15.01 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -84.92 150.65 24.8 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.21 -1.17 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.6 m -70.7 91.29 0.81 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -64.19 135.2 56.08 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.809 0.814 . . . . 0.0 110.312 -178.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 167' ' ' VAL . 34.7 m120 -154.68 93.81 2.79 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -62.3 43.72 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 121.497 1.464 . . . . 0.0 110.907 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 165' ' ' ASN . 10.5 p -88.56 148.23 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -79.74 149.97 71.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 120.992 -1.067 . . . . 0.0 109.716 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.326 -0.638 0 C-N-CA 120.879 1.053 . . . . 0.0 109.791 179.237 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.8 mt -70.05 139.85 52.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.104 -0.998 . . . . 0.0 109.725 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 56.2 p -94.67 165.49 12.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.373 -0.829 . . . . 0.0 109.49 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.75 134.38 47.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.086 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.89 -175.94 54.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ARG . 32.7 m120 -80.01 125.82 81.0 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.12 -1.224 . . . . 0.0 109.001 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.57 51.66 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 N-CA-C 109.672 -0.934 . . . . 0.0 109.672 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' ASN . 98.2 mtt180 -140.28 141.74 35.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.002 -1.061 . . . . 0.0 109.067 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -69.86 127.49 33.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.397 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 -11.93 58.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.501 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -87.55 144.77 26.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.474 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 63.7 p -90.64 -4.86 56.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.075 . . . . 0.0 108.67 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 50.4 m80 -123.57 137.57 54.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.16 161.46 34.35 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.1 p -129.34 151.96 49.42 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -146.07 152.94 40.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.8 ttt-85 -146.0 135.59 23.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 0.0 109.792 -179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.0 mt -88.63 120.46 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.9 mt-10 -69.0 -35.58 76.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.9 m-20 -158.24 166.38 32.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.016 -1.053 . . . . 0.0 110.009 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -114.9 139.25 49.94 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 t -73.6 131.76 81.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.123 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.98 -3.27 5.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.42 -39.91 94.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 109.494 179.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.7 mt -135.53 149.06 68.29 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 146.22 77.75 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.968 1.112 . . . . 0.0 109.68 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -62.21 -32.1 72.72 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.36 89.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 0.0 110.243 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -79.63 -28.67 40.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.921 -1.112 . . . . 0.0 110.097 -179.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.8 t -70.01 -41.75 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.948 -1.095 . . . . 0.0 109.23 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -57.39 -42.1 81.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 108.865 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.98 -46.33 89.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.388 -0.82 . . . . 0.0 109.679 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.6 84.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 0.0 109.907 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.81 -43.5 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.039 -1.038 . . . . 0.0 109.076 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.37 -40.13 89.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.21 -41.37 96.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.882 . . . . 0.0 110.736 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.75 74.92 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.959 -1.088 . . . . 0.0 110.674 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -60.27 -40.09 89.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.46 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -60.87 -40.44 93.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.964 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.19 -43.62 95.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.018 . . . . 0.0 110.182 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.64 -40.49 69.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 110.187 -178.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -69.18 -33.61 73.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.394 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -56.69 -32.96 65.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.283 -0.885 . . . . 0.0 110.367 -179.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 m -105.83 10.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.265 -0.897 . . . . 0.0 111.184 -178.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' LEU . 19.1 p -148.36 148.84 30.14 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 120.66 -1.275 . . . . 0.0 109.978 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -66.16 8.34 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.063 1.175 . . . . 0.0 109.554 178.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.8 mt -72.49 145.11 47.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 66.7 p -134.36 143.14 47.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.736 . . . . 0.0 109.137 179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.73 135.37 54.94 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 109.685 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.8 m -120.07 129.91 54.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.635 -0.666 . . . . 0.0 109.625 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -78.87 130.54 35.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.779 . . . . 0.0 108.936 179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 52' ' ' VAL . 35.5 m -123.75 128.97 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.397 -0.814 . . . . 0.0 108.953 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -93.27 -3.88 52.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.208 -0.932 . . . . 0.0 110.559 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -144.64 159.98 41.93 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.954 -1.091 . . . . 0.0 109.794 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.0 177.03 51.36 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.58 146.49 27.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -1.229 . . . . 0.0 109.083 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.96 149.25 33.52 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.73 -40.15 87.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.094 -1.004 . . . . 0.0 109.688 -179.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.5 mt -120.07 118.43 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.662 -0.649 . . . . 0.0 109.295 -179.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.8 mtp -102.3 127.66 49.19 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.303 -0.873 . . . . 0.0 110.009 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.62 130.61 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.6 p -149.09 158.32 44.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.972 -1.08 . . . . 0.0 110.489 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.4 130.98 55.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.65 166.35 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.1 -1.0 . . . . 0.0 110.92 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -125.3 146.71 49.43 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.548 0.69 . . . . 0.0 110.201 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.98 -144.64 1.18 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.002 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 65.0 t0 -66.21 134.83 53.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.975 . . . . 0.0 110.424 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.5 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 48.6 p-80 -137.29 57.98 1.73 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.581 -0.699 . . . . 0.0 109.163 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 69' ' ' ARG . 46.6 mtm-85 53.43 52.26 13.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 108.878 -179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.8 t0 -144.51 158.66 43.65 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 47.7 p-10 -92.13 9.33 33.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -0.996 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.7 m -134.71 67.35 70.9 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.333 -0.855 . . . . 0.0 110.231 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.18 153.12 78.17 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.592 1.528 . . . . 0.0 109.875 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -76.32 133.36 40.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.957 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -97.46 64.4 1.85 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.431 -0.793 . . . . 0.0 109.184 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 76.4 179.32 46.8 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.7 12.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.699 1.599 . . . . 0.0 110.703 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.64 169.97 21.72 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.82 -157.69 41.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.93 153.13 42.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -1.129 . . . . 0.0 109.668 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.73 -9.12 50.59 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.52 175.6 2.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -165.84 165.1 18.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.21 164.41 32.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.23 169.12 10.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.442 ' H ' ' CD ' ' A' ' 86' ' ' GLN . 27.0 mp0 -69.05 147.32 97.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.064 -1.023 . . . . 0.0 109.001 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.02 104.91 0.13 Allowed 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 120.943 1.096 . . . . 0.0 110.194 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.64 165.3 36.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -61.92 -169.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.447 1.431 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.66 -127.65 42.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 tt -80.21 -10.78 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -1.025 . . . . 0.0 109.938 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.73 140.63 47.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.36 38.44 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -64.49 141.66 58.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -1.034 . . . . 0.0 109.941 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.29 127.48 41.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.386 -0.822 . . . . 0.0 108.926 179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -107.91 136.01 48.33 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.43 -0.794 . . . . 0.0 109.75 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 42.4 m-85 -114.1 137.13 52.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.605 -0.684 . . . . 0.0 109.427 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -66.37 102.27 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.402 -0.812 . . . . 0.0 109.179 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -77.46 -8.25 57.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 110.358 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -79.29 -20.24 48.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.927 -1.108 . . . . 0.0 109.852 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.51 160.03 20.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.947 . . . . 0.0 109.647 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.4 ttm-85 -90.07 109.09 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -89.08 145.49 25.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.311 -0.868 . . . . 0.0 109.662 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 38.5 p -135.38 160.21 39.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.477 -0.765 . . . . 0.0 109.313 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -117.48 30.49 7.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.598 -0.689 . . . . 0.0 109.595 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.802 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -144.33 -153.78 0.49 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.023 -1.048 . . . . 0.0 110.123 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -80.0 9.49 5.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.198 -0.939 . . . . 0.0 110.676 -178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.607 ' CG ' HD21 ' A' ' 106' ' ' ASN . 14.7 mmm180 -57.66 -165.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 110.577 -179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.75 -59.68 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.604 -0.685 . . . . 0.0 112.718 -177.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 62.2 m-85 -121.85 134.79 54.88 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.119 -0.988 . . . . 0.0 111.341 -177.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -96.45 120.13 36.2 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.77 -39.99 86.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -178.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.03 -41.18 91.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.147 -0.97 . . . . 0.0 111.195 -178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -59.42 -44.87 92.79 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.837 -1.164 . . . . 0.0 110.09 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.3 -41.05 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.006 -1.059 . . . . 0.0 110.048 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.42 84.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 109.295 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.1 84.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.256 -0.902 . . . . 0.0 109.133 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -61.13 -50.59 72.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.12 -0.988 . . . . 0.0 109.735 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.511 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 39.9 mt-10 -61.87 -39.93 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.429 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.11 -35.65 80.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.271 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.34 94.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -68.51 -40.05 80.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -1.155 . . . . 0.0 109.4 179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.5 p -55.84 -30.43 61.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.462 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -82.22 -6.69 59.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.26 51.31 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.8 mt -78.36 150.44 33.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.931 -1.335 . . . . 0.0 108.75 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.7 m -103.95 166.84 10.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.86 . . . . 0.0 109.928 -179.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -66.18 173.1 3.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.428 -0.795 . . . . 0.0 109.328 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -153.42 159.37 42.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.2 p -98.27 7.58 46.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -83.49 114.37 21.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.081 -1.012 . . . . 0.0 109.403 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.27 -27.85 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.47 -0.769 . . . . 0.0 110.523 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.58 2.4 72.95 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.54 138.89 33.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -1.234 . . . . 0.0 109.478 179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 137' ' ' TYR . 90.7 mt -70.0 -29.5 66.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.1 mmm -73.0 21.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.797 . . . . 0.0 109.626 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.8 t80 -64.89 135.23 96.31 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.807 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -60.59 9.58 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.099 1.2 . . . . 0.0 111.675 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . 32.3 t -153.38 153.01 31.72 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -64.28 140.03 58.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.544 -0.723 . . . . 0.0 109.457 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 56.6 p -149.04 131.3 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.329 -0.857 . . . . 0.0 108.99 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -80.31 123.06 27.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.3 p -124.34 10.09 8.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.58 -0.7 . . . . 0.0 109.538 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.47 -110.0 2.93 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -74.22 157.89 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 109.734 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.4 t -99.08 114.63 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -139.66 152.78 47.02 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.24 157.94 34.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.876 -1.14 . . . . 0.0 109.03 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.57 159.84 15.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 109.358 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -59.99 -39.56 86.15 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 109.558 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.48 -39.87 85.16 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.232 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -75.91 -40.12 54.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 109.704 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.07 -47.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.31 -39.63 87.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.092 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.84 -51.49 40.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.837 -179.154 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.39 -30.04 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.776 -1.426 . . . . 0.0 109.171 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 161' ' ' GLY . 63.9 mm-40 -67.96 -41.04 83.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.928 . . . . 0.0 109.168 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.91 92.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.194 -0.941 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -69.8 -43.45 79.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.0 110.403 -179.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.49 ' CE1' HD21 ' A' ' 47' ' ' LEU . 80.8 m-85 -107.8 -64.44 1.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 135.88 -166.79 24.53 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 162' ' ' ARG . 53.2 mtt-85 -87.56 144.25 26.79 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -1.058 . . . . 0.0 110.104 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 6.0 m -72.97 84.41 1.26 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 98.7 mt-30 -71.02 135.9 48.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 -179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.824 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 5.7 m-80 -152.73 -34.84 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 0.0 113.322 -179.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.824 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 2.6 Cg_endo -68.2 76.59 0.67 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 N-CA-C 109.415 -1.033 . . . . 0.0 109.415 -178.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 61.5 t -90.84 120.03 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 109.804 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.65 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 11.4 mt-30 -104.25 -32.01 0.21 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.395 -0.816 . . . . 0.0 112.269 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 2.3 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 118.012 -0.912 . . . . 0.0 109.91 -179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.661 ' C ' HD13 ' A' ' 2' ' ' LEU . 3.1 tm? -62.02 -40.9 97.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.135 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.7 p -97.09 123.87 40.95 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.4 127.19 32.41 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.056 . . . . 0.0 108.394 178.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.87 -126.52 17.73 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -79.14 150.71 74.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.17 -1.194 . . . . 0.0 108.292 179.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.37 99.53 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -144.6 148.88 34.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.213 -0.929 . . . . 0.0 109.089 -179.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -69.05 132.02 45.96 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.29 -0.881 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.82 -33.85 66.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.825 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -82.42 145.06 30.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.053 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.3 p -90.2 -4.48 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.57 135.09 55.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.5 mt -134.57 163.56 29.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.295 -0.878 . . . . 0.0 109.862 -179.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.6 p -126.92 165.48 19.32 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -145.22 158.21 43.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.118 -0.989 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -143.54 130.81 20.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.549 -0.719 . . . . 0.0 109.989 -178.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.8 mt -91.77 118.43 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 20' ' ' ASN . 96.9 mt-10 -69.62 -40.03 76.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.977 -1.077 . . . . 0.0 110.855 -179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 64.3 m-80 -160.22 161.62 33.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 109.721 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -106.7 133.32 51.54 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.566 -0.709 . . . . 0.0 109.157 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 t -70.14 132.0 88.47 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.955 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -64.27 -0.25 2.72 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.14 -39.84 95.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 108.963 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 mt -137.92 150.08 66.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -57.96 156.34 29.21 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 120.877 1.051 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -68.32 -30.76 69.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 0.0 110.091 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.27 -40.0 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.08 -31.28 50.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.18 -41.7 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.098 -1.001 . . . . 0.0 108.937 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.39 -43.74 92.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.151 -0.968 . . . . 0.0 108.991 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -61.61 -45.1 95.51 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 109.329 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.4 73.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.453 -0.779 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.6 mm -69.95 -42.77 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.159 -0.963 . . . . 0.0 109.518 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.39 -43.19 96.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.087 -1.008 . . . . 0.0 110.052 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.82 -40.05 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.447 -179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.93 -52.17 65.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.912 -1.118 . . . . 0.0 110.599 -178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -59.46 -40.06 85.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.781 -1.199 . . . . 0.0 110.34 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.13 -40.84 91.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.852 -1.155 . . . . 0.0 109.838 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.86 -40.72 94.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.961 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -72.2 -40.57 67.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.996 -1.065 . . . . 0.0 110.031 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 t -69.43 -29.43 67.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.21 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.07 -37.85 78.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' THR . 5.9 m -109.23 20.58 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.304 -0.872 . . . . 0.0 110.679 -179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 HG23 HG23 ' A' ' 44' ' ' VAL . 69.3 p -147.78 145.87 22.48 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.613 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.8 3.56 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.118 1.212 . . . . 0.0 109.909 178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.7 mt -74.77 150.79 39.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.994 -1.066 . . . . 0.0 109.444 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 p -129.18 141.66 51.09 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.37 -0.831 . . . . 0.0 109.171 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -123.24 131.0 53.52 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.459 -0.776 . . . . 0.0 109.648 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.1 m -126.46 135.42 51.34 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.554 -0.716 . . . . 0.0 110.051 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -79.26 138.89 37.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -118.48 132.14 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 121.196 -0.94 . . . . 0.0 109.191 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -90.5 -5.36 56.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -147.35 156.09 42.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.0 109.577 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.11 164.18 31.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLN . 25.7 mp0 -84.34 143.42 29.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.284 -1.127 . . . . 0.0 108.995 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.81 158.1 16.75 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.02 -40.0 87.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.867 . . . . 0.0 109.797 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -114.49 116.38 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.397 -0.814 . . . . 0.0 109.567 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.5 mtp -105.82 134.25 49.25 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.396 -0.815 . . . . 0.0 110.323 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.47 131.47 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.8 p -148.07 160.58 42.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.954 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.12 139.01 50.26 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.26 172.64 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.209 -0.932 . . . . 0.0 110.544 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -128.25 137.56 52.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.579 -0.701 . . . . 0.0 110.224 -179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.96 -141.16 15.54 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.358 -0.839 . . . . 0.0 111.261 178.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 62.7 t0 -67.96 134.49 50.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.62 -0.93 . . . . 0.0 110.298 -179.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.4 p-80 -129.16 41.2 3.51 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 69' ' ' ARG . 48.0 mtt-85 55.92 56.69 5.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.09 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.531 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 15.7 p-10 -140.97 178.33 7.44 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -92.63 8.34 39.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.024 -1.047 . . . . 0.0 109.394 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -136.0 68.84 64.12 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.426 -0.796 . . . . 0.0 110.125 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.77 143.69 56.71 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.408 1.405 . . . . 0.0 109.409 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -75.8 142.25 42.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.959 -1.088 . . . . 0.0 108.968 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -116.0 74.65 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.454 -0.779 . . . . 0.0 109.352 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 79.62 -177.67 54.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.03 0.36 2.16 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.375 1.383 . . . . 0.0 109.137 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -101.55 -175.4 28.47 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.39 -159.28 46.51 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -72.1 146.73 47.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -1.13 . . . . 0.0 109.633 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.8 mt -95.31 -9.13 33.89 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.725 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.03 171.37 3.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 109.19 -179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -167.54 169.16 12.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.26 163.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 109.199 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.79 163.44 13.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 0.0 109.014 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -69.06 150.34 97.54 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.107 -0.996 . . . . 0.0 109.038 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.89 110.79 0.61 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.961 1.107 . . . . 0.0 110.133 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.76 165.97 39.18 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 -177.57 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.285 1.323 . . . . 0.0 109.541 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.07 -133.38 39.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.65 -7.75 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -1.078 . . . . 0.0 109.772 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.84 142.66 34.15 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.478 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.93 -21.89 10.58 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.403 -1.057 . . . . 0.0 110.575 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.5 130.17 43.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.02 -1.282 . . . . 0.0 110.531 -179.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.22 123.78 45.88 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.468 -0.77 . . . . 0.0 109.099 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -110.69 132.1 54.48 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -116.03 136.17 53.28 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.656 -0.652 . . . . 0.0 109.69 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -69.0 112.65 5.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.723 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -77.96 -9.86 59.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 109.935 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.18 -19.43 58.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.997 -1.065 . . . . 0.0 109.714 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -82.99 151.16 25.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -90.35 111.16 22.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.061 -1.025 . . . . 0.0 108.703 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -88.72 145.45 25.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.409 -0.807 . . . . 0.0 110.557 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.1 p -135.64 167.23 21.5 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -109.92 23.79 13.89 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.445 -0.784 . . . . 0.0 109.713 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.771 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.27 -163.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.992 -1.067 . . . . 0.0 110.106 -179.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -70.15 -7.04 38.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.253 -0.904 . . . . 0.0 111.553 -178.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.512 ' O ' ' C ' ' A' ' 109' ' ' GLU . 52.2 mtt-85 -60.51 -171.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.756 -1.215 . . . . 0.0 110.123 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 108' ' ' ARG . 80.0 mm-40 -3.33 -94.81 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 151.74 51.26 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.404 -0.81 . . . . 0.0 109.9 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HH ' ' A' ' 140' ' ' TYR . 2.7 p30 -98.03 115.41 28.16 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.57 -39.97 85.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.452 -0.78 . . . . 0.0 110.632 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -58.68 -44.37 90.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.956 -1.09 . . . . 0.0 110.346 -178.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.7 ttt-85 -60.05 -45.47 92.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.673 -1.267 . . . . 0.0 109.78 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.27 -40.16 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 109.503 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.77 81.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 108.873 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.62 86.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.1 -49.15 78.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.017 179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -63.09 -39.92 96.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 109.159 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -64.32 -39.79 94.61 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.435 -0.79 . . . . 0.0 108.915 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.75 -42.16 77.46 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -67.98 -40.02 83.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -1.214 . . . . 0.0 109.347 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.2 p -61.27 -23.09 65.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.139 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.48 -5.44 59.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.187 -0.946 . . . . 0.0 109.441 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.86 9.0 61.45 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.01 149.27 35.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.271 . . . . 0.0 108.735 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.4 m -108.68 165.89 11.21 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.406 -0.809 . . . . 0.0 109.996 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.14 169.29 2.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.535 -0.728 . . . . 0.0 109.465 -179.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.1 t -150.0 160.89 43.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 109.166 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.0 p -95.58 9.93 38.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.334 -0.854 . . . . 0.0 109.609 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -82.58 113.94 20.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.0 tt -59.44 -30.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.053 -1.03 . . . . 0.0 109.477 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.08 3.46 51.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.88 138.81 35.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.05 -1.265 . . . . 0.0 109.463 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.95 -25.11 63.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.8 mmm -73.68 13.93 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.456 -0.777 . . . . 0.0 109.821 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -66.05 137.08 95.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 108.625 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -41.03 56.13 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.01 1.14 . . . . 0.0 111.571 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.8 m -84.25 137.72 33.32 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.641 -1.287 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 111' ' ' ASN . 50.9 t80 -78.2 134.75 37.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -149.24 134.16 17.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.255 -0.903 . . . . 0.0 109.02 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -77.98 129.85 35.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.727 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.1 m -110.48 149.75 29.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.643 -0.661 . . . . 0.0 109.56 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.2 -45.43 96.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -125.28 133.59 52.59 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.548 -0.972 . . . . 0.0 109.002 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.62 107.67 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.156 -0.965 . . . . 0.0 109.348 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -143.71 168.73 19.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.63 151.41 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.171 -0.955 . . . . 0.0 108.95 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.13 162.52 12.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.4 -0.812 . . . . 0.0 109.347 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.72 -39.89 86.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.183 -0.948 . . . . 0.0 108.905 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.88 -39.99 87.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.26 -43.17 52.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.052 -1.03 . . . . 0.0 110.015 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.43 -50.21 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 0.0 109.802 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.0 -39.86 96.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.204 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.24 -50.15 58.01 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.422 -178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -69.93 -37.26 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.851 -1.382 . . . . 0.0 109.896 -179.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.2 mt-30 -68.75 -39.98 80.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.003 -1.06 . . . . 0.0 109.996 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.78 94.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.896 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.73 -48.76 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.563 -179.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.81 -67.8 0.83 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 109.341 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 153.1 -167.62 31.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -85.64 160.39 19.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 109.431 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.4 m -75.02 58.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.447 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -72.71 136.77 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.356 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -150.63 69.42 8.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 110.057 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.39 143.99 78.39 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.502 1.468 . . . . 0.0 109.44 179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.1 t -89.99 122.09 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 0.0 110.053 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -82.82 150.12 61.44 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.376 -0.827 . . . . 0.0 108.899 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 C--N 1.325 -0.678 0 C-N-CA 120.803 1.002 . . . . 0.0 109.885 179.736 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.74 140.11 58.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 p -90.79 -151.07 0.24 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.239 -0.913 . . . . 0.0 109.324 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' C ' ' H ' ' A' ' 6' ' ' ASN . 82.0 tt0 -65.15 153.77 39.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.11 29.71 0.06 OUTLIER Glycine 0 N--CA 1.497 2.707 0 C-N-CA 120.519 -0.848 . . . . 0.0 110.982 -179.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 4' ' ' GLU . 9.4 m120 -155.41 65.42 4.41 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.973 -1.31 . . . . 0.0 108.965 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -64.66 128.58 21.41 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 C-N-CA 121.351 1.368 . . . . 0.0 109.871 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 6' ' ' ASN . 44.7 mtm-85 -145.24 150.07 36.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.275 -0.891 . . . . 0.0 108.917 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -67.89 127.45 32.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.964 -1.085 . . . . 0.0 109.455 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 55.4 mp0 -85.23 -12.23 53.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.224 -0.923 . . . . 0.0 110.065 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -87.45 148.43 24.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.13 -0.981 . . . . 0.0 110.468 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.2 p -90.87 -4.65 56.41 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 109.019 179.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -125.61 143.25 51.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -136.57 161.74 35.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 p -129.38 156.76 43.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.495 -0.753 . . . . 0.0 109.098 -179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 35' ' ' GLU . 54.0 p90 -147.14 155.11 41.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -146.18 132.43 19.47 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 0.0 110.013 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 ' OH ' ' A' ' 21' ' ' TYR . 91.0 mt -90.49 122.26 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 108.497 178.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.38 -39.92 89.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.549 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -164.19 162.64 22.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 110.236 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.466 ' OH ' HD12 ' A' ' 18' ' ' ILE . 88.1 m-85 -110.82 136.95 49.1 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.697 -0.627 . . . . 0.0 109.327 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 22' ' ' THR . 2.0 t -78.67 139.29 58.43 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.058 -1.026 . . . . 0.0 108.961 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -64.32 -0.4 2.85 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 120.754 0.969 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' OD2' ' OE2' ' A' ' 99' ' ' GLU . 90.3 m-20 -62.98 -40.09 96.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.1 mt -138.23 149.85 64.85 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.87 152.77 67.96 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 N-CA-C 109.207 -1.113 . . . . 0.0 109.207 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -68.96 -29.0 67.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.769 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.95 82.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.406 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.95 -40.02 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.858 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.2 -44.49 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -58.7 -46.3 87.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 108.862 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -60.44 -43.25 97.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.32 -47.13 86.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.99 -46.54 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' OH ' ' A' ' 16' ' ' TYR . 50.3 tp10 -60.07 -42.11 93.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.35 -39.97 92.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.187 -0.945 . . . . 0.0 109.987 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.91 84.09 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 109.497 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.088 -1.007 . . . . 0.0 109.689 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 27.6 mt-30 -62.04 -40.67 96.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.023 . . . . 0.0 109.922 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.29 -40.88 92.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.06 -1.025 . . . . 0.0 109.804 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.3 m95 -70.58 -41.06 72.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 0.0 109.577 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -70.03 -39.58 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 110.023 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 20.7 m120 -50.37 -30.0 11.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.468 -0.77 . . . . 0.0 110.812 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 m -108.93 8.36 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.142 -0.973 . . . . 0.0 110.587 -179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 47' ' ' LEU . 20.7 p -149.78 151.18 32.17 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.725 -1.234 . . . . 0.0 109.488 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.94 10.33 0.31 Allowed 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.059 1.172 . . . . 0.0 109.782 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 45' ' ' THR . 98.2 mt -74.29 144.9 44.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.081 -1.012 . . . . 0.0 109.778 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.1 p -130.48 151.04 51.39 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.1 128.75 42.48 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -122.23 129.95 52.72 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.457 0.646 . . . . 0.0 109.623 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -77.85 142.08 38.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 108.959 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.0 134.02 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.33 -0.856 . . . . 0.0 109.773 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 t -91.83 0.0 57.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 110.001 -179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 1.6 pm0 -150.6 161.04 43.34 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.93 -1.106 . . . . 0.0 110.255 -179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.5 171.22 9.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -81.76 149.97 28.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 108.922 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.04 161.39 15.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.724 . . . . 0.0 109.287 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -59.32 -40.08 85.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 108.888 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.84 118.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.589 -0.695 . . . . 0.0 109.297 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.3 mmm -98.84 134.22 42.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.144 -0.972 . . . . 0.0 109.218 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.65 129.29 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.605 -0.685 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 p -149.96 159.05 44.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' OE1' ' A' ' 99' ' ' GLU . 84.8 m-85 -110.46 130.55 55.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.78 162.56 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.329 -0.857 . . . . 0.0 110.837 -178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -125.36 149.34 48.22 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.497 0.665 . . . . 0.0 109.995 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 43.81 -154.2 0.3 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.5 t0 -60.64 134.31 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.592 -0.946 . . . . 0.0 110.123 -179.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 70' ' ' ASP . 27.4 p-80 -138.93 53.28 1.76 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.552 -0.718 . . . . 0.0 109.598 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 69' ' ' ARG . 47.9 mtt-85 56.92 50.46 12.24 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.455 -0.778 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CG ' ' CE1' ' A' ' 68' ' ' HIS . 12.4 p-10 -140.0 161.51 37.43 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.206 -0.934 . . . . 0.0 109.276 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -89.77 8.89 29.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.6 m -135.39 69.21 68.24 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.409 -0.807 . . . . 0.0 109.885 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.28 148.75 91.04 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.431 1.42 . . . . 0.0 109.369 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -75.95 135.18 40.06 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 109.861 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -103.69 62.99 0.77 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.581 -0.7 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.14 -169.06 53.74 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.28 -1.19 5.09 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.569 1.513 . . . . 0.0 110.102 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -100.15 -179.35 30.13 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.29 -159.03 49.9 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -70.33 145.1 51.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -1.053 . . . . 0.0 109.61 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.04 -6.87 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.303 -0.873 . . . . 0.0 109.626 -179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . . . -175.77 177.67 1.66 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.388 -0.82 . . . . 0.0 108.95 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -168.4 163.45 12.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.17 162.57 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 108.982 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -95.94 152.65 18.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.258 -0.901 . . . . 0.0 109.679 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -60.27 148.73 78.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 108.92 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.06 113.56 1.49 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 121.092 1.195 . . . . 0.0 110.609 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.3 41.96 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -65.1 172.8 6.84 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.394 1.396 . . . . 0.0 109.718 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.72 -125.43 19.81 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.799 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.3 tt -81.69 -3.9 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.508 -0.995 . . . . 0.0 110.754 -178.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.28 141.41 45.79 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.047 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.35 -15.62 59.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.21 154.82 38.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.114 -1.227 . . . . 0.0 110.066 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.55 117.35 11.01 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -103.85 141.83 35.44 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.372 -0.83 . . . . 0.0 110.287 -179.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.537 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 63.7 m-85 -114.98 140.0 49.39 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.661 -0.649 . . . . 0.0 109.44 179.64 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -69.92 102.71 2.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 110.117 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.454 ' OE1' ' CD2' ' A' ' 63' ' ' PHE . 14.1 tp10 -78.45 -2.06 36.66 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.977 . . . . 0.0 109.772 179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.51 -37.01 65.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.702 -1.249 . . . . 0.0 108.844 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -83.0 160.46 21.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 108.976 179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -89.3 117.8 28.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -89.19 147.41 24.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.126 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 68.5 p -132.56 162.04 32.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.519 -0.738 . . . . 0.0 109.533 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.03 31.05 6.33 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -147.73 -162.55 1.57 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.213 -0.93 . . . . 0.0 110.237 -178.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 108' ' ' ARG . 59.2 m-85 -79.42 11.33 3.06 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.311 -0.868 . . . . 0.0 110.347 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 107' ' ' PHE . 98.4 mtt180 -57.35 -161.3 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.107 -0.995 . . . . 0.0 110.661 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -46.67 -59.95 2.7 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -0.81 . . . . 0.0 111.833 -177.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.7 m-85 -125.85 137.94 53.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.093 -1.004 . . . . 0.0 110.604 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -94.47 116.11 28.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.445 -0.784 . . . . 0.0 108.99 179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.95 -47.13 87.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 110.651 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -59.94 -41.93 92.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.052 -1.03 . . . . 0.0 110.962 -178.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.404 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 43.7 ttt-85 -60.05 -45.21 93.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.795 -1.191 . . . . 0.0 110.066 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.16 -40.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 109.517 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.31 -46.92 79.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 0.0 109.159 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.32 90.03 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.149 -0.97 . . . . 0.0 108.755 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.448 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 74.0 t60 -60.02 -47.54 85.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.411 -0.805 . . . . 0.0 109.015 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.1 mt-10 -61.92 -40.16 94.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 179.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 82.8 mt -65.72 -39.78 91.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 108.905 179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -52.67 -42.41 58.56 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.469 ' CE1' ' NE2' ' A' ' 128' ' ' HIS . 73.9 m-70 -67.27 -39.9 86.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.53 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 p -59.9 -27.27 66.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 108.656 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.56 -2.77 56.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 109.002 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.59 10.92 72.35 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.62 146.31 40.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.928 -1.337 . . . . 0.0 108.98 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.9 m -103.08 169.63 8.44 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.41 -0.806 . . . . 0.0 109.331 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.469 ' NE2' ' CE1' ' A' ' 122' ' ' HIS . 32.5 m170 -67.14 177.56 1.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 109.761 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.3 t -153.13 161.42 42.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.527 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.8 p -96.81 10.21 39.54 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -0.773 . . . . 0.0 109.666 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -85.4 120.0 26.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 109.913 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.8 mt -60.03 -40.25 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 110.539 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.83 7.97 12.91 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.289 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.06 138.53 36.03 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.886 -1.361 . . . . 0.0 109.651 179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 137' ' ' TYR . 74.6 mt -69.97 -29.68 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.108 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.448 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 98.6 mmm -70.66 20.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.12 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 135' ' ' LEU . 20.2 t80 -64.58 137.3 97.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.954 -1.091 . . . . 0.0 108.061 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.41 -55.21 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 120.968 1.112 . . . . 0.0 111.073 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -82.43 156.84 23.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.068 -1.02 . . . . 0.0 110.565 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -70.03 150.23 46.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.0 p -143.4 143.22 31.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.984 -1.073 . . . . 0.0 109.358 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -80.22 131.32 35.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.816 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.1 p -147.42 144.79 28.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 109.199 179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.2 -105.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.16 162.96 25.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 109.88 -179.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.02 116.26 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.295 -0.878 . . . . 0.0 108.805 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.29 154.19 49.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.406 -0.809 . . . . 0.0 109.487 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.91 158.47 29.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.861 . . . . 0.0 109.528 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.73 162.16 13.78 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.89 -40.03 87.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.75 -40.07 86.93 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.351 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.46 -40.46 61.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 110.012 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.18 -50.04 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 109.918 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.99 -39.9 91.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.002 -1.061 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.17 -52.01 52.76 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.333 -178.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -69.83 -39.89 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.739 -1.448 . . . . 0.0 109.522 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.5 mt-30 -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.035 . . . . 0.0 109.143 179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.02 88.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 108.819 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 80.8 mt -64.75 -51.34 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.454 -0.779 . . . . 0.0 109.671 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -96.02 -69.16 0.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.926 . . . . 0.0 109.189 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.84 -171.31 36.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.475 ' NH1' ' CB ' ' A' ' 162' ' ' ARG . 11.0 mtp-105 -88.82 148.39 23.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -1.16 . . . . 0.0 109.783 179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 m -79.0 83.85 5.06 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.044 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.51 135.78 44.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 109.721 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -155.58 69.94 5.35 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.117 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.34 84.28 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.345 1.363 . . . . 0.0 109.254 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.96 140.06 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.957 -1.089 . . . . 0.0 109.855 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.05 148.34 63.84 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--N 1.322 -0.835 0 C-N-CA 120.904 1.07 . . . . 0.0 109.633 179.415 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.5 mp -68.82 -28.33 66.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.189 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.5 p -91.19 158.8 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -0.837 . . . . 0.0 109.567 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.97 139.71 52.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.136 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.99 -157.02 53.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -77.54 148.65 77.17 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 0.0 108.55 179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.72 140.8 96.52 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.941 1.094 . . . . 0.0 109.855 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 8' ' ' ARG . 56.4 mtt-85 -86.87 166.89 14.82 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -66.48 122.32 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.797 -1.19 . . . . 0.0 108.843 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.37 -36.31 68.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.922 -179.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 13' ' ' HIS . 15.4 pt20 -82.88 150.18 26.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -90.01 -3.26 58.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.237 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.517 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 82.9 m-70 -115.52 135.67 53.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.672 -0.642 . . . . 0.0 109.268 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.4 mt -130.21 160.29 34.29 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.9 p -128.33 155.16 45.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -144.92 154.75 42.93 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.05 -1.031 . . . . 0.0 110.076 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -145.14 137.25 25.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.822 . . . . 0.0 109.695 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.74 120.06 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -67.6 -40.01 84.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.354 -179.075 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -164.81 162.62 21.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.897 -1.127 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -106.81 135.93 47.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.591 -0.693 . . . . 0.0 109.184 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -79.1 142.62 59.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 108.81 179.528 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.38 2.24 1.28 Allowed 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 120.775 0.983 . . . . 0.0 109.573 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 22' ' ' THR . 76.7 m-20 -62.65 -40.06 95.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.309 -0.87 . . . . 0.0 109.533 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD13 HD21 ' A' ' 105' ' ' ASN . 51.6 mt -142.31 150.17 54.11 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.58 146.31 76.31 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.537 -0.986 . . . . 0.0 109.537 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -60.18 -32.76 71.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.29 88.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -0.872 . . . . 0.0 110.403 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.25 -27.86 38.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.0 110.016 -179.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.15 -40.71 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.985 . . . . 0.0 108.957 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.94 -41.9 92.85 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 109.234 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.11 -47.61 85.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.553 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.51 77.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.963 -179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -70.02 -42.84 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.204 -0.935 . . . . 0.0 109.58 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.14 -40.62 90.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.89 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -64.55 -40.48 95.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 111.022 -178.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.72 72.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 110.757 -178.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -59.88 -40.07 87.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.995 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -63.21 -40.1 96.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.55 -41.52 94.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.079 -1.013 . . . . 0.0 110.654 -179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 90.2 m95 -71.44 -41.87 68.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.995 -1.066 . . . . 0.0 110.39 -178.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.3 -36.44 77.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 109.906 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -54.35 -30.04 50.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.408 -0.808 . . . . 0.0 111.044 -179.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -109.91 10.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.03 -1.043 . . . . 0.0 111.063 -178.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 16.0 p -144.19 149.97 46.99 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 120.817 -1.177 . . . . 0.0 109.113 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.95 8.07 0.9 Allowed 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 121.178 1.252 . . . . 0.0 109.685 179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.3 mt -74.19 148.27 41.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -128.45 143.15 50.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.9 127.15 46.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.455 -0.778 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.2 m -119.97 129.97 54.55 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.449 0.642 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -77.74 139.51 39.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.278 -0.889 . . . . 0.0 109.098 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . 34.5 m -121.71 129.98 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.387 -0.821 . . . . 0.0 109.154 179.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.0 t -90.28 -3.23 57.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -153.23 158.93 42.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.494 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.21 173.5 48.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -83.36 143.09 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.23 154.63 23.13 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.03 -39.93 87.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.682 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.4 mt -119.54 119.96 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.336 -0.853 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtp -101.81 128.73 48.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -110.03 129.62 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.7 p -148.32 158.68 44.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.014 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -112.13 132.11 55.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.75 160.68 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.305 -0.872 . . . . 0.0 110.978 -178.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 43.0 mtm-85 -122.98 138.54 54.66 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.05 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.13 -144.48 4.95 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.63 130.28 41.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.595 -0.944 . . . . 0.0 110.137 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.52 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.9 p-80 -136.1 65.5 1.53 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 109.733 179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 69' ' ' ARG . 38.6 mtt-85 56.52 46.41 20.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.655 -0.653 . . . . 0.0 109.849 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.1 m-20 -141.73 156.37 45.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.435 -0.791 . . . . 0.0 109.259 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.62 9.76 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.0 m -132.67 68.63 79.29 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.481 -0.762 . . . . 0.0 110.505 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -65.56 153.39 78.4 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.492 1.462 . . . . 0.0 109.345 178.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -74.76 144.5 43.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 109.373 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -101.42 66.25 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.306 -0.871 . . . . 0.0 109.643 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 71.23 -170.66 47.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -61.73 0.64 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 121.233 1.289 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -100.01 171.65 23.79 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -165.54 38.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -70.1 150.2 46.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -1.116 . . . . 0.0 109.383 -179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.6 mt -90.04 -7.99 52.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -175.48 177.47 1.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -167.81 169.2 11.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.76 169.56 20.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -96.48 160.2 14.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -64.52 148.99 96.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.04 110.51 0.6 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 121.065 1.177 . . . . 0.0 110.098 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.2 169.59 42.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -63.99 178.31 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.448 1.432 . . . . 0.0 109.729 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.93 -128.27 28.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -79.74 -8.21 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.62 -0.929 . . . . 0.0 110.256 -178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.84 139.21 46.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.69 -17.73 50.93 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -66.41 127.73 33.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.915 -1.344 . . . . 0.0 109.885 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.07 128.39 54.63 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.456 -0.777 . . . . 0.0 109.875 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -111.07 130.81 55.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 60.7 m-85 -108.54 133.56 52.51 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.335 -0.853 . . . . 0.0 109.71 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -68.17 101.14 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -0.963 . . . . 0.0 108.975 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -75.15 -0.72 20.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.419 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.89 -35.39 62.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 55.4 mp0 -83.01 162.17 21.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 109.761 -179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 102' ' ' ARG . 24.8 ttt-85 -86.46 126.72 34.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.27 -0.893 . . . . 0.0 109.153 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.26 136.15 34.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.017 -179.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 50.3 p -129.72 164.63 23.56 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 25' ' ' LEU . 80.7 m-20 -112.17 26.45 10.58 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.517 -0.739 . . . . 0.0 109.419 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -146.1 -163.26 1.7 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.148 -0.97 . . . . 0.0 110.283 -179.273 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 108' ' ' ARG . 45.3 p90 -74.91 11.4 1.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.833 . . . . 0.0 111.0 -178.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.546 ' CG ' HD21 ' A' ' 106' ' ' ASN . 28.4 mmt180 -58.31 -157.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.936 -1.102 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.07 -59.99 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.974 . . . . 0.0 110.766 -178.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 73.1 m-85 -136.66 137.14 39.72 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -92.03 116.22 28.74 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.84 -40.9 90.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 -178.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -59.98 -46.51 89.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 110.926 -178.624 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 57.5 mtt-85 -59.95 -43.53 94.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.199 . . . . 0.0 110.24 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.1 -40.5 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.077 -1.014 . . . . 0.0 109.841 -179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.86 83.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.68 89.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.415 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 84.9 t60 -59.97 -44.84 94.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.383 -0.823 . . . . 0.0 109.737 -179.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 88.8 mt-10 -60.44 -39.94 89.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.995 . . . . 0.0 109.578 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.58 -39.91 92.86 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.16 -43.25 83.72 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -64.98 -40.02 94.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -1.187 . . . . 0.0 108.731 179.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 54.3 p -61.88 -34.06 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.03 -2.02 54.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.098 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.12 10.69 74.38 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.298 -0.953 . . . . 0.0 110.86 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.92 142.08 40.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.744 -1.445 . . . . 0.0 109.233 179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 128' ' ' HIS . 58.1 m -107.8 159.44 16.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.419 -0.8 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 127' ' ' SER . 36.5 m170 -50.19 176.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.3 t -152.73 164.74 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.0 109.721 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.6 p -93.28 0.44 57.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.338 -0.851 . . . . 0.0 109.687 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -82.03 118.27 22.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.19 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.01 -39.98 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.9 3.75 3.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.387 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.66 137.33 33.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.969 -1.313 . . . . 0.0 109.091 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 137' ' ' TYR . 92.1 mt -67.5 -34.51 77.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.415 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 42.7 mtp -72.32 22.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.427 -0.795 . . . . 0.0 110.465 -179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.5 t80 -61.76 136.74 94.94 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.93 -50.28 14.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.016 1.144 . . . . 0.0 111.222 -178.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.8 m -83.2 145.82 28.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.009 -1.057 . . . . 0.0 110.45 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -78.84 132.44 36.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.5 p -151.93 144.89 24.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.968 -1.083 . . . . 0.0 109.777 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -79.01 124.4 28.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.442 -0.786 . . . . 0.0 108.929 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 97.4 p -114.24 20.05 15.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.495 -0.753 . . . . 0.0 110.211 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 77.04 -117.23 4.78 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.0 t0 -79.99 162.34 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.166 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.519 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 61.1 t -97.19 112.77 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.278 -0.889 . . . . 0.0 109.688 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -138.31 152.47 48.53 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.9 mt -76.27 158.24 31.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.437 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -107.49 149.12 28.32 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -53.1 -38.17 62.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.156 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -56.96 -39.96 75.58 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.157 -0.964 . . . . 0.0 108.426 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -75.57 -40.03 57.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.7 mm -60.12 -49.98 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.072 -1.017 . . . . 0.0 108.951 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.42 -39.98 89.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.897 . . . . 0.0 110.604 -179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.71 -49.22 51.09 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.664 -178.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 156' ' ' ILE . 10.6 tp -69.05 -37.58 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.753 -1.44 . . . . 0.0 109.497 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -66.91 -37.96 85.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 108.856 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.03 -47.87 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 109.999 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.59 -64.76 1.04 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.24 -0.913 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.26 -172.11 39.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -94.66 136.99 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -1.122 . . . . 0.0 109.685 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 165' ' ' ASN . 10.9 m -79.11 82.05 5.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 0.0 108.865 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -77.36 33.19 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.078 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 163' ' ' SER . 66.7 m-80 -157.1 73.46 4.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.058 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.23 88.09 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.136 1.224 . . . . 0.0 109.277 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.74 145.51 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 -179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -80.0 147.31 65.49 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 108.701 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--N 1.324 -0.757 0 C-N-CA 120.906 1.071 . . . . 0.0 109.804 179.511 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_